#BioGRID Chemical Interaction ID	BioGRID Gene ID	Entrez Gene ID	Systematic Name	Official Symbol	Synonyms	Organism ID	Organism	Action	Interaction Type	Author	Pubmed ID	BioGRID Publication ID	BioGRID Chemical ID	Chemical Name	Chemical Synonyms	Chemical Brands	Chemical Source	Chemical Source ID	Molecular Formula	Chemical Type	ATC Codes	CAS Number	Curated By	Method	Method Description	Related BioGRID Gene ID	Related Entrez Gene ID	Related Systematic Name	Related Official Symbol	Related Synonyms	Related Organism ID	Related Organism	Related Type	Notes	InChIKey
21	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2	Cetuximab	Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum	erbitux	DRUGBANK	DB00002	C6484H10042N1732O2023S36	biologic	L01XC06	205923-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
22	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2	Cetuximab	Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum	erbitux	DRUGBANK	DB00002	C6484H10042N1732O2023S36	biologic	L01XC06	205923-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
58	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	5	Etanercept	p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor	enbrel|brenzys	DRUGBANK	DB00005	C2224H3475N621O698S36	biologic	L04AB01	185243-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
59	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	5	Etanercept	p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor	enbrel|brenzys	DRUGBANK	DB00005	C2224H3475N621O698S36	biologic	L04AB01	185243-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
130	112645	6768	-	ST14	ARCI11|HAI|MT-SP1|MTSP1|PRSS14|SNC19|TADG15|TMPRSS14	9606	Homo sapiens	unknown	target	Kirchhofer D (2003)	12815039	171795	13	Urokinase	uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator	kinlytic (urokinase for inject	DRUGBANK	DB00013	C1376H2145N383O406S18	biologic	B01AD04	9039-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
131	112645	6768	-	ST14	ARCI11|HAI|MT-SP1|MTSP1|PRSS14|SNC19|TADG15|TMPRSS14	9606	Homo sapiens	unknown	target	Suzuki M (2004)	14747469	171794	13	Urokinase	uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator	kinlytic (urokinase for inject	DRUGBANK	DB00013	C1376H2145N383O406S18	biologic	B01AD04	9039-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
218	111544	5553	-	PRG2	BMPG|MBP|MBP1	9606	Homo sapiens	unknown	target	Letuve S (2006)	16522458	171845	20	Sargramostim	GM-CSF	leukine	DRUGBANK	DB00020	C639H1006N168O196S8	biologic	L03AA09	123774-72-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
219	111544	5553	-	PRG2	BMPG|MBP|MBP1	9606	Homo sapiens	unknown	target	Kang JH (2007)	17600316	171844	20	Sargramostim	GM-CSF	leukine	DRUGBANK	DB00020	C639H1006N168O196S8	biologic	L03AA09	123774-72-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
220	111544	5553	-	PRG2	BMPG|MBP|MBP1	9606	Homo sapiens	unknown	target	Menon K (2007)	17383764	171843	20	Sargramostim	GM-CSF	leukine	DRUGBANK	DB00020	C639H1006N168O196S8	biologic	L03AA09	123774-72-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
272	107271	821	-	CANX	CNX|IP90|P90	9606	Homo sapiens	chaperone	target	Imming P (2006)	17016423	171742	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
273	107271	821	-	CANX	CNX|IP90|P90	9606	Homo sapiens	chaperone	target	Overington JP (2006)	17139284	171741	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
274	107271	821	-	CANX	CNX|IP90|P90	9606	Homo sapiens	chaperone	target	Pipe SW (1998)	9525969	1039	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
275	107271	821	-	CANX	CNX|IP90|P90	9606	Homo sapiens	chaperone	target	Kaufman RJ (1997)	9607108	171871	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
276	107271	821	-	CANX	CNX|IP90|P90	9606	Homo sapiens	chaperone	target	Becker S (2004)	15213841	171872	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
277	107271	821	-	CANX	CNX|IP90|P90	9606	Homo sapiens	chaperone	target	Srour MA (2008)	17899080	171873	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
293	110215	4035	-	LRP1	A2MR|APOER|APR|CD91|IGFBP3R|LRP|LRP1A|TGFBR5	9606	Homo sapiens	modulator	target	Imming P (2006)	17016423	171742	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
294	110215	4035	-	LRP1	A2MR|APOER|APR|CD91|IGFBP3R|LRP|LRP1A|TGFBR5	9606	Homo sapiens	modulator	target	Overington JP (2006)	17139284	171741	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
295	110215	4035	-	LRP1	A2MR|APOER|APR|CD91|IGFBP3R|LRP|LRP1A|TGFBR5	9606	Homo sapiens	modulator	target	Franchini M (2011)	21391865	171876	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
387	107271	821	-	CANX	CNX|IP90|P90	9606	Homo sapiens	unknown	target	Allen S (1997)	9359841	1042	31	Tenecteplase	t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA	tnkase	DRUGBANK	DB00031	C2561H3919N747O781S40	biologic	B01AD11	191588-94-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
397	110215	4035	-	LRP1	A2MR|APOER|APR|CD91|IGFBP3R|LRP|LRP1A|TGFBR5	9606	Homo sapiens	unknown	target	Moestrup SK (1993)	8344937	6349	31	Tenecteplase	t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA	tnkase	DRUGBANK	DB00031	C2561H3919N747O781S40	biologic	B01AD11	191588-94-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
398	110215	4035	-	LRP1	A2MR|APOER|APR|CD91|IGFBP3R|LRP|LRP1A|TGFBR5	9606	Homo sapiens	unknown	target	Nykjaer A (1992)	1378833	171911	31	Tenecteplase	t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA	tnkase	DRUGBANK	DB00031	C2561H3919N747O781S40	biologic	B01AD11	191588-94-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
399	110215	4035	-	LRP1	A2MR|APOER|APR|CD91|IGFBP3R|LRP|LRP1A|TGFBR5	9606	Homo sapiens	unknown	target	Hu K (2006)	16303771	171910	31	Tenecteplase	t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA	tnkase	DRUGBANK	DB00031	C2561H3919N747O781S40	biologic	B01AD11	191588-94-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
425	107035	554	-	AVPR2	ADHR|DI1|DIR|DIR3|NDI|V2R	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	35	Desmopressin	DDAVP|Desmopressine|1-deamino-8-D-arginine vasopressin|Desmopresina|1-(3-mercaptopropionic acid)-8-D-arginine-vasopressin|Minirin|1-Desamino-8-D-arginine vasopressin|Desmopressinum|Stimate|Desmopressin	ddavp rhinal tube|ddavp melt|d	DRUGBANK	DB00035	C46H64N14O12S2	small molecule	H01BA02	16679-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NFLWUMRGJYTJIN-NXBWRCJVSA-N
426	107035	554	-	AVPR2	ADHR|DI1|DIR|DIR3|NDI|V2R	9606	Homo sapiens	agonist	target	Slusarz MJ (2006)	16333859	171922	35	Desmopressin	DDAVP|Desmopressine|1-deamino-8-D-arginine vasopressin|Desmopresina|1-(3-mercaptopropionic acid)-8-D-arginine-vasopressin|Minirin|1-Desamino-8-D-arginine vasopressin|Desmopressinum|Stimate|Desmopressin	ddavp rhinal tube|ddavp melt|d	DRUGBANK	DB00035	C46H64N14O12S2	small molecule	H01BA02	16679-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NFLWUMRGJYTJIN-NXBWRCJVSA-N
427	107035	554	-	AVPR2	ADHR|DI1|DIR|DIR3|NDI|V2R	9606	Homo sapiens	agonist	target	Del Tredici AL (2008)	18761325	171923	35	Desmopressin	DDAVP|Desmopressine|1-deamino-8-D-arginine vasopressin|Desmopresina|1-(3-mercaptopropionic acid)-8-D-arginine-vasopressin|Minirin|1-Desamino-8-D-arginine vasopressin|Desmopressinum|Stimate|Desmopressin	ddavp rhinal tube|ddavp melt|d	DRUGBANK	DB00035	C46H64N14O12S2	small molecule	H01BA02	16679-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NFLWUMRGJYTJIN-NXBWRCJVSA-N
474	108554	2263	-	FGFR2	BBDS|BEK|BFR-1|CD332|CEK3|CFD1|ECT1|JWS|K-SAM|KGFR|TK14|TK25	9606	Homo sapiens	binder	target	Beaven AW (2007)	17728847	171962	38	Palifermin	FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7	kepivance	DRUGBANK	DB00039	C721H1142N202O204S9	biologic	V03AF08	162394-19-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
475	108554	2263	-	FGFR2	BBDS|BEK|BFR-1|CD332|CEK3|CFD1|ECT1|JWS|K-SAM|KGFR|TK14|TK25	9606	Homo sapiens	binder	target	Cardoso WV (1997)	9056643	171963	38	Palifermin	FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7	kepivance	DRUGBANK	DB00039	C721H1142N202O204S9	biologic	V03AF08	162394-19-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
476	108554	2263	-	FGFR2	BBDS|BEK|BFR-1|CD332|CEK3|CFD1|ECT1|JWS|K-SAM|KGFR|TK14|TK25	9606	Homo sapiens	binder	target	Berman B (1999)	10593896	171966	38	Palifermin	FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7	kepivance	DRUGBANK	DB00039	C721H1142N202O204S9	biologic	V03AF08	162394-19-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
477	108554	2263	-	FGFR2	BBDS|BEK|BFR-1|CD332|CEK3|CFD1|ECT1|JWS|K-SAM|KGFR|TK14|TK25	9606	Homo sapiens	binder	target	Radtke ML (2005)	16390600	171967	38	Palifermin	FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7	kepivance	DRUGBANK	DB00039	C721H1142N202O204S9	biologic	V03AF08	162394-19-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
478	108554	2263	-	FGFR2	BBDS|BEK|BFR-1|CD332|CEK3|CFD1|ECT1|JWS|K-SAM|KGFR|TK14|TK25	9606	Homo sapiens	binder	target	Patrie KM (1995)	7499435	171964	38	Palifermin	FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7	kepivance	DRUGBANK	DB00039	C721H1142N202O204S9	biologic	V03AF08	162394-19-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
479	108554	2263	-	FGFR2	BBDS|BEK|BFR-1|CD332|CEK3|CFD1|ECT1|JWS|K-SAM|KGFR|TK14|TK25	9606	Homo sapiens	binder	target	Huang YW (2006)	16854582	171965	38	Palifermin	FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7	kepivance	DRUGBANK	DB00039	C721H1142N202O204S9	biologic	V03AF08	162394-19-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
480	108554	2263	-	FGFR2	BBDS|BEK|BFR-1|CD332|CEK3|CFD1|ECT1|JWS|K-SAM|KGFR|TK14|TK25	9606	Homo sapiens	binder	target	Zhu X (2007)	17456767	171968	38	Palifermin	FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7	kepivance	DRUGBANK	DB00039	C721H1142N202O204S9	biologic	V03AF08	162394-19-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
481	108554	2263	-	FGFR2	BBDS|BEK|BFR-1|CD332|CEK3|CFD1|ECT1|JWS|K-SAM|KGFR|TK14|TK25	9606	Homo sapiens	binder	target	Chen X (2002)	11752352	171740	38	Palifermin	FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7	kepivance	DRUGBANK	DB00039	C721H1142N202O204S9	biologic	V03AF08	162394-19-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
544	112710	6843	-	VAMP1	SPAX1|SYB1|VAMP-1	9606	Homo sapiens	binder	target	Imming P (2006)	17016423	171742	41	Botulinum Toxin Type B	RimabotulinumtoxinB|BTX-B|Botulinum neurotoxin type B precursor	myobloc	DRUGBANK	DB00042	-	biologic	-	93384-44-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
545	112710	6843	-	VAMP1	SPAX1|SYB1|VAMP-1	9606	Homo sapiens	binder	target	Chen X (2002)	11752352	171740	41	Botulinum Toxin Type B	RimabotulinumtoxinB|BTX-B|Botulinum neurotoxin type B precursor	myobloc	DRUGBANK	DB00042	-	biologic	-	93384-44-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
546	112710	6843	-	VAMP1	SPAX1|SYB1|VAMP-1	9606	Homo sapiens	binder	target	Overington JP (2006)	17139284	171741	41	Botulinum Toxin Type B	RimabotulinumtoxinB|BTX-B|Botulinum neurotoxin type B precursor	myobloc	DRUGBANK	DB00042	-	biologic	-	93384-44-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
561	112952	7097	-	TLR2	CD282|TIL4	9606	Homo sapiens	unknown	target	Welty DM (2003)	14617145	172016	44	OspA lipoprotein	Outer surface protein A precursor	-	DRUGBANK	DB00045	C1198H2012N322O422S2	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
605	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	50	Adalimumab	Ig gamma-1 chain C region	humira	DRUGBANK	DB00051	C6428H9912N1694O1987S46	biologic	L04AB04	331731-18-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
606	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	50	Adalimumab	Ig gamma-1 chain C region	humira	DRUGBANK	DB00051	C6428H9912N1694O1987S46	biologic	L04AB04	331731-18-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
641	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	53	Abciximab	7E3|7E3 antibody|antiGPIIBIIIa|C7E3	reopro	DRUGBANK	DB00054	C6462H9964N1690O2049S48	biologic	B01AC13	143653-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
642	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	53	Abciximab	7E3|7E3 antibody|antiGPIIBIIIa|C7E3	reopro	DRUGBANK	DB00054	C6462H9964N1690O2049S48	biologic	B01AC13	143653-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
720	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	55	Gemtuzumab ozogamicin	-	-	DRUGBANK	DB00056	-	biologic	-	220578-59-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
721	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	55	Gemtuzumab ozogamicin	-	-	DRUGBANK	DB00056	-	biologic	-	220578-59-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
786	107035	554	-	AVPR2	ADHR|DI1|DIR|DIR3|NDI|V2R	9606	Homo sapiens	agonist	target	Yi X (2007)	17287200	71892	66	Vasopressin	Antidiuretic hormone|Argipressin|AVP|8-L-arginine vasopressin|Vasopressin, unspecified|Arginine vasopressin|8-Arginine vasopressin|ADH	vasopressin injection usp|pitr	DRUGBANK	DB00067	C46H65N15O12S2	biologic	H01BA06|H01BA01	11000-17-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
787	107035	554	-	AVPR2	ADHR|DI1|DIR|DIR3|NDI|V2R	9606	Homo sapiens	agonist	target	Boson WL (2006)	17020465	172148	66	Vasopressin	Antidiuretic hormone|Argipressin|AVP|8-L-arginine vasopressin|Vasopressin, unspecified|Arginine vasopressin|8-Arginine vasopressin|ADH	vasopressin injection usp|pitr	DRUGBANK	DB00067	C46H65N15O12S2	biologic	H01BA06|H01BA01	11000-17-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
788	107035	554	-	AVPR2	ADHR|DI1|DIR|DIR3|NDI|V2R	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	66	Vasopressin	Antidiuretic hormone|Argipressin|AVP|8-L-arginine vasopressin|Vasopressin, unspecified|Arginine vasopressin|8-Arginine vasopressin|ADH	vasopressin injection usp|pitr	DRUGBANK	DB00067	C46H65N15O12S2	biologic	H01BA06|H01BA01	11000-17-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
789	107035	554	-	AVPR2	ADHR|DI1|DIR|DIR3|NDI|V2R	9606	Homo sapiens	agonist	target	Slusarz MJ (2006)	16333859	171922	66	Vasopressin	Antidiuretic hormone|Argipressin|AVP|8-L-arginine vasopressin|Vasopressin, unspecified|Arginine vasopressin|8-Arginine vasopressin|ADH	vasopressin injection usp|pitr	DRUGBANK	DB00067	C46H65N15O12S2	biologic	H01BA06|H01BA01	11000-17-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
790	107035	554	-	AVPR2	ADHR|DI1|DIR|DIR3|NDI|V2R	9606	Homo sapiens	agonist	target	Bouley R (2006)	16563128	172149	66	Vasopressin	Antidiuretic hormone|Argipressin|AVP|8-L-arginine vasopressin|Vasopressin, unspecified|Arginine vasopressin|8-Arginine vasopressin|ADH	vasopressin injection usp|pitr	DRUGBANK	DB00067	C46H65N15O12S2	biologic	H01BA06|H01BA01	11000-17-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
894	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	71	Trastuzumab	Anti HER2|Ig gamma-1 chain C region	herceptin|perjeta-herceptin	DRUGBANK	DB00072	C6470H10012N1726O2013S42	biologic	L01XC03	180288-69-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
895	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	71	Trastuzumab	Anti HER2|Ig gamma-1 chain C region	herceptin|perjeta-herceptin	DRUGBANK	DB00072	C6470H10012N1726O2013S42	biologic	L01XC03	180288-69-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
925	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	72	Rituximab	Ig gamma-1 chain C region|AntiCD20	rituxan sc|rituxan	DRUGBANK	DB00073	C6416H9874N1688O1987S44	biologic	L01XC02	174722-31-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
926	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	72	Rituximab	Ig gamma-1 chain C region|AntiCD20	rituxan sc|rituxan	DRUGBANK	DB00073	C6416H9874N1688O1987S44	biologic	L01XC02	174722-31-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
952	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	73	Basiliximab	chimeric mouse-human antiCD25|Ig gamma-1 chain C region	simulect	DRUGBANK	DB00074	C6378H9844N1698O1997S48	biologic	L04AC02	179045-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
953	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	73	Basiliximab	chimeric mouse-human antiCD25|Ig gamma-1 chain C region	simulect	DRUGBANK	DB00074	C6378H9844N1698O1997S48	biologic	L04AC02	179045-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
986	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	74	Muromonab	Anti-CD3|Muromonab-CD3	okt3|orthoclone okt 3 sterile 	DRUGBANK	DB00075	C6460H9946N1720O2043S56	biologic	L04AA02	140608-64-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
987	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	74	Muromonab	Anti-CD3|Muromonab-CD3	okt3|orthoclone okt 3 sterile 	DRUGBANK	DB00075	C6460H9946N1720O2043S56	biologic	L04AA02	140608-64-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1017	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	76	Ibritumomab tiuxetan	mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab	zevalin	DRUGBANK	DB00078	C6382H9830N1672O1979S54	biologic	-	206181-63-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1018	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	76	Ibritumomab tiuxetan	mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab	zevalin	DRUGBANK	DB00078	C6382H9830N1672O1979S54	biologic	-	206181-63-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1044	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	78	Tositumomab	Ig gamma-1 chain C region	bexxar therapy	DRUGBANK	DB00081	C6416H9874N1688O1987S44	biologic	-	208921-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1045	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	78	Tositumomab	Ig gamma-1 chain C region	bexxar therapy	DRUGBANK	DB00081	C6416H9874N1688O1987S44	biologic	-	208921-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1089	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	83	Alemtuzumab	-	mabcampath|lemtrada|campath	DRUGBANK	DB00087	C6468H10066N1732O2005S40	biologic	L04AA34	216503-57-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1090	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	83	Alemtuzumab	-	mabcampath|lemtrada|campath	DRUGBANK	DB00087	C6468H10066N1732O2005S40	biologic	L04AA34	216503-57-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1143	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	88	Alefacept	ASP0485	amevive	DRUGBANK	DB00092	C2306H3594N610O694S26	biologic	L04AA15	222535-22-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1144	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	88	Alefacept	ASP0485	amevive	DRUGBANK	DB00092	C2306H3594N610O694S26	biologic	L04AA15	222535-22-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1177	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	91	Efalizumab	antiCD11 alpha|anti alphaL integrin|hu1124|Raptiva	raptiva	DRUGBANK	DB00095	-	biologic	L04AA21	214745-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1178	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	91	Efalizumab	antiCD11 alpha|anti alphaL integrin|hu1124|Raptiva	raptiva	DRUGBANK	DB00095	-	biologic	L04AA21	214745-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1239	110215	4035	-	LRP1	A2MR|APOER|APR|CD91|IGFBP3R|LRP|LRP1A|TGFBR5	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	96	Coagulation Factor IX (Recombinant)	nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant)	benefix  - (250iu)|idelvion|ix	DRUGBANK	DB00100	C2041H3136N558O641S25	biologic	B02BD09	181054-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1240	110215	4035	-	LRP1	A2MR|APOER|APR|CD91|IGFBP3R|LRP|LRP1A|TGFBR5	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	96	Coagulation Factor IX (Recombinant)	nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant)	benefix  - (250iu)|idelvion|ix	DRUGBANK	DB00100	C2041H3136N558O641S25	biologic	B02BD09	181054-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1241	110215	4035	-	LRP1	A2MR|APOER|APR|CD91|IGFBP3R|LRP|LRP1A|TGFBR5	9606	Homo sapiens	unknown	target	Rohlena J (2003)	12522212	744	96	Coagulation Factor IX (Recombinant)	nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant)	benefix  - (250iu)|idelvion|ix	DRUGBANK	DB00100	C2041H3136N558O641S25	biologic	B02BD09	181054-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1299	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	103	Natalizumab	Anti-alpha4 integrin|Anti-VLA4	tysabri	DRUGBANK	DB00108	-	biologic	L04AA23	189261-10-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1300	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	103	Natalizumab	Anti-alpha4 integrin|Anti-VLA4	tysabri	DRUGBANK	DB00108	-	biologic	L04AA23	189261-10-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1324	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	105	Palivizumab	anti-RSV|Synagis	synagis	DRUGBANK	DB00110	-	biologic	J06BB16	188039-54-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1325	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	105	Palivizumab	anti-RSV|Synagis	synagis	DRUGBANK	DB00110	-	biologic	J06BB16	188039-54-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1347	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	106	Daclizumab	Dacliximab|Daclizumab beta	zenapax 5mg/ml|zinbryta	DRUGBANK	DB00111	C6332H9808N1678O1989S42	biologic	L04AC01	152923-56-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1348	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	106	Daclizumab	Dacliximab|Daclizumab beta	zenapax 5mg/ml|zinbryta	DRUGBANK	DB00111	C6332H9808N1678O1989S42	biologic	L04AC01	152923-56-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1379	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	107	Bevacizumab	antiVEGF|Avastin	avastin	DRUGBANK	DB00112	C6538H10034N1716O2033S44	biologic	L01XC07	216974-75-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1380	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	107	Bevacizumab	antiVEGF|Avastin	avastin	DRUGBANK	DB00112	C6538H10034N1716O2033S44	biologic	L01XC07	216974-75-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1920	125184	112398	-	EGLN2	EIT6|HIF-PH1|HIFPH1|HPH-1|HPH-3|PHD1	9606	Homo sapiens	unknown	target	Bruegge K (2007)	17627521	172876	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
1921	125184	112398	-	EGLN2	EIT6|HIF-PH1|HIFPH1|HPH-1|HPH-3|PHD1	9606	Homo sapiens	unknown	target	Nytko KJ (2007)	17627474	127532	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
2001	124869	91703	-	ACY3	ACY-3|HCBP1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
2002	124869	91703	-	ACY3	ACY-3|HCBP1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
2101	111551	5564	-	PRKAB1	AMPK|HAMPKb	9606	Homo sapiens	activator	target	Whitehead JP (2006)	16634986	173038	125	Adenosine monophosphate	Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate	-	DRUGBANK	DB00131	C10H14N5O7P	small molecule	-	61-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UDMBCSSLTHHNCD-KQYNXXCUSA-N
2102	111551	5564	-	PRKAB1	AMPK|HAMPKb	9606	Homo sapiens	activator	target	Ruderman NB (2006)	16642960	173039	125	Adenosine monophosphate	Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate	-	DRUGBANK	DB00131	C10H14N5O7P	small molecule	-	61-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UDMBCSSLTHHNCD-KQYNXXCUSA-N
2103	111551	5564	-	PRKAB1	AMPK|HAMPKb	9606	Homo sapiens	activator	target	McGee SL (2006)	16620308	173036	125	Adenosine monophosphate	Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate	-	DRUGBANK	DB00131	C10H14N5O7P	small molecule	-	61-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UDMBCSSLTHHNCD-KQYNXXCUSA-N
2104	111551	5564	-	PRKAB1	AMPK|HAMPKb	9606	Homo sapiens	activator	target	Neurath KM (2006)	16518831	173037	125	Adenosine monophosphate	Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate	-	DRUGBANK	DB00131	C10H14N5O7P	small molecule	-	61-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UDMBCSSLTHHNCD-KQYNXXCUSA-N
2105	111551	5564	-	PRKAB1	AMPK|HAMPKb	9606	Homo sapiens	activator	target	Richter EA (2006)	16513051	173035	125	Adenosine monophosphate	Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate	-	DRUGBANK	DB00131	C10H14N5O7P	small molecule	-	61-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UDMBCSSLTHHNCD-KQYNXXCUSA-N
2107	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	product of	target	Porteous DJ (2006)	16843095	173042	125	Adenosine monophosphate	Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate	-	DRUGBANK	DB00131	C10H14N5O7P	small molecule	-	61-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UDMBCSSLTHHNCD-KQYNXXCUSA-N
2108	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	product of	target	Siuciak JA (2007)	17333137	173041	125	Adenosine monophosphate	Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate	-	DRUGBANK	DB00131	C10H14N5O7P	small molecule	-	61-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UDMBCSSLTHHNCD-KQYNXXCUSA-N
2109	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	product of	target	Terrin A (2006)	17088426	173040	125	Adenosine monophosphate	Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate	-	DRUGBANK	DB00131	C10H14N5O7P	small molecule	-	61-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UDMBCSSLTHHNCD-KQYNXXCUSA-N
2155	113281	7442	-	TRPV1	VR1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	126	Alpha-Linolenic Acid	9,12,15-Octadecatrienoic acid|all-cis-9,12,15-Octadecatrienoic acid|alpha-Linolenic acid|(9Z,12Z,15Z)-Octadecatrienoic acid|9-cis,12-cis,15-cis-octadecatrienoic acid|-linolenic acid|(9,12,15)-linolenic acid|ALA|(Z,Z,Z)-9,12,15-octadecatrienoic acid|cis-delta(9,12,15)-Octadecatrienoic acid|Linolenic acid|cis,cis,cis-9,12,15-Octadecatrienoic acid	folcaps omega-3|ultimatecare o	DRUGBANK	DB00132	C18H30O2	small molecule	-	463-40-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTOSIQBPPRVQHS-PDBXOOCHSA-N
2156	113281	7442	-	TRPV1	VR1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	126	Alpha-Linolenic Acid	9,12,15-Octadecatrienoic acid|all-cis-9,12,15-Octadecatrienoic acid|alpha-Linolenic acid|(9Z,12Z,15Z)-Octadecatrienoic acid|9-cis,12-cis,15-cis-octadecatrienoic acid|-linolenic acid|(9,12,15)-linolenic acid|ALA|(Z,Z,Z)-9,12,15-octadecatrienoic acid|cis-delta(9,12,15)-Octadecatrienoic acid|Linolenic acid|cis,cis,cis-9,12,15-Octadecatrienoic acid	folcaps omega-3|ultimatecare o	DRUGBANK	DB00132	C18H30O2	small molecule	-	463-40-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTOSIQBPPRVQHS-PDBXOOCHSA-N
2397	127816	162417	-	NAGS	AGAS|ARGA	9606	Homo sapiens	unknown	target	Xu Y (2007)	17347518	173237	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2645	109007	2745	-	GLRX	GRX|GRX1	9606	Homo sapiens	unknown	target	Hakansson KO (2007)	17327665	173370	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2646	109007	2745	-	GLRX	GRX|GRX1	9606	Homo sapiens	unknown	target	Rouhier N (2007)	17460036	173368	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2647	109007	2745	-	GLRX	GRX|GRX1	9606	Homo sapiens	unknown	target	Diwakar L (2007)	17512091	173369	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2648	109007	2745	-	GLRX	GRX|GRX1	9606	Homo sapiens	unknown	target	Wang J (2007)	17431186	173366	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2649	109007	2745	-	GLRX	GRX|GRX1	9606	Homo sapiens	unknown	target	Lu J (2007)	17640917	173367	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2687	109138	2880	-	GPX5	HEL-S-75p	9606	Homo sapiens	cofactor	target	Koh CS (2007)	17531267	173387	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2945	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	unknown	target	Das UN (2005)	15990700	173594	148	Dihomo-gamma-linolenic acid	(Z,Z,Z)-8,11,14-Eicosatrienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoate|all-cis-Eicosa-8,11,14-triensaeure|Homo-gamma-linolenic acid|all-cis-icosa-8,11,14-trienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoic acid|Homo-gamma-linolensaeure|gamma-Homolinolenic acid|Dihomo--linolenic acid|DGLA|20:3, n-6,9,12 all-cis|8,11,14-Eicosatrienoic Acid|all-cis-8,11,14-eicosatrienoic acid|eicosa-8Z,11Z,14Z-trienoic acid|C20:3, n-6,9,12 all-cis|cis,cis,cis-8,11,14-eicosatrienoic acid|(8Z,11Z,14Z)-Icosatrienoic acid|all-cis-eicosa-8,11,14-trienoic acid|8c,11c,14c-Eicosatriensaeure|8c,11c,14c-eicosatrienoic acid|all-cis-8,11,14-icosatrienoic acid	-	DRUGBANK	DB00154	C20H34O2	small molecule	-	1783-84-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HOBAELRKJCKHQD-QNEBEIHSSA-N
2946	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	unknown	target	Das UN (2005)	16190133	173591	148	Dihomo-gamma-linolenic acid	(Z,Z,Z)-8,11,14-Eicosatrienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoate|all-cis-Eicosa-8,11,14-triensaeure|Homo-gamma-linolenic acid|all-cis-icosa-8,11,14-trienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoic acid|Homo-gamma-linolensaeure|gamma-Homolinolenic acid|Dihomo--linolenic acid|DGLA|20:3, n-6,9,12 all-cis|8,11,14-Eicosatrienoic Acid|all-cis-8,11,14-eicosatrienoic acid|eicosa-8Z,11Z,14Z-trienoic acid|C20:3, n-6,9,12 all-cis|cis,cis,cis-8,11,14-eicosatrienoic acid|(8Z,11Z,14Z)-Icosatrienoic acid|all-cis-eicosa-8,11,14-trienoic acid|8c,11c,14c-Eicosatriensaeure|8c,11c,14c-eicosatrienoic acid|all-cis-8,11,14-icosatrienoic acid	-	DRUGBANK	DB00154	C20H34O2	small molecule	-	1783-84-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HOBAELRKJCKHQD-QNEBEIHSSA-N
2947	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	unknown	target	Thuresson ED (2001)	11121413	173590	148	Dihomo-gamma-linolenic acid	(Z,Z,Z)-8,11,14-Eicosatrienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoate|all-cis-Eicosa-8,11,14-triensaeure|Homo-gamma-linolenic acid|all-cis-icosa-8,11,14-trienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoic acid|Homo-gamma-linolensaeure|gamma-Homolinolenic acid|Dihomo--linolenic acid|DGLA|20:3, n-6,9,12 all-cis|8,11,14-Eicosatrienoic Acid|all-cis-8,11,14-eicosatrienoic acid|eicosa-8Z,11Z,14Z-trienoic acid|C20:3, n-6,9,12 all-cis|cis,cis,cis-8,11,14-eicosatrienoic acid|(8Z,11Z,14Z)-Icosatrienoic acid|all-cis-eicosa-8,11,14-trienoic acid|8c,11c,14c-Eicosatriensaeure|8c,11c,14c-eicosatrienoic acid|all-cis-8,11,14-icosatrienoic acid	-	DRUGBANK	DB00154	C20H34O2	small molecule	-	1783-84-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HOBAELRKJCKHQD-QNEBEIHSSA-N
2948	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	unknown	target	Levin G (2002)	11939906	173592	148	Dihomo-gamma-linolenic acid	(Z,Z,Z)-8,11,14-Eicosatrienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoate|all-cis-Eicosa-8,11,14-triensaeure|Homo-gamma-linolenic acid|all-cis-icosa-8,11,14-trienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoic acid|Homo-gamma-linolensaeure|gamma-Homolinolenic acid|Dihomo--linolenic acid|DGLA|20:3, n-6,9,12 all-cis|8,11,14-Eicosatrienoic Acid|all-cis-8,11,14-eicosatrienoic acid|eicosa-8Z,11Z,14Z-trienoic acid|C20:3, n-6,9,12 all-cis|cis,cis,cis-8,11,14-eicosatrienoic acid|(8Z,11Z,14Z)-Icosatrienoic acid|all-cis-eicosa-8,11,14-trienoic acid|8c,11c,14c-Eicosatriensaeure|8c,11c,14c-eicosatrienoic acid|all-cis-8,11,14-icosatrienoic acid	-	DRUGBANK	DB00154	C20H34O2	small molecule	-	1783-84-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HOBAELRKJCKHQD-QNEBEIHSSA-N
3155	108082	1738	tcag7.39	DLD	DLDD|DLDH|E3|GCSL|LAD|PHE3	9606	Homo sapiens	unknown	target	Gutierrez-Correa J (2006)	17017892	173700	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3156	108082	1738	tcag7.39	DLD	DLDD|DLDH|E3|GCSL|LAD|PHE3	9606	Homo sapiens	unknown	target	Yan LJ (2007)	17315258	173701	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3157	108082	1738	tcag7.39	DLD	DLDD|DLDH|E3|GCSL|LAD|PHE3	9606	Homo sapiens	unknown	target	Islam MM (2007)	17314104	173702	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3232	106725	223	-	ALDH9A1	ALDH4|ALDH7|ALDH9|E3|TMABADH	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3233	106725	223	-	ALDH9A1	ALDH4|ALDH7|ALDH9|E3|TMABADH	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3234	106725	223	-	ALDH9A1	ALDH4|ALDH7|ALDH9|E3|TMABADH	9606	Homo sapiens	unknown	target	Prieto MI (1987)	3129020	173726	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3235	106725	223	-	ALDH9A1	ALDH4|ALDH7|ALDH9|E3|TMABADH	9606	Homo sapiens	unknown	target	Testore G (1995)	7584606	173727	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3374	110796	4716	-	NDUFB10	PDSW	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3375	110796	4716	-	NDUFB10	PDSW	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3450	113281	7442	-	TRPV1	VR1	9606	Homo sapiens	inducer	target	Matta JA (2007)	17038422	173841	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3453	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Machida T (2005)	16141635	173820	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3454	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Lee JY (2003)	12562875	173822	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3455	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chene G (2007)	17459764	173843	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3456	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Vecchio AJ (2010)	20463020	173819	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3457	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Das UN (2005)	16190133	173591	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3458	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Ait-Said F (2003)	12573452	173842	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3632	113281	7442	-	TRPV1	VR1	9606	Homo sapiens	inducer	target	Riera CE (2007)	17567713	173964	161	Aspartame	Asp-phe-ome|Aspartamum|3-Amino-N-(alpha-carboxyphenethyl)succinamic acid N-methyl ester|3-Amino-N-(-carboxyphenethyl)succinamic acid N-methyl ester|1-methyl N-L--aspartyl-L-phenylalanate|Aspartamo|1-Methyl N-L-alpha-aspartyl-L-phenylalanine|Aspartylphenylalanine methyl ester|Aspartam|L-Aspartyl-L-phenylalanine methyl ester|3-Amino-N-(alpha-methoxycarbonylphenethyl) succinamic acid|1-Methyl N-L-alpha-aspartyl-L-phenylalanate|3-Amino-N-(-methoxycarbonylphenethyl) succinamic acid|Aspartame	-	DRUGBANK	DB00168	C14H18N2O5	small molecule	-	22839-47-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IAOZJIPTCAWIRG-QWRGUYRKSA-N
3998	107560	1138	-	CHRNA5	LNCR2	9606	Homo sapiens	agonist	target	Zaniewska M (2010)	20081230	174183	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
3999	107560	1138	-	CHRNA5	LNCR2	9606	Homo sapiens	agonist	target	Jackson KJ (2010)	20400469	174182	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
4000	107560	1138	-	CHRNA5	LNCR2	9606	Homo sapiens	agonist	target	Narahashi T (2000)	11006350	174181	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
4001	107560	1138	-	CHRNA5	LNCR2	9606	Homo sapiens	agonist	target	Mansvelder HD (2009)	19560048	174180	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
4079	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	antagonist	target	Ulus IH (2000)	10799660	174228	184	Phentermine	Phenterminum|Fentermina|alpha,alpha-Dimethylphenethylamine	phentermine resin er|lomaira|f	DRUGBANK	DB00191	C10H15N	small molecule	A08AA01	122-09-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHHVAGZRUROJKS-UHFFFAOYSA-N
4080	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	antagonist	target	Kilpatrick IC (2001)	11673765	174229	184	Phentermine	Phenterminum|Fentermina|alpha,alpha-Dimethylphenethylamine	phentermine resin er|lomaira|f	DRUGBANK	DB00191	C10H15N	small molecule	A08AA01	122-09-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHHVAGZRUROJKS-UHFFFAOYSA-N
4081	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	antagonist	target	Rothman RB (1999)	10231134	174226	184	Phentermine	Phenterminum|Fentermina|alpha,alpha-Dimethylphenethylamine	phentermine resin er|lomaira|f	DRUGBANK	DB00191	C10H15N	small molecule	A08AA01	122-09-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHHVAGZRUROJKS-UHFFFAOYSA-N
4082	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	antagonist	target	Nandigama RK (2002)	11911838	174227	184	Phentermine	Phenterminum|Fentermina|alpha,alpha-Dimethylphenethylamine	phentermine resin er|lomaira|f	DRUGBANK	DB00191	C10H15N	small molecule	A08AA01	122-09-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHHVAGZRUROJKS-UHFFFAOYSA-N
4095	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Jaillon P (1989)	2688391	174237	185	Indecainide	Indecainide|Indecainidum|Indecainida	-	DRUGBANK	DB00192	C20H24N2O	small molecule	-	74517-78-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCEWGESNIULAGX-UHFFFAOYSA-N
4096	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	185	Indecainide	Indecainide|Indecainidum|Indecainida	-	DRUGBANK	DB00192	C20H24N2O	small molecule	-	74517-78-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCEWGESNIULAGX-UHFFFAOYSA-N
4097	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Steinberg MI (1984)	6206315	174238	185	Indecainide	Indecainide|Indecainidum|Indecainida	-	DRUGBANK	DB00192	C20H24N2O	small molecule	-	74517-78-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCEWGESNIULAGX-UHFFFAOYSA-N
4098	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	185	Indecainide	Indecainide|Indecainidum|Indecainida	-	DRUGBANK	DB00192	C20H24N2O	small molecule	-	74517-78-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCEWGESNIULAGX-UHFFFAOYSA-N
4099	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	185	Indecainide	Indecainide|Indecainidum|Indecainida	-	DRUGBANK	DB00192	C20H24N2O	small molecule	-	74517-78-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCEWGESNIULAGX-UHFFFAOYSA-N
4100	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Holland DR (1989)	2476626	174239	185	Indecainide	Indecainide|Indecainidum|Indecainida	-	DRUGBANK	DB00192	C20H24N2O	small molecule	-	74517-78-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCEWGESNIULAGX-UHFFFAOYSA-N
4188	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4189	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4190	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Daly JW (2007)	17514358	174335	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4239	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor, competitive	target	Ribeiro JA (2010)	20164566	174341	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4240	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor, competitive	target	Essayan DM (2001)	11692087	174342	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4366	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	209	Eletriptan	Eletriptanum	gd-eletriptan|relpax|apo-eletr	DRUGBANK	DB00216	C22H26N2O2S	small molecule	N02CC06	143322-58-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWVXXGRKLHYWKM-LJQANCHMSA-N
4367	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Johnson DE (2001)	11513839	174444	209	Eletriptan	Eletriptanum	gd-eletriptan|relpax|apo-eletr	DRUGBANK	DB00216	C22H26N2O2S	small molecule	N02CC06	143322-58-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWVXXGRKLHYWKM-LJQANCHMSA-N
4368	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Lambert GA (2002)	12384251	174445	209	Eletriptan	Eletriptanum	gd-eletriptan|relpax|apo-eletr	DRUGBANK	DB00216	C22H26N2O2S	small molecule	N02CC06	143322-58-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWVXXGRKLHYWKM-LJQANCHMSA-N
4369	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Napier C (1999)	10193663	174442	209	Eletriptan	Eletriptanum	gd-eletriptan|relpax|apo-eletr	DRUGBANK	DB00216	C22H26N2O2S	small molecule	N02CC06	143322-58-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWVXXGRKLHYWKM-LJQANCHMSA-N
4370	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Knyihar-Csillik E (2000)	11069595	174443	209	Eletriptan	Eletriptanum	gd-eletriptan|relpax|apo-eletr	DRUGBANK	DB00216	C22H26N2O2S	small molecule	N02CC06	143322-58-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWVXXGRKLHYWKM-LJQANCHMSA-N
4371	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	van den Broek RW (2000)	11050304	174441	209	Eletriptan	Eletriptanum	gd-eletriptan|relpax|apo-eletr	DRUGBANK	DB00216	C22H26N2O2S	small molecule	N02CC06	143322-58-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWVXXGRKLHYWKM-LJQANCHMSA-N
4503	109984	3783	-	KCNN4	IK1|IKCA1|KCA4|KCa3.1|SK4|hIKCa1|hKCa4|hSK4	9606	Homo sapiens	inhibitor	target	Namba T (2000)	10794813	174523	221	Enflurane	Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether	enflurane|ethrane liq inh|ethr	DRUGBANK	DB00228	C3H2ClF5O	small molecule	N01AB04	13838-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPGQOUSTVILISH-UHFFFAOYSA-N
4568	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Cipolla G (2002)	12208114	174550	226	Aminosalicylic Acid	PAS|4-amino-2-hydroxybenzoic acid|para-amino salicylic acid|p-aminosalicylic acid|4-aminosalicylic acid|para-aminosalicylic acid|4-aminosalicylate	paser|nemasol sodium tab 500mg	DRUGBANK	DB00233	C7H7NO3	small molecule	J04AA03|J04AA02|J04AA01	65-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUBBRNOQWQTFEX-UHFFFAOYSA-N
4569	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Generini S (2002)	12463455	174551	226	Aminosalicylic Acid	PAS|4-amino-2-hydroxybenzoic acid|para-amino salicylic acid|p-aminosalicylic acid|4-aminosalicylic acid|para-aminosalicylic acid|4-aminosalicylate	paser|nemasol sodium tab 500mg	DRUGBANK	DB00233	C7H7NO3	small molecule	J04AA03|J04AA02|J04AA01	65-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUBBRNOQWQTFEX-UHFFFAOYSA-N
4570	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Mifflin RC (2004)	14742690	174552	226	Aminosalicylic Acid	PAS|4-amino-2-hydroxybenzoic acid|para-amino salicylic acid|p-aminosalicylic acid|4-aminosalicylic acid|para-aminosalicylic acid|4-aminosalicylate	paser|nemasol sodium tab 500mg	DRUGBANK	DB00233	C7H7NO3	small molecule	J04AA03|J04AA02|J04AA01	65-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUBBRNOQWQTFEX-UHFFFAOYSA-N
4571	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Pruzanski W (1997)	9256165	174553	226	Aminosalicylic Acid	PAS|4-amino-2-hydroxybenzoic acid|para-amino salicylic acid|p-aminosalicylic acid|4-aminosalicylic acid|para-aminosalicylic acid|4-aminosalicylate	paser|nemasol sodium tab 500mg	DRUGBANK	DB00233	C7H7NO3	small molecule	J04AA03|J04AA02|J04AA01	65-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUBBRNOQWQTFEX-UHFFFAOYSA-N
4572	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Distrutti E (2006)	16855178	174554	226	Aminosalicylic Acid	PAS|4-amino-2-hydroxybenzoic acid|para-amino salicylic acid|p-aminosalicylic acid|4-aminosalicylic acid|para-aminosalicylic acid|4-aminosalicylate	paser|nemasol sodium tab 500mg	DRUGBANK	DB00233	C7H7NO3	small molecule	J04AA03|J04AA02|J04AA01	65-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUBBRNOQWQTFEX-UHFFFAOYSA-N
4689	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Rajamani S (2008)	19077543	174602	236	Ranolazine	-	ranexa	DRUGBANK	DB00243	C24H33N3O4	small molecule	C01EB18	95635-55-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKLMZUWKNUAPSZ-UHFFFAOYSA-N
4690	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Hale SL (2006)	17220471	174603	236	Ranolazine	-	ranexa	DRUGBANK	DB00243	C24H33N3O4	small molecule	C01EB18	95635-55-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKLMZUWKNUAPSZ-UHFFFAOYSA-N
4707	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Cipolla G (2002)	12208114	174550	237	Mesalazine	Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol	asacol 800|pentasa|pentasa sup	DRUGBANK	DB00244	C7H7NO3	small molecule	A07EC02	89-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBOPZPXVLCULAV-UHFFFAOYSA-N
4708	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Generini S (2002)	12463455	174551	237	Mesalazine	Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol	asacol 800|pentasa|pentasa sup	DRUGBANK	DB00244	C7H7NO3	small molecule	A07EC02	89-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBOPZPXVLCULAV-UHFFFAOYSA-N
4709	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Mifflin RC (2004)	14742690	174552	237	Mesalazine	Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol	asacol 800|pentasa|pentasa sup	DRUGBANK	DB00244	C7H7NO3	small molecule	A07EC02	89-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBOPZPXVLCULAV-UHFFFAOYSA-N
4710	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Pruzanski W (1997)	9256165	174553	237	Mesalazine	Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol	asacol 800|pentasa|pentasa sup	DRUGBANK	DB00244	C7H7NO3	small molecule	A07EC02	89-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBOPZPXVLCULAV-UHFFFAOYSA-N
4711	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Distrutti E (2006)	16855178	174554	237	Mesalazine	Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol	asacol 800|pentasa|pentasa sup	DRUGBANK	DB00244	C7H7NO3	small molecule	A07EC02	89-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBOPZPXVLCULAV-UHFFFAOYSA-N
4725	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4735	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4777	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	binder	target	Matsumoto I (1992)	1738111	174640	240	Methysergide	1-Methyllysergic acid butanolamide|(+)-N-(1-(Hydroxymethyl)propyl)-1-methyl-D-lysergamide|9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8-carboxamide|1-Methylmethylergonovine|Methysergidum|1-Methyl-D-lysergic acid butanolamide|(+)-9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8beta-carboxamide|Metisergido|Metisergida|1-Methyl-dextro-lysergic acid (+)-1-hydroxy-2-butylamide|Methysergide|N-(1-(Hydroxymethyl)propyl)-1-methyl-dextro-(+)-lysergamide	sansert	DRUGBANK	DB00247	C21H27N3O2	small molecule	N02CA04	361-37-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPJZHOPZRAFDTN-NQUBZZJWSA-N
4807	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4808	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4833	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4834	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Kvernmo T (2006)	16982285	174668	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4835	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Ichikawa K (2001)	11436517	174659	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4836	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4845	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Millan MJ (2002)	12388666	174654	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4858	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Mitiushin VM (1978)	150666	174681	245	Phenytoin	Phentytoin|Phenytoinum|5,5-diphenylimidazolidine-2,4-dione|Fenitoina|Phenytoine|Diphenylhydantoin|5,5-Diphenyl-imidazolidine-2,4-dione|5,5-Diphenyltetrahydro-1H-2,4-imidazoledione|5,5-diphenyltetrahydro-1H-2,4-imidazoledione	phenytoin sodium injection usp	DRUGBANK	DB00252	C15H12N2O2	small molecule	N03AB52|N03AB02	57-41-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXOFVDLJLONNDW-UHFFFAOYSA-N
4859	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Swadron SP (2004)	15001403	174682	245	Phenytoin	Phentytoin|Phenytoinum|5,5-diphenylimidazolidine-2,4-dione|Fenitoina|Phenytoine|Diphenylhydantoin|5,5-Diphenyl-imidazolidine-2,4-dione|5,5-Diphenyltetrahydro-1H-2,4-imidazoledione|5,5-diphenyltetrahydro-1H-2,4-imidazoledione	phenytoin sodium injection usp	DRUGBANK	DB00252	C15H12N2O2	small molecule	N03AB52|N03AB02	57-41-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXOFVDLJLONNDW-UHFFFAOYSA-N
4895	109984	3783	-	KCNN4	IK1|IKCA1|KCA4|KCa3.1|SK4|hIKCa1|hKCa4|hSK4	9606	Homo sapiens	inhibitor	target	Brugnara C (1996)	8636434	174708	250	Clotrimazole	Mycelex (tn)|1-(O-Chloro-alpha,alpha-diphenylbenzyl)imidazole|Clotrimazole|1-(o-Chlorotrityl)imidazole|Lotrimin (tn)|1-(-(2-Chlorophenyl)benzhydryl)imidazole|1-(o-Chloro-,-diphenylbenzyl)imidazole|1-((2-Chlorophenyl)diphenylmethyl)-1H-imidazole|1-(alpha-(2-Chlorophenyl)benzhydryl)imidazole	myclo solution|clotrimazole ex	DRUGBANK	DB00257	C22H17ClN2	small molecule	A01AB18|G01AF02|D01AC01	23593-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VNFPBHJOKIVQEB-UHFFFAOYSA-N
4896	109984	3783	-	KCNN4	IK1|IKCA1|KCA4|KCa3.1|SK4|hIKCa1|hKCa4|hSK4	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	250	Clotrimazole	Mycelex (tn)|1-(O-Chloro-alpha,alpha-diphenylbenzyl)imidazole|Clotrimazole|1-(o-Chlorotrityl)imidazole|Lotrimin (tn)|1-(-(2-Chlorophenyl)benzhydryl)imidazole|1-(o-Chloro-,-diphenylbenzyl)imidazole|1-((2-Chlorophenyl)diphenylmethyl)-1H-imidazole|1-(alpha-(2-Chlorophenyl)benzhydryl)imidazole	myclo solution|clotrimazole ex	DRUGBANK	DB00257	C22H17ClN2	small molecule	A01AB18|G01AF02|D01AC01	23593-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VNFPBHJOKIVQEB-UHFFFAOYSA-N
4952	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	261	Ropinirole	Ropinirolum|Ropinirole|Ropinirol	apo-ropinirole|phl-ropinirole|	DRUGBANK	DB00268	C16H24N2O	small molecule	N04BC04	91374-21-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UHSKFQJFRQCDBE-UHFFFAOYSA-N
4965	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	261	Ropinirole	Ropinirolum|Ropinirole|Ropinirol	apo-ropinirole|phl-ropinirole|	DRUGBANK	DB00268	C16H24N2O	small molecule	N04BC04	91374-21-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UHSKFQJFRQCDBE-UHFFFAOYSA-N
5033	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Lipworth BJ (2005)	15639300	174818	270	Theophylline	1,3-dimethyl-7H-purine-2,6-dione|Theophylline, anhydrous|Theophylline anhydrous|1,3-dimethylxanthine|Theophyllin	theo-24|idm tab|theolair|theop	DRUGBANK	DB00277	C7H8N4O2	small molecule	R03DA54|R03DA74|R03DB04|R03DA04	58-55-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZFXYFBGIUFBOJW-UHFFFAOYSA-N
5082	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	273	Disopyramide	Disopyramidum|Disopiramida	rythmodan cap 150mg|norpace ca	DRUGBANK	DB00280	C21H29N3O	small molecule	C01BA03	3737-09-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVTNFZQICZKOEM-UHFFFAOYNA-N
5083	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Shimizu W (2000)	11196553	174870	273	Disopyramide	Disopyramidum|Disopiramida	rythmodan cap 150mg|norpace ca	DRUGBANK	DB00280	C21H29N3O	small molecule	C01BA03	3737-09-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVTNFZQICZKOEM-UHFFFAOYNA-N
5084	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Sugao M (2005)	15897781	174868	273	Disopyramide	Disopyramidum|Disopiramida	rythmodan cap 150mg|norpace ca	DRUGBANK	DB00280	C21H29N3O	small molecule	C01BA03	3737-09-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVTNFZQICZKOEM-UHFFFAOYNA-N
5085	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Fujiki A (2004)	15028073	174869	273	Disopyramide	Disopyramidum|Disopiramida	rythmodan cap 150mg|norpace ca	DRUGBANK	DB00280	C21H29N3O	small molecule	C01BA03	3737-09-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVTNFZQICZKOEM-UHFFFAOYNA-N
5093	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Karoly R (2010)	20585544	174878	274	Lidocaine	2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide|alpha-diethylamino-2,6-dimethylacetanilide|Lignocaine|2-(Diethylamino)-2',6'-acetoxylidide|-diethylamino-2,6-dimethylacetanilide	scar zone burn gel|sting relie	DRUGBANK	DB00281	C14H22N2O	small molecule	C05AD01|N01BB52|D04AB01|C01BB01|N01BB02|R02AD02|S01HA07|S02DA01	137-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNJVILVZKWQKPM-UHFFFAOYSA-N
5094	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Cerne A (2006)	16840798	174886	274	Lidocaine	2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide|alpha-diethylamino-2,6-dimethylacetanilide|Lignocaine|2-(Diethylamino)-2',6'-acetoxylidide|-diethylamino-2,6-dimethylacetanilide	scar zone burn gel|sting relie	DRUGBANK	DB00281	C14H22N2O	small molecule	C05AD01|N01BB52|D04AB01|C01BB01|N01BB02|R02AD02|S01HA07|S02DA01	137-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNJVILVZKWQKPM-UHFFFAOYSA-N
5095	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Itoh H (2007)	17445919	174884	274	Lidocaine	2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide|alpha-diethylamino-2,6-dimethylacetanilide|Lignocaine|2-(Diethylamino)-2',6'-acetoxylidide|-diethylamino-2,6-dimethylacetanilide	scar zone burn gel|sting relie	DRUGBANK	DB00281	C14H22N2O	small molecule	C05AD01|N01BB52|D04AB01|C01BB01|N01BB02|R02AD02|S01HA07|S02DA01	137-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNJVILVZKWQKPM-UHFFFAOYSA-N
5096	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Wallace CH (2006)	17016511	174885	274	Lidocaine	2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide|alpha-diethylamino-2,6-dimethylacetanilide|Lignocaine|2-(Diethylamino)-2',6'-acetoxylidide|-diethylamino-2,6-dimethylacetanilide	scar zone burn gel|sting relie	DRUGBANK	DB00281	C14H22N2O	small molecule	C05AD01|N01BB52|D04AB01|C01BB01|N01BB02|R02AD02|S01HA07|S02DA01	137-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNJVILVZKWQKPM-UHFFFAOYSA-N
5097	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Fedida D (2006)	16686685	174883	274	Lidocaine	2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide|alpha-diethylamino-2,6-dimethylacetanilide|Lignocaine|2-(Diethylamino)-2',6'-acetoxylidide|-diethylamino-2,6-dimethylacetanilide	scar zone burn gel|sting relie	DRUGBANK	DB00281	C14H22N2O	small molecule	C05AD01|N01BB52|D04AB01|C01BB01|N01BB02|R02AD02|S01HA07|S02DA01	137-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNJVILVZKWQKPM-UHFFFAOYSA-N
5098	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Muroi Y (2009)	19088384	174879	274	Lidocaine	2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide|alpha-diethylamino-2,6-dimethylacetanilide|Lignocaine|2-(Diethylamino)-2',6'-acetoxylidide|-diethylamino-2,6-dimethylacetanilide	scar zone burn gel|sting relie	DRUGBANK	DB00281	C14H22N2O	small molecule	C05AD01|N01BB52|D04AB01|C01BB01|N01BB02|R02AD02|S01HA07|S02DA01	137-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNJVILVZKWQKPM-UHFFFAOYSA-N
5341	114817	9424	-	KCNK6	K2p6.1|KCNK8|TOSS|TWIK-2|TWIK2	9606	Homo sapiens	inhibitor	target	Doggrell SA (2005)	15926871	175081	301	Ibutilide	Ibutilida|N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide|Ibutilidum|Ibutilide|Ibutilid	ibutilide fumarate|corvert	DRUGBANK	DB00308	C20H36N2O3S	small molecule	C01BD05	122647-31-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALOBUEHUHMBRLE-UHFFFAOYSA-N
5342	114817	9424	-	KCNK6	K2p6.1|KCNK8|TOSS|TWIK-2|TWIK2	9606	Homo sapiens	inhibitor	target	Foster RH (1997)	9257085	175082	301	Ibutilide	Ibutilida|N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide|Ibutilidum|Ibutilide|Ibutilid	ibutilide fumarate|corvert	DRUGBANK	DB00308	C20H36N2O3S	small molecule	C01BD05	122647-31-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALOBUEHUHMBRLE-UHFFFAOYSA-N
5345	124667	90134	-	KCNH7	ERG3|HERG3|Kv11.3	9606	Homo sapiens	inhibitor	target	Doggrell SA (2005)	15926871	175081	301	Ibutilide	Ibutilida|N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide|Ibutilidum|Ibutilide|Ibutilid	ibutilide fumarate|corvert	DRUGBANK	DB00308	C20H36N2O3S	small molecule	C01BD05	122647-31-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALOBUEHUHMBRLE-UHFFFAOYSA-N
5346	124667	90134	-	KCNH7	ERG3|HERG3|Kv11.3	9606	Homo sapiens	inhibitor	target	Foster RH (1997)	9257085	175082	301	Ibutilide	Ibutilida|N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide|Ibutilidum|Ibutilide|Ibutilid	ibutilide fumarate|corvert	DRUGBANK	DB00308	C20H36N2O3S	small molecule	C01BD05	122647-31-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALOBUEHUHMBRLE-UHFFFAOYSA-N
5434	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	unknown	target	Farber NB (2002)	12192617	175117	306	Valproic Acid	2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico	dom-valproic acid syrup|divalp	DRUGBANK	DB00313	C8H16O2	small molecule	N03AG01	99-66-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIJJYAXOARWZEE-UHFFFAOYSA-N
5435	112229	6324	-	SCN1B	ATFB13|BRGDA5|GEFSP1	9606	Homo sapiens	unknown	target	Farber NB (2002)	12192617	175117	306	Valproic Acid	2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico	dom-valproic acid syrup|divalp	DRUGBANK	DB00313	C8H16O2	small molecule	N03AG01	99-66-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIJJYAXOARWZEE-UHFFFAOYSA-N
5466	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	de Almeida RM (2001)	11594437	175130	308	Zolmitriptan	Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90	sandoz zolmitriptan odt|mar-zo	DRUGBANK	DB00315	C16H21N3O2	small molecule	N02CC03	139264-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULSDMUVEXKOYBU-ZDUSSCGKSA-N
5467	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Pascual J (1998)	9859690	175129	308	Zolmitriptan	Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90	sandoz zolmitriptan odt|mar-zo	DRUGBANK	DB00315	C16H21N3O2	small molecule	N02CC03	139264-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULSDMUVEXKOYBU-ZDUSSCGKSA-N
5468	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Reuter U (2004)	15096229	175126	308	Zolmitriptan	Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90	sandoz zolmitriptan odt|mar-zo	DRUGBANK	DB00315	C16H21N3O2	small molecule	N02CC03	139264-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULSDMUVEXKOYBU-ZDUSSCGKSA-N
5469	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Le Grand B (2000)	10844127	175127	308	Zolmitriptan	Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90	sandoz zolmitriptan odt|mar-zo	DRUGBANK	DB00315	C16H21N3O2	small molecule	N02CC03	139264-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULSDMUVEXKOYBU-ZDUSSCGKSA-N
5470	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Whale R (1999)	10463324	175124	308	Zolmitriptan	Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90	sandoz zolmitriptan odt|mar-zo	DRUGBANK	DB00315	C16H21N3O2	small molecule	N02CC03	139264-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULSDMUVEXKOYBU-ZDUSSCGKSA-N
5471	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Martin GR (1997)	9399012	175123	308	Zolmitriptan	Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90	sandoz zolmitriptan odt|mar-zo	DRUGBANK	DB00315	C16H21N3O2	small molecule	N02CC03	139264-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULSDMUVEXKOYBU-ZDUSSCGKSA-N
5472	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Gowin JL (2010)	20407761	175128	308	Zolmitriptan	Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90	sandoz zolmitriptan odt|mar-zo	DRUGBANK	DB00315	C16H21N3O2	small molecule	N02CC03	139264-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULSDMUVEXKOYBU-ZDUSSCGKSA-N
5473	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Hargreaves RJ (1999)	10563228	175125	308	Zolmitriptan	Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90	sandoz zolmitriptan odt|mar-zo	DRUGBANK	DB00315	C16H21N3O2	small molecule	N02CC03	139264-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULSDMUVEXKOYBU-ZDUSSCGKSA-N
5474	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Johnson DE (2001)	11513839	174444	308	Zolmitriptan	Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90	sandoz zolmitriptan odt|mar-zo	DRUGBANK	DB00315	C16H21N3O2	small molecule	N02CC03	139264-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULSDMUVEXKOYBU-ZDUSSCGKSA-N
5475	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	308	Zolmitriptan	Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90	sandoz zolmitriptan odt|mar-zo	DRUGBANK	DB00315	C16H21N3O2	small molecule	N02CC03	139264-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULSDMUVEXKOYBU-ZDUSSCGKSA-N
5477	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Lee YS (2007)	17175104	175138	309	Acetaminophen	actaminophne|p-hydroxyacetanilide|p-acetamidophenol|p-hydroxy-acetanilid|p-acetaminophenol|Acenol|N-acetyl-p-aminophenol|4-(Acetylamino)phenol|Paracetamolum|4'-hydroxyacetanilide|Paractamol|p-Acetylaminophenol|Acetaminophen|p-hydroxyphenolacetamide|Paracetamol|4-acetamidophenol|APAP|acetaminofn	tylenol cold and flu nighttime	DRUGBANK	DB00316	C8H9NO2	small molecule	N02BE71|N02BE01|N02BE51	103-90-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZVAJINKPMORJF-UHFFFAOYSA-N
5478	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	309	Acetaminophen	actaminophne|p-hydroxyacetanilide|p-acetamidophenol|p-hydroxy-acetanilid|p-acetaminophenol|Acenol|N-acetyl-p-aminophenol|4-(Acetylamino)phenol|Paracetamolum|4'-hydroxyacetanilide|Paractamol|p-Acetylaminophenol|Acetaminophen|p-hydroxyphenolacetamide|Paracetamol|4-acetamidophenol|APAP|acetaminofn	tylenol cold and flu nighttime	DRUGBANK	DB00316	C8H9NO2	small molecule	N02BE71|N02BE01|N02BE51	103-90-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZVAJINKPMORJF-UHFFFAOYSA-N
5479	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Weinheimer EM (2007)	17322116	175137	309	Acetaminophen	actaminophne|p-hydroxyacetanilide|p-acetamidophenol|p-hydroxy-acetanilid|p-acetaminophenol|Acenol|N-acetyl-p-aminophenol|4-(Acetylamino)phenol|Paracetamolum|4'-hydroxyacetanilide|Paractamol|p-Acetylaminophenol|Acetaminophen|p-hydroxyphenolacetamide|Paracetamol|4-acetamidophenol|APAP|acetaminofn	tylenol cold and flu nighttime	DRUGBANK	DB00316	C8H9NO2	small molecule	N02BE71|N02BE01|N02BE51	103-90-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZVAJINKPMORJF-UHFFFAOYSA-N
5480	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Hinz B (2008)	17884974	175136	309	Acetaminophen	actaminophne|p-hydroxyacetanilide|p-acetamidophenol|p-hydroxy-acetanilid|p-acetaminophenol|Acenol|N-acetyl-p-aminophenol|4-(Acetylamino)phenol|Paracetamolum|4'-hydroxyacetanilide|Paractamol|p-Acetylaminophenol|Acetaminophen|p-hydroxyphenolacetamide|Paracetamol|4-acetamidophenol|APAP|acetaminofn	tylenol cold and flu nighttime	DRUGBANK	DB00316	C8H9NO2	small molecule	N02BE71|N02BE01|N02BE51	103-90-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZVAJINKPMORJF-UHFFFAOYSA-N
5511	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Buzzi MG (1991)	1660351	175180	313	Dihydroergotamine	Dihydroergotamine|Diidroergotamina|Dihydroergotamin|9,10-dihydro-12'-Hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione|(2R,4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1(16),9,12,14-tetraene-4-carboxamide|Dihidroergotamina|Dihydroergotaminum|9,10-dihydroergotamine|5'-Benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman	migranal nasal spray 4mg/ml|di	DRUGBANK	DB00320	C33H37N5O5	small molecule	N02CA01|N02CA51	511-12-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUZRJRNZXALNLM-JGRZULCMSA-N
5512	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Villalon CM (2004)	14744615	175174	313	Dihydroergotamine	Dihydroergotamine|Diidroergotamina|Dihydroergotamin|9,10-dihydro-12'-Hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione|(2R,4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1(16),9,12,14-tetraene-4-carboxamide|Dihidroergotamina|Dihydroergotaminum|9,10-dihydroergotamine|5'-Benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman	migranal nasal spray 4mg/ml|di	DRUGBANK	DB00320	C33H37N5O5	small molecule	N02CA01|N02CA51	511-12-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUZRJRNZXALNLM-JGRZULCMSA-N
5513	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Yu XJ (1996)	8622623	175177	313	Dihydroergotamine	Dihydroergotamine|Diidroergotamina|Dihydroergotamin|9,10-dihydro-12'-Hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione|(2R,4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1(16),9,12,14-tetraene-4-carboxamide|Dihidroergotamina|Dihydroergotaminum|9,10-dihydroergotamine|5'-Benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman	migranal nasal spray 4mg/ml|di	DRUGBANK	DB00320	C33H37N5O5	small molecule	N02CA01|N02CA51	511-12-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUZRJRNZXALNLM-JGRZULCMSA-N
5514	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Willems EW (1999)	10455274	175179	313	Dihydroergotamine	Dihydroergotamine|Diidroergotamina|Dihydroergotamin|9,10-dihydro-12'-Hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione|(2R,4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1(16),9,12,14-tetraene-4-carboxamide|Dihidroergotamina|Dihydroergotaminum|9,10-dihydroergotamine|5'-Benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman	migranal nasal spray 4mg/ml|di	DRUGBANK	DB00320	C33H37N5O5	small molecule	N02CA01|N02CA51	511-12-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUZRJRNZXALNLM-JGRZULCMSA-N
5515	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Pauwels PJ (1998)	9650800	175178	313	Dihydroergotamine	Dihydroergotamine|Diidroergotamina|Dihydroergotamin|9,10-dihydro-12'-Hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione|(2R,4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1(16),9,12,14-tetraene-4-carboxamide|Dihidroergotamina|Dihydroergotaminum|9,10-dihydroergotamine|5'-Benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman	migranal nasal spray 4mg/ml|di	DRUGBANK	DB00320	C33H37N5O5	small molecule	N02CA01|N02CA51	511-12-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUZRJRNZXALNLM-JGRZULCMSA-N
5517	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	binder	target	Werling LL (2007)	17689532	175182	314	Amitriptyline	3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene	amitriptyline hydrochloride|ip	DRUGBANK	DB00321	C20H23N	small molecule	N06AA09|N06CA01	50-48-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRMDCWKBEZIMAB-UHFFFAOYSA-N
5532	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	agonist	target	Villard V (2011)	21427517	175190	314	Amitriptyline	3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene	amitriptyline hydrochloride|ip	DRUGBANK	DB00321	C20H23N	small molecule	N06AA09|N06CA01	50-48-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRMDCWKBEZIMAB-UHFFFAOYSA-N
5533	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	agonist	target	Werling LL (2007)	17689532	175182	314	Amitriptyline	3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene	amitriptyline hydrochloride|ip	DRUGBANK	DB00321	C20H23N	small molecule	N06AA09|N06CA01	50-48-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRMDCWKBEZIMAB-UHFFFAOYSA-N
5614	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Pilane CM (2005)	15668944	175250	321	Indomethacin	Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina	indocid cap 25mg|tivorbex|apo 	DRUGBANK	DB00328	C19H16ClNO4	small molecule	M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03	53-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CGIGDMFJXJATDK-UHFFFAOYSA-N
5615	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Jerde TJ (2005)	15667901	175249	321	Indomethacin	Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina	indocid cap 25mg|tivorbex|apo 	DRUGBANK	DB00328	C19H16ClNO4	small molecule	M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03	53-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CGIGDMFJXJATDK-UHFFFAOYSA-N
5616	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Yokota A (2005)	15831440	175248	321	Indomethacin	Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina	indocid cap 25mg|tivorbex|apo 	DRUGBANK	DB00328	C19H16ClNO4	small molecule	M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03	53-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CGIGDMFJXJATDK-UHFFFAOYSA-N
5617	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Armstrong PJ (2005)	15770365	175247	321	Indomethacin	Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina	indocid cap 25mg|tivorbex|apo 	DRUGBANK	DB00328	C19H16ClNO4	small molecule	M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03	53-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CGIGDMFJXJATDK-UHFFFAOYSA-N
5618	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Zhang GS (2004)	15730717	175251	321	Indomethacin	Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina	indocid cap 25mg|tivorbex|apo 	DRUGBANK	DB00328	C19H16ClNO4	small molecule	M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03	53-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CGIGDMFJXJATDK-UHFFFAOYSA-N
5619	111551	5564	-	PRKAB1	AMPK|HAMPKb	9606	Homo sapiens	inducer	target	Ruderman NB (2003)	14500570	175273	323	Metformin	Metformine|Metformine pamoate|Haurymellin|1,1-Dimethylbiguanide|Metformina|N,N-Dimethylimidodicarbonimidic diamide|Metforminum|Metformin|Dimethylbiguanid	apo-metformin 850 mg tablets|g	DRUGBANK	DB00331	C4H11N5	small molecule	A10BD03|A10BD05|A10BD11|A10BD10|A10BD02|A10BD13|A10BD14|A10BD15|A10BD16|A10BD17|A10BD18|A10BD07|A10BD08|A10BA02|A10BD20	657-24-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XZWYZXLIPXDOLR-UHFFFAOYSA-N
5620	111551	5564	-	PRKAB1	AMPK|HAMPKb	9606	Homo sapiens	inducer	target	Kovacic S (2003)	12890675	175276	323	Metformin	Metformine|Metformine pamoate|Haurymellin|1,1-Dimethylbiguanide|Metformina|N,N-Dimethylimidodicarbonimidic diamide|Metforminum|Metformin|Dimethylbiguanid	apo-metformin 850 mg tablets|g	DRUGBANK	DB00331	C4H11N5	small molecule	A10BD03|A10BD05|A10BD11|A10BD10|A10BD02|A10BD13|A10BD14|A10BD15|A10BD16|A10BD17|A10BD18|A10BD07|A10BD08|A10BA02|A10BD20	657-24-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XZWYZXLIPXDOLR-UHFFFAOYSA-N
5621	111551	5564	-	PRKAB1	AMPK|HAMPKb	9606	Homo sapiens	inducer	target	Vucicevic L (2009)	19428322	175277	323	Metformin	Metformine|Metformine pamoate|Haurymellin|1,1-Dimethylbiguanide|Metformina|N,N-Dimethylimidodicarbonimidic diamide|Metforminum|Metformin|Dimethylbiguanid	apo-metformin 850 mg tablets|g	DRUGBANK	DB00331	C4H11N5	small molecule	A10BD03|A10BD05|A10BD11|A10BD10|A10BD02|A10BD13|A10BD14|A10BD15|A10BD16|A10BD17|A10BD18|A10BD07|A10BD08|A10BA02|A10BD20	657-24-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XZWYZXLIPXDOLR-UHFFFAOYSA-N
5622	111551	5564	-	PRKAB1	AMPK|HAMPKb	9606	Homo sapiens	inducer	target	Leverve XM (2003)	14502105	175274	323	Metformin	Metformine|Metformine pamoate|Haurymellin|1,1-Dimethylbiguanide|Metformina|N,N-Dimethylimidodicarbonimidic diamide|Metforminum|Metformin|Dimethylbiguanid	apo-metformin 850 mg tablets|g	DRUGBANK	DB00331	C4H11N5	small molecule	A10BD03|A10BD05|A10BD11|A10BD10|A10BD02|A10BD13|A10BD14|A10BD15|A10BD16|A10BD17|A10BD18|A10BD07|A10BD08|A10BA02|A10BD20	657-24-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XZWYZXLIPXDOLR-UHFFFAOYSA-N
5623	111551	5564	-	PRKAB1	AMPK|HAMPKb	9606	Homo sapiens	inducer	target	Leclerc I (2004)	14871885	175275	323	Metformin	Metformine|Metformine pamoate|Haurymellin|1,1-Dimethylbiguanide|Metformina|N,N-Dimethylimidodicarbonimidic diamide|Metforminum|Metformin|Dimethylbiguanid	apo-metformin 850 mg tablets|g	DRUGBANK	DB00331	C4H11N5	small molecule	A10BD03|A10BD05|A10BD11|A10BD10|A10BD02|A10BD13|A10BD14|A10BD15|A10BD16|A10BD17|A10BD18|A10BD07|A10BD08|A10BA02|A10BD20	657-24-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XZWYZXLIPXDOLR-UHFFFAOYSA-N
5624	111551	5564	-	PRKAB1	AMPK|HAMPKb	9606	Homo sapiens	inducer	target	Hardie DG (2003)	12960015	175278	323	Metformin	Metformine|Metformine pamoate|Haurymellin|1,1-Dimethylbiguanide|Metformina|N,N-Dimethylimidodicarbonimidic diamide|Metforminum|Metformin|Dimethylbiguanid	apo-metformin 850 mg tablets|g	DRUGBANK	DB00331	C4H11N5	small molecule	A10BD03|A10BD05|A10BD11|A10BD10|A10BD02|A10BD13|A10BD14|A10BD15|A10BD16|A10BD17|A10BD18|A10BD07|A10BD08|A10BA02|A10BD20	657-24-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XZWYZXLIPXDOLR-UHFFFAOYSA-N
5625	111551	5564	-	PRKAB1	AMPK|HAMPKb	9606	Homo sapiens	inducer	target	Towler MC (2007)	17307971	175279	323	Metformin	Metformine|Metformine pamoate|Haurymellin|1,1-Dimethylbiguanide|Metformina|N,N-Dimethylimidodicarbonimidic diamide|Metforminum|Metformin|Dimethylbiguanid	apo-metformin 850 mg tablets|g	DRUGBANK	DB00331	C4H11N5	small molecule	A10BD03|A10BD05|A10BD11|A10BD10|A10BD02|A10BD13|A10BD14|A10BD15|A10BD16|A10BD17|A10BD18|A10BD07|A10BD08|A10BA02|A10BD20	657-24-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XZWYZXLIPXDOLR-UHFFFAOYSA-N
5626	111551	5564	-	PRKAB1	AMPK|HAMPKb	9606	Homo sapiens	inducer	target	Musi N (2002)	12086935	175280	323	Metformin	Metformine|Metformine pamoate|Haurymellin|1,1-Dimethylbiguanide|Metformina|N,N-Dimethylimidodicarbonimidic diamide|Metforminum|Metformin|Dimethylbiguanid	apo-metformin 850 mg tablets|g	DRUGBANK	DB00331	C4H11N5	small molecule	A10BD03|A10BD05|A10BD11|A10BD10|A10BD02|A10BD13|A10BD14|A10BD15|A10BD16|A10BD17|A10BD18|A10BD07|A10BD08|A10BA02|A10BD20	657-24-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XZWYZXLIPXDOLR-UHFFFAOYSA-N
5648	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5662	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Shahid M (2009)	18308814	175311	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5663	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Fernandez J (2005)	15771415	175310	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5664	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5665	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Bymaster FP (1999)	10227113	175304	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5666	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5691	109593	3361	-	HTR5A	5-HT5A	9606	Homo sapiens	antagonist	target	Shahid M (2009)	18308814	175311	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5904	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	345	Methylergometrine	9,10-Didehydro-N-[1-(hydroxymethyl)-propyl]-D-lysergamide|D-lysergic acid 1-butanolamide|Mthylergomtrine|Metilergometrina|Methylergometrine|Methylergometrinum|Ergotyl|Methergine|Methylergometrin|Methylergobasin|Methylergonovine	methylergonovine maleate|methe	DRUGBANK	DB00353	C20H25N3O2	small molecule	G02AB01|G02AC01	113-42-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNBRKDKAWYKMIV-QWQRMKEZSA-N
5905	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	345	Methylergometrine	9,10-Didehydro-N-[1-(hydroxymethyl)-propyl]-D-lysergamide|D-lysergic acid 1-butanolamide|Mthylergomtrine|Metilergometrina|Methylergometrine|Methylergometrinum|Ergotyl|Methergine|Methylergometrin|Methylergobasin|Methylergonovine	methylergonovine maleate|methe	DRUGBANK	DB00353	C20H25N3O2	small molecule	G02AB01|G02AC01	113-42-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNBRKDKAWYKMIV-QWQRMKEZSA-N
5906	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	345	Methylergometrine	9,10-Didehydro-N-[1-(hydroxymethyl)-propyl]-D-lysergamide|D-lysergic acid 1-butanolamide|Mthylergomtrine|Metilergometrina|Methylergometrine|Methylergometrinum|Ergotyl|Methergine|Methylergometrin|Methylergobasin|Methylergonovine	methylergonovine maleate|methe	DRUGBANK	DB00353	C20H25N3O2	small molecule	G02AB01|G02AC01	113-42-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNBRKDKAWYKMIV-QWQRMKEZSA-N
5907	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Reyes FD (2005)	15930499	175441	345	Methylergometrine	9,10-Didehydro-N-[1-(hydroxymethyl)-propyl]-D-lysergamide|D-lysergic acid 1-butanolamide|Mthylergomtrine|Metilergometrina|Methylergometrine|Methylergometrinum|Ergotyl|Methergine|Methylergometrin|Methylergobasin|Methylergonovine	methylergonovine maleate|methe	DRUGBANK	DB00353	C20H25N3O2	small molecule	G02AB01|G02AC01	113-42-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNBRKDKAWYKMIV-QWQRMKEZSA-N
5908	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Nargeot R (1999)	10200235	175442	345	Methylergometrine	9,10-Didehydro-N-[1-(hydroxymethyl)-propyl]-D-lysergamide|D-lysergic acid 1-butanolamide|Mthylergomtrine|Metilergometrina|Methylergometrine|Methylergometrinum|Ergotyl|Methergine|Methylergometrin|Methylergobasin|Methylergonovine	methylergonovine maleate|methe	DRUGBANK	DB00353	C20H25N3O2	small molecule	G02AB01|G02AC01	113-42-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNBRKDKAWYKMIV-QWQRMKEZSA-N
5969	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
5978	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
6141	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	binder	target	de Boer T (1995)	8930006	175620	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6142	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	binder	target	Fernandez J (2005)	15771415	175310	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6143	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	binder	target	de Boer TH (1988)	3419539	175611	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6196	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	364	Thiethylperazine	Thiethylperazine|Tietilperazina|Thithylprazine|Norzine|Thiethylperazin|Thiethylperazinum|2-(ethylthio)-10-[3-(4-methylpiperazin-1-yl)propyl]-10H-phenothiazine	-	DRUGBANK	DB00372	C22H29N3S2	small molecule	R06AD03	1420-55-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCTYLCDETUVOIP-UHFFFAOYSA-N
6197	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	364	Thiethylperazine	Thiethylperazine|Tietilperazina|Thithylprazine|Norzine|Thiethylperazin|Thiethylperazinum|2-(ethylthio)-10-[3-(4-methylpiperazin-1-yl)propyl]-10H-phenothiazine	-	DRUGBANK	DB00372	C22H29N3S2	small molecule	R06AD03	1420-55-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCTYLCDETUVOIP-UHFFFAOYSA-N
6256	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Shimizu W (2000)	11196553	174870	371	Mexiletine	1-Methyl-2-(2,6-xylyloxy)ethanamine|(2RS)-1-(2,6-dimethylphenoxy)-2-aminopropane|Mexiltine|Mexiletinum|1-(2',6'-Dimethylphenoxy)-2-aminopropane|(+-)-1-(2,6-Dimethylphenoxy)propan-2-amine|Mexiletina|1-(2,6-Dimethylphenoxy)-2-propanamine	teva-mexiletine|mexitil cap 20	DRUGBANK	DB00379	C11H17NO	small molecule	C01BB02	31828-71-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VLPIATFUUWWMKC-UHFFFAOYSA-N
6257	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	371	Mexiletine	1-Methyl-2-(2,6-xylyloxy)ethanamine|(2RS)-1-(2,6-dimethylphenoxy)-2-aminopropane|Mexiltine|Mexiletinum|1-(2',6'-Dimethylphenoxy)-2-aminopropane|(+-)-1-(2,6-Dimethylphenoxy)propan-2-amine|Mexiletina|1-(2,6-Dimethylphenoxy)-2-propanamine	teva-mexiletine|mexitil cap 20	DRUGBANK	DB00379	C11H17NO	small molecule	C01BB02	31828-71-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VLPIATFUUWWMKC-UHFFFAOYSA-N
6258	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Fabritz L (2003)	12650887	175676	371	Mexiletine	1-Methyl-2-(2,6-xylyloxy)ethanamine|(2RS)-1-(2,6-dimethylphenoxy)-2-aminopropane|Mexiltine|Mexiletinum|1-(2',6'-Dimethylphenoxy)-2-aminopropane|(+-)-1-(2,6-Dimethylphenoxy)propan-2-amine|Mexiletina|1-(2,6-Dimethylphenoxy)-2-propanamine	teva-mexiletine|mexitil cap 20	DRUGBANK	DB00379	C11H17NO	small molecule	C01BB02	31828-71-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VLPIATFUUWWMKC-UHFFFAOYSA-N
6259	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Napolitano C (2006)	16168489	175677	371	Mexiletine	1-Methyl-2-(2,6-xylyloxy)ethanamine|(2RS)-1-(2,6-dimethylphenoxy)-2-aminopropane|Mexiltine|Mexiletinum|1-(2',6'-Dimethylphenoxy)-2-aminopropane|(+-)-1-(2,6-Dimethylphenoxy)propan-2-amine|Mexiletina|1-(2,6-Dimethylphenoxy)-2-propanamine	teva-mexiletine|mexitil cap 20	DRUGBANK	DB00379	C11H17NO	small molecule	C01BB02	31828-71-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VLPIATFUUWWMKC-UHFFFAOYSA-N
6260	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Valdivia CR (2002)	12123767	175674	371	Mexiletine	1-Methyl-2-(2,6-xylyloxy)ethanamine|(2RS)-1-(2,6-dimethylphenoxy)-2-aminopropane|Mexiltine|Mexiletinum|1-(2',6'-Dimethylphenoxy)-2-aminopropane|(+-)-1-(2,6-Dimethylphenoxy)propan-2-amine|Mexiletina|1-(2,6-Dimethylphenoxy)-2-propanamine	teva-mexiletine|mexitil cap 20	DRUGBANK	DB00379	C11H17NO	small molecule	C01BB02	31828-71-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VLPIATFUUWWMKC-UHFFFAOYSA-N
6261	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Wang HW (2003)	12676070	175675	371	Mexiletine	1-Methyl-2-(2,6-xylyloxy)ethanamine|(2RS)-1-(2,6-dimethylphenoxy)-2-aminopropane|Mexiltine|Mexiletinum|1-(2',6'-Dimethylphenoxy)-2-aminopropane|(+-)-1-(2,6-Dimethylphenoxy)propan-2-amine|Mexiletina|1-(2,6-Dimethylphenoxy)-2-propanamine	teva-mexiletine|mexitil cap 20	DRUGBANK	DB00379	C11H17NO	small molecule	C01BB02	31828-71-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VLPIATFUUWWMKC-UHFFFAOYSA-N
6262	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Chinushi M (2003)	12604879	175678	371	Mexiletine	1-Methyl-2-(2,6-xylyloxy)ethanamine|(2RS)-1-(2,6-dimethylphenoxy)-2-aminopropane|Mexiltine|Mexiletinum|1-(2',6'-Dimethylphenoxy)-2-aminopropane|(+-)-1-(2,6-Dimethylphenoxy)propan-2-amine|Mexiletina|1-(2,6-Dimethylphenoxy)-2-propanamine	teva-mexiletine|mexitil cap 20	DRUGBANK	DB00379	C11H17NO	small molecule	C01BB02	31828-71-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VLPIATFUUWWMKC-UHFFFAOYSA-N
6469	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	partial agonist	target	Cheng JT (2003)	12873745	175802	389	Phenylpropanolamine	PPA|Fenilpropanolamina|Phnylpropanolamine|Phenylpropanolamin|Phenylpropanolaminum|Norephedrine|-hydroxyamphetamine|2-amino-1-phenylpropan-1-ol|Norephedrin	trisulfaminic tab|tantacol dm 	DRUGBANK	DB00397	C9H13NO	small molecule	R01BA51|R01BA01	14838-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DLNKOYKMWOXYQA-VXNVDRBHSA-N
6600	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	400	Loxapine	Loxapinum|2-Chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine|Cloxazepine|oxilapine|Loxapine|Loxapina	loxapine succinate tablets 50m	DRUGBANK	DB00408	C18H18ClN3O	small molecule	N05AH01	1977-10-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJGVXQDUIWGIRW-UHFFFAOYSA-N
6610	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	antagonist	target	Lang A (1994)	7800667	175884	401	Remoxipride	Remoxipridum|Roxiam|Romoxipride|FLA-731|a-33547|Remoxipride|Remoxiprida	-	DRUGBANK	DB00409	C16H23BrN2O3	small molecule	N05AL04	80125-14-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUJRSXAPGDDABA-NSHDSACASA-N
6611	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	antagonist	target	Okuyama S (1999)	10562961	175883	401	Remoxipride	Remoxipridum|Roxiam|Romoxipride|FLA-731|a-33547|Remoxipride|Remoxiprida	-	DRUGBANK	DB00409	C16H23BrN2O3	small molecule	N05AL04	80125-14-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUJRSXAPGDDABA-NSHDSACASA-N
6640	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	unknown	target	Kvernmo T (2008)	18691132	174662	405	Pramipexole	(S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum	auro-pramipexole|mylan-pramipe	DRUGBANK	DB00413	C10H17N3S	small molecule	N04BC05	104632-26-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FASDKYOPVNHBLU-ZETCQYMHSA-N
6641	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	unknown	target	Lam YW (2000)	10641988	174664	405	Pramipexole	(S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum	auro-pramipexole|mylan-pramipe	DRUGBANK	DB00413	C10H17N3S	small molecule	N04BC05	104632-26-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FASDKYOPVNHBLU-ZETCQYMHSA-N
6660	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	unknown	target	Lam YW (2000)	10641988	174664	405	Pramipexole	(S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum	auro-pramipexole|mylan-pramipe	DRUGBANK	DB00413	C10H17N3S	small molecule	N04BC05	104632-26-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FASDKYOPVNHBLU-ZETCQYMHSA-N
6745	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	412	Promazine	10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine	promazine hcl inj 50mg/ml	DRUGBANK	DB00420	C17H20N2S	small molecule	N05AA03	58-40-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZGUGWUXLJSTTMA-UHFFFAOYSA-N
6746	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	412	Promazine	10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine	promazine hcl inj 50mg/ml	DRUGBANK	DB00420	C17H20N2S	small molecule	N05AA03	58-40-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZGUGWUXLJSTTMA-UHFFFAOYSA-N
7086	124667	90134	-	KCNH7	ERG3|HERG3|Kv11.3	9606	Homo sapiens	inhibitor	target	Thomas D (2004)	15098086	176200	449	Prazosin	Prazosine|Prazosinum|2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline|Prazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine	prazosin hydrochloride|alti-pr	DRUGBANK	DB00457	C19H21N5O4	small molecule	C02LE01|C02CA01	19216-56-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IENZQIKPVFGBNW-UHFFFAOYSA-N
7096	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	binder	target	Toll L (1998)	9686407	176206	450	Imipramine	N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin	tofranil|imipramine tab 25mg|i	DRUGBANK	DB00458	C19H24N2	small molecule	N06AA02	50-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCGWQEUPMDMJNV-UHFFFAOYSA-N
7154	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	453	Nabumetone	Nabumtone|4-(6-Methoxy-2-naphthalenyl)-2-butanone|Nabumetona|4-(6-Methoxy-2-naphthyl)-2-butanone|Nabumeton|Nabumetonum|Relafen|Nabumetone	apo-nabumetone|relafen tablets	DRUGBANK	DB00461	C15H16O2	small molecule	M01AX01	42924-53-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLXXJMDCKKHMKV-UHFFFAOYSA-N
7155	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Elliott SN (1995)	7615202	176244	453	Nabumetone	Nabumtone|4-(6-Methoxy-2-naphthalenyl)-2-butanone|Nabumetona|4-(6-Methoxy-2-naphthyl)-2-butanone|Nabumeton|Nabumetonum|Relafen|Nabumetone	apo-nabumetone|relafen tablets	DRUGBANK	DB00461	C15H16O2	small molecule	M01AX01	42924-53-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLXXJMDCKKHMKV-UHFFFAOYSA-N
7156	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Roy HK (2001)	11304699	176245	453	Nabumetone	Nabumtone|4-(6-Methoxy-2-naphthalenyl)-2-butanone|Nabumetona|4-(6-Methoxy-2-naphthyl)-2-butanone|Nabumeton|Nabumetonum|Relafen|Nabumetone	apo-nabumetone|relafen tablets	DRUGBANK	DB00461	C15H16O2	small molecule	M01AX01	42924-53-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLXXJMDCKKHMKV-UHFFFAOYSA-N
7157	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Hedner T (2004)	15456329	176242	453	Nabumetone	Nabumtone|4-(6-Methoxy-2-naphthalenyl)-2-butanone|Nabumetona|4-(6-Methoxy-2-naphthyl)-2-butanone|Nabumeton|Nabumetonum|Relafen|Nabumetone	apo-nabumetone|relafen tablets	DRUGBANK	DB00461	C15H16O2	small molecule	M01AX01	42924-53-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLXXJMDCKKHMKV-UHFFFAOYSA-N
7158	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	van Kraaij DJ (2002)	12047490	176243	453	Nabumetone	Nabumtone|4-(6-Methoxy-2-naphthalenyl)-2-butanone|Nabumetona|4-(6-Methoxy-2-naphthyl)-2-butanone|Nabumeton|Nabumetonum|Relafen|Nabumetone	apo-nabumetone|relafen tablets	DRUGBANK	DB00461	C15H16O2	small molecule	M01AX01	42924-53-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLXXJMDCKKHMKV-UHFFFAOYSA-N
7159	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Fackovcova D (2001)	11153163	176241	453	Nabumetone	Nabumtone|4-(6-Methoxy-2-naphthalenyl)-2-butanone|Nabumetona|4-(6-Methoxy-2-naphthyl)-2-butanone|Nabumeton|Nabumetonum|Relafen|Nabumetone	apo-nabumetone|relafen tablets	DRUGBANK	DB00461	C15H16O2	small molecule	M01AX01	42924-53-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLXXJMDCKKHMKV-UHFFFAOYSA-N
7205	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Blais V (2002)	12446609	176260	457	Ketorolac	Ketorolacum|Ketorolaco|Ktorolac|(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid|rac-Ketorolac|(+-)-Ketorolac|Ketorolac	toradol|acular ls|toradol tab 	DRUGBANK	DB00465	C15H13NO3	small molecule	M01AB15|S01BC05	74103-06-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZWKMVRBQXNZKK-UHFFFAOYSA-N
7206	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Ma W (2003)	14568028	176261	457	Ketorolac	Ketorolacum|Ketorolaco|Ktorolac|(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid|rac-Ketorolac|(+-)-Ketorolac|Ketorolac	toradol|acular ls|toradol tab 	DRUGBANK	DB00465	C15H13NO3	small molecule	M01AB15|S01BC05	74103-06-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZWKMVRBQXNZKK-UHFFFAOYSA-N
7207	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Padi SS (2004)	15102535	176262	457	Ketorolac	Ketorolacum|Ketorolaco|Ktorolac|(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid|rac-Ketorolac|(+-)-Ketorolac|Ketorolac	toradol|acular ls|toradol tab 	DRUGBANK	DB00465	C15H13NO3	small molecule	M01AB15|S01BC05	74103-06-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZWKMVRBQXNZKK-UHFFFAOYSA-N
7208	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Hoecherl K (2002)	12110513	176263	457	Ketorolac	Ketorolacum|Ketorolaco|Ktorolac|(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid|rac-Ketorolac|(+-)-Ketorolac|Ketorolac	toradol|acular ls|toradol tab 	DRUGBANK	DB00465	C15H13NO3	small molecule	M01AB15|S01BC05	74103-06-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZWKMVRBQXNZKK-UHFFFAOYSA-N
7209	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Ma W (2003)	14568029	176264	457	Ketorolac	Ketorolacum|Ketorolaco|Ktorolac|(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid|rac-Ketorolac|(+-)-Ketorolac|Ketorolac	toradol|acular ls|toradol tab 	DRUGBANK	DB00465	C15H13NO3	small molecule	M01AB15|S01BC05	74103-06-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZWKMVRBQXNZKK-UHFFFAOYSA-N
7226	109984	3783	-	KCNN4	IK1|IKCA1|KCA4|KCa3.1|SK4|hIKCa1|hKCa4|hSK4	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	460	Quinine	(-)-Quinine|(8S,9R)-Quinine|Chinin|Chininum|(R)-(-)-Quinine|Chinine|Quinina|6'-Methoxycinchonidine|Quinine|(R)-(6-Methoxyquinolin-4-yl)((2S,4S,8R)-8-vinylquinuclidin-2-yl)methanol	quinine sulfate|quinine - odan	DRUGBANK	DB00468	C20H24N2O2	small molecule	M09AA72|P01BC01	130-95-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LOUPRKONTZGTKE-WZBLMQSHSA-N
7232	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	461	Tenoxicam	Tenoxicamum|Tnoxicam|Tenoxicam	tenoxicam tablets|tenoxicam-20	DRUGBANK	DB00469	C13H11N3O4S2	small molecule	M01AC02	59804-37-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZNWYQJJBLGYLT-UHFFFAOYSA-N
7233	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Galvao RI (2005)	15756931	176291	461	Tenoxicam	Tenoxicamum|Tnoxicam|Tenoxicam	tenoxicam tablets|tenoxicam-20	DRUGBANK	DB00469	C13H11N3O4S2	small molecule	M01AC02	59804-37-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZNWYQJJBLGYLT-UHFFFAOYSA-N
7234	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Yamada M (1997)	9152412	176290	461	Tenoxicam	Tenoxicamum|Tnoxicam|Tenoxicam	tenoxicam tablets|tenoxicam-20	DRUGBANK	DB00469	C13H11N3O4S2	small molecule	M01AC02	59804-37-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZNWYQJJBLGYLT-UHFFFAOYSA-N
7235	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Yilmaz H (2005)	16245223	176292	461	Tenoxicam	Tenoxicamum|Tnoxicam|Tenoxicam	tenoxicam tablets|tenoxicam-20	DRUGBANK	DB00469	C13H11N3O4S2	small molecule	M01AC02	59804-37-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZNWYQJJBLGYLT-UHFFFAOYSA-N
7236	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Kothekar V (2001)	11563332	176288	461	Tenoxicam	Tenoxicamum|Tnoxicam|Tenoxicam	tenoxicam tablets|tenoxicam-20	DRUGBANK	DB00469	C13H11N3O4S2	small molecule	M01AC02	59804-37-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZNWYQJJBLGYLT-UHFFFAOYSA-N
7237	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Ozgocmen S (2005)	15943176	176289	461	Tenoxicam	Tenoxicamum|Tnoxicam|Tenoxicam	tenoxicam tablets|tenoxicam-20	DRUGBANK	DB00469	C13H11N3O4S2	small molecule	M01AC02	59804-37-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZNWYQJJBLGYLT-UHFFFAOYSA-N
7261	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	465	Hexylcaine	Cyclaine|Hexylcaine|Hexilcaina|Hexylcainum	-	DRUGBANK	DB00473	C16H23NO2	small molecule	-	532-77-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKLKMKYDWHYZTD-UHFFFAOYSA-N
7262	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	465	Hexylcaine	Cyclaine|Hexylcaine|Hexilcaina|Hexylcainum	-	DRUGBANK	DB00473	C16H23NO2	small molecule	-	532-77-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKLKMKYDWHYZTD-UHFFFAOYSA-N
7263	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	465	Hexylcaine	Cyclaine|Hexylcaine|Hexilcaina|Hexylcainum	-	DRUGBANK	DB00473	C16H23NO2	small molecule	-	532-77-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKLKMKYDWHYZTD-UHFFFAOYSA-N
7318	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Kanba S (1994)	7918347	176330	469	Chlorpromazine	Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine	chlorpromanyl 20 syr|chlorprom	DRUGBANK	DB00477	C17H19ClN2S	small molecule	N05AA01	50-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPEIMTDSQAKGNT-UHFFFAOYSA-N
7327	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	unknown	target	Seeman P (1993)	8104554	176336	469	Chlorpromazine	Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine	chlorpromanyl 20 syr|chlorprom	DRUGBANK	DB00477	C17H19ClN2S	small molecule	N05AA01	50-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPEIMTDSQAKGNT-UHFFFAOYSA-N
7367	107438	1003	-	CDH5	7B4|CD144	9606	Homo sapiens	antagonist	target	Lu L (2009)	18805433	176372	472	Lenalidomide	1-oxo-2-(2,6-Dioxopiperidin-3-yl)-4-aminoisoindoline|IMid-1|CC-5013|IMiD3|Revlimid|3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione|CDC 501	revlimid	DRUGBANK	DB00480	C13H13N3O3	small molecule	L04AX04	191732-72-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GOTYRUGSSMKFNF-UHFFFAOYSA-N
7368	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	negative modulator	target	Payvandi F (2004)	15598423	176374	472	Lenalidomide	1-oxo-2-(2,6-Dioxopiperidin-3-yl)-4-aminoisoindoline|IMid-1|CC-5013|IMiD3|Revlimid|3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione|CDC 501	revlimid	DRUGBANK	DB00480	C13H13N3O3	small molecule	L04AX04	191732-72-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GOTYRUGSSMKFNF-UHFFFAOYSA-N
7369	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	negative modulator	target	Zeldis JB (2003)	12720152	176373	472	Lenalidomide	1-oxo-2-(2,6-Dioxopiperidin-3-yl)-4-aminoisoindoline|IMid-1|CC-5013|IMiD3|Revlimid|3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione|CDC 501	revlimid	DRUGBANK	DB00480	C13H13N3O3	small molecule	L04AX04	191732-72-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GOTYRUGSSMKFNF-UHFFFAOYSA-N
7390	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	474	Celecoxib	P-(5-P-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide|Celecoxibum|Celecoxib|Celebrex|Clcoxib	lupin-celecoxib|bio-celecoxib|	DRUGBANK	DB00482	C17H14F3N3O2S	small molecule	L01XX33|M01AH01	169590-42-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZEKVGVHFLEQIL-UHFFFAOYSA-N
7391	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Ahmad SR (2002)	12093311	176398	474	Celecoxib	P-(5-P-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide|Celecoxibum|Celecoxib|Celebrex|Clcoxib	lupin-celecoxib|bio-celecoxib|	DRUGBANK	DB00482	C17H14F3N3O2S	small molecule	L01XX33|M01AH01	169590-42-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZEKVGVHFLEQIL-UHFFFAOYSA-N
7392	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Scheiman JM (2002)	12086292	176394	474	Celecoxib	P-(5-P-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide|Celecoxibum|Celecoxib|Celebrex|Clcoxib	lupin-celecoxib|bio-celecoxib|	DRUGBANK	DB00482	C17H14F3N3O2S	small molecule	L01XX33|M01AH01	169590-42-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZEKVGVHFLEQIL-UHFFFAOYSA-N
7393	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Reddy BS (2002)	12086402	176395	474	Celecoxib	P-(5-P-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide|Celecoxibum|Celecoxib|Celebrex|Clcoxib	lupin-celecoxib|bio-celecoxib|	DRUGBANK	DB00482	C17H14F3N3O2S	small molecule	L01XX33|M01AH01	169590-42-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZEKVGVHFLEQIL-UHFFFAOYSA-N
7394	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Lu S (2002)	12104042	176396	474	Celecoxib	P-(5-P-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide|Celecoxibum|Celecoxib|Celebrex|Clcoxib	lupin-celecoxib|bio-celecoxib|	DRUGBANK	DB00482	C17H14F3N3O2S	small molecule	L01XX33|M01AH01	169590-42-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZEKVGVHFLEQIL-UHFFFAOYSA-N
7395	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Sigthorsson G (2002)	12055598	176397	474	Celecoxib	P-(5-P-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide|Celecoxibum|Celecoxib|Celebrex|Clcoxib	lupin-celecoxib|bio-celecoxib|	DRUGBANK	DB00482	C17H14F3N3O2S	small molecule	L01XX33|M01AH01	169590-42-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZEKVGVHFLEQIL-UHFFFAOYSA-N
7537	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	492	Tolmetin	Tolmetina|1-Methyl-5-(4-methylbenzoyl)-pyrrole-2-acetic acid|Tolmetino|5-(P-Toluoyl)-1-methylpyrrole-2-acetic acid|1-Methyl-5-P-toluoylpyrrole-2-acetic acid|Tolmetin|Tolmtine|Tolmetinum	tolectin 400 cap 400mg|tolmeti	DRUGBANK	DB00500	C15H15NO3	small molecule	M01AB03|M02AA21	26171-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UPSPUYADGBWSHF-UHFFFAOYSA-N
7538	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Kennedy JH (2003)	14613550	176516	492	Tolmetin	Tolmetina|1-Methyl-5-(4-methylbenzoyl)-pyrrole-2-acetic acid|Tolmetino|5-(P-Toluoyl)-1-methylpyrrole-2-acetic acid|1-Methyl-5-P-toluoylpyrrole-2-acetic acid|Tolmetin|Tolmtine|Tolmetinum	tolectin 400 cap 400mg|tolmeti	DRUGBANK	DB00500	C15H15NO3	small molecule	M01AB03|M02AA21	26171-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UPSPUYADGBWSHF-UHFFFAOYSA-N
7539	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Capasso A (1997)	9253954	176515	492	Tolmetin	Tolmetina|1-Methyl-5-(4-methylbenzoyl)-pyrrole-2-acetic acid|Tolmetino|5-(P-Toluoyl)-1-methylpyrrole-2-acetic acid|1-Methyl-5-P-toluoylpyrrole-2-acetic acid|Tolmetin|Tolmtine|Tolmetinum	tolectin 400 cap 400mg|tolmeti	DRUGBANK	DB00500	C15H15NO3	small molecule	M01AB03|M02AA21	26171-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UPSPUYADGBWSHF-UHFFFAOYSA-N
7540	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Burdan F (2004)	15458776	176519	492	Tolmetin	Tolmetina|1-Methyl-5-(4-methylbenzoyl)-pyrrole-2-acetic acid|Tolmetino|5-(P-Toluoyl)-1-methylpyrrole-2-acetic acid|1-Methyl-5-P-toluoylpyrrole-2-acetic acid|Tolmetin|Tolmtine|Tolmetinum	tolectin 400 cap 400mg|tolmeti	DRUGBANK	DB00500	C15H15NO3	small molecule	M01AB03|M02AA21	26171-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UPSPUYADGBWSHF-UHFFFAOYSA-N
7541	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Capasso A (1999)	10465690	176518	492	Tolmetin	Tolmetina|1-Methyl-5-(4-methylbenzoyl)-pyrrole-2-acetic acid|Tolmetino|5-(P-Toluoyl)-1-methylpyrrole-2-acetic acid|1-Methyl-5-P-toluoylpyrrole-2-acetic acid|Tolmetin|Tolmtine|Tolmetinum	tolectin 400 cap 400mg|tolmeti	DRUGBANK	DB00500	C15H15NO3	small molecule	M01AB03|M02AA21	26171-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UPSPUYADGBWSHF-UHFFFAOYSA-N
7542	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Kirkova M (2007)	17391279	176520	492	Tolmetin	Tolmetina|1-Methyl-5-(4-methylbenzoyl)-pyrrole-2-acetic acid|Tolmetino|5-(P-Toluoyl)-1-methylpyrrole-2-acetic acid|1-Methyl-5-P-toluoylpyrrole-2-acetic acid|Tolmetin|Tolmtine|Tolmetinum	tolectin 400 cap 400mg|tolmeti	DRUGBANK	DB00500	C15H15NO3	small molecule	M01AB03|M02AA21	26171-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UPSPUYADGBWSHF-UHFFFAOYSA-N
7567	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Cai G (1999)	10531405	176548	494	Haloperidol	1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol	apo-haloperidol tab 2mg|teva-h	DRUGBANK	DB00502	C21H23ClFNO2	small molecule	N05AD01	52-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNEPOXFFQSENCJ-UHFFFAOYSA-N
7568	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	494	Haloperidol	1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol	apo-haloperidol tab 2mg|teva-h	DRUGBANK	DB00502	C21H23ClFNO2	small molecule	N05AD01	52-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNEPOXFFQSENCJ-UHFFFAOYSA-N
7586	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	499	Triflupromazine	Fluopromazine|Triflupromazine|2-Trifluoromethyl-10-(gamma-dimethylaminopropyl)phenothiazine|Triflupromazinum|Triflupromazina|2-(Trifluoromethyl)promazine|Triflupromazin|10-(3-(Dimethylamino)propyl)-2-(trifluoromethyl)phenothiazine	-	DRUGBANK	DB00508	C18H19F3N2S	small molecule	N05AA05	146-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSCGXQMFQXDFCW-UHFFFAOYSA-N
7587	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	499	Triflupromazine	Fluopromazine|Triflupromazine|2-Trifluoromethyl-10-(gamma-dimethylaminopropyl)phenothiazine|Triflupromazinum|Triflupromazina|2-(Trifluoromethyl)promazine|Triflupromazin|10-(3-(Dimethylamino)propyl)-2-(trifluoromethyl)phenothiazine	-	DRUGBANK	DB00508	C18H19F3N2S	small molecule	N05AA05	146-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSCGXQMFQXDFCW-UHFFFAOYSA-N
7644	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	504	Dextromethorphan	Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum	tylenol cold and flu nighttime	DRUGBANK	DB00514	C18H25NO	small molecule	N07XX59|R05DA09	125-71-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKXZASYAUGDDCJ-NJAFHUGGSA-N
7645	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	504	Dextromethorphan	Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum	tylenol cold and flu nighttime	DRUGBANK	DB00514	C18H25NO	small molecule	N07XX59|R05DA09	125-71-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKXZASYAUGDDCJ-NJAFHUGGSA-N
7646	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	agonist	target	Chou YC (1999)	10064839	176582	504	Dextromethorphan	Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum	tylenol cold and flu nighttime	DRUGBANK	DB00514	C18H25NO	small molecule	N07XX59|R05DA09	125-71-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKXZASYAUGDDCJ-NJAFHUGGSA-N
7654	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	agonist	target	Shin EJ (2005)	15723099	176586	504	Dextromethorphan	Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum	tylenol cold and flu nighttime	DRUGBANK	DB00514	C18H25NO	small molecule	N07XX59|R05DA09	125-71-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKXZASYAUGDDCJ-NJAFHUGGSA-N
7655	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	agonist	target	Shin EJ (2007)	17386960	176587	504	Dextromethorphan	Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum	tylenol cold and flu nighttime	DRUGBANK	DB00514	C18H25NO	small molecule	N07XX59|R05DA09	125-71-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKXZASYAUGDDCJ-NJAFHUGGSA-N
7656	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	agonist	target	Church AJ (2005)	15716633	176585	504	Dextromethorphan	Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum	tylenol cold and flu nighttime	DRUGBANK	DB00514	C18H25NO	small molecule	N07XX59|R05DA09	125-71-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKXZASYAUGDDCJ-NJAFHUGGSA-N
7657	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	504	Dextromethorphan	Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum	tylenol cold and flu nighttime	DRUGBANK	DB00514	C18H25NO	small molecule	N07XX59|R05DA09	125-71-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKXZASYAUGDDCJ-NJAFHUGGSA-N
7679	115656	10383	RP13-122B23.2	TUBB4B	Beta2|TUBB2|TUBB2C	9606	Homo sapiens	inhibitor	target	Solana HD (2002)	11980387	176620	508	Albendazole	Zentel|Eskazole|Proftril|Ricobendazole|Albendazolum|Albenza|Valbazen|Rycobendazole|Albendazol|(5-(Propylthio)-1H-benzimidazol-2-yl)carbamic acid methyl ester|Albendazole|5-(Propylthio)-2-carbomethoxyaminobenzimidazole|O-Methyl N-(5-(propylthio)-2-benzimidazolyl)carbamate	albenza	DRUGBANK	DB00518	C12H15N3O2S	small molecule	P02CA03	54965-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXHWSAZORRCQMX-UHFFFAOYSA-N
7680	115656	10383	RP13-122B23.2	TUBB4B	Beta2|TUBB2|TUBB2C	9606	Homo sapiens	inhibitor	target	Chu SW (2009)	19846910	176618	508	Albendazole	Zentel|Eskazole|Proftril|Ricobendazole|Albendazolum|Albenza|Valbazen|Rycobendazole|Albendazol|(5-(Propylthio)-1H-benzimidazol-2-yl)carbamic acid methyl ester|Albendazole|5-(Propylthio)-2-carbomethoxyaminobenzimidazole|O-Methyl N-(5-(propylthio)-2-benzimidazolyl)carbamate	albenza	DRUGBANK	DB00518	C12H15N3O2S	small molecule	P02CA03	54965-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXHWSAZORRCQMX-UHFFFAOYSA-N
7681	115656	10383	RP13-122B23.2	TUBB4B	Beta2|TUBB2|TUBB2C	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	508	Albendazole	Zentel|Eskazole|Proftril|Ricobendazole|Albendazolum|Albenza|Valbazen|Rycobendazole|Albendazol|(5-(Propylthio)-1H-benzimidazol-2-yl)carbamic acid methyl ester|Albendazole|5-(Propylthio)-2-carbomethoxyaminobenzimidazole|O-Methyl N-(5-(propylthio)-2-benzimidazolyl)carbamate	albenza	DRUGBANK	DB00518	C12H15N3O2S	small molecule	P02CA03	54965-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXHWSAZORRCQMX-UHFFFAOYSA-N
7742	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Louro SR (1998)	9742684	176670	517	Cinchocaine	alpha-Butyloxycinchoninic acid diethylethylenediamide|Cincocainio|N-(2-(Diethylamino)ethyl)-2-butoxycinchoninamide|2-Butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide|Dibucaine|CINCHOCAINE|2-Butoxy-N-(alpha-diethylaminoethyl)cinchoninamide|2-Butoxy-N-(beta-diethylaminoethyl)cinchoninamide|2-N-Butoxy-N-(2-diethylaminoethyl)cinchoninamide|2-Butoxy-quinoline-4-carboxylic acid (2-diethylamino-ethyl)-amide|Cinchocainum|2-Butoxyquinoline-4-carboxylic acid diethylaminoethylamide|Dibucaine base|2-Butoxy-N-(2-(diethylamino)ethyl)cinchoninamide|alpha-Butyloxycinchonic acid-gamma-diethylethylenediamine	proctol ointment|proctosone su	DRUGBANK	DB00527	C20H29N3O2	small molecule	S01HA06|D04AB02|C05AD04|N01BB06|S02DA04	85-79-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUFQVTATUTYEAL-UHFFFAOYSA-N
7743	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	517	Cinchocaine	alpha-Butyloxycinchoninic acid diethylethylenediamide|Cincocainio|N-(2-(Diethylamino)ethyl)-2-butoxycinchoninamide|2-Butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide|Dibucaine|CINCHOCAINE|2-Butoxy-N-(alpha-diethylaminoethyl)cinchoninamide|2-Butoxy-N-(beta-diethylaminoethyl)cinchoninamide|2-N-Butoxy-N-(2-diethylaminoethyl)cinchoninamide|2-Butoxy-quinoline-4-carboxylic acid (2-diethylamino-ethyl)-amide|Cinchocainum|2-Butoxyquinoline-4-carboxylic acid diethylaminoethylamide|Dibucaine base|2-Butoxy-N-(2-(diethylamino)ethyl)cinchoninamide|alpha-Butyloxycinchonic acid-gamma-diethylethylenediamine	proctol ointment|proctosone su	DRUGBANK	DB00527	C20H29N3O2	small molecule	S01HA06|D04AB02|C05AD04|N01BB06|S02DA04	85-79-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUFQVTATUTYEAL-UHFFFAOYSA-N
7744	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Oka M (2002)	12354567	176672	517	Cinchocaine	alpha-Butyloxycinchoninic acid diethylethylenediamide|Cincocainio|N-(2-(Diethylamino)ethyl)-2-butoxycinchoninamide|2-Butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide|Dibucaine|CINCHOCAINE|2-Butoxy-N-(alpha-diethylaminoethyl)cinchoninamide|2-Butoxy-N-(beta-diethylaminoethyl)cinchoninamide|2-N-Butoxy-N-(2-diethylaminoethyl)cinchoninamide|2-Butoxy-quinoline-4-carboxylic acid (2-diethylamino-ethyl)-amide|Cinchocainum|2-Butoxyquinoline-4-carboxylic acid diethylaminoethylamide|Dibucaine base|2-Butoxy-N-(2-(diethylamino)ethyl)cinchoninamide|alpha-Butyloxycinchonic acid-gamma-diethylethylenediamine	proctol ointment|proctosone su	DRUGBANK	DB00527	C20H29N3O2	small molecule	S01HA06|D04AB02|C05AD04|N01BB06|S02DA04	85-79-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUFQVTATUTYEAL-UHFFFAOYSA-N
7745	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Ryan SE (1996)	8798723	176671	517	Cinchocaine	alpha-Butyloxycinchoninic acid diethylethylenediamide|Cincocainio|N-(2-(Diethylamino)ethyl)-2-butoxycinchoninamide|2-Butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide|Dibucaine|CINCHOCAINE|2-Butoxy-N-(alpha-diethylaminoethyl)cinchoninamide|2-Butoxy-N-(beta-diethylaminoethyl)cinchoninamide|2-N-Butoxy-N-(2-diethylaminoethyl)cinchoninamide|2-Butoxy-quinoline-4-carboxylic acid (2-diethylamino-ethyl)-amide|Cinchocainum|2-Butoxyquinoline-4-carboxylic acid diethylaminoethylamide|Dibucaine base|2-Butoxy-N-(2-(diethylamino)ethyl)cinchoninamide|alpha-Butyloxycinchonic acid-gamma-diethylethylenediamine	proctol ointment|proctosone su	DRUGBANK	DB00527	C20H29N3O2	small molecule	S01HA06|D04AB02|C05AD04|N01BB06|S02DA04	85-79-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUFQVTATUTYEAL-UHFFFAOYSA-N
7746	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	517	Cinchocaine	alpha-Butyloxycinchoninic acid diethylethylenediamide|Cincocainio|N-(2-(Diethylamino)ethyl)-2-butoxycinchoninamide|2-Butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide|Dibucaine|CINCHOCAINE|2-Butoxy-N-(alpha-diethylaminoethyl)cinchoninamide|2-Butoxy-N-(beta-diethylaminoethyl)cinchoninamide|2-N-Butoxy-N-(2-diethylaminoethyl)cinchoninamide|2-Butoxy-quinoline-4-carboxylic acid (2-diethylamino-ethyl)-amide|Cinchocainum|2-Butoxyquinoline-4-carboxylic acid diethylaminoethylamide|Dibucaine base|2-Butoxy-N-(2-(diethylamino)ethyl)cinchoninamide|alpha-Butyloxycinchonic acid-gamma-diethylethylenediamine	proctol ointment|proctosone su	DRUGBANK	DB00527	C20H29N3O2	small molecule	S01HA06|D04AB02|C05AD04|N01BB06|S02DA04	85-79-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUFQVTATUTYEAL-UHFFFAOYSA-N
7747	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	517	Cinchocaine	alpha-Butyloxycinchoninic acid diethylethylenediamide|Cincocainio|N-(2-(Diethylamino)ethyl)-2-butoxycinchoninamide|2-Butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide|Dibucaine|CINCHOCAINE|2-Butoxy-N-(alpha-diethylaminoethyl)cinchoninamide|2-Butoxy-N-(beta-diethylaminoethyl)cinchoninamide|2-N-Butoxy-N-(2-diethylaminoethyl)cinchoninamide|2-Butoxy-quinoline-4-carboxylic acid (2-diethylamino-ethyl)-amide|Cinchocainum|2-Butoxyquinoline-4-carboxylic acid diethylaminoethylamide|Dibucaine base|2-Butoxy-N-(2-(diethylamino)ethyl)cinchoninamide|alpha-Butyloxycinchonic acid-gamma-diethylethylenediamine	proctol ointment|proctosone su	DRUGBANK	DB00527	C20H29N3O2	small molecule	S01HA06|D04AB02|C05AD04|N01BB06|S02DA04	85-79-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUFQVTATUTYEAL-UHFFFAOYSA-N
7768	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Lenkowski PW (2004)	15066664	176695	522	Mephenytoin	-	-	DRUGBANK	DB00532	C12H14N2O2	small molecule	N03AB04|N03AB54	50-12-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMHKMTDVRCWUDX-UHFFFAOYSA-N
7769	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	522	Mephenytoin	-	-	DRUGBANK	DB00532	C12H14N2O2	small molecule	N03AB04|N03AB54	50-12-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMHKMTDVRCWUDX-UHFFFAOYSA-N
7770	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Swadron SP (2004)	15001403	174682	522	Mephenytoin	-	-	DRUGBANK	DB00532	C12H14N2O2	small molecule	N03AB04|N03AB54	50-12-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMHKMTDVRCWUDX-UHFFFAOYSA-N
7774	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Malmstrom K (1999)	10566562	176707	523	Rofecoxib	-	vioxx tab 25mg|vioxx suspensio	DRUGBANK	DB00533	C17H14O4S	small molecule	M01AH02	162011-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZJQGNCSTQAWON-UHFFFAOYSA-N
7775	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Matheson AJ (2001)	11398914	176706	523	Rofecoxib	-	vioxx tab 25mg|vioxx suspensio	DRUGBANK	DB00533	C17H14O4S	small molecule	M01AH02	162011-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZJQGNCSTQAWON-UHFFFAOYSA-N
7776	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Langman MJ (1999)	10580458	176705	523	Rofecoxib	-	vioxx tab 25mg|vioxx suspensio	DRUGBANK	DB00533	C17H14O4S	small molecule	M01AH02	162011-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZJQGNCSTQAWON-UHFFFAOYSA-N
7777	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chakraborti AK (2010)	20166930	176704	523	Rofecoxib	-	vioxx tab 25mg|vioxx suspensio	DRUGBANK	DB00533	C17H14O4S	small molecule	M01AH02	162011-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZJQGNCSTQAWON-UHFFFAOYSA-N
7778	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Ashok V (2011)	20724158	176703	523	Rofecoxib	-	vioxx tab 25mg|vioxx suspensio	DRUGBANK	DB00533	C17H14O4S	small molecule	M01AH02	162011-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZJQGNCSTQAWON-UHFFFAOYSA-N
7779	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Baron JA (2008)	18922570	176702	523	Rofecoxib	-	vioxx tab 25mg|vioxx suspensio	DRUGBANK	DB00533	C17H14O4S	small molecule	M01AH02	162011-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZJQGNCSTQAWON-UHFFFAOYSA-N
7780	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	523	Rofecoxib	-	vioxx tab 25mg|vioxx suspensio	DRUGBANK	DB00533	C17H14O4S	small molecule	M01AH02	162011-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZJQGNCSTQAWON-UHFFFAOYSA-N
7781	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Pascucci RA (1999)	10643177	176709	523	Rofecoxib	-	vioxx tab 25mg|vioxx suspensio	DRUGBANK	DB00533	C17H14O4S	small molecule	M01AH02	162011-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZJQGNCSTQAWON-UHFFFAOYSA-N
7782	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Hawkey C (2000)	10693877	176708	523	Rofecoxib	-	vioxx tab 25mg|vioxx suspensio	DRUGBANK	DB00533	C17H14O4S	small molecule	M01AH02	162011-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZJQGNCSTQAWON-UHFFFAOYSA-N
7783	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Ehrich EW (1999)	10555907	176710	523	Rofecoxib	-	vioxx tab 25mg|vioxx suspensio	DRUGBANK	DB00533	C17H14O4S	small molecule	M01AH02	162011-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZJQGNCSTQAWON-UHFFFAOYSA-N
7865	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	antagonist	target	Gozlan H (1991)	1666997	176778	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7866	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Nasu R (2000)	11180191	176779	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
8012	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	544	Piroxicam	4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid|Feldene|Pyroxycam|Piroxicam|Piroxicamum	feldene cap 20mg|nu-pirox cap 	DRUGBANK	DB00554	C15H13N3O4S	small molecule	M01AC01|M02AA07|S01BC06	36322-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QYSPLQLAKJAUJT-UHFFFAOYSA-N
8013	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Fackovcova D (2001)	11153163	176241	544	Piroxicam	4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid|Feldene|Pyroxycam|Piroxicam|Piroxicamum	feldene cap 20mg|nu-pirox cap 	DRUGBANK	DB00554	C15H13N3O4S	small molecule	M01AC01|M02AA07|S01BC06	36322-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QYSPLQLAKJAUJT-UHFFFAOYSA-N
8014	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Blanco FJ (1999)	10381057	176844	544	Piroxicam	4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid|Feldene|Pyroxycam|Piroxicam|Piroxicamum	feldene cap 20mg|nu-pirox cap 	DRUGBANK	DB00554	C15H13N3O4S	small molecule	M01AC01|M02AA07|S01BC06	36322-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QYSPLQLAKJAUJT-UHFFFAOYSA-N
8015	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Bugajski J (2001)	11785774	176845	544	Piroxicam	4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid|Feldene|Pyroxycam|Piroxicam|Piroxicamum	feldene cap 20mg|nu-pirox cap 	DRUGBANK	DB00554	C15H13N3O4S	small molecule	M01AC01|M02AA07|S01BC06	36322-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QYSPLQLAKJAUJT-UHFFFAOYSA-N
8016	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Raju J (2002)	11952155	176846	544	Piroxicam	4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid|Feldene|Pyroxycam|Piroxicam|Piroxicamum	feldene cap 20mg|nu-pirox cap 	DRUGBANK	DB00554	C15H13N3O4S	small molecule	M01AC01|M02AA07|S01BC06	36322-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QYSPLQLAKJAUJT-UHFFFAOYSA-N
8017	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Veiga AP (2004)	15464832	176843	544	Piroxicam	4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid|Feldene|Pyroxycam|Piroxicam|Piroxicamum	feldene cap 20mg|nu-pirox cap 	DRUGBANK	DB00554	C15H13N3O4S	small molecule	M01AC01|M02AA07|S01BC06	36322-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QYSPLQLAKJAUJT-UHFFFAOYSA-N
8055	107225	771	-	CA12	CAXII|HsT18816	9606	Homo sapiens	inhibitor	target	Temperini C (2009)	19119014	174539	552	Benzthiazide	Benzothiazide|3-((Benzylthio)methyl)-6-chloro-7-sulfamoyl-2H-benzo-1,2,4-thiadiazine 1,1-dioxide|Benzthiazid|Benzotiazida|Benzthiazide|3-Benzylthiomethyl-6-chloro-7-sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide|3-Benzylthiomethyl-6-chloro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|6-chloro-1,1-dioxo-3-(Phenylmethylsulfanylmethyl)-4H-benzo[e][1,2,4]thiadiazine-7-sulfonamide|Benztiazide|Benzthiazidum|6-chloro-7-Sulfamoyl-3-benzylthiomethyl-2H-1,2,4-benzothiadiazine 1,1-dioxide	-	DRUGBANK	DB00562	C15H14ClN3O4S3	small molecule	-	91-33-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NDTSRXAMMQDVSW-UHFFFAOYSA-N
8072	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	554	Carbamazepine	Carbamazepin|Carbamazepen|5-Carbamoyl-5H-dibenz(b,f)azepine|Carbamazepina|5-Carbamoyl-5H-dibenzo(b,F)azepine|5H-Dibenz(b,F)azepine-5-carboxamide|Carbamazpine|Carbamazepinum|5-Carbamoyl-5H-dibenz[b,F]azepine|CBZ|5-Carbamyl-5H-dibenzo(b,F)azepine	tegretol cr tab 200mg|carbamaz	DRUGBANK	DB00564	C15H12N2O	small molecule	N03AF01	298-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FFGPTBGBLSHEPO-UHFFFAOYSA-N
8073	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Yang YC (2010)	20526191	176913	554	Carbamazepine	Carbamazepin|Carbamazepen|5-Carbamoyl-5H-dibenz(b,f)azepine|Carbamazepina|5-Carbamoyl-5H-dibenzo(b,F)azepine|5H-Dibenz(b,F)azepine-5-carboxamide|Carbamazpine|Carbamazepinum|5-Carbamoyl-5H-dibenz[b,F]azepine|CBZ|5-Carbamyl-5H-dibenzo(b,F)azepine	tegretol cr tab 200mg|carbamaz	DRUGBANK	DB00564	C15H12N2O	small molecule	N03AF01	298-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FFGPTBGBLSHEPO-UHFFFAOYSA-N
8074	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	554	Carbamazepine	Carbamazepin|Carbamazepen|5-Carbamoyl-5H-dibenz(b,f)azepine|Carbamazepina|5-Carbamoyl-5H-dibenzo(b,F)azepine|5H-Dibenz(b,F)azepine-5-carboxamide|Carbamazpine|Carbamazepinum|5-Carbamoyl-5H-dibenz[b,F]azepine|CBZ|5-Carbamyl-5H-dibenzo(b,F)azepine	tegretol cr tab 200mg|carbamaz	DRUGBANK	DB00564	C15H12N2O	small molecule	N03AF01	298-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FFGPTBGBLSHEPO-UHFFFAOYSA-N
8075	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Yang YC (2002)	12391287	176914	554	Carbamazepine	Carbamazepin|Carbamazepen|5-Carbamoyl-5H-dibenz(b,f)azepine|Carbamazepina|5-Carbamoyl-5H-dibenzo(b,F)azepine|5H-Dibenz(b,F)azepine-5-carboxamide|Carbamazpine|Carbamazepinum|5-Carbamoyl-5H-dibenz[b,F]azepine|CBZ|5-Carbamyl-5H-dibenzo(b,F)azepine	tegretol cr tab 200mg|carbamaz	DRUGBANK	DB00564	C15H12N2O	small molecule	N03AF01	298-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FFGPTBGBLSHEPO-UHFFFAOYSA-N
8076	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Lipkind GM (2010)	20643904	176915	554	Carbamazepine	Carbamazepin|Carbamazepen|5-Carbamoyl-5H-dibenz(b,f)azepine|Carbamazepina|5-Carbamoyl-5H-dibenzo(b,F)azepine|5H-Dibenz(b,F)azepine-5-carboxamide|Carbamazpine|Carbamazepinum|5-Carbamoyl-5H-dibenz[b,F]azepine|CBZ|5-Carbamyl-5H-dibenzo(b,F)azepine	tegretol cr tab 200mg|carbamaz	DRUGBANK	DB00564	C15H12N2O	small molecule	N03AF01	298-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FFGPTBGBLSHEPO-UHFFFAOYSA-N
8102	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	binder	target	Nasu R (2000)	11180191	176779	558	Cinnarizine	1-Cinnamyl-4-(diphenylmethyl)piperazine|Cinnarizin|1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine|Cinnarizine|Cinarizina|1-Benzhydryl-4-cinnamylpiperazin|Cinnarizinum	-	DRUGBANK	DB00568	C26H28N2	small molecule	N07CA02|N07CA52	298-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DERZBLKQOCDDDZ-JLHYYAGUSA-N
8154	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	unknown	target	Bailey SR (1998)	9760032	176970	561	Propranolol	Propranololo|-Propranolol|1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol|Propranololum|Propanolol|1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol|beta-Propranolol|Propranolol|Propanalol	nu-propranolol tab 120mg|heman	DRUGBANK	DB00571	C16H21NO2	small molecule	C07BA05|C07AA05|C07FA05	525-66-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQHHHDLHHXJYJD-UHFFFAOYSA-N
8155	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	unknown	target	Choppin A (1995)	7881730	176969	561	Propranolol	Propranololo|-Propranolol|1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol|Propranololum|Propanolol|1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol|beta-Propranolol|Propranolol|Propanalol	nu-propranolol tab 120mg|heman	DRUGBANK	DB00571	C16H21NO2	small molecule	C07BA05|C07AA05|C07FA05	525-66-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQHHHDLHHXJYJD-UHFFFAOYSA-N
8176	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Poggi JC (2006)	17050798	176976	563	Fenoprofen	2-(3-phenoxyphenyl)propionic acid|Fenoprofen|(+/-)-m-phenoxyhydratropic acid|DL-2-(3-phenoxyphenyl)propionic acid|alpha-(m-Phenoxyphenyl)propionic acid|(+/-)-fenoprofen|Fenoprofeno|Fnoprofne|(+-)-2-(3-Phenoxyphenyl)propionic acid|3-phenoxyhydratropic acid|2-(m-phenoxyphenyl)propionic acid|Fenoprofenum|alpha-Methyl-3-phenoxybenzeneacetic acid	nalfon tab 600mg|fenoprofen|na	DRUGBANK	DB00573	C15H14O3	small molecule	M01AE04	29679-58-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RDJGLLICXDHJDY-UHFFFAOYSA-N
8219	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Talley JJ (2000)	10715145	177027	570	Valdecoxib	-	-	DRUGBANK	DB00580	C16H14N2O3S	small molecule	M01AH03	181695-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNPDTQAFDNKSHK-UHFFFAOYSA-N
8220	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Hood WF (2003)	12644588	177026	570	Valdecoxib	-	-	DRUGBANK	DB00580	C16H14N2O3S	small molecule	M01AH03	181695-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNPDTQAFDNKSHK-UHFFFAOYSA-N
8221	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Jain KK (2000)	11060833	177030	570	Valdecoxib	-	-	DRUGBANK	DB00580	C16H14N2O3S	small molecule	M01AH03	181695-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNPDTQAFDNKSHK-UHFFFAOYSA-N
8222	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Gierse JK (2005)	15494548	177031	570	Valdecoxib	-	-	DRUGBANK	DB00580	C16H14N2O3S	small molecule	M01AH03	181695-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNPDTQAFDNKSHK-UHFFFAOYSA-N
8223	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	570	Valdecoxib	-	-	DRUGBANK	DB00580	C16H14N2O3S	small molecule	M01AH03	181695-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNPDTQAFDNKSHK-UHFFFAOYSA-N
8224	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Tacconelli S (2003)	12564662	177029	570	Valdecoxib	-	-	DRUGBANK	DB00580	C16H14N2O3S	small molecule	M01AH03	181695-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNPDTQAFDNKSHK-UHFFFAOYSA-N
8225	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Yuan JJ (2002)	12167567	177028	570	Valdecoxib	-	-	DRUGBANK	DB00580	C16H14N2O3S	small molecule	M01AH03	181695-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNPDTQAFDNKSHK-UHFFFAOYSA-N
8314	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Kirchheiner J (2003)	12534640	177083	576	Diclofenac	2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco	dom-diclofenac|diclofenac sodi	DRUGBANK	DB00586	C14H11Cl2NO2	small molecule	D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05	15307-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCOPUUMXTXDBNB-UHFFFAOYSA-N
8315	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chavez ML (2003)	12852704	177085	576	Diclofenac	2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco	dom-diclofenac|diclofenac sodi	DRUGBANK	DB00586	C14H11Cl2NO2	small molecule	D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05	15307-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCOPUUMXTXDBNB-UHFFFAOYSA-N
8316	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Rowlinson SW (2003)	12925531	177102	576	Diclofenac	2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco	dom-diclofenac|diclofenac sodi	DRUGBANK	DB00586	C14H11Cl2NO2	small molecule	D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05	15307-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCOPUUMXTXDBNB-UHFFFAOYSA-N
8317	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Beubler E (2003)	12705061	177100	576	Diclofenac	2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco	dom-diclofenac|diclofenac sodi	DRUGBANK	DB00586	C14H11Cl2NO2	small molecule	D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05	15307-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCOPUUMXTXDBNB-UHFFFAOYSA-N
8318	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Blomme EA (2003)	12588370	177101	576	Diclofenac	2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco	dom-diclofenac|diclofenac sodi	DRUGBANK	DB00586	C14H11Cl2NO2	small molecule	D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05	15307-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCOPUUMXTXDBNB-UHFFFAOYSA-N
8337	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	579	Lisuride	N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethylurea|Lisuridum|Lisuride|Lisurid|Lisurida	-	DRUGBANK	DB00589	C20H26N4O	small molecule	G02CB02|N02CA07	18016-80-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BKRGVLQUQGGVSM-KBXCAEBGSA-N
8353	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	579	Lisuride	N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethylurea|Lisuridum|Lisuride|Lisurid|Lisurida	-	DRUGBANK	DB00589	C20H26N4O	small molecule	G02CB02|N02CA07	18016-80-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BKRGVLQUQGGVSM-KBXCAEBGSA-N
8354	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Kvernmo T (2008)	18691132	174662	579	Lisuride	N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethylurea|Lisuridum|Lisuride|Lisurid|Lisurida	-	DRUGBANK	DB00589	C20H26N4O	small molecule	G02CB02|N02CA07	18016-80-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BKRGVLQUQGGVSM-KBXCAEBGSA-N
8355	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	579	Lisuride	N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethylurea|Lisuridum|Lisuride|Lisurid|Lisurida	-	DRUGBANK	DB00589	C20H26N4O	small molecule	G02CB02|N02CA07	18016-80-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BKRGVLQUQGGVSM-KBXCAEBGSA-N
8372	124667	90134	-	KCNH7	ERG3|HERG3|Kv11.3	9606	Homo sapiens	inhibitor	target	Thomas D (2004)	15098086	176200	580	Doxazosin	1-(4-Amino-6,7-Dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazin|Doxazosina|Doxazosinum|Doxazosine|1-(4-Amino-6,7-dimethoxy-2-chinazolinyl)-4-(2,3-dihydro-1,4-benzodioxixin-2-ylcarbonyl)piperazin	cardura-1 tab 1mg|doxazosin-2|	DRUGBANK	DB00590	C23H25N5O5	small molecule	C02CA04	74191-85-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUZYUOTYCVRMRZ-UHFFFAOYSA-N
8560	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Giuliano F (1999)	10372826	177229	595	Sulindac	cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum	sulindac|clinoril tab 150mg|ap	DRUGBANK	DB00605	C20H17FO3S	small molecule	M01AB02	38194-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLKXDPUZXIRXEP-MFOYZWKCSA-N
8561	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Yip-Schneider MT (2000)	10657949	177245	595	Sulindac	cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum	sulindac|clinoril tab 150mg|ap	DRUGBANK	DB00605	C20H17FO3S	small molecule	M01AB02	38194-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLKXDPUZXIRXEP-MFOYZWKCSA-N
8562	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Fosslien E (2000)	11078056	177244	595	Sulindac	cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum	sulindac|clinoril tab 150mg|ap	DRUGBANK	DB00605	C20H17FO3S	small molecule	M01AB02	38194-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLKXDPUZXIRXEP-MFOYZWKCSA-N
8563	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Molina MA (1999)	10485483	177247	595	Sulindac	cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum	sulindac|clinoril tab 150mg|ap	DRUGBANK	DB00605	C20H17FO3S	small molecule	M01AB02	38194-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLKXDPUZXIRXEP-MFOYZWKCSA-N
8564	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Taylor MT (2000)	11118042	177246	595	Sulindac	cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum	sulindac|clinoril tab 150mg|ap	DRUGBANK	DB00605	C20H17FO3S	small molecule	M01AB02	38194-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLKXDPUZXIRXEP-MFOYZWKCSA-N
8628	109418	3176	-	HNMT	HMT|HNMT-S1|HNMT-S2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	603	Amodiaquine	Amodiaquina|Amodiaquinum|Amodiaquine	-	DRUGBANK	DB00613	C20H22ClN3O	small molecule	P01BF03|P01BA06	86-42-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OVCDSSHSILBFBN-UHFFFAOYSA-N
8629	109418	3176	-	HNMT	HMT|HNMT-S1|HNMT-S2	9606	Homo sapiens	inhibitor	target	Nowak JZ (1980)	6789797	177300	603	Amodiaquine	Amodiaquina|Amodiaquinum|Amodiaquine	-	DRUGBANK	DB00613	C20H22ClN3O	small molecule	P01BF03|P01BA06	86-42-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OVCDSSHSILBFBN-UHFFFAOYSA-N
8630	109418	3176	-	HNMT	HMT|HNMT-S1|HNMT-S2	9606	Homo sapiens	inhibitor	target	Barth H (1975)	1203620	177301	603	Amodiaquine	Amodiaquina|Amodiaquinum|Amodiaquine	-	DRUGBANK	DB00613	C20H22ClN3O	small molecule	P01BF03|P01BA06	86-42-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OVCDSSHSILBFBN-UHFFFAOYSA-N
8631	109418	3176	-	HNMT	HMT|HNMT-S1|HNMT-S2	9606	Homo sapiens	inhibitor	target	Yokoyama A (2007)	17222819	177299	603	Amodiaquine	Amodiaquina|Amodiaquinum|Amodiaquine	-	DRUGBANK	DB00613	C20H22ClN3O	small molecule	P01BF03|P01BA06	86-42-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OVCDSSHSILBFBN-UHFFFAOYSA-N
8732	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Seeman P (2002)	11873706	174626	613	Fluphenazine	Fluphnazine|Fluphenazin|2-(Trifluoromethyl)-10-(3-(1-(beta-hydroxyethyl)-4-piperazinyl)propyl)phenothiazine|Flufenazina|Fluorfenazine|Triflumethazine|10-(3-(2-Hydroxyethyl)piperazinopropyl)-2-(trifluoromethyl)phenothiazine|1-(2-Hydroxyethyl)-4-(3-(trifluoromethyl-10-phenothiazinyl)propyl)-piperazine|Fluorophenazine|4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-1-piperazineethanol|Fluorphenazine|4-(3-(2-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|4-(3-(-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|2-(4-(3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl)-1-piperazinyl)ethanol|Fluphenazinum|10-(3'-(4''-(beta-hydroxyethyl)-1''-piperazinyl)-propyl)-3-trifluoromethylphenothiazine	apo fluphenazine tab 2.5mg|apo	DRUGBANK	DB00623	C22H26F3N3OS	small molecule	N05AB02	69-23-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PLDUPXSUYLZYBN-UHFFFAOYSA-N
8733	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Cai G (1999)	10531405	176548	613	Fluphenazine	Fluphnazine|Fluphenazin|2-(Trifluoromethyl)-10-(3-(1-(beta-hydroxyethyl)-4-piperazinyl)propyl)phenothiazine|Flufenazina|Fluorfenazine|Triflumethazine|10-(3-(2-Hydroxyethyl)piperazinopropyl)-2-(trifluoromethyl)phenothiazine|1-(2-Hydroxyethyl)-4-(3-(trifluoromethyl-10-phenothiazinyl)propyl)-piperazine|Fluorophenazine|4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-1-piperazineethanol|Fluorphenazine|4-(3-(2-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|4-(3-(-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|2-(4-(3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl)-1-piperazinyl)ethanol|Fluphenazinum|10-(3'-(4''-(beta-hydroxyethyl)-1''-piperazinyl)-propyl)-3-trifluoromethylphenothiazine	apo fluphenazine tab 2.5mg|apo	DRUGBANK	DB00623	C22H26F3N3OS	small molecule	N05AB02	69-23-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PLDUPXSUYLZYBN-UHFFFAOYSA-N
8734	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	613	Fluphenazine	Fluphnazine|Fluphenazin|2-(Trifluoromethyl)-10-(3-(1-(beta-hydroxyethyl)-4-piperazinyl)propyl)phenothiazine|Flufenazina|Fluorfenazine|Triflumethazine|10-(3-(2-Hydroxyethyl)piperazinopropyl)-2-(trifluoromethyl)phenothiazine|1-(2-Hydroxyethyl)-4-(3-(trifluoromethyl-10-phenothiazinyl)propyl)-piperazine|Fluorophenazine|4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-1-piperazineethanol|Fluorphenazine|4-(3-(2-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|4-(3-(-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|2-(4-(3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl)-1-piperazinyl)ethanol|Fluphenazinum|10-(3'-(4''-(beta-hydroxyethyl)-1''-piperazinyl)-propyl)-3-trifluoromethylphenothiazine	apo fluphenazine tab 2.5mg|apo	DRUGBANK	DB00623	C22H26F3N3OS	small molecule	N05AB02	69-23-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PLDUPXSUYLZYBN-UHFFFAOYSA-N
8735	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Van Kampen JM (2000)	11113312	177396	613	Fluphenazine	Fluphnazine|Fluphenazin|2-(Trifluoromethyl)-10-(3-(1-(beta-hydroxyethyl)-4-piperazinyl)propyl)phenothiazine|Flufenazina|Fluorfenazine|Triflumethazine|10-(3-(2-Hydroxyethyl)piperazinopropyl)-2-(trifluoromethyl)phenothiazine|1-(2-Hydroxyethyl)-4-(3-(trifluoromethyl-10-phenothiazinyl)propyl)-piperazine|Fluorophenazine|4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-1-piperazineethanol|Fluorphenazine|4-(3-(2-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|4-(3-(-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|2-(4-(3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl)-1-piperazinyl)ethanol|Fluphenazinum|10-(3'-(4''-(beta-hydroxyethyl)-1''-piperazinyl)-propyl)-3-trifluoromethylphenothiazine	apo fluphenazine tab 2.5mg|apo	DRUGBANK	DB00623	C22H26F3N3OS	small molecule	N05AB02	69-23-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PLDUPXSUYLZYBN-UHFFFAOYSA-N
8956	115656	10383	RP13-122B23.2	TUBB4B	Beta2|TUBB2|TUBB2C	9606	Homo sapiens	inhibitor	target	Lubega GW (1993)	8139621	177533	633	Mebendazole	Vermox|(5-benzoyl-1H-benzimidazol-2-yl)-carbamic acid methyl ester|Mebendazol|Mbendazole|Mebendazolum|MBDZ	vermox|vermox tablets 100 mg|m	DRUGBANK	DB00643	C16H13N3O3	small molecule	P02CA01|P02CA51	31431-39-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OPXLLQIJSORQAM-UHFFFAOYSA-N
8957	115656	10383	RP13-122B23.2	TUBB4B	Beta2|TUBB2|TUBB2C	9606	Homo sapiens	inhibitor	target	Wampande EM (2007)	17662615	177537	633	Mebendazole	Vermox|(5-benzoyl-1H-benzimidazol-2-yl)-carbamic acid methyl ester|Mebendazol|Mbendazole|Mebendazolum|MBDZ	vermox|vermox tablets 100 mg|m	DRUGBANK	DB00643	C16H13N3O3	small molecule	P02CA01|P02CA51	31431-39-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OPXLLQIJSORQAM-UHFFFAOYSA-N
8958	115656	10383	RP13-122B23.2	TUBB4B	Beta2|TUBB2|TUBB2C	9606	Homo sapiens	inhibitor	target	Oxberry ME (2001)	11444621	177536	633	Mebendazole	Vermox|(5-benzoyl-1H-benzimidazol-2-yl)-carbamic acid methyl ester|Mebendazol|Mbendazole|Mebendazolum|MBDZ	vermox|vermox tablets 100 mg|m	DRUGBANK	DB00643	C16H13N3O3	small molecule	P02CA01|P02CA51	31431-39-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OPXLLQIJSORQAM-UHFFFAOYSA-N
8959	115656	10383	RP13-122B23.2	TUBB4B	Beta2|TUBB2|TUBB2C	9606	Homo sapiens	inhibitor	target	Ochola DO (2002)	12099434	177535	633	Mebendazole	Vermox|(5-benzoyl-1H-benzimidazol-2-yl)-carbamic acid methyl ester|Mebendazol|Mbendazole|Mebendazolum|MBDZ	vermox|vermox tablets 100 mg|m	DRUGBANK	DB00643	C16H13N3O3	small molecule	P02CA01|P02CA51	31431-39-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OPXLLQIJSORQAM-UHFFFAOYSA-N
8960	115656	10383	RP13-122B23.2	TUBB4B	Beta2|TUBB2|TUBB2C	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	633	Mebendazole	Vermox|(5-benzoyl-1H-benzimidazol-2-yl)-carbamic acid methyl ester|Mebendazol|Mbendazole|Mebendazolum|MBDZ	vermox|vermox tablets 100 mg|m	DRUGBANK	DB00643	C16H13N3O3	small molecule	P02CA01|P02CA51	31431-39-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OPXLLQIJSORQAM-UHFFFAOYSA-N
8961	115656	10383	RP13-122B23.2	TUBB4B	Beta2|TUBB2|TUBB2C	9606	Homo sapiens	inhibitor	target	MacDonald LM (2004)	15500920	177534	633	Mebendazole	Vermox|(5-benzoyl-1H-benzimidazol-2-yl)-carbamic acid methyl ester|Mebendazol|Mbendazole|Mebendazolum|MBDZ	vermox|vermox tablets 100 mg|m	DRUGBANK	DB00643	C16H13N3O3	small molecule	P02CA01|P02CA51	31431-39-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OPXLLQIJSORQAM-UHFFFAOYSA-N
8998	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	641	Dyphylline	Diprophylline|7-(beta,gamma-Dihydroxypropyl)theophylline|(1,2-Dihydroxy-3-propyl)thiophyllin|1,3-Dimethyl-7-(2,3-dihydroxypropyl)xanthine|(+-)-Dyphylline|(+-)-Diprophylline|Diprophyllinum|Dyphylline|()-dyphylline|Diprofilina|()-diprophylline|(+-)-7-(2,3-Dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione|7-(,-dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)theophylline|Dihydroxypropyl theopylin|7-(2,3-Dihydroxypropyl)-1,3-dimethylxanthine	protophylline sup 500mg adulte	DRUGBANK	DB00651	C10H14N4O4	small molecule	R03DB01|R03DA01|R03DA51	479-18-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KSCFJBIXMNOVSH-UHFFFAOYSA-N
8999	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	641	Dyphylline	Diprophylline|7-(beta,gamma-Dihydroxypropyl)theophylline|(1,2-Dihydroxy-3-propyl)thiophyllin|1,3-Dimethyl-7-(2,3-dihydroxypropyl)xanthine|(+-)-Dyphylline|(+-)-Diprophylline|Diprophyllinum|Dyphylline|()-dyphylline|Diprofilina|()-diprophylline|(+-)-7-(2,3-Dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione|7-(,-dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)theophylline|Dihydroxypropyl theopylin|7-(2,3-Dihydroxypropyl)-1,3-dimethylxanthine	protophylline sup 500mg adulte	DRUGBANK	DB00651	C10H14N4O4	small molecule	R03DB01|R03DA01|R03DA51	479-18-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KSCFJBIXMNOVSH-UHFFFAOYSA-N
9000	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Hariton C (1994)	7925603	177565	641	Dyphylline	Diprophylline|7-(beta,gamma-Dihydroxypropyl)theophylline|(1,2-Dihydroxy-3-propyl)thiophyllin|1,3-Dimethyl-7-(2,3-dihydroxypropyl)xanthine|(+-)-Dyphylline|(+-)-Diprophylline|Diprophyllinum|Dyphylline|()-dyphylline|Diprofilina|()-diprophylline|(+-)-7-(2,3-Dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione|7-(,-dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)theophylline|Dihydroxypropyl theopylin|7-(2,3-Dihydroxypropyl)-1,3-dimethylxanthine	protophylline sup 500mg adulte	DRUGBANK	DB00651	C10H14N4O4	small molecule	R03DB01|R03DA01|R03DA51	479-18-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KSCFJBIXMNOVSH-UHFFFAOYSA-N
9001	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Iancu L (1979)	225216	177566	641	Dyphylline	Diprophylline|7-(beta,gamma-Dihydroxypropyl)theophylline|(1,2-Dihydroxy-3-propyl)thiophyllin|1,3-Dimethyl-7-(2,3-dihydroxypropyl)xanthine|(+-)-Dyphylline|(+-)-Diprophylline|Diprophyllinum|Dyphylline|()-dyphylline|Diprofilina|()-diprophylline|(+-)-7-(2,3-Dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione|7-(,-dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)theophylline|Dihydroxypropyl theopylin|7-(2,3-Dihydroxypropyl)-1,3-dimethylxanthine	protophylline sup 500mg adulte	DRUGBANK	DB00651	C10H14N4O4	small molecule	R03DB01|R03DA01|R03DA51	479-18-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KSCFJBIXMNOVSH-UHFFFAOYSA-N
9017	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	agonist	target	Pal A (2007)	17622576	177568	642	Pentazocine	Pentazocin|Pentazocinum|Fortral|Pentazocine|Pentazocina	pentazocine hcl and acetaminop	DRUGBANK	DB00652	C19H27NO	small molecule	N02AD01	359-83-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOKSWYLNZZRQPF-GDIGMMSISA-N
9018	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	agonist	target	Mamolo MG (2008)	18069094	177569	642	Pentazocine	Pentazocin|Pentazocinum|Fortral|Pentazocine|Pentazocina	pentazocine hcl and acetaminop	DRUGBANK	DB00652	C19H27NO	small molecule	N02AD01	359-83-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOKSWYLNZZRQPF-GDIGMMSISA-N
9019	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	agonist	target	Chien CC (1995)	8788445	177572	642	Pentazocine	Pentazocin|Pentazocinum|Fortral|Pentazocine|Pentazocina	pentazocine hcl and acetaminop	DRUGBANK	DB00652	C19H27NO	small molecule	N02AD01	359-83-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOKSWYLNZZRQPF-GDIGMMSISA-N
9020	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	agonist	target	Colabufo NA (2009)	20021350	177571	642	Pentazocine	Pentazocin|Pentazocinum|Fortral|Pentazocine|Pentazocina	pentazocine hcl and acetaminop	DRUGBANK	DB00652	C19H27NO	small molecule	N02AD01	359-83-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOKSWYLNZZRQPF-GDIGMMSISA-N
9021	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	agonist	target	Dun Y (2007)	17898305	177570	642	Pentazocine	Pentazocin|Pentazocinum|Fortral|Pentazocine|Pentazocina	pentazocine hcl and acetaminop	DRUGBANK	DB00652	C19H27NO	small molecule	N02AD01	359-83-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOKSWYLNZZRQPF-GDIGMMSISA-N
9130	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	unknown	target	Milberg P (2005)	15944809	177625	651	Verapamil	D-365|Verapamil|Vrapamil|Verapamilo|Iproveratril|Tarka|CP-16533-1|Isoptin sr|Calan sr|CP-165331|Isoptin|Verelan|Covera-hs|Calan|Verapamilum	verapamil hydrochloride inject	DRUGBANK	DB00661	C27H38N2O4	small molecule	C08DA01|C08DA51|C09BB10	52-53-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGTNSNPWRIOYBX-UHFFFAOYSA-N
9236	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Mitsikostas DD (2002)	12110114	177691	659	Sumatriptan	Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan	phl-sumatriptan|sumavel dosepr	DRUGBANK	DB00669	C14H21N3O2S	small molecule	N02CC01	103628-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQKPFRSPSRPDEB-UHFFFAOYSA-N
9237	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	659	Sumatriptan	Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan	phl-sumatriptan|sumavel dosepr	DRUGBANK	DB00669	C14H21N3O2S	small molecule	N02CC01	103628-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQKPFRSPSRPDEB-UHFFFAOYSA-N
9238	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Nikai T (2008)	18723285	177683	659	Sumatriptan	Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan	phl-sumatriptan|sumavel dosepr	DRUGBANK	DB00669	C14H21N3O2S	small molecule	N02CC01	103628-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQKPFRSPSRPDEB-UHFFFAOYSA-N
9239	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Cohen ML (1999)	10454495	177682	659	Sumatriptan	Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan	phl-sumatriptan|sumavel dosepr	DRUGBANK	DB00669	C14H21N3O2S	small molecule	N02CC01	103628-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQKPFRSPSRPDEB-UHFFFAOYSA-N
9240	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Granaes C (1999)	10513577	177696	659	Sumatriptan	Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan	phl-sumatriptan|sumavel dosepr	DRUGBANK	DB00669	C14H21N3O2S	small molecule	N02CC01	103628-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQKPFRSPSRPDEB-UHFFFAOYSA-N
9241	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Cohen Z (1999)	10458598	177697	659	Sumatriptan	Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan	phl-sumatriptan|sumavel dosepr	DRUGBANK	DB00669	C14H21N3O2S	small molecule	N02CC01	103628-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQKPFRSPSRPDEB-UHFFFAOYSA-N
9242	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Razzaque Z (2002)	11874390	177687	659	Sumatriptan	Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan	phl-sumatriptan|sumavel dosepr	DRUGBANK	DB00669	C14H21N3O2S	small molecule	N02CC01	103628-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQKPFRSPSRPDEB-UHFFFAOYSA-N
9243	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Akin D (2002)	12010765	177686	659	Sumatriptan	Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan	phl-sumatriptan|sumavel dosepr	DRUGBANK	DB00669	C14H21N3O2S	small molecule	N02CC01	103628-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQKPFRSPSRPDEB-UHFFFAOYSA-N
9244	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Roy A (2000)	10772044	177685	659	Sumatriptan	Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan	phl-sumatriptan|sumavel dosepr	DRUGBANK	DB00669	C14H21N3O2S	small molecule	N02CC01	103628-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQKPFRSPSRPDEB-UHFFFAOYSA-N
9245	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Mitsikostas DD (1999)	10225363	177688	659	Sumatriptan	Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan	phl-sumatriptan|sumavel dosepr	DRUGBANK	DB00669	C14H21N3O2S	small molecule	N02CC01	103628-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQKPFRSPSRPDEB-UHFFFAOYSA-N
9246	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Dupuis DS (1999)	10101238	177698	659	Sumatriptan	Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan	phl-sumatriptan|sumavel dosepr	DRUGBANK	DB00669	C14H21N3O2S	small molecule	N02CC01	103628-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQKPFRSPSRPDEB-UHFFFAOYSA-N
9355	107560	1138	-	CHRNA5	LNCR2	9606	Homo sapiens	allosteric modulator	target	Guillou C (2000)	20480924	177724	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9356	107560	1138	-	CHRNA5	LNCR2	9606	Homo sapiens	allosteric modulator	target	Scott LJ (2000)	11129124	177725	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9357	107560	1138	-	CHRNA5	LNCR2	9606	Homo sapiens	allosteric modulator	target	Lilienfeld S (2000)	10971048	177719	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9358	107560	1138	-	CHRNA5	LNCR2	9606	Homo sapiens	allosteric modulator	target	Woodruff-Pak DS (2002)	12481195	177718	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9359	107560	1138	-	CHRNA5	LNCR2	9606	Homo sapiens	allosteric modulator	target	Lilienfeld S (2002)	12177686	177716	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9360	107560	1138	-	CHRNA5	LNCR2	9606	Homo sapiens	allosteric modulator	target	Olin J (2002)	12137632	177715	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9425	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Hammock RG (1995)	8720030	177776	669	Thioridazine	Mellaril|10-[2-(1-Methyl-2-piperidyl)ethyl]-2-methylsulfanyl-phenothiazine|Sonapax|2-Methylmercapto-10-(2-(N-methyl-2-piperidyl)ethyl)phenothiazine|Mellaril-S|Orsanil|Meleril|3-Methylmercapto-N-(2'-(N-methyl-2-piperidyl)ethyl)phenothiazine|Thioridazinum|Mellerets|Mallorol|Malloryl|Tioridazina|Thioridazin|Mellerette|Melleril	thioridazine tab 50mg|novo-rid	DRUGBANK	DB00679	C21H26N2S2	small molecule	N05AC02	50-52-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KLBQZWRITKRQQV-UHFFFAOYSA-N
9432	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	670	Moricizine	Moracizina|EN-313|Ethyl 10-(3-morpholinopropionyl)phenothiazine-2-carbamate|Moracizin|Ethmozin|Moricizine|Moracizinum|Etmozin|[10-(3-Morpholin-4-yl-propionyl)-10H-phenothiazin-2-yl]-carbamic acid ethyl ester|Ethyl 10-(beta-N-morpholinylpropionyl)phenothiazine-2-carbamate|Moracizine	-	DRUGBANK	DB00680	C22H25N3O4S	small molecule	C01BG01	31883-05-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FUBVWMNBEHXPSU-UHFFFAOYSA-N
9433	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	670	Moricizine	Moracizina|EN-313|Ethyl 10-(3-morpholinopropionyl)phenothiazine-2-carbamate|Moracizin|Ethmozin|Moricizine|Moracizinum|Etmozin|[10-(3-Morpholin-4-yl-propionyl)-10H-phenothiazin-2-yl]-carbamic acid ethyl ester|Ethyl 10-(beta-N-morpholinylpropionyl)phenothiazine-2-carbamate|Moracizine	-	DRUGBANK	DB00680	C22H25N3O4S	small molecule	C01BG01	31883-05-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FUBVWMNBEHXPSU-UHFFFAOYSA-N
9434	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	670	Moricizine	Moracizina|EN-313|Ethyl 10-(3-morpholinopropionyl)phenothiazine-2-carbamate|Moracizin|Ethmozin|Moricizine|Moracizinum|Etmozin|[10-(3-Morpholin-4-yl-propionyl)-10H-phenothiazin-2-yl]-carbamic acid ethyl ester|Ethyl 10-(beta-N-morpholinylpropionyl)phenothiazine-2-carbamate|Moracizine	-	DRUGBANK	DB00680	C22H25N3O4S	small molecule	C01BG01	31883-05-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FUBVWMNBEHXPSU-UHFFFAOYSA-N
9435	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Ahmmed GU (2002)	12402511	177783	670	Moricizine	Moracizina|EN-313|Ethyl 10-(3-morpholinopropionyl)phenothiazine-2-carbamate|Moracizin|Ethmozin|Moricizine|Moracizinum|Etmozin|[10-(3-Morpholin-4-yl-propionyl)-10H-phenothiazin-2-yl]-carbamic acid ethyl ester|Ethyl 10-(beta-N-morpholinylpropionyl)phenothiazine-2-carbamate|Moracizine	-	DRUGBANK	DB00680	C22H25N3O4S	small molecule	C01BG01	31883-05-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FUBVWMNBEHXPSU-UHFFFAOYSA-N
9588	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Willems EW (1999)	10455274	175179	686	Ergotamine	Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione	gravergol capsules|ergomar sub	DRUGBANK	DB00696	C33H35N5O5	small molecule	N02CA02|N02CA72|N02CA52	113-15-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCGSFFUVFURLIX-VFGNJEKYSA-N
9589	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Villalon CM (1999)	10188968	177882	686	Ergotamine	Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione	gravergol capsules|ergomar sub	DRUGBANK	DB00696	C33H35N5O5	small molecule	N02CA02|N02CA72|N02CA52	113-15-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCGSFFUVFURLIX-VFGNJEKYSA-N
9590	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Valdivia LF (2004)	15224175	177881	686	Ergotamine	Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione	gravergol capsules|ergomar sub	DRUGBANK	DB00696	C33H35N5O5	small molecule	N02CA02|N02CA72|N02CA52	113-15-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCGSFFUVFURLIX-VFGNJEKYSA-N
9591	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Cohen ML (2000)	11015308	177695	686	Ergotamine	Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione	gravergol capsules|ergomar sub	DRUGBANK	DB00696	C33H35N5O5	small molecule	N02CA02|N02CA72|N02CA52	113-15-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCGSFFUVFURLIX-VFGNJEKYSA-N
9611	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Bigal ME (2003)	12525272	177883	686	Ergotamine	Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione	gravergol capsules|ergomar sub	DRUGBANK	DB00696	C33H35N5O5	small molecule	N02CA02|N02CA72|N02CA52	113-15-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCGSFFUVFURLIX-VFGNJEKYSA-N
9662	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	antagonist	target	Herz A (1997)	9040115	177911	694	Naltrexone	N-Cyclopropylmethylnoroxymorphone|Naltrexone|Naltrexona|17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one|Naltrexon|Naltrexonum|N-Cyclopropylmethyl-14-hydroxydihydromorphinone|17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one	revia - tab 50mg|revia|naltrex	DRUGBANK	DB00704	C20H23NO4	small molecule	N07BB04|A08AA62	16590-41-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQCKKXVULJGBQN-XFWGSAIBSA-N
9663	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	antagonist	target	Wee S (2009)	19484223	177910	694	Naltrexone	N-Cyclopropylmethylnoroxymorphone|Naltrexone|Naltrexona|17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one|Naltrexon|Naltrexonum|N-Cyclopropylmethyl-14-hydroxydihydromorphinone|17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one	revia - tab 50mg|revia|naltrex	DRUGBANK	DB00704	C20H23NO4	small molecule	N07BB04|A08AA62	16590-41-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQCKKXVULJGBQN-XFWGSAIBSA-N
9664	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	antagonist	target	Helm S (2008)	18354714	177912	694	Naltrexone	N-Cyclopropylmethylnoroxymorphone|Naltrexone|Naltrexona|17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one|Naltrexon|Naltrexonum|N-Cyclopropylmethyl-14-hydroxydihydromorphinone|17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one	revia - tab 50mg|revia|naltrex	DRUGBANK	DB00704	C20H23NO4	small molecule	N07BB04|A08AA62	16590-41-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQCKKXVULJGBQN-XFWGSAIBSA-N
9720	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Bayly CI (1999)	10091674	177979	702	Flurbiprofen	Flurbiprofenum|3-Fluoro-4-phenylhydratropic acid|S-flurbiprofen|2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid|(+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid|2-(2-Fluorobiphenyl-4-yl)propanoic acid|Flurbiprofen|Flurbiprofeno|FLP|Ansaid|Flurbiprofene	nu-flurbiprofen tab 50mg|ratio	DRUGBANK	DB00712	C15H13FO2	small molecule	M02AA19|S01BC04|M01AE09|R02AX01	5104-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYTBZMRGLBWNTM-UHFFFAOYSA-N
9721	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Hinz B (2001)	11405284	177978	702	Flurbiprofen	Flurbiprofenum|3-Fluoro-4-phenylhydratropic acid|S-flurbiprofen|2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid|(+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid|2-(2-Fluorobiphenyl-4-yl)propanoic acid|Flurbiprofen|Flurbiprofeno|FLP|Ansaid|Flurbiprofene	nu-flurbiprofen tab 50mg|ratio	DRUGBANK	DB00712	C15H13FO2	small molecule	M02AA19|S01BC04|M01AE09|R02AX01	5104-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYTBZMRGLBWNTM-UHFFFAOYSA-N
9722	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	van Haeringen NJ (2000)	10977131	177980	702	Flurbiprofen	Flurbiprofenum|3-Fluoro-4-phenylhydratropic acid|S-flurbiprofen|2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid|(+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid|2-(2-Fluorobiphenyl-4-yl)propanoic acid|Flurbiprofen|Flurbiprofeno|FLP|Ansaid|Flurbiprofene	nu-flurbiprofen tab 50mg|ratio	DRUGBANK	DB00712	C15H13FO2	small molecule	M02AA19|S01BC04|M01AE09|R02AX01	5104-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYTBZMRGLBWNTM-UHFFFAOYSA-N
9723	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Nivsarkar M (2008)	19066416	177973	702	Flurbiprofen	Flurbiprofenum|3-Fluoro-4-phenylhydratropic acid|S-flurbiprofen|2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid|(+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid|2-(2-Fluorobiphenyl-4-yl)propanoic acid|Flurbiprofen|Flurbiprofeno|FLP|Ansaid|Flurbiprofene	nu-flurbiprofen tab 50mg|ratio	DRUGBANK	DB00712	C15H13FO2	small molecule	M02AA19|S01BC04|M01AE09|R02AX01	5104-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYTBZMRGLBWNTM-UHFFFAOYSA-N
9724	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Smith T (2000)	11006278	160486	702	Flurbiprofen	Flurbiprofenum|3-Fluoro-4-phenylhydratropic acid|S-flurbiprofen|2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid|(+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid|2-(2-Fluorobiphenyl-4-yl)propanoic acid|Flurbiprofen|Flurbiprofeno|FLP|Ansaid|Flurbiprofene	nu-flurbiprofen tab 50mg|ratio	DRUGBANK	DB00712	C15H13FO2	small molecule	M02AA19|S01BC04|M01AE09|R02AX01	5104-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYTBZMRGLBWNTM-UHFFFAOYSA-N
9725	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Hewett SJ (2000)	10773011	177971	702	Flurbiprofen	Flurbiprofenum|3-Fluoro-4-phenylhydratropic acid|S-flurbiprofen|2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid|(+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid|2-(2-Fluorobiphenyl-4-yl)propanoic acid|Flurbiprofen|Flurbiprofeno|FLP|Ansaid|Flurbiprofene	nu-flurbiprofen tab 50mg|ratio	DRUGBANK	DB00712	C15H13FO2	small molecule	M02AA19|S01BC04|M01AE09|R02AX01	5104-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYTBZMRGLBWNTM-UHFFFAOYSA-N
9726	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Basselin M (2007)	17562170	177977	702	Flurbiprofen	Flurbiprofenum|3-Fluoro-4-phenylhydratropic acid|S-flurbiprofen|2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid|(+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid|2-(2-Fluorobiphenyl-4-yl)propanoic acid|Flurbiprofen|Flurbiprofeno|FLP|Ansaid|Flurbiprofene	nu-flurbiprofen tab 50mg|ratio	DRUGBANK	DB00712	C15H13FO2	small molecule	M02AA19|S01BC04|M01AE09|R02AX01	5104-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYTBZMRGLBWNTM-UHFFFAOYSA-N
9734	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	704	Apomorphine	(-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin	movapo|apokyn	DRUGBANK	DB00714	C17H17NO2	small molecule	G04BE07|N04BC07	58-00-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMWNQDUVQKEIOC-CYBMUJFWSA-N
9753	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	704	Apomorphine	(-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin	movapo|apokyn	DRUGBANK	DB00714	C17H17NO2	small molecule	G04BE07|N04BC07	58-00-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMWNQDUVQKEIOC-CYBMUJFWSA-N
9754	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	704	Apomorphine	(-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin	movapo|apokyn	DRUGBANK	DB00714	C17H17NO2	small molecule	G04BE07|N04BC07	58-00-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMWNQDUVQKEIOC-CYBMUJFWSA-N
9755	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	704	Apomorphine	(-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin	movapo|apokyn	DRUGBANK	DB00714	C17H17NO2	small molecule	G04BE07|N04BC07	58-00-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMWNQDUVQKEIOC-CYBMUJFWSA-N
9756	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Guo H (2002)	12453049	177992	704	Apomorphine	(-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin	movapo|apokyn	DRUGBANK	DB00714	C17H17NO2	small molecule	G04BE07|N04BC07	58-00-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMWNQDUVQKEIOC-CYBMUJFWSA-N
9805	106789	292	-	SLC25A5	2F1|AAC2|ANT2|T2|T3	9606	Homo sapiens	inhibitor	target	Lehenkari PP (2002)	11961144	178023	710	Clodronate	Dichloromethanediphosphonic acid|Clodronsure|Dichloromethylene-1,1-diphosphonic acid|(Dichloro-phosphono-methyl)-phosphonic acid|Clodronate|Acido Clodronico|Dichloromethylidene diphosphonate|(Dichloromethylene)diphosphonic acid|Acide Clodronique|(Dichloromethylene)bisphosphonic acid|Acidum Clodronicum|Clodronsaeure|Dichloromethylene-1,1-bisphosphonic acid	bonefos|clasteon|ostac cap 400	DRUGBANK	DB00720	CH4Cl2O6P2	small molecule	-	10596-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACSIXWWBWUQEHA-UHFFFAOYSA-N
9810	109984	3783	-	KCNN4	IK1|IKCA1|KCA4|KCa3.1|SK4|hIKCa1|hKCa4|hSK4	9606	Homo sapiens	binder	target	Benham CD (1985)	2580269	178026	711	Procaine	Procaina|4-aminobenzoic acid 2-diethylaminoethyl ester|-(diethylamino)ethyl 4-aminobenzoate|2-Diethylaminoethyl p-aminobenzoate|Vitamin H3|Procainum|Novocaine|p-Aminobenzoic acid 2-diethylaminoethyl ester|-(diethylamino)ethyl p-aminobenzoate	novocain 20 mg/ml|novocain liq	DRUGBANK	DB00721	C13H20N2O2	small molecule	S01HA05|C05AD05|N01BA52|N01BA02	59-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFDFERRIHVXMIY-UHFFFAOYSA-N
9827	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	unknown	target	MacFarlane MD (1975)	1109354	178033	711	Procaine	Procaina|4-aminobenzoic acid 2-diethylaminoethyl ester|-(diethylamino)ethyl 4-aminobenzoate|2-Diethylaminoethyl p-aminobenzoate|Vitamin H3|Procainum|Novocaine|p-Aminobenzoic acid 2-diethylaminoethyl ester|-(diethylamino)ethyl p-aminobenzoate	novocain 20 mg/ml|novocain liq	DRUGBANK	DB00721	C13H20N2O2	small molecule	S01HA05|C05AD05|N01BA52|N01BA02	59-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFDFERRIHVXMIY-UHFFFAOYSA-N
9895	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	binder	target	Berger M (1996)	8863001	178063	716	Trimipramine	Trimipramine|Trimeproprimine|RP-7162|Trimipramina|10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine|5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine|Trimeprimina|Trimeprimine|Trimipraminum|beta-Methylimipramine|5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Sapilent	nu-trimipramine tab 100mg|trim	DRUGBANK	DB00726	C20H26N2	small molecule	N06AA06	739-71-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZSCDBOWYZJWBIY-UHFFFAOYSA-N
9984	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Keks NA (1999)	15992090	178094	724	Risperidone	Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone	risperdal m-tab|risperidone - 	DRUGBANK	DB00734	C23H27FN4O2	small molecule	N05AX08	106266-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAPZEAPATHNIPO-UHFFFAOYSA-N
9985	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Leysen JE (1994)	7520908	175510	724	Risperidone	Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone	risperdal m-tab|risperidone - 	DRUGBANK	DB00734	C23H27FN4O2	small molecule	N05AX08	106266-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAPZEAPATHNIPO-UHFFFAOYSA-N
10008	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Song JH (1997)	9262334	178121	730	Riluzole	Riluzolum|Riluzole|Riluzol	mylan-riluzole|rilutek|apo-ril	DRUGBANK	DB00740	C8H5F3N2OS	small molecule	N07XX02	1744-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTALBRSUTCGOEG-UHFFFAOYSA-N
10009	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Weiss S (2010)	20590601	178120	730	Riluzole	Riluzolum|Riluzole|Riluzol	mylan-riluzole|rilutek|apo-ril	DRUGBANK	DB00740	C8H5F3N2OS	small molecule	N07XX02	1744-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTALBRSUTCGOEG-UHFFFAOYSA-N
10010	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	730	Riluzole	Riluzolum|Riluzole|Riluzol	mylan-riluzole|rilutek|apo-ril	DRUGBANK	DB00740	C8H5F3N2OS	small molecule	N07XX02	1744-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTALBRSUTCGOEG-UHFFFAOYSA-N
10011	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Schwartz G (2002)	12440368	178119	730	Riluzole	Riluzolum|Riluzole|Riluzol	mylan-riluzole|rilutek|apo-ril	DRUGBANK	DB00740	C8H5F3N2OS	small molecule	N07XX02	1744-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTALBRSUTCGOEG-UHFFFAOYSA-N
10012	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	730	Riluzole	Riluzolum|Riluzole|Riluzol	mylan-riluzole|rilutek|apo-ril	DRUGBANK	DB00740	C8H5F3N2OS	small molecule	N07XX02	1744-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTALBRSUTCGOEG-UHFFFAOYSA-N
10061	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen WS (2001)	11275997	178176	739	Etodolac	Etodolac|(1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid|todolac|1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid|1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid|Etodolaco|Etodolacum|Etodolsure|Etodolic acid|(+-)-1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid|1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid	taro-etodolac 200 mg|etodolac|	DRUGBANK	DB00749	C17H21NO3	small molecule	M01AB08	41340-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNYBQONXHNTVIJ-UHFFFAOYSA-N
10062	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Svendsen KB (2000)	11009046	178174	739	Etodolac	Etodolac|(1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid|todolac|1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid|1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid|Etodolaco|Etodolacum|Etodolsure|Etodolic acid|(+-)-1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid|1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid	taro-etodolac 200 mg|etodolac|	DRUGBANK	DB00749	C17H21NO3	small molecule	M01AB08	41340-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNYBQONXHNTVIJ-UHFFFAOYSA-N
10063	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Kusuhara H (1999)	10594327	178175	739	Etodolac	Etodolac|(1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid|todolac|1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid|1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid|Etodolaco|Etodolacum|Etodolsure|Etodolic acid|(+-)-1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid|1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid	taro-etodolac 200 mg|etodolac|	DRUGBANK	DB00749	C17H21NO3	small molecule	M01AB08	41340-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNYBQONXHNTVIJ-UHFFFAOYSA-N
10064	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen WS (2003)	12824918	178173	739	Etodolac	Etodolac|(1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid|todolac|1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid|1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid|Etodolaco|Etodolacum|Etodolsure|Etodolic acid|(+-)-1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid|1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid	taro-etodolac 200 mg|etodolac|	DRUGBANK	DB00749	C17H21NO3	small molecule	M01AB08	41340-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNYBQONXHNTVIJ-UHFFFAOYSA-N
10065	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Wilson JE (2004)	15198222	178171	739	Etodolac	Etodolac|(1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid|todolac|1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid|1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid|Etodolaco|Etodolacum|Etodolsure|Etodolic acid|(+-)-1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid|1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid	taro-etodolac 200 mg|etodolac|	DRUGBANK	DB00749	C17H21NO3	small molecule	M01AB08	41340-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNYBQONXHNTVIJ-UHFFFAOYSA-N
10066	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	739	Etodolac	Etodolac|(1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid|todolac|1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid|1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid|Etodolaco|Etodolacum|Etodolsure|Etodolic acid|(+-)-1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid|1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid	taro-etodolac 200 mg|etodolac|	DRUGBANK	DB00749	C17H21NO3	small molecule	M01AB08	41340-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNYBQONXHNTVIJ-UHFFFAOYSA-N
10067	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	740	Prilocaine	O-Methyl-2-propylaminopropionanilide|Prilocaina|2-Methyl-alpha-propylaminopropionanilide|Prilocane|Propitocaine|Prilocain|alpha-N-Propylamino-2-methylpropionanilide|2-(Propylamino)-O-propionotoluidide|N-(2-Methylphenyl)-2-(propylamino)propanamide|Prilocaine base|O-Methyl-alpha-propylaminopropionanilide|Prilocainum	prikaan|relador pak plus|derma	DRUGBANK	DB00750	C13H20N2O	small molecule	N01BB54|N01BB04	721-50-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVFGUOIZUNYYSO-UHFFFAOYSA-N
10068	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	740	Prilocaine	O-Methyl-2-propylaminopropionanilide|Prilocaina|2-Methyl-alpha-propylaminopropionanilide|Prilocane|Propitocaine|Prilocain|alpha-N-Propylamino-2-methylpropionanilide|2-(Propylamino)-O-propionotoluidide|N-(2-Methylphenyl)-2-(propylamino)propanamide|Prilocaine base|O-Methyl-alpha-propylaminopropionanilide|Prilocainum	prikaan|relador pak plus|derma	DRUGBANK	DB00750	C13H20N2O	small molecule	N01BB54|N01BB04	721-50-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVFGUOIZUNYYSO-UHFFFAOYSA-N
10069	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	740	Prilocaine	O-Methyl-2-propylaminopropionanilide|Prilocaina|2-Methyl-alpha-propylaminopropionanilide|Prilocane|Propitocaine|Prilocain|alpha-N-Propylamino-2-methylpropionanilide|2-(Propylamino)-O-propionotoluidide|N-(2-Methylphenyl)-2-(propylamino)propanamide|Prilocaine base|O-Methyl-alpha-propylaminopropionanilide|Prilocainum	prikaan|relador pak plus|derma	DRUGBANK	DB00750	C13H20N2O	small molecule	N01BB54|N01BB04	721-50-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVFGUOIZUNYYSO-UHFFFAOYSA-N
10092	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Shioda K (2010)	20655983	178189	742	Tranylcypromine	Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum	parnate|tranylcypromine sulfat	DRUGBANK	DB00752	C9H11N	small molecule	N06AF04	155-09-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AELCINSCMGFISI-YGPZHTELSA-N
10093	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Wiest SA (1999)	10494892	178188	742	Tranylcypromine	Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum	parnate|tranylcypromine sulfat	DRUGBANK	DB00752	C9H11N	small molecule	N06AF04	155-09-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AELCINSCMGFISI-YGPZHTELSA-N
10094	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Salsali M (2004)	15049511	178194	742	Tranylcypromine	Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum	parnate|tranylcypromine sulfat	DRUGBANK	DB00752	C9H11N	small molecule	N06AF04	155-09-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AELCINSCMGFISI-YGPZHTELSA-N
10095	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Todd KG (1995)	8749840	178187	742	Tranylcypromine	Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum	parnate|tranylcypromine sulfat	DRUGBANK	DB00752	C9H11N	small molecule	N06AF04	155-09-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AELCINSCMGFISI-YGPZHTELSA-N
10096	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Finberg JP (2002)	12504917	178196	742	Tranylcypromine	Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum	parnate|tranylcypromine sulfat	DRUGBANK	DB00752	C9H11N	small molecule	N06AF04	155-09-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AELCINSCMGFISI-YGPZHTELSA-N
10097	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Gatch MB (2006)	16495723	178197	742	Tranylcypromine	Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum	parnate|tranylcypromine sulfat	DRUGBANK	DB00752	C9H11N	small molecule	N06AF04	155-09-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AELCINSCMGFISI-YGPZHTELSA-N
10098	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Nolen WA (2003)	14574774	178190	742	Tranylcypromine	Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum	parnate|tranylcypromine sulfat	DRUGBANK	DB00752	C9H11N	small molecule	N06AF04	155-09-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AELCINSCMGFISI-YGPZHTELSA-N
10099	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Volz HP (1998)	9829163	178186	742	Tranylcypromine	Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum	parnate|tranylcypromine sulfat	DRUGBANK	DB00752	C9H11N	small molecule	N06AF04	155-09-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AELCINSCMGFISI-YGPZHTELSA-N
10100	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Lang W (2004)	15351283	178192	742	Tranylcypromine	Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum	parnate|tranylcypromine sulfat	DRUGBANK	DB00752	C9H11N	small molecule	N06AF04	155-09-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AELCINSCMGFISI-YGPZHTELSA-N
10101	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Shioda K (2004)	15276688	178191	742	Tranylcypromine	Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum	parnate|tranylcypromine sulfat	DRUGBANK	DB00752	C9H11N	small molecule	N06AF04	155-09-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AELCINSCMGFISI-YGPZHTELSA-N
10102	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Cohen C (1999)	10548268	178195	742	Tranylcypromine	Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum	parnate|tranylcypromine sulfat	DRUGBANK	DB00752	C9H11N	small molecule	N06AF04	155-09-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AELCINSCMGFISI-YGPZHTELSA-N
10103	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Loescher W (1999)	10027835	178193	742	Tranylcypromine	Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum	parnate|tranylcypromine sulfat	DRUGBANK	DB00752	C9H11N	small molecule	N06AF04	155-09-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AELCINSCMGFISI-YGPZHTELSA-N
10104	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	742	Tranylcypromine	Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum	parnate|tranylcypromine sulfat	DRUGBANK	DB00752	C9H11N	small molecule	N06AF04	155-09-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AELCINSCMGFISI-YGPZHTELSA-N
10125	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Lenkowski PW (2004)	15066664	176695	744	Ethotoin	3-Ethyl-5-phenyl-imidazolidine-2,4-dione|(+-)-3-Ethyl-5-phenylhydantoin|Ethotone|Etotoina|3-Ethyl-5-phenylhydantoin|Ethotoin|Ethotoinum|3-Ethyl-5-phenylimidazolidin-2,4-dione|1-Ethyl-2,5-dioxo-4-phenylimidazolidine|3-Ethyl-5-phenyl-2,4-imidazolidinedione	peganone	DRUGBANK	DB00754	C11H12N2O2	small molecule	N03AB01	86-35-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SZQIFWWUIBRPBZ-UHFFFAOYSA-N
10126	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	744	Ethotoin	3-Ethyl-5-phenyl-imidazolidine-2,4-dione|(+-)-3-Ethyl-5-phenylhydantoin|Ethotone|Etotoina|3-Ethyl-5-phenylhydantoin|Ethotoin|Ethotoinum|3-Ethyl-5-phenylimidazolidin-2,4-dione|1-Ethyl-2,5-dioxo-4-phenylimidazolidine|3-Ethyl-5-phenyl-2,4-imidazolidinedione	peganone	DRUGBANK	DB00754	C11H12N2O2	small molecule	N03AB01	86-35-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SZQIFWWUIBRPBZ-UHFFFAOYSA-N
10127	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	744	Ethotoin	3-Ethyl-5-phenyl-imidazolidine-2,4-dione|(+-)-3-Ethyl-5-phenylhydantoin|Ethotone|Etotoina|3-Ethyl-5-phenylhydantoin|Ethotoin|Ethotoinum|3-Ethyl-5-phenylimidazolidin-2,4-dione|1-Ethyl-2,5-dioxo-4-phenylimidazolidine|3-Ethyl-5-phenyl-2,4-imidazolidinedione	peganone	DRUGBANK	DB00754	C11H12N2O2	small molecule	N03AB01	86-35-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SZQIFWWUIBRPBZ-UHFFFAOYSA-N
10128	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	744	Ethotoin	3-Ethyl-5-phenyl-imidazolidine-2,4-dione|(+-)-3-Ethyl-5-phenylhydantoin|Ethotone|Etotoina|3-Ethyl-5-phenylhydantoin|Ethotoin|Ethotoinum|3-Ethyl-5-phenylimidazolidin-2,4-dione|1-Ethyl-2,5-dioxo-4-phenylimidazolidine|3-Ethyl-5-phenyl-2,4-imidazolidinedione	peganone	DRUGBANK	DB00754	C11H12N2O2	small molecule	N03AB01	86-35-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SZQIFWWUIBRPBZ-UHFFFAOYSA-N
10286	111704	5732	-	PTGER2	EP2	9606	Homo sapiens	agonist	target	Dijkstra BG (1999)	10509658	178309	760	Alprostadil	(13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate|Prostaglandin e1|PGE|Alprostadil|Alprostadil Alfadex|11alpha,15alpha-Dihydroxy-9-oxo-13-trans-prostenoic acid|Prostin vr|Edex|Befar|Caverject|Muse|Alprostadilum|PGE1 -CD|PGE-1|(11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid	prostin vr sterile solution|ca	DRUGBANK	DB00770	C20H34O5	small molecule	G04BE01|C01EA01	745-65-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMVPRGQOIOIIMI-DWKJAMRDSA-N
10287	111704	5732	-	PTGER2	EP2	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	760	Alprostadil	(13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate|Prostaglandin e1|PGE|Alprostadil|Alprostadil Alfadex|11alpha,15alpha-Dihydroxy-9-oxo-13-trans-prostenoic acid|Prostin vr|Edex|Befar|Caverject|Muse|Alprostadilum|PGE1 -CD|PGE-1|(11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid	prostin vr sterile solution|ca	DRUGBANK	DB00770	C20H34O5	small molecule	G04BE01|C01EA01	745-65-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMVPRGQOIOIIMI-DWKJAMRDSA-N
10288	111704	5732	-	PTGER2	EP2	9606	Homo sapiens	agonist	target	Takahashi HK (2005)	15840408	178310	760	Alprostadil	(13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate|Prostaglandin e1|PGE|Alprostadil|Alprostadil Alfadex|11alpha,15alpha-Dihydroxy-9-oxo-13-trans-prostenoic acid|Prostin vr|Edex|Befar|Caverject|Muse|Alprostadilum|PGE1 -CD|PGE-1|(11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid	prostin vr sterile solution|ca	DRUGBANK	DB00770	C20H34O5	small molecule	G04BE01|C01EA01	745-65-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMVPRGQOIOIIMI-DWKJAMRDSA-N
10310	107225	771	-	CA12	CAXII|HsT18816	9606	Homo sapiens	inhibitor	target	Temperini C (2009)	19119014	174539	764	Hydroflumethiazide	Hidroflumetiazida|Hydroflumthiazide|Dihydroflumethazide|Hydroflumethiazide|Hidroflumetiazid|Metforylthiadiazin|Saluron|Idroflumetiazide|Hydroflumethiazidum	-	DRUGBANK	DB00774	C8H8F3N3O4S2	small molecule	C03AB02|C03AH02|C03AA02	135-09-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DMDGGSIALPNSEE-UHFFFAOYSA-N
10336	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	766	Oxcarbazepine	OCBZ|Oxcarbazepina|Oxcarbazepine|Oxcarbamazepine|Oxcarbazepinum|10,11-Dihydro-10-oxo-5H-dibenz(b,F)azepine-5-carboxamide	jamp-oxcarbazepine|trileptal 3	DRUGBANK	DB00776	C15H12N2O2	small molecule	N03AF02	28721-07-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CTRLABGOLIVAIY-UHFFFAOYSA-N
10337	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Vohora D (2010)	20502724	178335	766	Oxcarbazepine	OCBZ|Oxcarbazepina|Oxcarbazepine|Oxcarbamazepine|Oxcarbazepinum|10,11-Dihydro-10-oxo-5H-dibenz(b,F)azepine-5-carboxamide	jamp-oxcarbazepine|trileptal 3	DRUGBANK	DB00776	C15H12N2O2	small molecule	N03AF02	28721-07-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CTRLABGOLIVAIY-UHFFFAOYSA-N
10338	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	766	Oxcarbazepine	OCBZ|Oxcarbazepina|Oxcarbazepine|Oxcarbamazepine|Oxcarbazepinum|10,11-Dihydro-10-oxo-5H-dibenz(b,F)azepine-5-carboxamide	jamp-oxcarbazepine|trileptal 3	DRUGBANK	DB00776	C15H12N2O2	small molecule	N03AF02	28721-07-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CTRLABGOLIVAIY-UHFFFAOYSA-N
10341	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	767	Propiomazine	10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum	-	DRUGBANK	DB00777	C20H24N2OS	small molecule	N05CM06	362-29-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVOIBTBFPOZKGP-UHFFFAOYSA-N
10342	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	767	Propiomazine	10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum	-	DRUGBANK	DB00777	C20H24N2OS	small molecule	N05CM06	362-29-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVOIBTBFPOZKGP-UHFFFAOYSA-N
10387	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	770	Phenelzine	Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen	nardil|phenelzine sulfate	DRUGBANK	DB00780	C8H12N2	small molecule	N06AF03	51-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMUCZJUITONUFY-UHFFFAOYSA-N
10388	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	antagonist	target	Nolen WA (2003)	14574774	178190	770	Phenelzine	Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen	nardil|phenelzine sulfate	DRUGBANK	DB00780	C8H12N2	small molecule	N06AF03	51-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMUCZJUITONUFY-UHFFFAOYSA-N
10389	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	antagonist	target	Volz HP (1998)	9829163	178186	770	Phenelzine	Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen	nardil|phenelzine sulfate	DRUGBANK	DB00780	C8H12N2	small molecule	N06AF03	51-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMUCZJUITONUFY-UHFFFAOYSA-N
10390	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	antagonist	target	McIntyre RS (2006)	16370964	178345	770	Phenelzine	Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen	nardil|phenelzine sulfate	DRUGBANK	DB00780	C8H12N2	small molecule	N06AF03	51-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMUCZJUITONUFY-UHFFFAOYSA-N
10391	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	antagonist	target	Wooters TE (2007)	17912044	178344	770	Phenelzine	Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen	nardil|phenelzine sulfate	DRUGBANK	DB00780	C8H12N2	small molecule	N06AF03	51-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMUCZJUITONUFY-UHFFFAOYSA-N
10392	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	antagonist	target	Pickar D (1982)	7092487	178347	770	Phenelzine	Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen	nardil|phenelzine sulfate	DRUGBANK	DB00780	C8H12N2	small molecule	N06AF03	51-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMUCZJUITONUFY-UHFFFAOYSA-N
10393	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	antagonist	target	Chiche F (2009)	19201819	178346	770	Phenelzine	Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen	nardil|phenelzine sulfate	DRUGBANK	DB00780	C8H12N2	small molecule	N06AF03	51-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMUCZJUITONUFY-UHFFFAOYSA-N
10394	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	antagonist	target	MacKenzie EM (2008)	17768678	178353	770	Phenelzine	Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen	nardil|phenelzine sulfate	DRUGBANK	DB00780	C8H12N2	small molecule	N06AF03	51-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMUCZJUITONUFY-UHFFFAOYSA-N
10395	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	antagonist	target	Chenu F (2009)	18700056	178343	770	Phenelzine	Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen	nardil|phenelzine sulfate	DRUGBANK	DB00780	C8H12N2	small molecule	N06AF03	51-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMUCZJUITONUFY-UHFFFAOYSA-N
10426	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Bhat AS (2005)	15792781	65577	774	Mefenamic acid	CN 35355|CN-35355|Mefenaminsaeure|Acidum mefenamicum|Acido mefenamico|Mefenaminsure|INF-3355|INF 3355|N-(2,3-Xylyl)-2-aminobenzoic acid|Ponstel|N-2,3-Xylylanthranilic acid|Acide mfnamique|CI-473	mefenamic acid|nu-mefenamic 25	DRUGBANK	DB00784	C15H15NO2	small molecule	M01AG01	61-68-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYYBABOKPJLUIN-UHFFFAOYSA-N
10427	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Walton LJ (1999)	10393680	178381	774	Mefenamic acid	CN 35355|CN-35355|Mefenaminsaeure|Acidum mefenamicum|Acido mefenamico|Mefenaminsure|INF-3355|INF 3355|N-(2,3-Xylyl)-2-aminobenzoic acid|Ponstel|N-2,3-Xylylanthranilic acid|Acide mfnamique|CI-473	mefenamic acid|nu-mefenamic 25	DRUGBANK	DB00784	C15H15NO2	small molecule	M01AG01	61-68-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYYBABOKPJLUIN-UHFFFAOYSA-N
10428	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Gierse JK (1995)	7832763	178380	774	Mefenamic acid	CN 35355|CN-35355|Mefenaminsaeure|Acidum mefenamicum|Acido mefenamico|Mefenaminsure|INF-3355|INF 3355|N-(2,3-Xylyl)-2-aminobenzoic acid|Ponstel|N-2,3-Xylylanthranilic acid|Acide mfnamique|CI-473	mefenamic acid|nu-mefenamic 25	DRUGBANK	DB00784	C15H15NO2	small molecule	M01AG01	61-68-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYYBABOKPJLUIN-UHFFFAOYSA-N
10429	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	774	Mefenamic acid	CN 35355|CN-35355|Mefenaminsaeure|Acidum mefenamicum|Acido mefenamico|Mefenaminsure|INF-3355|INF 3355|N-(2,3-Xylyl)-2-aminobenzoic acid|Ponstel|N-2,3-Xylylanthranilic acid|Acide mfnamique|CI-473	mefenamic acid|nu-mefenamic 25	DRUGBANK	DB00784	C15H15NO2	small molecule	M01AG01	61-68-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYYBABOKPJLUIN-UHFFFAOYSA-N
10430	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Bhat AS (2007)	17150210	178382	774	Mefenamic acid	CN 35355|CN-35355|Mefenaminsaeure|Acidum mefenamicum|Acido mefenamico|Mefenaminsure|INF-3355|INF 3355|N-(2,3-Xylyl)-2-aminobenzoic acid|Ponstel|N-2,3-Xylylanthranilic acid|Acide mfnamique|CI-473	mefenamic acid|nu-mefenamic 25	DRUGBANK	DB00784	C15H15NO2	small molecule	M01AG01	61-68-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYYBABOKPJLUIN-UHFFFAOYSA-N
10431	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Cryer B (1998)	9626023	178378	774	Mefenamic acid	CN 35355|CN-35355|Mefenaminsaeure|Acidum mefenamicum|Acido mefenamico|Mefenaminsure|INF-3355|INF 3355|N-(2,3-Xylyl)-2-aminobenzoic acid|Ponstel|N-2,3-Xylylanthranilic acid|Acide mfnamique|CI-473	mefenamic acid|nu-mefenamic 25	DRUGBANK	DB00784	C15H15NO2	small molecule	M01AG01	61-68-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYYBABOKPJLUIN-UHFFFAOYSA-N
10501	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Dhir A (2007)	17604186	178398	778	Naproxen	(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid|(+)-(S)-Naproxen|Naproxne|Naproxeno|(+)-Naproxen|Naproxenum|(S)-(+)-Naproxen|(+)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(Methoxy-2-naphthyl)-propionic acid|(+)-(S)-6-Methoxy--methyl-2-naphthaleneacetic acid|(S)-Naproxen|(S)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(Methoxy-2-naphthyl)-propionsure|Naproxen|Naprolag|(S)-2-(6-Methoxy-2-naphthyl)propanoic acid|(S)-(+)-2-(6-Methoxy-2-naphthyl)propionic acid	ntp-naproxen sodium|naprosyn 5	DRUGBANK	DB00788	C14H14O3	small molecule	M01AE56|G02CC02|M02AA12|M01AE52|M01AE02	22204-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CMWTZPSULFXXJA-VIFPVBQESA-N
10502	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	White WB (2007)	17612049	178399	778	Naproxen	(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid|(+)-(S)-Naproxen|Naproxne|Naproxeno|(+)-Naproxen|Naproxenum|(S)-(+)-Naproxen|(+)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(Methoxy-2-naphthyl)-propionic acid|(+)-(S)-6-Methoxy--methyl-2-naphthaleneacetic acid|(S)-Naproxen|(S)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(Methoxy-2-naphthyl)-propionsure|Naproxen|Naprolag|(S)-2-(6-Methoxy-2-naphthyl)propanoic acid|(S)-(+)-2-(6-Methoxy-2-naphthyl)propionic acid	ntp-naproxen sodium|naprosyn 5	DRUGBANK	DB00788	C14H14O3	small molecule	M01AE56|G02CC02|M02AA12|M01AE52|M01AE02	22204-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CMWTZPSULFXXJA-VIFPVBQESA-N
10503	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	778	Naproxen	(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid|(+)-(S)-Naproxen|Naproxne|Naproxeno|(+)-Naproxen|Naproxenum|(S)-(+)-Naproxen|(+)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(Methoxy-2-naphthyl)-propionic acid|(+)-(S)-6-Methoxy--methyl-2-naphthaleneacetic acid|(S)-Naproxen|(S)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(Methoxy-2-naphthyl)-propionsure|Naproxen|Naprolag|(S)-2-(6-Methoxy-2-naphthyl)propanoic acid|(S)-(+)-2-(6-Methoxy-2-naphthyl)propionic acid	ntp-naproxen sodium|naprosyn 5	DRUGBANK	DB00788	C14H14O3	small molecule	M01AE56|G02CC02|M02AA12|M01AE52|M01AE02	22204-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CMWTZPSULFXXJA-VIFPVBQESA-N
10504	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Hassan-Alin M (2007)	17532719	178402	778	Naproxen	(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid|(+)-(S)-Naproxen|Naproxne|Naproxeno|(+)-Naproxen|Naproxenum|(S)-(+)-Naproxen|(+)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(Methoxy-2-naphthyl)-propionic acid|(+)-(S)-6-Methoxy--methyl-2-naphthaleneacetic acid|(S)-Naproxen|(S)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(Methoxy-2-naphthyl)-propionsure|Naproxen|Naprolag|(S)-2-(6-Methoxy-2-naphthyl)propanoic acid|(S)-(+)-2-(6-Methoxy-2-naphthyl)propionic acid	ntp-naproxen sodium|naprosyn 5	DRUGBANK	DB00788	C14H14O3	small molecule	M01AE56|G02CC02|M02AA12|M01AE52|M01AE02	22204-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CMWTZPSULFXXJA-VIFPVBQESA-N
10505	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Kumar P (2007)	17521299	178400	778	Naproxen	(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid|(+)-(S)-Naproxen|Naproxne|Naproxeno|(+)-Naproxen|Naproxenum|(S)-(+)-Naproxen|(+)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(Methoxy-2-naphthyl)-propionic acid|(+)-(S)-6-Methoxy--methyl-2-naphthaleneacetic acid|(S)-Naproxen|(S)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(Methoxy-2-naphthyl)-propionsure|Naproxen|Naprolag|(S)-2-(6-Methoxy-2-naphthyl)propanoic acid|(S)-(+)-2-(6-Methoxy-2-naphthyl)propionic acid	ntp-naproxen sodium|naprosyn 5	DRUGBANK	DB00788	C14H14O3	small molecule	M01AE56|G02CC02|M02AA12|M01AE52|M01AE02	22204-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CMWTZPSULFXXJA-VIFPVBQESA-N
10506	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Albertini R (2007)	17607546	178401	778	Naproxen	(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid|(+)-(S)-Naproxen|Naproxne|Naproxeno|(+)-Naproxen|Naproxenum|(S)-(+)-Naproxen|(+)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(Methoxy-2-naphthyl)-propionic acid|(+)-(S)-6-Methoxy--methyl-2-naphthaleneacetic acid|(S)-Naproxen|(S)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(Methoxy-2-naphthyl)-propionsure|Naproxen|Naprolag|(S)-2-(6-Methoxy-2-naphthyl)propanoic acid|(S)-(+)-2-(6-Methoxy-2-naphthyl)propionic acid	ntp-naproxen sodium|naprosyn 5	DRUGBANK	DB00788	C14H14O3	small molecule	M01AE56|G02CC02|M02AA12|M01AE52|M01AE02	22204-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CMWTZPSULFXXJA-VIFPVBQESA-N
10564	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Cipolla G (2002)	12208114	174550	785	Sulfasalazine	Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid	ratio-sulfasalazine tab 500mg|	DRUGBANK	DB00795	C18H14N4O5S	small molecule	A07EC01	599-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCEXYHBECQHGNR-QZQOTICOSA-N
10565	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Generini S (2002)	12463455	174551	785	Sulfasalazine	Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid	ratio-sulfasalazine tab 500mg|	DRUGBANK	DB00795	C18H14N4O5S	small molecule	A07EC01	599-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCEXYHBECQHGNR-QZQOTICOSA-N
10566	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Mifflin RC (2004)	14742690	174552	785	Sulfasalazine	Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid	ratio-sulfasalazine tab 500mg|	DRUGBANK	DB00795	C18H14N4O5S	small molecule	A07EC01	599-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCEXYHBECQHGNR-QZQOTICOSA-N
10567	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Pruzanski W (1997)	9256165	174553	785	Sulfasalazine	Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid	ratio-sulfasalazine tab 500mg|	DRUGBANK	DB00795	C18H14N4O5S	small molecule	A07EC01	599-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCEXYHBECQHGNR-QZQOTICOSA-N
10568	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Distrutti E (2006)	16855178	174554	785	Sulfasalazine	Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid	ratio-sulfasalazine tab 500mg|	DRUGBANK	DB00795	C18H14N4O5S	small molecule	A07EC01	599-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCEXYHBECQHGNR-QZQOTICOSA-N
10618	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	790	Fenoldopam	Fenoldopam|Fenoldopamum|Fnoldopam	corlopam	DRUGBANK	DB00800	C16H16ClNO3	small molecule	C01CA19	67227-56-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TVURRHSHRRELCG-UHFFFAOYSA-N
10619	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Dhasmana KM (1993)	8103596	178446	790	Fenoldopam	Fenoldopam|Fenoldopamum|Fnoldopam	corlopam	DRUGBANK	DB00800	C16H16ClNO3	small molecule	C01CA19	67227-56-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TVURRHSHRRELCG-UHFFFAOYSA-N
10620	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Zeng C (2009)	19293728	178445	790	Fenoldopam	Fenoldopam|Fenoldopamum|Fnoldopam	corlopam	DRUGBANK	DB00800	C16H16ClNO3	small molecule	C01CA19	67227-56-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TVURRHSHRRELCG-UHFFFAOYSA-N
10684	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	795	Minaprine	4-(2-((4-Methyl-6-phenyl-3-pyridazinyl)amino)ethyl)morpholine|Minaprinum|4-Methyl-3-(2-morpholinoethylamino)-6-phenylpyridazin|Minaprina|N-(4-Methyl-6-phenyl-3-pyridazinyl)-4-morpholineethanamine	-	DRUGBANK	DB00805	C17H22N4O	small molecule	N06AX07	25905-77-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LDMWSLGGVTVJPG-UHFFFAOYSA-N
10685	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	795	Minaprine	4-(2-((4-Methyl-6-phenyl-3-pyridazinyl)amino)ethyl)morpholine|Minaprinum|4-Methyl-3-(2-morpholinoethylamino)-6-phenylpyridazin|Minaprina|N-(4-Methyl-6-phenyl-3-pyridazinyl)-4-morpholineethanamine	-	DRUGBANK	DB00805	C17H22N4O	small molecule	N06AX07	25905-77-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LDMWSLGGVTVJPG-UHFFFAOYSA-N
10688	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Kan JP (1986)	3954800	178464	795	Minaprine	4-(2-((4-Methyl-6-phenyl-3-pyridazinyl)amino)ethyl)morpholine|Minaprinum|4-Methyl-3-(2-morpholinoethylamino)-6-phenylpyridazin|Minaprina|N-(4-Methyl-6-phenyl-3-pyridazinyl)-4-morpholineethanamine	-	DRUGBANK	DB00805	C17H22N4O	small molecule	N06AX07	25905-77-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LDMWSLGGVTVJPG-UHFFFAOYSA-N
10706	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	796	Pentoxifylline	Pentoxil|Trental|Pentoxifilina|Pentoxifyllinum|Pentoxifylline|Oxpentifylline|Pentoxifyllin	trental tab 400mg|gapeam budib	DRUGBANK	DB00806	C13H18N4O3	small molecule	C04AD03	6493-05-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYPFEZZEUUWMEJ-UHFFFAOYSA-N
10707	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	796	Pentoxifylline	Pentoxil|Trental|Pentoxifilina|Pentoxifyllinum|Pentoxifylline|Oxpentifylline|Pentoxifyllin	trental tab 400mg|gapeam budib	DRUGBANK	DB00806	C13H18N4O3	small molecule	C04AD03	6493-05-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYPFEZZEUUWMEJ-UHFFFAOYSA-N
10755	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Takada Y (2004)	15489888	178495	802	Phenylbutazone	Phenylbutazon|3,5-Dioxo-1,2-diphenyl-4-n-butylpyrazolidine|Phenylbutazonum|4-BUTYL-1,2-diphenyl-pyrazolidine-3,5-dione|Phenylbutazone|Phenbutazone|4-n-Butyl-1,2-diphenyl-3,5-pyrazolidinedione|Fenilbutazona	alka phenyl tab|novo-butazone 	DRUGBANK	DB00812	C19H20N2O2	small molecule	M01AA01|M02AA01|M01BA01	50-33-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYMDGNCVAMGZFE-UHFFFAOYSA-N
10756	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Arifah AK (2002)	12213119	178494	802	Phenylbutazone	Phenylbutazon|3,5-Dioxo-1,2-diphenyl-4-n-butylpyrazolidine|Phenylbutazonum|4-BUTYL-1,2-diphenyl-pyrazolidine-3,5-dione|Phenylbutazone|Phenbutazone|4-n-Butyl-1,2-diphenyl-3,5-pyrazolidinedione|Fenilbutazona	alka phenyl tab|novo-butazone 	DRUGBANK	DB00812	C19H20N2O2	small molecule	M01AA01|M02AA01|M01BA01	50-33-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYMDGNCVAMGZFE-UHFFFAOYSA-N
10757	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	802	Phenylbutazone	Phenylbutazon|3,5-Dioxo-1,2-diphenyl-4-n-butylpyrazolidine|Phenylbutazonum|4-BUTYL-1,2-diphenyl-pyrazolidine-3,5-dione|Phenylbutazone|Phenbutazone|4-n-Butyl-1,2-diphenyl-3,5-pyrazolidinedione|Fenilbutazona	alka phenyl tab|novo-butazone 	DRUGBANK	DB00812	C19H20N2O2	small molecule	M01AA01|M02AA01|M01BA01	50-33-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYMDGNCVAMGZFE-UHFFFAOYSA-N
10758	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Beretta C (2005)	15939622	178489	802	Phenylbutazone	Phenylbutazon|3,5-Dioxo-1,2-diphenyl-4-n-butylpyrazolidine|Phenylbutazonum|4-BUTYL-1,2-diphenyl-pyrazolidine-3,5-dione|Phenylbutazone|Phenbutazone|4-n-Butyl-1,2-diphenyl-3,5-pyrazolidinedione|Fenilbutazona	alka phenyl tab|novo-butazone 	DRUGBANK	DB00812	C19H20N2O2	small molecule	M01AA01|M02AA01|M01BA01	50-33-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYMDGNCVAMGZFE-UHFFFAOYSA-N
10775	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Tegeder I (1999)	10340919	178510	804	Meloxicam	Mloxicam|Meloxicamum|UNII-vg2qf83cgl|Mobic|Meloxicam	ava-meloxicam|auro-meloxicam|a	DRUGBANK	DB00814	C14H13N3O4S2	small molecule	M01AC56|M01AC06	71125-38-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRVUJXDFFKFLMG-UHFFFAOYSA-N
10776	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Poulsen Nautrup B (1999)	10220944	178511	804	Meloxicam	Mloxicam|Meloxicamum|UNII-vg2qf83cgl|Mobic|Meloxicam	ava-meloxicam|auro-meloxicam|a	DRUGBANK	DB00814	C14H13N3O4S2	small molecule	M01AC56|M01AC06	71125-38-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRVUJXDFFKFLMG-UHFFFAOYSA-N
10777	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	804	Meloxicam	Mloxicam|Meloxicamum|UNII-vg2qf83cgl|Mobic|Meloxicam	ava-meloxicam|auro-meloxicam|a	DRUGBANK	DB00814	C14H13N3O4S2	small molecule	M01AC56|M01AC06	71125-38-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRVUJXDFFKFLMG-UHFFFAOYSA-N
10778	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Blanco FJ (1999)	10381057	176844	804	Meloxicam	Mloxicam|Meloxicamum|UNII-vg2qf83cgl|Mobic|Meloxicam	ava-meloxicam|auro-meloxicam|a	DRUGBANK	DB00814	C14H13N3O4S2	small molecule	M01AC56|M01AC06	71125-38-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRVUJXDFFKFLMG-UHFFFAOYSA-N
10779	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Gross JM (1999)	10567199	178509	804	Meloxicam	Mloxicam|Meloxicamum|UNII-vg2qf83cgl|Mobic|Meloxicam	ava-meloxicam|auro-meloxicam|a	DRUGBANK	DB00814	C14H13N3O4S2	small molecule	M01AC56|M01AC06	71125-38-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRVUJXDFFKFLMG-UHFFFAOYSA-N
10780	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Panara MR (1999)	10381787	178508	804	Meloxicam	Mloxicam|Meloxicamum|UNII-vg2qf83cgl|Mobic|Meloxicam	ava-meloxicam|auro-meloxicam|a	DRUGBANK	DB00814	C14H13N3O4S2	small molecule	M01AC56|M01AC06	71125-38-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRVUJXDFFKFLMG-UHFFFAOYSA-N
10827	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Wilson JE (2004)	15198222	178171	811	Carprofen	(+-)-6-chloro-alpha-Methylcarbazole-2-acetic acid|Carprofeno|2-(6-Chloro-9H-carbazol-2-yl)-propionic acid|6-chloro-alpha-Methyl-9H-carbazole-2-acetic acid|Carprofne|Carprofen|Carprofenum|(+/-)-2-(3-chloro-9H-carbazol-7-yl)propanoic acid	-	DRUGBANK	DB00821	C15H12ClNO2	small molecule	-	53716-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUXBGTOOZJQSKH-UHFFFAOYSA-N
10828	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	811	Carprofen	(+-)-6-chloro-alpha-Methylcarbazole-2-acetic acid|Carprofeno|2-(6-Chloro-9H-carbazol-2-yl)-propionic acid|6-chloro-alpha-Methyl-9H-carbazole-2-acetic acid|Carprofne|Carprofen|Carprofenum|(+/-)-2-(3-chloro-9H-carbazol-7-yl)propanoic acid	-	DRUGBANK	DB00821	C15H12ClNO2	small molecule	-	53716-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUXBGTOOZJQSKH-UHFFFAOYSA-N
10829	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Brideau C (2001)	11703020	178550	811	Carprofen	(+-)-6-chloro-alpha-Methylcarbazole-2-acetic acid|Carprofeno|2-(6-Chloro-9H-carbazol-2-yl)-propionic acid|6-chloro-alpha-Methyl-9H-carbazole-2-acetic acid|Carprofne|Carprofen|Carprofenum|(+/-)-2-(3-chloro-9H-carbazol-7-yl)propanoic acid	-	DRUGBANK	DB00821	C15H12ClNO2	small molecule	-	53716-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUXBGTOOZJQSKH-UHFFFAOYSA-N
10830	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Narlawar R (2006)	17181139	178551	811	Carprofen	(+-)-6-chloro-alpha-Methylcarbazole-2-acetic acid|Carprofeno|2-(6-Chloro-9H-carbazol-2-yl)-propionic acid|6-chloro-alpha-Methyl-9H-carbazole-2-acetic acid|Carprofne|Carprofen|Carprofenum|(+/-)-2-(3-chloro-9H-carbazol-7-yl)propanoic acid	-	DRUGBANK	DB00821	C15H12ClNO2	small molecule	-	53716-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUXBGTOOZJQSKH-UHFFFAOYSA-N
10831	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Kay-Mugford P (2000)	10895904	178552	811	Carprofen	(+-)-6-chloro-alpha-Methylcarbazole-2-acetic acid|Carprofeno|2-(6-Chloro-9H-carbazol-2-yl)-propionic acid|6-chloro-alpha-Methyl-9H-carbazole-2-acetic acid|Carprofne|Carprofen|Carprofenum|(+/-)-2-(3-chloro-9H-carbazol-7-yl)propanoic acid	-	DRUGBANK	DB00821	C15H12ClNO2	small molecule	-	53716-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUXBGTOOZJQSKH-UHFFFAOYSA-N
10832	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Beretta C (2005)	15939622	178489	811	Carprofen	(+-)-6-chloro-alpha-Methylcarbazole-2-acetic acid|Carprofeno|2-(6-Chloro-9H-carbazol-2-yl)-propionic acid|6-chloro-alpha-Methyl-9H-carbazole-2-acetic acid|Carprofne|Carprofen|Carprofenum|(+/-)-2-(3-chloro-9H-carbazol-7-yl)propanoic acid	-	DRUGBANK	DB00821	C15H12ClNO2	small molecule	-	53716-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUXBGTOOZJQSKH-UHFFFAOYSA-N
10842	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	814	Enprofylline	3-Propylxanthine|3,7-dihydro-3-Propyl-1H-purine-2,6-dione|Enprofilina|3-Propyl-3,7-dihydro-purine-2,6-dione|3-n-Propylxanthine|Enprofylline|Enprofyllinum	-	DRUGBANK	DB00824	C8H10N4O2	small molecule	-	41078-02-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SIQPXVQCUCHWDI-UHFFFAOYSA-N
10843	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	814	Enprofylline	3-Propylxanthine|3,7-dihydro-3-Propyl-1H-purine-2,6-dione|Enprofilina|3-Propyl-3,7-dihydro-purine-2,6-dione|3-n-Propylxanthine|Enprofylline|Enprofyllinum	-	DRUGBANK	DB00824	C8H10N4O2	small molecule	-	41078-02-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SIQPXVQCUCHWDI-UHFFFAOYSA-N
10863	114471	8989	-	TRPA1	ANKTM1|FEPS	9606	Homo sapiens	inducer	target	Namer B (2005)	15931068	178572	815	Menthol	(1R-(1-alpha,2-beta,5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol|Levomentholum|(1alpha,2beta,5alpha)-5-Methyl-2(1-methylethyl)cyclohexanol|L-menthol|L-(-)-menthol|(r)-(-)-menthol|Levomenthol|(-)-(1R,3R,4S)-Menthol|(1R,3R,4S)-(-)-Menthol|Levomentol|(-)-menthol	prozero|western family pain re	DRUGBANK	DB00825	C10H20O	small molecule	-	2216-51-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOOLISFMXDJSKH-KXUCPTDWSA-N
10864	114471	8989	-	TRPA1	ANKTM1|FEPS	9606	Homo sapiens	inducer	target	Chen X (2002)	11752352	171740	815	Menthol	(1R-(1-alpha,2-beta,5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol|Levomentholum|(1alpha,2beta,5alpha)-5-Methyl-2(1-methylethyl)cyclohexanol|L-menthol|L-(-)-menthol|(r)-(-)-menthol|Levomenthol|(-)-(1R,3R,4S)-Menthol|(1R,3R,4S)-(-)-Menthol|Levomentol|(-)-menthol	prozero|western family pain re	DRUGBANK	DB00825	C10H20O	small molecule	-	2216-51-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOOLISFMXDJSKH-KXUCPTDWSA-N
10865	114471	8989	-	TRPA1	ANKTM1|FEPS	9606	Homo sapiens	inducer	target	Macpherson LJ (2006)	16829128	178571	815	Menthol	(1R-(1-alpha,2-beta,5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol|Levomentholum|(1alpha,2beta,5alpha)-5-Methyl-2(1-methylethyl)cyclohexanol|L-menthol|L-(-)-menthol|(r)-(-)-menthol|Levomenthol|(-)-(1R,3R,4S)-Menthol|(1R,3R,4S)-(-)-Menthol|Levomentol|(-)-menthol	prozero|western family pain re	DRUGBANK	DB00825	C10H20O	small molecule	-	2216-51-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOOLISFMXDJSKH-KXUCPTDWSA-N
10866	114471	8989	-	TRPA1	ANKTM1|FEPS	9606	Homo sapiens	inducer	target	Story GM (2003)	12654248	178565	815	Menthol	(1R-(1-alpha,2-beta,5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol|Levomentholum|(1alpha,2beta,5alpha)-5-Methyl-2(1-methylethyl)cyclohexanol|L-menthol|L-(-)-menthol|(r)-(-)-menthol|Levomenthol|(-)-(1R,3R,4S)-Menthol|(1R,3R,4S)-(-)-Menthol|Levomentol|(-)-menthol	prozero|western family pain re	DRUGBANK	DB00825	C10H20O	small molecule	-	2216-51-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOOLISFMXDJSKH-KXUCPTDWSA-N
11153	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Dolzan V (2007)	17455212	178693	840	Perphenazine	Perphenazin|Chlorpiprazine|Etaperazin|Etaperazine|gamma-(4-(beta-Hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine|4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazineethanol|Perphnazine|2-chloro-10-(3-(4-(2-Hydroxyethyl)piperazin-1-yl)propyl)phenothiazine|2-(4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol|Trilafon|4-[3-(2-Chlorophenothiazin-10-yl)propyl]-1-piperazineethanol|Ethaperazine|Perfenazine|Perfenazina|Perphenazinum	pms perphenazine tab 16mg|perp	DRUGBANK	DB00850	C21H26ClN3OS	small molecule	N05AB03	58-39-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGCVKNLCSQQDEP-UHFFFAOYSA-N
11154	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Farde L (1989)	2573104	178690	840	Perphenazine	Perphenazin|Chlorpiprazine|Etaperazin|Etaperazine|gamma-(4-(beta-Hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine|4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazineethanol|Perphnazine|2-chloro-10-(3-(4-(2-Hydroxyethyl)piperazin-1-yl)propyl)phenothiazine|2-(4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol|Trilafon|4-[3-(2-Chlorophenothiazin-10-yl)propyl]-1-piperazineethanol|Ethaperazine|Perfenazine|Perfenazina|Perphenazinum	pms perphenazine tab 16mg|perp	DRUGBANK	DB00850	C21H26ClN3OS	small molecule	N05AB03	58-39-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGCVKNLCSQQDEP-UHFFFAOYSA-N
11216	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Cappon GD (2003)	12852483	178741	851	Diflunisal	2',4'-Difluoro-4-hydroxy-3-biphenylcarboxylic acid|Dolobid|Diflunisalum|5-(2,4-Difluorophenyl)salicylic acid|2-(Hydroxy)-5-(2,4-difluorophenyl)benzoic acid|Diflunisal	diflunisal-500 - tab 500mg|nu-	DRUGBANK	DB00861	C13H8F2O3	small molecule	N02BA11	22494-42-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUPFGZXOMWLGNK-UHFFFAOYSA-N
11217	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	851	Diflunisal	2',4'-Difluoro-4-hydroxy-3-biphenylcarboxylic acid|Dolobid|Diflunisalum|5-(2,4-Difluorophenyl)salicylic acid|2-(Hydroxy)-5-(2,4-difluorophenyl)benzoic acid|Diflunisal	diflunisal-500 - tab 500mg|nu-	DRUGBANK	DB00861	C13H8F2O3	small molecule	N02BA11	22494-42-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUPFGZXOMWLGNK-UHFFFAOYSA-N
11218	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Young JM (1996)	8737748	178742	851	Diflunisal	2',4'-Difluoro-4-hydroxy-3-biphenylcarboxylic acid|Dolobid|Diflunisalum|5-(2,4-Difluorophenyl)salicylic acid|2-(Hydroxy)-5-(2,4-difluorophenyl)benzoic acid|Diflunisal	diflunisal-500 - tab 500mg|nu-	DRUGBANK	DB00861	C13H8F2O3	small molecule	N02BA11	22494-42-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUPFGZXOMWLGNK-UHFFFAOYSA-N
11219	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Jeske AH (1999)	10825891	178745	851	Diflunisal	2',4'-Difluoro-4-hydroxy-3-biphenylcarboxylic acid|Dolobid|Diflunisalum|5-(2,4-Difluorophenyl)salicylic acid|2-(Hydroxy)-5-(2,4-difluorophenyl)benzoic acid|Diflunisal	diflunisal-500 - tab 500mg|nu-	DRUGBANK	DB00861	C13H8F2O3	small molecule	N02BA11	22494-42-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUPFGZXOMWLGNK-UHFFFAOYSA-N
11220	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Mao H (2001)	11673972	178744	851	Diflunisal	2',4'-Difluoro-4-hydroxy-3-biphenylcarboxylic acid|Dolobid|Diflunisalum|5-(2,4-Difluorophenyl)salicylic acid|2-(Hydroxy)-5-(2,4-difluorophenyl)benzoic acid|Diflunisal	diflunisal-500 - tab 500mg|nu-	DRUGBANK	DB00861	C13H8F2O3	small molecule	N02BA11	22494-42-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUPFGZXOMWLGNK-UHFFFAOYSA-N
11221	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Moore PA (2001)	11315375	178743	851	Diflunisal	2',4'-Difluoro-4-hydroxy-3-biphenylcarboxylic acid|Dolobid|Diflunisalum|5-(2,4-Difluorophenyl)salicylic acid|2-(Hydroxy)-5-(2,4-difluorophenyl)benzoic acid|Diflunisal	diflunisal-500 - tab 500mg|nu-	DRUGBANK	DB00861	C13H8F2O3	small molecule	N02BA11	22494-42-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUPFGZXOMWLGNK-UHFFFAOYSA-N
11263	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	antagonist	target	Thimann DA (2012)	23258970	178790	858	Benzonatate	Benzononatine|3,6,9,12,15,18,21,24,27-Nonaoxaoctacosyl 4-butylaminobenzoate|Benzonatat|Benzonatate|P-Butylaminobenzoic acid omega-O-methylnonaethyleneglycol ester|2-[2-[2-[2-[2-[2-[2-[2-(2-Methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl 4-butylaminobenzoate|Nonaethyleneglycol monomethyl ether P-N-butylaminobenzoate|Benzonatato|4-(Butylamino)benzoic acid 3,6,9,12,15,18,21,24,27-nonaoxaoctacos-1-yl ester|2,5,8,11,14,17,20,23,26-Nonaoxaoctacosan-28-yl P-(butylamino)benzoate|Benzonatatum	zonatuss|benzonatate|tessalon	DRUGBANK	DB00868	C30H53NO11	small molecule	R05DB01	104-31-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MAFMQEKGGFWBAB-UHFFFAOYSA-N
11281	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	860	Suprofen	alpha-Methyl-4-(2-thienylcarbonyl)benzeneacetic acid|Suprofenum|2-[4-(Thiophene-2-carbonyl)-phenyl]-propionic acid|Suprofne|2-(4-(2-Thenoyl)phenyl)propionsaeure|4-(2-Thenoyl)hydratropsaeure|Suprofene|SUTOPROFEN|(+-)-2-(P-(2-Thenoyl)phenyl)propionic acid|P-2-Thenoylhydratropic acid|Suprofeno|Suprofen|PROFENAL	-	DRUGBANK	DB00870	C14H12O3S	small molecule	M01AE07	40828-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MDKGKXOCJGEUJW-UHFFFAOYSA-N
11282	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Llorens O (2002)	11885959	178800	860	Suprofen	alpha-Methyl-4-(2-thienylcarbonyl)benzeneacetic acid|Suprofenum|2-[4-(Thiophene-2-carbonyl)-phenyl]-propionic acid|Suprofne|2-(4-(2-Thenoyl)phenyl)propionsaeure|4-(2-Thenoyl)hydratropsaeure|Suprofene|SUTOPROFEN|(+-)-2-(P-(2-Thenoyl)phenyl)propionic acid|P-2-Thenoylhydratropic acid|Suprofeno|Suprofen|PROFENAL	-	DRUGBANK	DB00870	C14H12O3S	small molecule	M01AE07	40828-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MDKGKXOCJGEUJW-UHFFFAOYSA-N
11283	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	860	Suprofen	alpha-Methyl-4-(2-thienylcarbonyl)benzeneacetic acid|Suprofenum|2-[4-(Thiophene-2-carbonyl)-phenyl]-propionic acid|Suprofne|2-(4-(2-Thenoyl)phenyl)propionsaeure|4-(2-Thenoyl)hydratropsaeure|Suprofene|SUTOPROFEN|(+-)-2-(P-(2-Thenoyl)phenyl)propionic acid|P-2-Thenoylhydratropic acid|Suprofeno|Suprofen|PROFENAL	-	DRUGBANK	DB00870	C14H12O3S	small molecule	M01AE07	40828-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MDKGKXOCJGEUJW-UHFFFAOYSA-N
11294	107035	554	-	AVPR2	ADHR|DI1|DIR|DIR3|NDI|V2R	9606	Homo sapiens	antagonist	target	Wada K (2005)	15659304	178813	862	Conivaptan	4'-((4,5-dihydro-2-Methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide|Conivaptan	vaprisol dextrose in plastic c	DRUGBANK	DB00872	C32H26N4O2	small molecule	C03XA02	210101-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKENVDNFQMCRTR-UHFFFAOYSA-N
11295	107035	554	-	AVPR2	ADHR|DI1|DIR|DIR3|NDI|V2R	9606	Homo sapiens	antagonist	target	Ali F (2007)	17428103	178812	862	Conivaptan	4'-((4,5-dihydro-2-Methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide|Conivaptan	vaprisol dextrose in plastic c	DRUGBANK	DB00872	C32H26N4O2	small molecule	C03XA02	210101-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKENVDNFQMCRTR-UHFFFAOYSA-N
11296	107035	554	-	AVPR2	ADHR|DI1|DIR|DIR3|NDI|V2R	9606	Homo sapiens	antagonist	target	Hoque MZ (2009)	19663609	178815	862	Conivaptan	4'-((4,5-dihydro-2-Methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide|Conivaptan	vaprisol dextrose in plastic c	DRUGBANK	DB00872	C32H26N4O2	small molecule	C03XA02	210101-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKENVDNFQMCRTR-UHFFFAOYSA-N
11297	107035	554	-	AVPR2	ADHR|DI1|DIR|DIR3|NDI|V2R	9606	Homo sapiens	antagonist	target	Palm C (2006)	16843091	178814	862	Conivaptan	4'-((4,5-dihydro-2-Methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide|Conivaptan	vaprisol dextrose in plastic c	DRUGBANK	DB00872	C32H26N4O2	small molecule	C03XA02	210101-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKENVDNFQMCRTR-UHFFFAOYSA-N
11298	107035	554	-	AVPR2	ADHR|DI1|DIR|DIR3|NDI|V2R	9606	Homo sapiens	antagonist	target	Ali F (2007)	17919259	178817	862	Conivaptan	4'-((4,5-dihydro-2-Methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide|Conivaptan	vaprisol dextrose in plastic c	DRUGBANK	DB00872	C32H26N4O2	small molecule	C03XA02	210101-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKENVDNFQMCRTR-UHFFFAOYSA-N
11299	107035	554	-	AVPR2	ADHR|DI1|DIR|DIR3|NDI|V2R	9606	Homo sapiens	antagonist	target	Ghali JK (2006)	16522696	178816	862	Conivaptan	4'-((4,5-dihydro-2-Methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide|Conivaptan	vaprisol dextrose in plastic c	DRUGBANK	DB00872	C32H26N4O2	small molecule	C03XA02	210101-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKENVDNFQMCRTR-UHFFFAOYSA-N
11300	107035	554	-	AVPR2	ADHR|DI1|DIR|DIR3|NDI|V2R	9606	Homo sapiens	antagonist	target	Mao ZL (2009)	19695403	178819	862	Conivaptan	4'-((4,5-dihydro-2-Methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide|Conivaptan	vaprisol dextrose in plastic c	DRUGBANK	DB00872	C32H26N4O2	small molecule	C03XA02	210101-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKENVDNFQMCRTR-UHFFFAOYSA-N
11301	107035	554	-	AVPR2	ADHR|DI1|DIR|DIR3|NDI|V2R	9606	Homo sapiens	antagonist	target	Annane D (2009)	19057376	178818	862	Conivaptan	4'-((4,5-dihydro-2-Methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide|Conivaptan	vaprisol dextrose in plastic c	DRUGBANK	DB00872	C32H26N4O2	small molecule	C03XA02	210101-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKENVDNFQMCRTR-UHFFFAOYSA-N
11302	107035	554	-	AVPR2	ADHR|DI1|DIR|DIR3|NDI|V2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	862	Conivaptan	4'-((4,5-dihydro-2-Methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide|Conivaptan	vaprisol dextrose in plastic c	DRUGBANK	DB00872	C32H26N4O2	small molecule	C03XA02	210101-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKENVDNFQMCRTR-UHFFFAOYSA-N
11303	107035	554	-	AVPR2	ADHR|DI1|DIR|DIR3|NDI|V2R	9606	Homo sapiens	antagonist	target	Wada K (2007)	17202666	178820	862	Conivaptan	4'-((4,5-dihydro-2-Methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide|Conivaptan	vaprisol dextrose in plastic c	DRUGBANK	DB00872	C32H26N4O2	small molecule	C03XA02	210101-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKENVDNFQMCRTR-UHFFFAOYSA-N
11304	107035	554	-	AVPR2	ADHR|DI1|DIR|DIR3|NDI|V2R	9606	Homo sapiens	antagonist	target	Walter KA (2007)	17592003	178821	862	Conivaptan	4'-((4,5-dihydro-2-Methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide|Conivaptan	vaprisol dextrose in plastic c	DRUGBANK	DB00872	C32H26N4O2	small molecule	C03XA02	210101-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKENVDNFQMCRTR-UHFFFAOYSA-N
11305	107035	554	-	AVPR2	ADHR|DI1|DIR|DIR3|NDI|V2R	9606	Homo sapiens	antagonist	target	Ghali JK (2010)	20054444	178822	862	Conivaptan	4'-((4,5-dihydro-2-Methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide|Conivaptan	vaprisol dextrose in plastic c	DRUGBANK	DB00872	C32H26N4O2	small molecule	C03XA02	210101-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKENVDNFQMCRTR-UHFFFAOYSA-N
11330	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	865	Flupentixol	Flupentixol|Flupentixolum|Flupenthixole|Flupenthixol|Flupentixolo	fluanxol depot inj 20mg/ml|flu	DRUGBANK	DB00875	C23H27F3N2OS	small molecule	N05AF01	2709-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTTVNHWDONBIKE-DVZOWYKESA-N
11331	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Cai G (1999)	10531405	176548	865	Flupentixol	Flupentixol|Flupentixolum|Flupenthixole|Flupenthixol|Flupentixolo	fluanxol depot inj 20mg/ml|flu	DRUGBANK	DB00875	C23H27F3N2OS	small molecule	N05AF01	2709-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTTVNHWDONBIKE-DVZOWYKESA-N
11332	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	865	Flupentixol	Flupentixol|Flupentixolum|Flupenthixole|Flupenthixol|Flupentixolo	fluanxol depot inj 20mg/ml|flu	DRUGBANK	DB00875	C23H27F3N2OS	small molecule	N05AF01	2709-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTTVNHWDONBIKE-DVZOWYKESA-N
11333	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Reimold M (2007)	17111172	178827	865	Flupentixol	Flupentixol|Flupentixolum|Flupenthixole|Flupenthixol|Flupentixolo	fluanxol depot inj 20mg/ml|flu	DRUGBANK	DB00875	C23H27F3N2OS	small molecule	N05AF01	2709-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTTVNHWDONBIKE-DVZOWYKESA-N
11586	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	unknown	target	van Wijngaarden I (1990)	2164935	178972	894	Ondansetron	Zofran odt	riva-ondansetron|septa-ondanse	DRUGBANK	DB00904	C18H19N3O	small molecule	A04AA01	99614-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FELGMEQIXOGIFQ-UHFFFAOYSA-N
11628	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Satish OS (2005)	15880981	179008	897	Cocaine	Methyl benzoylecgonine|Cocainum|Cocaine|Kokain|L-Cocain|2-Methyl-3beta-hydroxy-1alphah,5alphah-tropane-2beta-carboxylate benzoate (ester)|Benzoylmethylecgonine|Methyl [1R-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate|Cocain|beta-Cocain|L-Cocaine|(-)-Cocaine|()-cocaine|Neurocaine|[1R-(Exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester|Cocaina	cocaine hydrochloride top sol 	DRUGBANK	DB00907	C17H21NO4	small molecule	N01BC01|S02DA02|R02AD03|S01HA01	50-36-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPUCINDJVBIVPJ-LJISPDSOSA-N
11629	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Antzelevitch C (2006)	17038146	179007	897	Cocaine	Methyl benzoylecgonine|Cocainum|Cocaine|Kokain|L-Cocain|2-Methyl-3beta-hydroxy-1alphah,5alphah-tropane-2beta-carboxylate benzoate (ester)|Benzoylmethylecgonine|Methyl [1R-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate|Cocain|beta-Cocain|L-Cocaine|(-)-Cocaine|()-cocaine|Neurocaine|[1R-(Exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester|Cocaina	cocaine hydrochloride top sol 	DRUGBANK	DB00907	C17H21NO4	small molecule	N01BC01|S02DA02|R02AD03|S01HA01	50-36-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPUCINDJVBIVPJ-LJISPDSOSA-N
11630	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Wright SN (1999)	9876137	179006	897	Cocaine	Methyl benzoylecgonine|Cocainum|Cocaine|Kokain|L-Cocain|2-Methyl-3beta-hydroxy-1alphah,5alphah-tropane-2beta-carboxylate benzoate (ester)|Benzoylmethylecgonine|Methyl [1R-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate|Cocain|beta-Cocain|L-Cocaine|(-)-Cocaine|()-cocaine|Neurocaine|[1R-(Exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester|Cocaina	cocaine hydrochloride top sol 	DRUGBANK	DB00907	C17H21NO4	small molecule	N01BC01|S02DA02|R02AD03|S01HA01	50-36-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPUCINDJVBIVPJ-LJISPDSOSA-N
11633	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Itoh H (2005)	15877619	179012	898	Quinidine	CIN-QUIN|Pitayine|beta-Quinine|6-Methoxy-alpha-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol|(+)-quinidine|Chinidin|Quinidine|(S)-(6-Methoxyquinolin-4-yl)((2R,5R)-5-vinylquinuclidin-2-yl)methanol|Quinidina|Conchinin|alpha-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol|-quinine|(R)-(6-Methoxyquinolin-4-yl)((3S,4R,7S)-3-vinylquinuclidin-7-yl)methanol|(S)-(6-Methoxy-quinolin-4-yl)-((2R,5R)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol|Kinidin|Conquinine|Chinidinum|(8R,9S)-Quinidine	cardioquin tablets|quinidex ex	DRUGBANK	DB00908	C20H24N2O2	small molecule	C01BA51|C01BA01|C01BA71	56-54-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LOUPRKONTZGTKE-LHHVKLHASA-N
11634	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Stokoe KS (2007)	17023504	179013	898	Quinidine	CIN-QUIN|Pitayine|beta-Quinine|6-Methoxy-alpha-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol|(+)-quinidine|Chinidin|Quinidine|(S)-(6-Methoxyquinolin-4-yl)((2R,5R)-5-vinylquinuclidin-2-yl)methanol|Quinidina|Conchinin|alpha-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol|-quinine|(R)-(6-Methoxyquinolin-4-yl)((3S,4R,7S)-3-vinylquinuclidin-7-yl)methanol|(S)-(6-Methoxy-quinolin-4-yl)-((2R,5R)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol|Kinidin|Conquinine|Chinidinum|(8R,9S)-Quinidine	cardioquin tablets|quinidex ex	DRUGBANK	DB00908	C20H24N2O2	small molecule	C01BA51|C01BA01|C01BA71	56-54-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LOUPRKONTZGTKE-LHHVKLHASA-N
11635	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Grant AO (2005)	16138883	179016	898	Quinidine	CIN-QUIN|Pitayine|beta-Quinine|6-Methoxy-alpha-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol|(+)-quinidine|Chinidin|Quinidine|(S)-(6-Methoxyquinolin-4-yl)((2R,5R)-5-vinylquinuclidin-2-yl)methanol|Quinidina|Conchinin|alpha-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol|-quinine|(R)-(6-Methoxyquinolin-4-yl)((3S,4R,7S)-3-vinylquinuclidin-7-yl)methanol|(S)-(6-Methoxy-quinolin-4-yl)-((2R,5R)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol|Kinidin|Conquinine|Chinidinum|(8R,9S)-Quinidine	cardioquin tablets|quinidex ex	DRUGBANK	DB00908	C20H24N2O2	small molecule	C01BA51|C01BA01|C01BA71	56-54-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LOUPRKONTZGTKE-LHHVKLHASA-N
11636	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Ohgo T (2007)	17556186	179014	898	Quinidine	CIN-QUIN|Pitayine|beta-Quinine|6-Methoxy-alpha-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol|(+)-quinidine|Chinidin|Quinidine|(S)-(6-Methoxyquinolin-4-yl)((2R,5R)-5-vinylquinuclidin-2-yl)methanol|Quinidina|Conchinin|alpha-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol|-quinine|(R)-(6-Methoxyquinolin-4-yl)((3S,4R,7S)-3-vinylquinuclidin-7-yl)methanol|(S)-(6-Methoxy-quinolin-4-yl)-((2R,5R)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol|Kinidin|Conquinine|Chinidinum|(8R,9S)-Quinidine	cardioquin tablets|quinidex ex	DRUGBANK	DB00908	C20H24N2O2	small molecule	C01BA51|C01BA01|C01BA71	56-54-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LOUPRKONTZGTKE-LHHVKLHASA-N
11637	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Napolitano C (2006)	16972995	179015	898	Quinidine	CIN-QUIN|Pitayine|beta-Quinine|6-Methoxy-alpha-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol|(+)-quinidine|Chinidin|Quinidine|(S)-(6-Methoxyquinolin-4-yl)((2R,5R)-5-vinylquinuclidin-2-yl)methanol|Quinidina|Conchinin|alpha-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol|-quinine|(R)-(6-Methoxyquinolin-4-yl)((3S,4R,7S)-3-vinylquinuclidin-7-yl)methanol|(S)-(6-Methoxy-quinolin-4-yl)-((2R,5R)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol|Kinidin|Conquinine|Chinidinum|(8R,9S)-Quinidine	cardioquin tablets|quinidex ex	DRUGBANK	DB00908	C20H24N2O2	small molecule	C01BA51|C01BA01|C01BA71	56-54-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LOUPRKONTZGTKE-LHHVKLHASA-N
11638	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	898	Quinidine	CIN-QUIN|Pitayine|beta-Quinine|6-Methoxy-alpha-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol|(+)-quinidine|Chinidin|Quinidine|(S)-(6-Methoxyquinolin-4-yl)((2R,5R)-5-vinylquinuclidin-2-yl)methanol|Quinidina|Conchinin|alpha-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol|-quinine|(R)-(6-Methoxyquinolin-4-yl)((3S,4R,7S)-3-vinylquinuclidin-7-yl)methanol|(S)-(6-Methoxy-quinolin-4-yl)-((2R,5R)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol|Kinidin|Conquinine|Chinidinum|(8R,9S)-Quinidine	cardioquin tablets|quinidex ex	DRUGBANK	DB00908	C20H24N2O2	small molecule	C01BA51|C01BA01|C01BA71	56-54-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LOUPRKONTZGTKE-LHHVKLHASA-N
11639	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Tella SR (1998)	9476974	177548	898	Quinidine	CIN-QUIN|Pitayine|beta-Quinine|6-Methoxy-alpha-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol|(+)-quinidine|Chinidin|Quinidine|(S)-(6-Methoxyquinolin-4-yl)((2R,5R)-5-vinylquinuclidin-2-yl)methanol|Quinidina|Conchinin|alpha-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol|-quinine|(R)-(6-Methoxyquinolin-4-yl)((3S,4R,7S)-3-vinylquinuclidin-7-yl)methanol|(S)-(6-Methoxy-quinolin-4-yl)-((2R,5R)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol|Kinidin|Conquinine|Chinidinum|(8R,9S)-Quinidine	cardioquin tablets|quinidex ex	DRUGBANK	DB00908	C20H24N2O2	small molecule	C01BA51|C01BA01|C01BA71	56-54-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LOUPRKONTZGTKE-LHHVKLHASA-N
11640	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Sheets MF (2010)	20685573	175038	898	Quinidine	CIN-QUIN|Pitayine|beta-Quinine|6-Methoxy-alpha-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol|(+)-quinidine|Chinidin|Quinidine|(S)-(6-Methoxyquinolin-4-yl)((2R,5R)-5-vinylquinuclidin-2-yl)methanol|Quinidina|Conchinin|alpha-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol|-quinine|(R)-(6-Methoxyquinolin-4-yl)((3S,4R,7S)-3-vinylquinuclidin-7-yl)methanol|(S)-(6-Methoxy-quinolin-4-yl)-((2R,5R)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol|Kinidin|Conquinine|Chinidinum|(8R,9S)-Quinidine	cardioquin tablets|quinidex ex	DRUGBANK	DB00908	C20H24N2O2	small molecule	C01BA51|C01BA01|C01BA71	56-54-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LOUPRKONTZGTKE-LHHVKLHASA-N
11641	114817	9424	-	KCNK6	K2p6.1|KCNK8|TOSS|TWIK-2|TWIK2	9606	Homo sapiens	inhibitor	target	Patel AJ (2000)	10887187	179018	898	Quinidine	CIN-QUIN|Pitayine|beta-Quinine|6-Methoxy-alpha-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol|(+)-quinidine|Chinidin|Quinidine|(S)-(6-Methoxyquinolin-4-yl)((2R,5R)-5-vinylquinuclidin-2-yl)methanol|Quinidina|Conchinin|alpha-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol|-quinine|(R)-(6-Methoxyquinolin-4-yl)((3S,4R,7S)-3-vinylquinuclidin-7-yl)methanol|(S)-(6-Methoxy-quinolin-4-yl)-((2R,5R)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol|Kinidin|Conquinine|Chinidinum|(8R,9S)-Quinidine	cardioquin tablets|quinidex ex	DRUGBANK	DB00908	C20H24N2O2	small molecule	C01BA51|C01BA01|C01BA71	56-54-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LOUPRKONTZGTKE-LHHVKLHASA-N
11642	114817	9424	-	KCNK6	K2p6.1|KCNK8|TOSS|TWIK-2|TWIK2	9606	Homo sapiens	inhibitor	target	Guerard NC (2008)	18582585	179017	898	Quinidine	CIN-QUIN|Pitayine|beta-Quinine|6-Methoxy-alpha-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol|(+)-quinidine|Chinidin|Quinidine|(S)-(6-Methoxyquinolin-4-yl)((2R,5R)-5-vinylquinuclidin-2-yl)methanol|Quinidina|Conchinin|alpha-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol|-quinine|(R)-(6-Methoxyquinolin-4-yl)((3S,4R,7S)-3-vinylquinuclidin-7-yl)methanol|(S)-(6-Methoxy-quinolin-4-yl)-((2R,5R)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol|Kinidin|Conquinine|Chinidinum|(8R,9S)-Quinidine	cardioquin tablets|quinidex ex	DRUGBANK	DB00908	C20H24N2O2	small molecule	C01BA51|C01BA01|C01BA71	56-54-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LOUPRKONTZGTKE-LHHVKLHASA-N
11656	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Murata M (2010)	20502722	179028	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11657	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Okada M (1995)	8991786	179032	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11704	112229	6324	-	SCN1B	ATFB13|BRGDA5|GEFSP1	9606	Homo sapiens	inhibitor	target	Leppik IE (2004)	15511691	179038	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11705	112229	6324	-	SCN1B	ATFB13|BRGDA5|GEFSP1	9606	Homo sapiens	inhibitor	target	Kothare SV (2008)	18433351	179039	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11706	112229	6324	-	SCN1B	ATFB13|BRGDA5|GEFSP1	9606	Homo sapiens	inhibitor	target	Sobieszek G (2004)	14704463	179034	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11707	112229	6324	-	SCN1B	ATFB13|BRGDA5|GEFSP1	9606	Homo sapiens	inhibitor	target	Schulze-Bonhage A (2010)	20001433	179035	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11708	112229	6324	-	SCN1B	ATFB13|BRGDA5|GEFSP1	9606	Homo sapiens	inhibitor	target	Zaccara G (2009)	19557119	179036	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11709	112229	6324	-	SCN1B	ATFB13|BRGDA5|GEFSP1	9606	Homo sapiens	inhibitor	target	Janszky J (2009)	20025128	179037	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11710	112229	6324	-	SCN1B	ATFB13|BRGDA5|GEFSP1	9606	Homo sapiens	inhibitor	target	Sonsalla PK (2010)	19948168	179031	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11776	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Leppik IE (2004)	15511691	179038	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11777	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Kothare SV (2008)	18433351	179039	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11778	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Sobieszek G (2004)	14704463	179034	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11779	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Schulze-Bonhage A (2010)	20001433	179035	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11780	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Zaccara G (2009)	19557119	179036	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11781	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Janszky J (2009)	20025128	179037	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11782	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Sonsalla PK (2010)	19948168	179031	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11805	107225	771	-	CA12	CAXII|HsT18816	9606	Homo sapiens	inhibitor	target	Farooq MU (2008)	18782051	179029	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11806	107225	771	-	CA12	CAXII|HsT18816	9606	Homo sapiens	inhibitor	target	Unknown Authors (2007)	17582922	179041	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11807	107225	771	-	CA12	CAXII|HsT18816	9606	Homo sapiens	inhibitor	target	Biton V (2007)	17762320	179040	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11808	107225	771	-	CA12	CAXII|HsT18816	9606	Homo sapiens	inhibitor	target	De Simone G (2009)	19703035	179043	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11809	107225	771	-	CA12	CAXII|HsT18816	9606	Homo sapiens	inhibitor	target	Supuran CT (2008)	18537527	179042	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11879	111704	5732	-	PTGER2	EP2	9606	Homo sapiens	agonist	target	Legler DF (2010)	19788928	179085	907	Dinoprostone	Dinoprostone|(e,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid|Dinoprostone Prostaglandin E2|Prostaglandin E2|Dinoproston|Prepidil|Prostin e2|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate|(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid|PGE2|Dinoprostonum|(15S)-Prostaglandin e2|Propess|(5Z,11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid|Dinoprostona|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate	dinoprostone|prostin e2 tablet	DRUGBANK	DB00917	C20H32O5	small molecule	G02AD02	363-24-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XEYBRNLFEZDVAW-ARSRFYASSA-N
11880	111704	5732	-	PTGER2	EP2	9606	Homo sapiens	agonist	target	Sugimoto Y (2007)	17329241	179083	907	Dinoprostone	Dinoprostone|(e,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid|Dinoprostone Prostaglandin E2|Prostaglandin E2|Dinoproston|Prepidil|Prostin e2|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate|(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid|PGE2|Dinoprostonum|(15S)-Prostaglandin e2|Propess|(5Z,11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid|Dinoprostona|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate	dinoprostone|prostin e2 tablet	DRUGBANK	DB00917	C20H32O5	small molecule	G02AD02	363-24-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XEYBRNLFEZDVAW-ARSRFYASSA-N
11881	111704	5732	-	PTGER2	EP2	9606	Homo sapiens	agonist	target	Tamiji J (2010)	20599704	179082	907	Dinoprostone	Dinoprostone|(e,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid|Dinoprostone Prostaglandin E2|Prostaglandin E2|Dinoproston|Prepidil|Prostin e2|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate|(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid|PGE2|Dinoprostonum|(15S)-Prostaglandin e2|Propess|(5Z,11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid|Dinoprostona|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate	dinoprostone|prostin e2 tablet	DRUGBANK	DB00917	C20H32O5	small molecule	G02AD02	363-24-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XEYBRNLFEZDVAW-ARSRFYASSA-N
11882	111704	5732	-	PTGER2	EP2	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	907	Dinoprostone	Dinoprostone|(e,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid|Dinoprostone Prostaglandin E2|Prostaglandin E2|Dinoproston|Prepidil|Prostin e2|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate|(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid|PGE2|Dinoprostonum|(15S)-Prostaglandin e2|Propess|(5Z,11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid|Dinoprostona|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate	dinoprostone|prostin e2 tablet	DRUGBANK	DB00917	C20H32O5	small molecule	G02AD02	363-24-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XEYBRNLFEZDVAW-ARSRFYASSA-N
11883	111704	5732	-	PTGER2	EP2	9606	Homo sapiens	agonist	target	Baryawno N (2008)	18715952	179084	907	Dinoprostone	Dinoprostone|(e,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid|Dinoprostone Prostaglandin E2|Prostaglandin E2|Dinoproston|Prepidil|Prostin e2|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate|(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid|PGE2|Dinoprostonum|(15S)-Prostaglandin e2|Propess|(5Z,11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid|Dinoprostona|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate	dinoprostone|prostin e2 tablet	DRUGBANK	DB00917	C20H32O5	small molecule	G02AD02	363-24-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XEYBRNLFEZDVAW-ARSRFYASSA-N
11901	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Fleishaker JC (2000)	10824628	179089	908	Almotriptan	1-(((3-(2-(Dimethylamino)ethyl)indol-5-yl)methyl)sulfonyl)pyrrolidine	axert 12.5mg|sandoz almotripta	DRUGBANK	DB00918	C17H25N3O2S	small molecule	N02CC05	154323-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WKEMJKQOLOHJLZ-UHFFFAOYSA-N
11902	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	908	Almotriptan	1-(((3-(2-(Dimethylamino)ethyl)indol-5-yl)methyl)sulfonyl)pyrrolidine	axert 12.5mg|sandoz almotripta	DRUGBANK	DB00918	C17H25N3O2S	small molecule	N02CC05	154323-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WKEMJKQOLOHJLZ-UHFFFAOYSA-N
11903	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Bou J (2000)	11134654	179087	908	Almotriptan	1-(((3-(2-(Dimethylamino)ethyl)indol-5-yl)methyl)sulfonyl)pyrrolidine	axert 12.5mg|sandoz almotripta	DRUGBANK	DB00918	C17H25N3O2S	small molecule	N02CC05	154323-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WKEMJKQOLOHJLZ-UHFFFAOYSA-N
11904	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Napier C (1999)	10193663	174442	908	Almotriptan	1-(((3-(2-(Dimethylamino)ethyl)indol-5-yl)methyl)sulfonyl)pyrrolidine	axert 12.5mg|sandoz almotripta	DRUGBANK	DB00918	C17H25N3O2S	small molecule	N02CC05	154323-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WKEMJKQOLOHJLZ-UHFFFAOYSA-N
11905	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Knyihar-Csillik E (2000)	11069595	174443	908	Almotriptan	1-(((3-(2-(Dimethylamino)ethyl)indol-5-yl)methyl)sulfonyl)pyrrolidine	axert 12.5mg|sandoz almotripta	DRUGBANK	DB00918	C17H25N3O2S	small molecule	N02CC05	154323-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WKEMJKQOLOHJLZ-UHFFFAOYSA-N
11906	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	van den Broek RW (2000)	11050304	174441	908	Almotriptan	1-(((3-(2-(Dimethylamino)ethyl)indol-5-yl)methyl)sulfonyl)pyrrolidine	axert 12.5mg|sandoz almotripta	DRUGBANK	DB00918	C17H25N3O2S	small molecule	N02CC05	154323-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WKEMJKQOLOHJLZ-UHFFFAOYSA-N
11920	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Huang Z (2006)	16313925	179103	910	Ketotifen	Ketotifenum|Ketotifene|Ketotifeno	nu-ketotifen syrup - 1mg/5ml|z	DRUGBANK	DB00920	C19H19NOS	small molecule	R06AX17|S01GX08	34580-13-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZCVMWBYGMWKGHF-UHFFFAOYSA-N
11921	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Castillo JG (1990)	1702263	179104	910	Ketotifen	Ketotifenum|Ketotifene|Ketotifeno	nu-ketotifen syrup - 1mg/5ml|z	DRUGBANK	DB00920	C19H19NOS	small molecule	R06AX17|S01GX08	34580-13-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZCVMWBYGMWKGHF-UHFFFAOYSA-N
12025	111704	5732	-	PTGER2	EP2	9606	Homo sapiens	agonist	target	Li J (2008)	18472336	179162	919	Misoprostol	Cytotec|Misoprostolum	pms-misoprostol (0.2mg)|arthro	DRUGBANK	DB00929	C22H38O5	small molecule	M01AE56|A02BB01|G02AD06	59122-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJLOPKGSLYJEMD-URPKTTJQSA-N
12026	111704	5732	-	PTGER2	EP2	9606	Homo sapiens	agonist	target	Guan Y (2002)	12097143	179163	919	Misoprostol	Cytotec|Misoprostolum	pms-misoprostol (0.2mg)|arthro	DRUGBANK	DB00929	C22H38O5	small molecule	M01AE56|A02BB01|G02AD06	59122-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJLOPKGSLYJEMD-URPKTTJQSA-N
12027	111704	5732	-	PTGER2	EP2	9606	Homo sapiens	agonist	target	Nataraj C (2001)	11602631	179160	919	Misoprostol	Cytotec|Misoprostolum	pms-misoprostol (0.2mg)|arthro	DRUGBANK	DB00929	C22H38O5	small molecule	M01AE56|A02BB01|G02AD06	59122-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJLOPKGSLYJEMD-URPKTTJQSA-N
12028	111704	5732	-	PTGER2	EP2	9606	Homo sapiens	agonist	target	Nakae K (2005)	16039053	179161	919	Misoprostol	Cytotec|Misoprostolum	pms-misoprostol (0.2mg)|arthro	DRUGBANK	DB00929	C22H38O5	small molecule	M01AE56|A02BB01|G02AD06	59122-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJLOPKGSLYJEMD-URPKTTJQSA-N
12029	111704	5732	-	PTGER2	EP2	9606	Homo sapiens	agonist	target	Kiriyama M (1997)	9313928	179164	919	Misoprostol	Cytotec|Misoprostolum	pms-misoprostol (0.2mg)|arthro	DRUGBANK	DB00929	C22H38O5	small molecule	M01AE56|A02BB01|G02AD06	59122-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJLOPKGSLYJEMD-URPKTTJQSA-N
12105	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Graham GG (2004)	15035793	179201	926	Salicylic acid	2-Carboxyphenol|2-Hydroxybenzoic acid|O-hydroxybenzoic acid|O-carboxyphenol	md cell scalp|neutrogena oil f	DRUGBANK	DB00936	C7H6O3	small molecule	N02BA04|D01AE12|S01BC08	69-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YGSDEFSMJLZEOE-UHFFFAOYSA-N
12106	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chae HJ (2004)	15106733	179207	926	Salicylic acid	2-Carboxyphenol|2-Hydroxybenzoic acid|O-hydroxybenzoic acid|O-carboxyphenol	md cell scalp|neutrogena oil f	DRUGBANK	DB00936	C7H6O3	small molecule	N02BA04|D01AE12|S01BC08	69-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YGSDEFSMJLZEOE-UHFFFAOYSA-N
12107	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Fiebich BL (2004)	15070163	179206	926	Salicylic acid	2-Carboxyphenol|2-Hydroxybenzoic acid|O-hydroxybenzoic acid|O-carboxyphenol	md cell scalp|neutrogena oil f	DRUGBANK	DB00936	C7H6O3	small molecule	N02BA04|D01AE12|S01BC08	69-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YGSDEFSMJLZEOE-UHFFFAOYSA-N
12108	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Vane JR (1971)	5284360	179204	926	Salicylic acid	2-Carboxyphenol|2-Hydroxybenzoic acid|O-hydroxybenzoic acid|O-carboxyphenol	md cell scalp|neutrogena oil f	DRUGBANK	DB00936	C7H6O3	small molecule	N02BA04|D01AE12|S01BC08	69-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YGSDEFSMJLZEOE-UHFFFAOYSA-N
12109	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Wu KK (2003)	15199473	179209	926	Salicylic acid	2-Carboxyphenol|2-Hydroxybenzoic acid|O-hydroxybenzoic acid|O-carboxyphenol	md cell scalp|neutrogena oil f	DRUGBANK	DB00936	C7H6O3	small molecule	N02BA04|D01AE12|S01BC08	69-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YGSDEFSMJLZEOE-UHFFFAOYSA-N
12110	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Elvira C (2001)	15348270	179208	926	Salicylic acid	2-Carboxyphenol|2-Hydroxybenzoic acid|O-hydroxybenzoic acid|O-carboxyphenol	md cell scalp|neutrogena oil f	DRUGBANK	DB00936	C7H6O3	small molecule	N02BA04|D01AE12|S01BC08	69-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YGSDEFSMJLZEOE-UHFFFAOYSA-N
12131	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Narsinghani T (2006)	16290292	179228	929	Meclofenamic acid	N-(3-Methyl-2,6-dichlorophenyl)anthranilic acid|Acide meclofenamique|Acidum meclofenamicum|Meclofenamate|N-(2,6-Dichloro-3-methylphenyl)anthranilic acid|INF 4668|N-(2,6-Dichloro-m-tolyl)anthranilic acid|CI-583|Acido meclofenamico	meclofenamate sodium	DRUGBANK	DB00939	C14H11Cl2NO2	small molecule	M01AG04|M02AA18	644-62-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SBDNJUWAMKYJOX-UHFFFAOYSA-N
12132	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Kalgutkar AS (2000)	10639181	179223	929	Meclofenamic acid	N-(3-Methyl-2,6-dichlorophenyl)anthranilic acid|Acide meclofenamique|Acidum meclofenamicum|Meclofenamate|N-(2,6-Dichloro-3-methylphenyl)anthranilic acid|INF 4668|N-(2,6-Dichloro-m-tolyl)anthranilic acid|CI-583|Acido meclofenamico	meclofenamate sodium	DRUGBANK	DB00939	C14H11Cl2NO2	small molecule	M01AG04|M02AA18	644-62-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SBDNJUWAMKYJOX-UHFFFAOYSA-N
12133	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Wilson JE (2004)	15198222	178171	929	Meclofenamic acid	N-(3-Methyl-2,6-dichlorophenyl)anthranilic acid|Acide meclofenamique|Acidum meclofenamicum|Meclofenamate|N-(2,6-Dichloro-3-methylphenyl)anthranilic acid|INF 4668|N-(2,6-Dichloro-m-tolyl)anthranilic acid|CI-583|Acido meclofenamico	meclofenamate sodium	DRUGBANK	DB00939	C14H11Cl2NO2	small molecule	M01AG04|M02AA18	644-62-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SBDNJUWAMKYJOX-UHFFFAOYSA-N
12134	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Traupe T (2002)	12409963	179227	929	Meclofenamic acid	N-(3-Methyl-2,6-dichlorophenyl)anthranilic acid|Acide meclofenamique|Acidum meclofenamicum|Meclofenamate|N-(2,6-Dichloro-3-methylphenyl)anthranilic acid|INF 4668|N-(2,6-Dichloro-m-tolyl)anthranilic acid|CI-583|Acido meclofenamico	meclofenamate sodium	DRUGBANK	DB00939	C14H11Cl2NO2	small molecule	M01AG04|M02AA18	644-62-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SBDNJUWAMKYJOX-UHFFFAOYSA-N
12135	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Smith WL (1994)	7825862	179226	929	Meclofenamic acid	N-(3-Methyl-2,6-dichlorophenyl)anthranilic acid|Acide meclofenamique|Acidum meclofenamicum|Meclofenamate|N-(2,6-Dichloro-3-methylphenyl)anthranilic acid|INF 4668|N-(2,6-Dichloro-m-tolyl)anthranilic acid|CI-583|Acido meclofenamico	meclofenamate sodium	DRUGBANK	DB00939	C14H11Cl2NO2	small molecule	M01AG04|M02AA18	644-62-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SBDNJUWAMKYJOX-UHFFFAOYSA-N
12158	111551	5564	-	PRKAB1	AMPK|HAMPKb	9606	Homo sapiens	activator	target	Din FV (2012)	22406476	179247	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12159	111551	5564	-	PRKAB1	AMPK|HAMPKb	9606	Homo sapiens	activator	target	Hawley SA (2012)	22517326	179246	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12177	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Shen J (2006)	17181859	179252	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12178	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Nakano M (2007)	17258197	179253	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12179	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Wang HJ (2006)	17037745	179254	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12180	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Hall MN (2007)	17301265	179255	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12181	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Brzozowski T (2006)	17033106	179256	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12182	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12238	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Hoskin KL (2004)	14725972	179299	942	Naratriptan	N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum	teva-naratriptan|naratriptan|s	DRUGBANK	DB00952	C17H25N3O2S	small molecule	N02CC02	121679-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AMKVXSZCKVJAGH-UHFFFAOYSA-N
12239	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Akin D (2002)	12010764	179302	942	Naratriptan	N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum	teva-naratriptan|naratriptan|s	DRUGBANK	DB00952	C17H25N3O2S	small molecule	N02CC02	121679-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AMKVXSZCKVJAGH-UHFFFAOYSA-N
12240	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Dulli DA (1999)	10410185	179300	942	Naratriptan	N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum	teva-naratriptan|naratriptan|s	DRUGBANK	DB00952	C17H25N3O2S	small molecule	N02CC02	121679-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AMKVXSZCKVJAGH-UHFFFAOYSA-N
12241	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Johnston MM (2010)	20687618	179301	942	Naratriptan	N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum	teva-naratriptan|naratriptan|s	DRUGBANK	DB00952	C17H25N3O2S	small molecule	N02CC02	121679-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AMKVXSZCKVJAGH-UHFFFAOYSA-N
12242	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Lambert GA (2006)	16389295	179306	942	Naratriptan	N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum	teva-naratriptan|naratriptan|s	DRUGBANK	DB00952	C17H25N3O2S	small molecule	N02CC02	121679-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AMKVXSZCKVJAGH-UHFFFAOYSA-N
12243	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Boers PM (2004)	14728705	179304	942	Naratriptan	N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum	teva-naratriptan|naratriptan|s	DRUGBANK	DB00952	C17H25N3O2S	small molecule	N02CC02	121679-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AMKVXSZCKVJAGH-UHFFFAOYSA-N
12244	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Massiou H (2002)	12463278	179305	942	Naratriptan	N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum	teva-naratriptan|naratriptan|s	DRUGBANK	DB00952	C17H25N3O2S	small molecule	N02CC02	121679-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AMKVXSZCKVJAGH-UHFFFAOYSA-N
12245	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Pauwels PJ (1998)	9650800	175178	942	Naratriptan	N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum	teva-naratriptan|naratriptan|s	DRUGBANK	DB00952	C17H25N3O2S	small molecule	N02CC02	121679-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AMKVXSZCKVJAGH-UHFFFAOYSA-N
12246	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	942	Naratriptan	N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum	teva-naratriptan|naratriptan|s	DRUGBANK	DB00952	C17H25N3O2S	small molecule	N02CC02	121679-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AMKVXSZCKVJAGH-UHFFFAOYSA-N
12247	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Tfelt-Hansen P (2000)	11152011	174448	942	Naratriptan	N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum	teva-naratriptan|naratriptan|s	DRUGBANK	DB00952	C17H25N3O2S	small molecule	N02CC02	121679-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AMKVXSZCKVJAGH-UHFFFAOYSA-N
12262	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Wellington K (2002)	12269863	179311	943	Rizatriptan	Rizatriptan|Risatriptan|N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine|N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-ethanamine|Rizatriptanum|Rizatriptn	maxalt|ipg-rizatriptan|jamp-ri	DRUGBANK	DB00953	C15H19N5	small molecule	N02CC04	144034-80-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULFRLSNUDGIQQP-UHFFFAOYSA-N
12263	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Ikemoto F (2004)	15056946	179310	943	Rizatriptan	Rizatriptan|Risatriptan|N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine|N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-ethanamine|Rizatriptanum|Rizatriptn	maxalt|ipg-rizatriptan|jamp-ri	DRUGBANK	DB00953	C15H19N5	small molecule	N02CC04	144034-80-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULFRLSNUDGIQQP-UHFFFAOYSA-N
12264	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	943	Rizatriptan	Rizatriptan|Risatriptan|N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine|N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-ethanamine|Rizatriptanum|Rizatriptn	maxalt|ipg-rizatriptan|jamp-ri	DRUGBANK	DB00953	C15H19N5	small molecule	N02CC04	144034-80-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULFRLSNUDGIQQP-UHFFFAOYSA-N
12265	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Williamson DJ (2001)	11487512	179315	943	Rizatriptan	Rizatriptan|Risatriptan|N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine|N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-ethanamine|Rizatriptanum|Rizatriptn	maxalt|ipg-rizatriptan|jamp-ri	DRUGBANK	DB00953	C15H19N5	small molecule	N02CC04	144034-80-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULFRLSNUDGIQQP-UHFFFAOYSA-N
12266	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Wellington K (2002)	12093318	179314	943	Rizatriptan	Rizatriptan|Risatriptan|N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine|N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-ethanamine|Rizatriptanum|Rizatriptn	maxalt|ipg-rizatriptan|jamp-ri	DRUGBANK	DB00953	C15H19N5	small molecule	N02CC04	144034-80-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULFRLSNUDGIQQP-UHFFFAOYSA-N
12267	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Pauwels PJ (1998)	9650800	175178	943	Rizatriptan	Rizatriptan|Risatriptan|N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine|N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-ethanamine|Rizatriptanum|Rizatriptn	maxalt|ipg-rizatriptan|jamp-ri	DRUGBANK	DB00953	C15H19N5	small molecule	N02CC04	144034-80-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULFRLSNUDGIQQP-UHFFFAOYSA-N
12268	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Wackenfors A (2005)	15821444	174449	943	Rizatriptan	Rizatriptan|Risatriptan|N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine|N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-ethanamine|Rizatriptanum|Rizatriptn	maxalt|ipg-rizatriptan|jamp-ri	DRUGBANK	DB00953	C15H19N5	small molecule	N02CC04	144034-80-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULFRLSNUDGIQQP-UHFFFAOYSA-N
12312	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	unknown	target	Dawson LA (2000)	10727715	179355	950	Pindolol	Pindololum|Carvisken|Prinodolol|Decreten|Durapindol|Pynastin|4-(2-Hydroxy-3-isopropylaminopropoxy)-indole|Pectobloc|Cardilate|Betapindol|Pinbetol|1-(1H-indol-4-Yloxy)-3-[(1-methylethyl)amino]propan-2-ol|Blocklin L|Blockin L|Pindolol|Blocklin-L|1-(1H-indol-4-Yloxy)-3-(isopropylamino)propan-2-ol|Glauco-visken|Visken|Calvisken|1-(1H-indol-4-Yloxy)-3-(propan-2-ylamino)-propan-2-ol	apo-pindol tab 5mg|teva-pindol	DRUGBANK	DB00960	C14H20N2O2	small molecule	C07CA03|C07AA03	13523-86-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZQKKSLKJUAGIC-UHFFFAOYSA-N
12313	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	unknown	target	Herrick-Davis K (1988)	3141589	179357	950	Pindolol	Pindololum|Carvisken|Prinodolol|Decreten|Durapindol|Pynastin|4-(2-Hydroxy-3-isopropylaminopropoxy)-indole|Pectobloc|Cardilate|Betapindol|Pinbetol|1-(1H-indol-4-Yloxy)-3-[(1-methylethyl)amino]propan-2-ol|Blocklin L|Blockin L|Pindolol|Blocklin-L|1-(1H-indol-4-Yloxy)-3-(isopropylamino)propan-2-ol|Glauco-visken|Visken|Calvisken|1-(1H-indol-4-Yloxy)-3-(propan-2-ylamino)-propan-2-ol	apo-pindol tab 5mg|teva-pindol	DRUGBANK	DB00960	C14H20N2O2	small molecule	C07CA03|C07AA03	13523-86-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZQKKSLKJUAGIC-UHFFFAOYSA-N
12314	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	unknown	target	Leonhardt S (1989)	2664084	179356	950	Pindolol	Pindololum|Carvisken|Prinodolol|Decreten|Durapindol|Pynastin|4-(2-Hydroxy-3-isopropylaminopropoxy)-indole|Pectobloc|Cardilate|Betapindol|Pinbetol|1-(1H-indol-4-Yloxy)-3-[(1-methylethyl)amino]propan-2-ol|Blocklin L|Blockin L|Pindolol|Blocklin-L|1-(1H-indol-4-Yloxy)-3-(isopropylamino)propan-2-ol|Glauco-visken|Visken|Calvisken|1-(1H-indol-4-Yloxy)-3-(propan-2-ylamino)-propan-2-ol	apo-pindol tab 5mg|teva-pindol	DRUGBANK	DB00960	C14H20N2O2	small molecule	C07CA03|C07AA03	13523-86-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZQKKSLKJUAGIC-UHFFFAOYSA-N
12315	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	unknown	target	Ariani K (1989)	2512511	179359	950	Pindolol	Pindololum|Carvisken|Prinodolol|Decreten|Durapindol|Pynastin|4-(2-Hydroxy-3-isopropylaminopropoxy)-indole|Pectobloc|Cardilate|Betapindol|Pinbetol|1-(1H-indol-4-Yloxy)-3-[(1-methylethyl)amino]propan-2-ol|Blocklin L|Blockin L|Pindolol|Blocklin-L|1-(1H-indol-4-Yloxy)-3-(isopropylamino)propan-2-ol|Glauco-visken|Visken|Calvisken|1-(1H-indol-4-Yloxy)-3-(propan-2-ylamino)-propan-2-ol	apo-pindol tab 5mg|teva-pindol	DRUGBANK	DB00960	C14H20N2O2	small molecule	C07CA03|C07AA03	13523-86-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZQKKSLKJUAGIC-UHFFFAOYSA-N
12316	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	unknown	target	Terron JA (1994)	7944828	179358	950	Pindolol	Pindololum|Carvisken|Prinodolol|Decreten|Durapindol|Pynastin|4-(2-Hydroxy-3-isopropylaminopropoxy)-indole|Pectobloc|Cardilate|Betapindol|Pinbetol|1-(1H-indol-4-Yloxy)-3-[(1-methylethyl)amino]propan-2-ol|Blocklin L|Blockin L|Pindolol|Blocklin-L|1-(1H-indol-4-Yloxy)-3-(isopropylamino)propan-2-ol|Glauco-visken|Visken|Calvisken|1-(1H-indol-4-Yloxy)-3-(propan-2-ylamino)-propan-2-ol	apo-pindol tab 5mg|teva-pindol	DRUGBANK	DB00960	C14H20N2O2	small molecule	C07CA03|C07AA03	13523-86-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZQKKSLKJUAGIC-UHFFFAOYSA-N
12330	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Sanchez-Matienzo D (2006)	16982289	179368	953	Bromfenac	Bromfenaco|2-amino-3-(4-Bromobenzoyl)benzeneacetic acid|[2-Amino-3-(4-bromo-benzoyl)-phenyl]-acetic acid|Bromfenacum	prolensa|bromsite 0.075%|bromd	DRUGBANK	DB00963	C15H12BrNO3	small molecule	S01BC11	91714-94-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBPLOVFIXSTCRZ-UHFFFAOYSA-N
12331	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Waterbury LD (2006)	16846546	179366	953	Bromfenac	Bromfenaco|2-amino-3-(4-Bromobenzoyl)benzeneacetic acid|[2-Amino-3-(4-bromo-benzoyl)-phenyl]-acetic acid|Bromfenacum	prolensa|bromsite 0.075%|bromd	DRUGBANK	DB00963	C15H12BrNO3	small molecule	S01BC11	91714-94-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBPLOVFIXSTCRZ-UHFFFAOYSA-N
12332	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chitturi S (2002)	12016548	179367	953	Bromfenac	Bromfenaco|2-amino-3-(4-Bromobenzoyl)benzeneacetic acid|[2-Amino-3-(4-bromo-benzoyl)-phenyl]-acetic acid|Bromfenacum	prolensa|bromsite 0.075%|bromd	DRUGBANK	DB00963	C15H12BrNO3	small molecule	S01BC11	91714-94-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBPLOVFIXSTCRZ-UHFFFAOYSA-N
12513	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Dolzan V (2007)	17455212	178693	978	Dopamine	4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin	dopamine hydrochloride and dex	DRUGBANK	DB00988	C8H11NO2	small molecule	C01CA04	51-61-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYFYYTLLBUKUHU-UHFFFAOYSA-N
12514	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Fu W (2007)	17468175	179523	978	Dopamine	4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin	dopamine hydrochloride and dex	DRUGBANK	DB00988	C8H11NO2	small molecule	C01CA04	51-61-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYFYYTLLBUKUHU-UHFFFAOYSA-N
12515	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Ostadali MR (2004)	17301410	179521	978	Dopamine	4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin	dopamine hydrochloride and dex	DRUGBANK	DB00988	C8H11NO2	small molecule	C01CA04	51-61-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYFYYTLLBUKUHU-UHFFFAOYSA-N
12516	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Hoenicka J (2007)	17449449	179524	978	Dopamine	4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin	dopamine hydrochloride and dex	DRUGBANK	DB00988	C8H11NO2	small molecule	C01CA04	51-61-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYFYYTLLBUKUHU-UHFFFAOYSA-N
12517	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	da Silva Lobo DS (2007)	17394052	179525	978	Dopamine	4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin	dopamine hydrochloride and dex	DRUGBANK	DB00988	C8H11NO2	small molecule	C01CA04	51-61-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYFYYTLLBUKUHU-UHFFFAOYSA-N
12528	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Huebner H (2000)	10691700	179533	978	Dopamine	4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin	dopamine hydrochloride and dex	DRUGBANK	DB00988	C8H11NO2	small molecule	C01CA04	51-61-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYFYYTLLBUKUHU-UHFFFAOYSA-N
12565	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Kawai S (1998)	9650852	159681	981	Oxaprozin	Duraprox|Walix|Daypro|Dayrun|Oxaprozinum|Danoprox|Oxaprozina|Deflam|Oxaprozine	apo-oxaprozin|rhoxal-oxaprozin	DRUGBANK	DB00991	C18H15NO3	small molecule	M01AE12	21256-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFPXSFXSNFPTHF-UHFFFAOYSA-N
12566	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Yamazaki R (2002)	12065695	179564	981	Oxaprozin	Duraprox|Walix|Daypro|Dayrun|Oxaprozinum|Danoprox|Oxaprozina|Deflam|Oxaprozine	apo-oxaprozin|rhoxal-oxaprozin	DRUGBANK	DB00991	C18H15NO3	small molecule	M01AE12	21256-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFPXSFXSNFPTHF-UHFFFAOYSA-N
12567	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Kawai S (1998)	9831331	179562	981	Oxaprozin	Duraprox|Walix|Daypro|Dayrun|Oxaprozinum|Danoprox|Oxaprozina|Deflam|Oxaprozine	apo-oxaprozin|rhoxal-oxaprozin	DRUGBANK	DB00991	C18H15NO3	small molecule	M01AE12	21256-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFPXSFXSNFPTHF-UHFFFAOYSA-N
12568	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Ottonello L (2009)	19338579	179563	981	Oxaprozin	Duraprox|Walix|Daypro|Dayrun|Oxaprozinum|Danoprox|Oxaprozina|Deflam|Oxaprozine	apo-oxaprozin|rhoxal-oxaprozin	DRUGBANK	DB00991	C18H15NO3	small molecule	M01AE12	21256-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFPXSFXSNFPTHF-UHFFFAOYSA-N
12569	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Yood MU (2006)	17024689	179560	981	Oxaprozin	Duraprox|Walix|Daypro|Dayrun|Oxaprozinum|Danoprox|Oxaprozina|Deflam|Oxaprozine	apo-oxaprozin|rhoxal-oxaprozin	DRUGBANK	DB00991	C18H15NO3	small molecule	M01AE12	21256-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFPXSFXSNFPTHF-UHFFFAOYSA-N
12570	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Zhou XP (2009)	19952416	179561	981	Oxaprozin	Duraprox|Walix|Daypro|Dayrun|Oxaprozinum|Danoprox|Oxaprozina|Deflam|Oxaprozine	apo-oxaprozin|rhoxal-oxaprozin	DRUGBANK	DB00991	C18H15NO3	small molecule	M01AE12	21256-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFPXSFXSNFPTHF-UHFFFAOYSA-N
12625	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Easthope SE (2001)	11735616	179593	988	Frovatriptan	-	teva-frovatriptan|apo-frovatri	DRUGBANK	DB00998	C14H17N3O	small molecule	N02CC07	158747-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPSQPHWEGNHMSK-SECBINFHSA-N
12626	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Deleu D (2000)	10883409	179597	988	Frovatriptan	-	teva-frovatriptan|apo-frovatri	DRUGBANK	DB00998	C14H17N3O	small molecule	N02CC07	158747-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPSQPHWEGNHMSK-SECBINFHSA-N
12627	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Parsons AA (1998)	9700983	179596	988	Frovatriptan	-	teva-frovatriptan|apo-frovatri	DRUGBANK	DB00998	C14H17N3O	small molecule	N02CC07	158747-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPSQPHWEGNHMSK-SECBINFHSA-N
12628	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Elkind AH (2004)	15342617	179595	988	Frovatriptan	-	teva-frovatriptan|apo-frovatri	DRUGBANK	DB00998	C14H17N3O	small molecule	N02CC07	158747-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPSQPHWEGNHMSK-SECBINFHSA-N
12629	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Balbisi EA (2004)	15311727	179594	988	Frovatriptan	-	teva-frovatriptan|apo-frovatri	DRUGBANK	DB00998	C14H17N3O	small molecule	N02CC07	158747-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPSQPHWEGNHMSK-SECBINFHSA-N
12630	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	988	Frovatriptan	-	teva-frovatriptan|apo-frovatri	DRUGBANK	DB00998	C14H17N3O	small molecule	N02CC07	158747-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPSQPHWEGNHMSK-SECBINFHSA-N
12631	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Buchan P (2002)	12028322	179598	988	Frovatriptan	-	teva-frovatriptan|apo-frovatri	DRUGBANK	DB00998	C14H17N3O	small molecule	N02CC07	158747-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPSQPHWEGNHMSK-SECBINFHSA-N
12632	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Dodick DW (2006)	17190530	179602	988	Frovatriptan	-	teva-frovatriptan|apo-frovatri	DRUGBANK	DB00998	C14H17N3O	small molecule	N02CC07	158747-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPSQPHWEGNHMSK-SECBINFHSA-N
12633	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Markus F (2007)	18001261	179601	988	Frovatriptan	-	teva-frovatriptan|apo-frovatri	DRUGBANK	DB00998	C14H17N3O	small molecule	N02CC07	158747-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPSQPHWEGNHMSK-SECBINFHSA-N
12634	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Balbisi EA (2006)	18360605	179600	988	Frovatriptan	-	teva-frovatriptan|apo-frovatri	DRUGBANK	DB00998	C14H17N3O	small molecule	N02CC07	158747-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPSQPHWEGNHMSK-SECBINFHSA-N
12635	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Comer MB (2002)	12028320	179599	988	Frovatriptan	-	teva-frovatriptan|apo-frovatri	DRUGBANK	DB00998	C14H17N3O	small molecule	N02CC07	158747-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPSQPHWEGNHMSK-SECBINFHSA-N
12636	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Tfelt-Hansen P (2000)	11152011	174448	988	Frovatriptan	-	teva-frovatriptan|apo-frovatri	DRUGBANK	DB00998	C14H17N3O	small molecule	N02CC07	158747-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPSQPHWEGNHMSK-SECBINFHSA-N
12637	107225	771	-	CA12	CAXII|HsT18816	9606	Homo sapiens	inhibitor	target	Temperini C (2009)	19119014	174539	989	Hydrochlorothiazide	HCTZ|Microzide|Esidrix	amlodipine, valsartan, hydroch	DRUGBANK	DB00999	C7H8ClN3O4S2	small molecule	C03AB03|C09XA52|C03AA03|C09XA54|C03EA01|C09DX01|C09DX03|C03AX01	58-93-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZUFKLXOESDKRF-UHFFFAOYSA-N
12703	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Wilson JE (2004)	15198222	178171	999	Ketoprofen	m-Benzoylhydratropic acid|3-Benzoyl--methylbenzeneacetic acid|3-Benzoyl-alpha-methylbenzeneacetic acid|2-(3-Benzoylphenyl)propionic acid|Ketoprofen|3-Benzoylhydratropic acid|Orudis (tn)|L'Acide (benzoyl-3-phenyl)-2-propionique	nu-ketoprofen-e ect 50mg|orudi	DRUGBANK	DB01009	C16H14O3	small molecule	M01AE53|M01AE03|M02AA10	22071-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKYWVDODHFEZIM-UHFFFAOYSA-N
12704	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Zuniga J (2003)	14513718	179627	999	Ketoprofen	m-Benzoylhydratropic acid|3-Benzoyl--methylbenzeneacetic acid|3-Benzoyl-alpha-methylbenzeneacetic acid|2-(3-Benzoylphenyl)propionic acid|Ketoprofen|3-Benzoylhydratropic acid|Orudis (tn)|L'Acide (benzoyl-3-phenyl)-2-propionique	nu-ketoprofen-e ect 50mg|orudi	DRUGBANK	DB01009	C16H14O3	small molecule	M01AE53|M01AE03|M02AA10	22071-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKYWVDODHFEZIM-UHFFFAOYSA-N
12705	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Sommerauer M (2001)	11729362	179635	999	Ketoprofen	m-Benzoylhydratropic acid|3-Benzoyl--methylbenzeneacetic acid|3-Benzoyl-alpha-methylbenzeneacetic acid|2-(3-Benzoylphenyl)propionic acid|Ketoprofen|3-Benzoylhydratropic acid|Orudis (tn)|L'Acide (benzoyl-3-phenyl)-2-propionique	nu-ketoprofen-e ect 50mg|orudi	DRUGBANK	DB01009	C16H14O3	small molecule	M01AE53|M01AE03|M02AA10	22071-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKYWVDODHFEZIM-UHFFFAOYSA-N
12706	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Levoin N (2002)	11814865	179634	999	Ketoprofen	m-Benzoylhydratropic acid|3-Benzoyl--methylbenzeneacetic acid|3-Benzoyl-alpha-methylbenzeneacetic acid|2-(3-Benzoylphenyl)propionic acid|Ketoprofen|3-Benzoylhydratropic acid|Orudis (tn)|L'Acide (benzoyl-3-phenyl)-2-propionique	nu-ketoprofen-e ect 50mg|orudi	DRUGBANK	DB01009	C16H14O3	small molecule	M01AE53|M01AE03|M02AA10	22071-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKYWVDODHFEZIM-UHFFFAOYSA-N
12707	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	999	Ketoprofen	m-Benzoylhydratropic acid|3-Benzoyl--methylbenzeneacetic acid|3-Benzoyl-alpha-methylbenzeneacetic acid|2-(3-Benzoylphenyl)propionic acid|Ketoprofen|3-Benzoylhydratropic acid|Orudis (tn)|L'Acide (benzoyl-3-phenyl)-2-propionique	nu-ketoprofen-e ect 50mg|orudi	DRUGBANK	DB01009	C16H14O3	small molecule	M01AE53|M01AE03|M02AA10	22071-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKYWVDODHFEZIM-UHFFFAOYSA-N
12708	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Kay-Mugford P (2000)	10895904	178552	999	Ketoprofen	m-Benzoylhydratropic acid|3-Benzoyl--methylbenzeneacetic acid|3-Benzoyl-alpha-methylbenzeneacetic acid|2-(3-Benzoylphenyl)propionic acid|Ketoprofen|3-Benzoylhydratropic acid|Orudis (tn)|L'Acide (benzoyl-3-phenyl)-2-propionique	nu-ketoprofen-e ect 50mg|orudi	DRUGBANK	DB01009	C16H14O3	small molecule	M01AE53|M01AE03|M02AA10	22071-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKYWVDODHFEZIM-UHFFFAOYSA-N
12745	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	1004	Balsalazide	Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid	balsalazide disodium|colazal|g	DRUGBANK	DB01014	C17H15N3O6	small molecule	A07EC04	80573-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPOKCKJONYRRHP-FMQUCBEESA-N
12746	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Stolfi C (2008)	17981262	179660	1004	Balsalazide	Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid	balsalazide disodium|colazal|g	DRUGBANK	DB01014	C17H15N3O6	small molecule	A07EC04	80573-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPOKCKJONYRRHP-FMQUCBEESA-N
12747	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	1004	Balsalazide	Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid	balsalazide disodium|colazal|g	DRUGBANK	DB01014	C17H15N3O6	small molecule	A07EC04	80573-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPOKCKJONYRRHP-FMQUCBEESA-N
12748	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Allgayer H (2003)	12950415	174544	1004	Balsalazide	Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid	balsalazide disodium|colazal|g	DRUGBANK	DB01014	C17H15N3O6	small molecule	A07EC04	80573-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPOKCKJONYRRHP-FMQUCBEESA-N
12749	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Wiggins JB (2009)	19743890	179656	1004	Balsalazide	Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid	balsalazide disodium|colazal|g	DRUGBANK	DB01014	C17H15N3O6	small molecule	A07EC04	80573-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPOKCKJONYRRHP-FMQUCBEESA-N
13028	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1024	Procainamide	Procainamida|Procainamide|Biocoryl|p-Aminobenzoic diethylaminoethylamide|Procainamidum|p-Amino-N-(2-diethylaminoethyl)benzamide	apo-procainamide cap 375mg|pro	DRUGBANK	DB01035	C13H21N3O	small molecule	C01BA02	51-06-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	REQCZEXYDRLIBE-UHFFFAOYSA-N
13029	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Brugada J (1999)	11225790	179818	1024	Procainamide	Procainamida|Procainamide|Biocoryl|p-Aminobenzoic diethylaminoethylamide|Procainamidum|p-Amino-N-(2-diethylaminoethyl)benzamide	apo-procainamide cap 375mg|pro	DRUGBANK	DB01035	C13H21N3O	small molecule	C01BA02	51-06-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	REQCZEXYDRLIBE-UHFFFAOYSA-N
13030	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Weiss R (2002)	11839626	179819	1024	Procainamide	Procainamida|Procainamide|Biocoryl|p-Aminobenzoic diethylaminoethylamide|Procainamidum|p-Amino-N-(2-diethylaminoethyl)benzamide	apo-procainamide cap 375mg|pro	DRUGBANK	DB01035	C13H21N3O	small molecule	C01BA02	51-06-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	REQCZEXYDRLIBE-UHFFFAOYSA-N
13031	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Brugada R (2000)	10662748	179816	1024	Procainamide	Procainamida|Procainamide|Biocoryl|p-Aminobenzoic diethylaminoethylamide|Procainamidum|p-Amino-N-(2-diethylaminoethyl)benzamide	apo-procainamide cap 375mg|pro	DRUGBANK	DB01035	C13H21N3O	small molecule	C01BA02	51-06-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	REQCZEXYDRLIBE-UHFFFAOYSA-N
13032	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Chen SM (2000)	11155778	179817	1024	Procainamide	Procainamida|Procainamide|Biocoryl|p-Aminobenzoic diethylaminoethylamide|Procainamidum|p-Amino-N-(2-diethylaminoethyl)benzamide	apo-procainamide cap 375mg|pro	DRUGBANK	DB01035	C13H21N3O	small molecule	C01BA02	51-06-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	REQCZEXYDRLIBE-UHFFFAOYSA-N
13033	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Brugada J (1999)	10443304	179815	1024	Procainamide	Procainamida|Procainamide|Biocoryl|p-Aminobenzoic diethylaminoethylamide|Procainamidum|p-Amino-N-(2-diethylaminoethyl)benzamide	apo-procainamide cap 375mg|pro	DRUGBANK	DB01035	C13H21N3O	small molecule	C01BA02	51-06-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	REQCZEXYDRLIBE-UHFFFAOYSA-N
13062	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Patkar AA (2006)	16641841	179836	1026	Selegiline	L-Deprenalin|Selegilinum|()-selegiline|Selegilina	dom-selegiline|mylan-selegilin	DRUGBANK	DB01037	C13H17N	small molecule	N04BD01	14611-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEZLKOACVSPNER-UHFFFAOYSA-N
13063	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Azzaro AJ (2007)	17715422	179828	1026	Selegiline	L-Deprenalin|Selegilinum|()-selegiline|Selegilina	dom-selegiline|mylan-selegilin	DRUGBANK	DB01037	C13H17N	small molecule	N04BD01	14611-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEZLKOACVSPNER-UHFFFAOYSA-N
13064	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Baker GB (2007)	17823646	179831	1026	Selegiline	L-Deprenalin|Selegilinum|()-selegiline|Selegilina	dom-selegiline|mylan-selegilin	DRUGBANK	DB01037	C13H17N	small molecule	N04BD01	14611-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEZLKOACVSPNER-UHFFFAOYSA-N
13065	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Lee KC (2007)	19300583	179829	1026	Selegiline	L-Deprenalin|Selegilinum|()-selegiline|Selegilina	dom-selegiline|mylan-selegilin	DRUGBANK	DB01037	C13H17N	small molecule	N04BD01	14611-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEZLKOACVSPNER-UHFFFAOYSA-N
13073	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Bora G (1968)	4887393	179838	1027	Carphenazine	Carphenazin|Carfenazine	-	DRUGBANK	DB01038	C23H29N3O2S	small molecule	-	2622-30-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYCNETKPCXPXNW-UHFFFAOYSA-N
13074	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Platz AR (1967)	4861216	179839	1027	Carphenazine	Carphenazin|Carfenazine	-	DRUGBANK	DB01038	C23H29N3O2S	small molecule	-	2622-30-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYCNETKPCXPXNW-UHFFFAOYSA-N
13075	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Vinar O (1967)	4889058	179840	1027	Carphenazine	Carphenazin|Carfenazine	-	DRUGBANK	DB01038	C23H29N3O2S	small molecule	-	2622-30-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYCNETKPCXPXNW-UHFFFAOYSA-N
13087	108554	2263	-	FGFR2	BBDS|BEK|BFR-1|CD332|CEK3|CFD1|ECT1|JWS|K-SAM|KGFR|TK14|TK25	9606	Homo sapiens	antagonist	target	Eichholz A (2010)	20616958	179850	1030	Thalidomide	alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide	thalomid	DRUGBANK	DB01041	C13H10N2O4	small molecule	L04AX02	50-35-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UEJJHQNACJXSKW-UHFFFAOYSA-N
13098	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	antagonist	target	Kim JH (2011)	21507989	179857	1030	Thalidomide	alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide	thalomid	DRUGBANK	DB01041	C13H10N2O4	small molecule	L04AX02	50-35-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UEJJHQNACJXSKW-UHFFFAOYSA-N
13099	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	antagonist	target	Payvandi F (2004)	15598423	176374	1030	Thalidomide	alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide	thalomid	DRUGBANK	DB01041	C13H10N2O4	small molecule	L04AX02	50-35-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UEJJHQNACJXSKW-UHFFFAOYSA-N
13100	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	antagonist	target	Hada M (2004)	15446566	179858	1030	Thalidomide	alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide	thalomid	DRUGBANK	DB01041	C13H10N2O4	small molecule	L04AX02	50-35-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UEJJHQNACJXSKW-UHFFFAOYSA-N
13101	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	antagonist	target	Horrobin DF (2003)	12710892	179859	1030	Thalidomide	alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide	thalomid	DRUGBANK	DB01041	C13H10N2O4	small molecule	L04AX02	50-35-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UEJJHQNACJXSKW-UHFFFAOYSA-N
13102	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	antagonist	target	Wiedmann MW (2005)	15892618	179861	1030	Thalidomide	alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide	thalomid	DRUGBANK	DB01041	C13H10N2O4	small molecule	L04AX02	50-35-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UEJJHQNACJXSKW-UHFFFAOYSA-N
13103	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	antagonist	target	Du GJ (2005)	15982930	179860	1030	Thalidomide	alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide	thalomid	DRUGBANK	DB01041	C13H10N2O4	small molecule	L04AX02	50-35-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UEJJHQNACJXSKW-UHFFFAOYSA-N
13147	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Korneyev AY (1996)	8786706	179892	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13148	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Markstein R (1985)	2869188	179893	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13149	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Flynn BL (1999)	10084415	179894	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13150	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Wadworth AN (1992)	1606351	179895	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13151	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Korneyev AY (1996)	8786706	179892	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13152	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Markstein R (1985)	2869188	179893	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13153	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Flynn BL (1999)	10084415	179894	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13154	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Wadworth AN (1992)	1606351	179895	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13234	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	antagonist	target	Korneyev AY (1996)	8786706	179892	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13235	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	antagonist	target	Markstein R (1985)	2869188	179893	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13236	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	antagonist	target	Flynn BL (1999)	10084415	179894	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13237	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	antagonist	target	Wadworth AN (1992)	1606351	179895	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13289	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chavez ML (2003)	12852704	177085	1039	Ibuprofen	Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin	advil cold and sinus nighttime	DRUGBANK	DB01050	C13H18O2	small molecule	M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51	15687-27-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEFNNWSXXWATRW-UHFFFAOYSA-N
13290	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1039	Ibuprofen	Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin	advil cold and sinus nighttime	DRUGBANK	DB01050	C13H18O2	small molecule	M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51	15687-27-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEFNNWSXXWATRW-UHFFFAOYSA-N
13291	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Gallego-Sandin S (2004)	15481334	179907	1039	Ibuprofen	Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin	advil cold and sinus nighttime	DRUGBANK	DB01050	C13H18O2	small molecule	M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51	15687-27-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEFNNWSXXWATRW-UHFFFAOYSA-N
13292	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Murphey LJ (2004)	15494133	179908	1039	Ibuprofen	Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin	advil cold and sinus nighttime	DRUGBANK	DB01050	C13H18O2	small molecule	M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51	15687-27-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEFNNWSXXWATRW-UHFFFAOYSA-N
13293	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Ouellet M (2004)	14510637	179909	1039	Ibuprofen	Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin	advil cold and sinus nighttime	DRUGBANK	DB01050	C13H18O2	small molecule	M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51	15687-27-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEFNNWSXXWATRW-UHFFFAOYSA-N
13294	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Sanchez-Fidalgo S (2004)	15556152	179910	1039	Ibuprofen	Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin	advil cold and sinus nighttime	DRUGBANK	DB01050	C13H18O2	small molecule	M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51	15687-27-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEFNNWSXXWATRW-UHFFFAOYSA-N
13314	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1044	Tocainide	2-amino-N-(2,6-Dimethylphenyl)propanamide|Tocainidum|2-Amino-N-(2,6-dimethylphenyl)propionamid|Tocainida|Alanyl-2,6-xylidide|2-Amino-2',6'-propionoxylidide	tonocard tab 400 mg	DRUGBANK	DB01056	C11H16N2O	small molecule	C01BB03	41708-72-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BUJAGSGYPOAWEI-UHFFFAOYSA-N
13315	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Georgijevic Milic L (2000)	10953551	179920	1044	Tocainide	2-amino-N-(2,6-Dimethylphenyl)propanamide|Tocainidum|2-Amino-N-(2,6-dimethylphenyl)propionamid|Tocainida|Alanyl-2,6-xylidide|2-Amino-2',6'-propionoxylidide	tonocard tab 400 mg	DRUGBANK	DB01056	C11H16N2O	small molecule	C01BB03	41708-72-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BUJAGSGYPOAWEI-UHFFFAOYSA-N
13342	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1051	Acetophenazine	Acetophenazine	-	DRUGBANK	DB01063	C23H29N3O2S	small molecule	N05AB07	2751-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WNTYBHLDCKXEOT-UHFFFAOYSA-N
13343	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1051	Acetophenazine	Acetophenazine	-	DRUGBANK	DB01063	C23H29N3O2S	small molecule	N05AB07	2751-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WNTYBHLDCKXEOT-UHFFFAOYSA-N
13626	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inducer	target	Schermuly RT (2003)	12952271	180070	1076	Iloprost	-	ventavis	DRUGBANK	DB01088	C22H32O4	small molecule	B01AC11	78919-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIFJCPQKFCZDDL-ACWOEMLNSA-N
13627	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inducer	target	Wilkens H (2001)	11551870	180069	1076	Iloprost	-	ventavis	DRUGBANK	DB01088	C22H32O4	small molecule	B01AC11	78919-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIFJCPQKFCZDDL-ACWOEMLNSA-N
13628	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inducer	target	Ghofrani HA (2002)	12441759	180068	1076	Iloprost	-	ventavis	DRUGBANK	DB01088	C22H32O4	small molecule	B01AC11	78919-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIFJCPQKFCZDDL-ACWOEMLNSA-N
13629	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inducer	target	Grant PG (1988)	2461561	180067	1076	Iloprost	-	ventavis	DRUGBANK	DB01088	C22H32O4	small molecule	B01AC11	78919-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIFJCPQKFCZDDL-ACWOEMLNSA-N
13871	124667	90134	-	KCNH7	ERG3|HERG3|Kv11.3	9606	Homo sapiens	inhibitor	target	Hatton CJ (1996)	8760033	180211	1098	Miconazole	1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole	aloe vesta antifungal|triple p	DRUGBANK	DB01110	C18H14Cl4N2O	small molecule	S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09	22916-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYBLEWFAAKGYCD-UHFFFAOYSA-N
13872	124667	90134	-	KCNH7	ERG3|HERG3|Kv11.3	9606	Homo sapiens	inhibitor	target	Kikuchi K (2005)	15778703	180212	1098	Miconazole	1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole	aloe vesta antifungal|triple p	DRUGBANK	DB01110	C18H14Cl4N2O	small molecule	S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09	22916-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYBLEWFAAKGYCD-UHFFFAOYSA-N
13873	109984	3783	-	KCNN4	IK1|IKCA1|KCA4|KCa3.1|SK4|hIKCa1|hKCa4|hSK4	9606	Homo sapiens	inhibitor	target	Hatton CJ (1996)	8760033	180211	1098	Miconazole	1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole	aloe vesta antifungal|triple p	DRUGBANK	DB01110	C18H14Cl4N2O	small molecule	S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09	22916-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYBLEWFAAKGYCD-UHFFFAOYSA-N
13874	109984	3783	-	KCNN4	IK1|IKCA1|KCA4|KCa3.1|SK4|hIKCa1|hKCa4|hSK4	9606	Homo sapiens	inhibitor	target	Alvarez J (1992)	1376313	180213	1098	Miconazole	1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole	aloe vesta antifungal|triple p	DRUGBANK	DB01110	C18H14Cl4N2O	small molecule	S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09	22916-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYBLEWFAAKGYCD-UHFFFAOYSA-N
13894	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	1101	Papaverine	Mesotina	papaverine hydrochloride injec	DRUGBANK	DB01113	C20H21NO4	small molecule	G04BE02|G04BE52|A03AD01	58-74-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XQYZDYMELSJDRZ-UHFFFAOYSA-N
13895	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	1101	Papaverine	Mesotina	papaverine hydrochloride injec	DRUGBANK	DB01113	C20H21NO4	small molecule	G04BE02|G04BE52|A03AD01	58-74-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XQYZDYMELSJDRZ-UHFFFAOYSA-N
13896	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Xin ZC (2003)	12646997	180221	1101	Papaverine	Mesotina	papaverine hydrochloride injec	DRUGBANK	DB01113	C20H21NO4	small molecule	G04BE02|G04BE52|A03AD01	58-74-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XQYZDYMELSJDRZ-UHFFFAOYSA-N
13897	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Zhu S (2009)	19231363	180222	1101	Papaverine	Mesotina	papaverine hydrochloride injec	DRUGBANK	DB01113	C20H21NO4	small molecule	G04BE02|G04BE52|A03AD01	58-74-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XQYZDYMELSJDRZ-UHFFFAOYSA-N
14344	109984	3783	-	KCNN4	IK1|IKCA1|KCA4|KCa3.1|SK4|hIKCa1|hKCa4|hSK4	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	1147	Halothane	Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane	fluothane liq inh 1000mg/gm|ha	DRUGBANK	DB01159	C2HBrClF3	small molecule	N01AB01	151-67-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCQZXOMGPXTTIC-UHFFFAOYSA-N
14345	109984	3783	-	KCNN4	IK1|IKCA1|KCA4|KCa3.1|SK4|hIKCa1|hKCa4|hSK4	9606	Homo sapiens	inhibitor	target	Namba T (2000)	10794813	174523	1147	Halothane	Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane	fluothane liq inh 1000mg/gm|ha	DRUGBANK	DB01159	C2HBrClF3	small molecule	N01AB01	151-67-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCQZXOMGPXTTIC-UHFFFAOYSA-N
14346	109984	3783	-	KCNN4	IK1|IKCA1|KCA4|KCa3.1|SK4|hIKCa1|hKCa4|hSK4	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	1147	Halothane	Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane	fluothane liq inh 1000mg/gm|ha	DRUGBANK	DB01159	C2HBrClF3	small molecule	N01AB01	151-67-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCQZXOMGPXTTIC-UHFFFAOYSA-N
14350	109965	3763	-	KCNJ6	BIR1|GIRK-2|GIRK2|KATP-2|KATP2|KCNJ7|KIR3.2|hiGIRK2	9606	Homo sapiens	inhibitor	target	Milovic S (2004)	15175324	180409	1147	Halothane	Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane	fluothane liq inh 1000mg/gm|ha	DRUGBANK	DB01159	C2HBrClF3	small molecule	N01AB01	151-67-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCQZXOMGPXTTIC-UHFFFAOYSA-N
14351	109965	3763	-	KCNJ6	BIR1|GIRK-2|GIRK2|KATP-2|KATP2|KCNJ7|KIR3.2|hiGIRK2	9606	Homo sapiens	inhibitor	target	Hara K (2005)	16243998	180417	1147	Halothane	Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane	fluothane liq inh 1000mg/gm|ha	DRUGBANK	DB01159	C2HBrClF3	small molecule	N01AB01	151-67-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCQZXOMGPXTTIC-UHFFFAOYSA-N
14384	124667	90134	-	KCNH7	ERG3|HERG3|Kv11.3	9606	Homo sapiens	inhibitor	target	Thomas D (2004)	15098086	176200	1150	Terazosin	Terazosine|Terazosin|Terazosinum|Terazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)piperazine	hytrin-7 tabs 1mg-7 tabs 2mg-1	DRUGBANK	DB01162	C19H25N5O4	small molecule	G04CA03	63590-64-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VCKUSRYTPJJLNI-UHFFFAOYSA-N
14428	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1159	Moclobemide	p-Chloro-N-(2-morpholinoethyl)benzamide|Moclobemida|4-Chloro-N-(2-(4-morpholinyl)ethyl)benzamide|Moclobemidum|Moclaime|Moclamine|4-Chlor-N-(2-morpholinoethyl)benzamid|4-Chloro-N-(2-morpholin-4-yl-ethyl)-benzamide|Aurorix|Moclamide|Moclobemide|Moclobemid	manerix|nu-moclobemide|manerix	DRUGBANK	DB01171	C13H17ClN2O2	small molecule	N06AG02	71320-77-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHXISWVBGDMDLQ-UHFFFAOYSA-N
14429	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Berlin I (1990)	1705137	180461	1159	Moclobemide	p-Chloro-N-(2-morpholinoethyl)benzamide|Moclobemida|4-Chloro-N-(2-(4-morpholinyl)ethyl)benzamide|Moclobemidum|Moclaime|Moclamine|4-Chlor-N-(2-morpholinoethyl)benzamid|4-Chloro-N-(2-morpholin-4-yl-ethyl)-benzamide|Aurorix|Moclamide|Moclobemide|Moclobemid	manerix|nu-moclobemide|manerix	DRUGBANK	DB01171	C13H17ClN2O2	small molecule	N06AG02	71320-77-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHXISWVBGDMDLQ-UHFFFAOYSA-N
14430	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Fulton B (1996)	8875133	180460	1159	Moclobemide	p-Chloro-N-(2-morpholinoethyl)benzamide|Moclobemida|4-Chloro-N-(2-(4-morpholinyl)ethyl)benzamide|Moclobemidum|Moclaime|Moclamine|4-Chlor-N-(2-morpholinoethyl)benzamid|4-Chloro-N-(2-morpholin-4-yl-ethyl)-benzamide|Aurorix|Moclamide|Moclobemide|Moclobemid	manerix|nu-moclobemide|manerix	DRUGBANK	DB01171	C13H17ClN2O2	small molecule	N06AG02	71320-77-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHXISWVBGDMDLQ-UHFFFAOYSA-N
14522	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	1170	Propafenone	1-(2-(2-Hydroxy-3-(propylamino)propoxy)phenyl)-3-phenyl-1-propanone|Propafenonum|Propafenona|2-(2'-Hydroxy-3'-propylaminopropoxy)-omega-phenylpropiophenone	mylan-propafenone|propafenone|	DRUGBANK	DB01182	C21H27NO3	small molecule	C01BC03	54063-53-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWHAUXFOSRPERK-UHFFFAOYSA-N
14523	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	1170	Propafenone	1-(2-(2-Hydroxy-3-(propylamino)propoxy)phenyl)-3-phenyl-1-propanone|Propafenonum|Propafenona|2-(2'-Hydroxy-3'-propylaminopropoxy)-omega-phenylpropiophenone	mylan-propafenone|propafenone|	DRUGBANK	DB01182	C21H27NO3	small molecule	C01BC03	54063-53-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWHAUXFOSRPERK-UHFFFAOYSA-N
14584	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	1174	Pergolide	Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida	permax tab 0.25mg|permax tab 0	DRUGBANK	DB01186	C19H26N2S	small molecule	N04BC02	66104-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEHCICAEULNIGD-MZMPZRCHSA-N
14585	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	1174	Pergolide	Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida	permax tab 0.25mg|permax tab 0	DRUGBANK	DB01186	C19H26N2S	small molecule	N04BC02	66104-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEHCICAEULNIGD-MZMPZRCHSA-N
14607	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	1174	Pergolide	Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida	permax tab 0.25mg|permax tab 0	DRUGBANK	DB01186	C19H26N2S	small molecule	N04BC02	66104-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEHCICAEULNIGD-MZMPZRCHSA-N
14608	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1174	Pergolide	Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida	permax tab 0.25mg|permax tab 0	DRUGBANK	DB01186	C19H26N2S	small molecule	N04BC02	66104-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEHCICAEULNIGD-MZMPZRCHSA-N
14609	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	1174	Pergolide	Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida	permax tab 0.25mg|permax tab 0	DRUGBANK	DB01186	C19H26N2S	small molecule	N04BC02	66104-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEHCICAEULNIGD-MZMPZRCHSA-N
14699	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Shimizu W (2000)	11196553	174870	1183	Flecainide	(+-)-Flecainide|Flecainida|CCRIS 313|N-(2-Piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide|Flecainidum|Flecaine	flecainide|tambocor|auro-fleca	DRUGBANK	DB01195	C17H20F6N2O3	small molecule	C01BC04	54143-55-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DJBNUMBKLMJRSA-UHFFFAOYSA-N
14700	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Liu H (2003)	12601084	180559	1183	Flecainide	(+-)-Flecainide|Flecainida|CCRIS 313|N-(2-Piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide|Flecainidum|Flecaine	flecainide|tambocor|auro-fleca	DRUGBANK	DB01195	C17H20F6N2O3	small molecule	C01BC04	54143-55-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DJBNUMBKLMJRSA-UHFFFAOYSA-N
14701	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Priori SG (2000)	10961955	180562	1183	Flecainide	(+-)-Flecainide|Flecainida|CCRIS 313|N-(2-Piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide|Flecainidum|Flecaine	flecainide|tambocor|auro-fleca	DRUGBANK	DB01195	C17H20F6N2O3	small molecule	C01BC04	54143-55-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DJBNUMBKLMJRSA-UHFFFAOYSA-N
14702	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Benhorin J (2000)	10758053	180563	1183	Flecainide	(+-)-Flecainide|Flecainida|CCRIS 313|N-(2-Piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide|Flecainidum|Flecaine	flecainide|tambocor|auro-fleca	DRUGBANK	DB01195	C17H20F6N2O3	small molecule	C01BC04	54143-55-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DJBNUMBKLMJRSA-UHFFFAOYSA-N
14703	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Cerrone M (2001)	11307783	180560	1183	Flecainide	(+-)-Flecainide|Flecainida|CCRIS 313|N-(2-Piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide|Flecainidum|Flecaine	flecainide|tambocor|auro-fleca	DRUGBANK	DB01195	C17H20F6N2O3	small molecule	C01BC04	54143-55-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DJBNUMBKLMJRSA-UHFFFAOYSA-N
14704	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Nagatomo T (2000)	10617684	180561	1183	Flecainide	(+-)-Flecainide|Flecainida|CCRIS 313|N-(2-Piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide|Flecainidum|Flecaine	flecainide|tambocor|auro-fleca	DRUGBANK	DB01195	C17H20F6N2O3	small molecule	C01BC04	54143-55-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DJBNUMBKLMJRSA-UHFFFAOYSA-N
14705	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1183	Flecainide	(+-)-Flecainide|Flecainida|CCRIS 313|N-(2-Piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide|Flecainidum|Flecaine	flecainide|tambocor|auro-fleca	DRUGBANK	DB01195	C17H20F6N2O3	small molecule	C01BC04	54143-55-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DJBNUMBKLMJRSA-UHFFFAOYSA-N
14706	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Viswanathan PC (2001)	11535580	180564	1183	Flecainide	(+-)-Flecainide|Flecainida|CCRIS 313|N-(2-Piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide|Flecainidum|Flecaine	flecainide|tambocor|auro-fleca	DRUGBANK	DB01195	C17H20F6N2O3	small molecule	C01BC04	54143-55-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DJBNUMBKLMJRSA-UHFFFAOYSA-N
14707	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Ramos E (2004)	15272045	180565	1183	Flecainide	(+-)-Flecainide|Flecainida|CCRIS 313|N-(2-Piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide|Flecainidum|Flecaine	flecainide|tambocor|auro-fleca	DRUGBANK	DB01195	C17H20F6N2O3	small molecule	C01BC04	54143-55-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DJBNUMBKLMJRSA-UHFFFAOYSA-N
14784	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	1188	Bromocriptine	2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine	syn-bromocriptine cap 5mg|co b	DRUGBANK	DB01200	C32H40BrN5O5	small molecule	G02CB01|N04BC01	25614-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZVBMTJYIDMWIL-AYFBDAFISA-N
14785	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	1188	Bromocriptine	2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine	syn-bromocriptine cap 5mg|co b	DRUGBANK	DB01200	C32H40BrN5O5	small molecule	G02CB01|N04BC01	25614-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZVBMTJYIDMWIL-AYFBDAFISA-N
14802	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	1188	Bromocriptine	2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine	syn-bromocriptine cap 5mg|co b	DRUGBANK	DB01200	C32H40BrN5O5	small molecule	G02CB01|N04BC01	25614-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZVBMTJYIDMWIL-AYFBDAFISA-N
15012	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	antagonist	target	Martin LL (1982)	6460944	180704	1209	Ketamine	KETAMINE|Special k|2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone|Ketaminum|(+-)-Ketamine|2-(methylamino)-2-(2-chlorophenyl)cyclohexanone|NMDA|()-ketamine|2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone|Ketamina|DL-ketamine	ketamine hydrochloride injecti	DRUGBANK	DB01221	C13H16ClNO	small molecule	N01AX03	6740-88-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQEZLKZALYSWHR-UHFFFAOYSA-N
15030	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15033	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	unknown	target	Nasrallah HA (2008)	17848919	174616	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15108	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	1216	Encainide	(+-)-4-Methoxy-N-(2-(2-(1-methyl-2-piperidinyl)ethyl)phenyl)benzamide|Encainide|Encainida|(+-)-2'-[2-(1-Methyl-2-piperidyl)ethyl]-P-anisanilide|4-Methoxy-N-{2-[2-(1-methyl-piperidin-2-yl)-ethyl]-phenyl}-benzamide|Encainidum|4-Methoxy-2'-[2-(1-methyl-2-piperidyl)ethyl]benzanilide	-	DRUGBANK	DB01228	C22H28N2O2	small molecule	C01BC08	66778-36-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PJWPNDMDCLXCOM-UHFFFAOYSA-N
15109	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Guo J (2006)	16751287	180732	1216	Encainide	(+-)-4-Methoxy-N-(2-(2-(1-methyl-2-piperidinyl)ethyl)phenyl)benzamide|Encainide|Encainida|(+-)-2'-[2-(1-Methyl-2-piperidyl)ethyl]-P-anisanilide|4-Methoxy-N-{2-[2-(1-methyl-piperidin-2-yl)-ethyl]-phenyl}-benzamide|Encainidum|4-Methoxy-2'-[2-(1-methyl-2-piperidyl)ethyl]benzanilide	-	DRUGBANK	DB01228	C22H28N2O2	small molecule	C01BC08	66778-36-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PJWPNDMDCLXCOM-UHFFFAOYSA-N
15110	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Starmer CF (1991)	1653123	180731	1216	Encainide	(+-)-4-Methoxy-N-(2-(2-(1-methyl-2-piperidinyl)ethyl)phenyl)benzamide|Encainide|Encainida|(+-)-2'-[2-(1-Methyl-2-piperidyl)ethyl]-P-anisanilide|4-Methoxy-N-{2-[2-(1-methyl-piperidin-2-yl)-ethyl]-phenyl}-benzamide|Encainidum|4-Methoxy-2'-[2-(1-methyl-2-piperidyl)ethyl]benzanilide	-	DRUGBANK	DB01228	C22H28N2O2	small molecule	C01BC08	66778-36-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PJWPNDMDCLXCOM-UHFFFAOYSA-N
15111	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Krishnan SC (1998)	9835260	180730	1216	Encainide	(+-)-4-Methoxy-N-(2-(2-(1-methyl-2-piperidinyl)ethyl)phenyl)benzamide|Encainide|Encainida|(+-)-2'-[2-(1-Methyl-2-piperidyl)ethyl]-P-anisanilide|4-Methoxy-N-{2-[2-(1-methyl-piperidin-2-yl)-ethyl]-phenyl}-benzamide|Encainidum|4-Methoxy-2'-[2-(1-methyl-2-piperidyl)ethyl]benzanilide	-	DRUGBANK	DB01228	C22H28N2O2	small molecule	C01BC08	66778-36-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PJWPNDMDCLXCOM-UHFFFAOYSA-N
15112	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1216	Encainide	(+-)-4-Methoxy-N-(2-(2-(1-methyl-2-piperidinyl)ethyl)phenyl)benzamide|Encainide|Encainida|(+-)-2'-[2-(1-Methyl-2-piperidyl)ethyl]-P-anisanilide|4-Methoxy-N-{2-[2-(1-methyl-piperidin-2-yl)-ethyl]-phenyl}-benzamide|Encainidum|4-Methoxy-2'-[2-(1-methyl-2-piperidyl)ethyl]benzanilide	-	DRUGBANK	DB01228	C22H28N2O2	small molecule	C01BC08	66778-36-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PJWPNDMDCLXCOM-UHFFFAOYSA-N
15182	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Koller WC (1998)	9633680	180775	1223	Levodopa	3-Hydroxy-L-tyrosine|(-)-3-(3,4-Dihydroxyphenyl)-L-alanine|L-beta-(3,4-Dihydroxyphenyl)alanine|3,4-Dihydroxy-L-phenylalanine|Dopar|()-3-(3,4-dihydroxyphenyl)-L-alanine|Dihydroxy-L-phenylalanine|(-)-Dopa|Levodopum|Levodopa|L-3,4-dihydroxyphenylalanine|3,4-DIHYDROXYPHENYLALANINE|L-DOPA|beta-(3,4-Dihydroxyphenyl)alanine|-(3,4-dihydroxyphenyl)alanine|beta-(3,4-Dihydroxyphenyl)-L-alanine|()-dopa	sinemet 100/25|sinemet 250/25|	DRUGBANK	DB01235	C9H11NO4	small molecule	N04BA02|N04BA03|N04BA01	59-92-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WTDRDQBEARUVNC-LURJTMIESA-N
15183	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Deleu D (2002)	11978145	179837	1223	Levodopa	3-Hydroxy-L-tyrosine|(-)-3-(3,4-Dihydroxyphenyl)-L-alanine|L-beta-(3,4-Dihydroxyphenyl)alanine|3,4-Dihydroxy-L-phenylalanine|Dopar|()-3-(3,4-dihydroxyphenyl)-L-alanine|Dihydroxy-L-phenylalanine|(-)-Dopa|Levodopum|Levodopa|L-3,4-dihydroxyphenylalanine|3,4-DIHYDROXYPHENYLALANINE|L-DOPA|beta-(3,4-Dihydroxyphenyl)alanine|-(3,4-dihydroxyphenyl)alanine|beta-(3,4-Dihydroxyphenyl)-L-alanine|()-dopa	sinemet 100/25|sinemet 250/25|	DRUGBANK	DB01235	C9H11NO4	small molecule	N04BA02|N04BA03|N04BA01	59-92-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WTDRDQBEARUVNC-LURJTMIESA-N
15184	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Onofrj M (2008)	18549347	180774	1223	Levodopa	3-Hydroxy-L-tyrosine|(-)-3-(3,4-Dihydroxyphenyl)-L-alanine|L-beta-(3,4-Dihydroxyphenyl)alanine|3,4-Dihydroxy-L-phenylalanine|Dopar|()-3-(3,4-dihydroxyphenyl)-L-alanine|Dihydroxy-L-phenylalanine|(-)-Dopa|Levodopum|Levodopa|L-3,4-dihydroxyphenylalanine|3,4-DIHYDROXYPHENYLALANINE|L-DOPA|beta-(3,4-Dihydroxyphenyl)alanine|-(3,4-dihydroxyphenyl)alanine|beta-(3,4-Dihydroxyphenyl)-L-alanine|()-dopa	sinemet 100/25|sinemet 250/25|	DRUGBANK	DB01235	C9H11NO4	small molecule	N04BA02|N04BA03|N04BA01	59-92-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WTDRDQBEARUVNC-LURJTMIESA-N
15215	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	partial agonist	target	Nasrallah HA (2008)	17848919	174616	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15216	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15218	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15276	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1227	Chlorprothixene	Chlorprotixene|Chlorprothixine|Alpha-Chlorprothixene|Chlorprotixen|Chlorprothixen|Chlothixen|Chlorprotixine	-	DRUGBANK	DB01239	C18H18ClNS	small molecule	N05AF03	113-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSPOMRSOLSGNFJ-VGOFMYFVSA-N
15277	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1227	Chlorprothixene	Chlorprotixene|Chlorprothixine|Alpha-Chlorprothixene|Chlorprotixen|Chlorprothixen|Chlothixen|Chlorprotixine	-	DRUGBANK	DB01239	C18H18ClNS	small molecule	N05AF03	113-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSPOMRSOLSGNFJ-VGOFMYFVSA-N
15278	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Fux M (1991)	1830565	180792	1227	Chlorprothixene	Chlorprotixene|Chlorprothixine|Alpha-Chlorprothixene|Chlorprotixen|Chlorprothixen|Chlothixen|Chlorprotixine	-	DRUGBANK	DB01239	C18H18ClNS	small molecule	N05AF03	113-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSPOMRSOLSGNFJ-VGOFMYFVSA-N
15363	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Kettler R (1990)	2248058	180832	1235	Isocarboxazid	Isocarboxazide|Isocarboxazidum|Marplan|Isocarboxazida	marplan	DRUGBANK	DB01247	C12H13N3O2	small molecule	N06AF01	59-63-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKFPYPQQHFEXRZ-UHFFFAOYSA-N
15364	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Thase ME (1995)	7612154	180834	1235	Isocarboxazid	Isocarboxazide|Isocarboxazidum|Marplan|Isocarboxazida	marplan	DRUGBANK	DB01247	C12H13N3O2	small molecule	N06AF01	59-63-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKFPYPQQHFEXRZ-UHFFFAOYSA-N
15365	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1235	Isocarboxazid	Isocarboxazide|Isocarboxazidum|Marplan|Isocarboxazida	marplan	DRUGBANK	DB01247	C12H13N3O2	small molecule	N06AF01	59-63-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKFPYPQQHFEXRZ-UHFFFAOYSA-N
15430	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	multitarget	target	Chen X (2002)	11752352	171740	1242	Dasatinib	Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum|BDBM13216	sprycel	DRUGBANK	DB01254	C22H26ClN7O2S	small molecule	L01XE06	302962-49-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBNZXTGUTAYRHI-UHFFFAOYSA-N
15431	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	multitarget	target	Lindauer M (2010)	20072833	180857	1242	Dasatinib	Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum|BDBM13216	sprycel	DRUGBANK	DB01254	C22H26ClN7O2S	small molecule	L01XE06	302962-49-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBNZXTGUTAYRHI-UHFFFAOYSA-N
15432	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	multitarget	target	Das J (2006)	17154512	180872	1242	Dasatinib	Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum|BDBM13216	sprycel	DRUGBANK	DB01254	C22H26ClN7O2S	small molecule	L01XE06	302962-49-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBNZXTGUTAYRHI-UHFFFAOYSA-N
15558	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Leysen JE (1994)	7520908	175510	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15559	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Megens AA (1994)	7531353	178096	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15621	110251	4074	-	M6PR	CD-MPR|MPR 46|MPR-46|MPR46|SMPR	9606	Homo sapiens	binder	target	Chavez CA (2007)	17927214	173188	1259	Alglucosidase alfa	Aglucosidase alfa|Aglucosidase alpha|Acid-alpha glucosidase|alpha-1,4-glucosidase|Acid maltase|Lysosomal Alpha-Glucosidase|Alpha-glucosidase	lumizyme|myozyme	DRUGBANK	DB01272	C4435H6739N1175O1279S32	biologic	A16AB07	420784-05-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15731	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Kalbag J (2004)	15177307	181038	1270	Lumiracoxib	COX189|Lumiracoxibum|2-((2-chloro-6-Fluorophenyl)amino)-5-methylbenzeneacetic acid|COX 189|Prexige|COX-189	-	DRUGBANK	DB01283	C15H13ClFNO2	small molecule	M01AH06	220991-20-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KHPKQFYUPIUARC-UHFFFAOYSA-N
15732	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Tacconelli S (2004)	14965322	181037	1270	Lumiracoxib	COX189|Lumiracoxibum|2-((2-chloro-6-Fluorophenyl)amino)-5-methylbenzeneacetic acid|COX 189|Prexige|COX-189	-	DRUGBANK	DB01283	C15H13ClFNO2	small molecule	M01AH06	220991-20-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KHPKQFYUPIUARC-UHFFFAOYSA-N
15733	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Atherton C (2004)	15017615	181036	1270	Lumiracoxib	COX189|Lumiracoxibum|2-((2-chloro-6-Fluorophenyl)amino)-5-methylbenzeneacetic acid|COX 189|Prexige|COX-189	-	DRUGBANK	DB01283	C15H13ClFNO2	small molecule	M01AH06	220991-20-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KHPKQFYUPIUARC-UHFFFAOYSA-N
15734	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Esser R (2005)	15655513	181035	1270	Lumiracoxib	COX189|Lumiracoxibum|2-((2-chloro-6-Fluorophenyl)amino)-5-methylbenzeneacetic acid|COX 189|Prexige|COX-189	-	DRUGBANK	DB01283	C15H13ClFNO2	small molecule	M01AH06	220991-20-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KHPKQFYUPIUARC-UHFFFAOYSA-N
15735	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Capone ML (2003)	14552704	181033	1270	Lumiracoxib	COX189|Lumiracoxibum|2-((2-chloro-6-Fluorophenyl)amino)-5-methylbenzeneacetic acid|COX 189|Prexige|COX-189	-	DRUGBANK	DB01283	C15H13ClFNO2	small molecule	M01AH06	220991-20-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KHPKQFYUPIUARC-UHFFFAOYSA-N
15736	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1270	Lumiracoxib	COX189|Lumiracoxibum|2-((2-chloro-6-Fluorophenyl)amino)-5-methylbenzeneacetic acid|COX 189|Prexige|COX-189	-	DRUGBANK	DB01283	C15H13ClFNO2	small molecule	M01AH06	220991-20-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KHPKQFYUPIUARC-UHFFFAOYSA-N
15828	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Lenkowski PW (2004)	15066664	176695	1288	Fosphenytoin	Fosphenytoin|Cerebyx|Fosphenytoine|Fosphenytoinum|Fosfenitoina|(3-Phosphoryloxymethyl)phenytoin	fosphenytoin|cerebyx|fosphenyt	DRUGBANK	DB01320	C16H15N2O6P	small molecule	N03AB05	93390-81-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XWLUWCNOOVRFPX-UHFFFAOYSA-N
15829	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Mantegazza M (2010)	20298965	174680	1288	Fosphenytoin	Fosphenytoin|Cerebyx|Fosphenytoine|Fosphenytoinum|Fosfenitoina|(3-Phosphoryloxymethyl)phenytoin	fosphenytoin|cerebyx|fosphenyt	DRUGBANK	DB01320	C16H15N2O6P	small molecule	N03AB05	93390-81-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XWLUWCNOOVRFPX-UHFFFAOYSA-N
15830	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1288	Fosphenytoin	Fosphenytoin|Cerebyx|Fosphenytoine|Fosphenytoinum|Fosfenitoina|(3-Phosphoryloxymethyl)phenytoin	fosphenytoin|cerebyx|fosphenyt	DRUGBANK	DB01320	C16H15N2O6P	small molecule	N03AB05	93390-81-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XWLUWCNOOVRFPX-UHFFFAOYSA-N
15831	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Swadron SP (2004)	15001403	174682	1288	Fosphenytoin	Fosphenytoin|Cerebyx|Fosphenytoine|Fosphenytoinum|Fosfenitoina|(3-Phosphoryloxymethyl)phenytoin	fosphenytoin|cerebyx|fosphenyt	DRUGBANK	DB01320	C16H15N2O6P	small molecule	N03AB05	93390-81-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XWLUWCNOOVRFPX-UHFFFAOYSA-N
15945	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Itoh H (2005)	15877619	179012	1311	Quinidine barbiturate	-	-	DRUGBANK	DB01346	C32H36N4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHRUERMOPBDCFD-UHFFFAOYSA-N
15946	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Stokoe KS (2007)	17023504	179013	1311	Quinidine barbiturate	-	-	DRUGBANK	DB01346	C32H36N4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHRUERMOPBDCFD-UHFFFAOYSA-N
15947	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Grant AO (2005)	16138883	179016	1311	Quinidine barbiturate	-	-	DRUGBANK	DB01346	C32H36N4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHRUERMOPBDCFD-UHFFFAOYSA-N
15948	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Ohgo T (2007)	17556186	179014	1311	Quinidine barbiturate	-	-	DRUGBANK	DB01346	C32H36N4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHRUERMOPBDCFD-UHFFFAOYSA-N
15949	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Napolitano C (2006)	16972995	179015	1311	Quinidine barbiturate	-	-	DRUGBANK	DB01346	C32H36N4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHRUERMOPBDCFD-UHFFFAOYSA-N
15950	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1311	Quinidine barbiturate	-	-	DRUGBANK	DB01346	C32H36N4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHRUERMOPBDCFD-UHFFFAOYSA-N
15951	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Tella SR (1998)	9476974	177548	1311	Quinidine barbiturate	-	-	DRUGBANK	DB01346	C32H36N4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHRUERMOPBDCFD-UHFFFAOYSA-N
15952	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Sheets MF (2010)	20685573	175038	1311	Quinidine barbiturate	-	-	DRUGBANK	DB01346	C32H36N4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHRUERMOPBDCFD-UHFFFAOYSA-N
16126	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	antagonist	target	Hjorth S (1993)	8098761	181159	1322	Penbutolol	Levatol|HOE 893|Penbutololum|HOE 893D|1-(tert-Butylamino)-3-(o-cyclopentylphenoxy)propan-2-ol|2-Propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-, (S)-|(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol|Penbutolol	-	DRUGBANK	DB01359	C18H29NO2	small molecule	C07AA23|C07CA23	38363-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQXKVJAGOJTNJS-HNNXBMFYSA-N
16139	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Ulus IH (2000)	10799660	174228	1325	Ephedra	Chinese jointfir|Ma huang|Indian jointfir	stacker 2 nasal decongestant|e	DRUGBANK	DB01363	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16140	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Sulzer D (2005)	15955613	174152	1325	Ephedra	Chinese jointfir|Ma huang|Indian jointfir	stacker 2 nasal decongestant|e	DRUGBANK	DB01363	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16352	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	antagonist	target	Millan MJ (2000)	10611634	181251	1342	Yohimbine	(+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester	yohimbine hydrochloride tablet	DRUGBANK	DB01392	C21H26N2O3	small molecule	G04BE04	146-48-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLGXFZZNTVWLAY-SCYLSFHTSA-N
16353	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	antagonist	target	Kaumann AJ (1983)	6136920	181260	1342	Yohimbine	(+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester	yohimbine hydrochloride tablet	DRUGBANK	DB01392	C21H26N2O3	small molecule	G04BE04	146-48-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLGXFZZNTVWLAY-SCYLSFHTSA-N
16414	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Graham GG (2004)	15035793	179201	1347	Magnesium salicylate	Magnesium salicylate anhydrous	diurex water pills|herbogesic|	DRUGBANK	DB01397	C14H10MgO6	small molecule	-	18917-89-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MQHWFIOJQSCFNM-UHFFFAOYSA-L
16415	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Elvira C (2001)	15348270	179208	1347	Magnesium salicylate	Magnesium salicylate anhydrous	diurex water pills|herbogesic|	DRUGBANK	DB01397	C14H10MgO6	small molecule	-	18917-89-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MQHWFIOJQSCFNM-UHFFFAOYSA-L
16416	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chae HJ (2004)	15106733	179207	1347	Magnesium salicylate	Magnesium salicylate anhydrous	diurex water pills|herbogesic|	DRUGBANK	DB01397	C14H10MgO6	small molecule	-	18917-89-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MQHWFIOJQSCFNM-UHFFFAOYSA-L
16417	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Fiebich BL (2004)	15070163	179206	1347	Magnesium salicylate	Magnesium salicylate anhydrous	diurex water pills|herbogesic|	DRUGBANK	DB01397	C14H10MgO6	small molecule	-	18917-89-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MQHWFIOJQSCFNM-UHFFFAOYSA-L
16418	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Wu KK (2003)	15199473	179209	1347	Magnesium salicylate	Magnesium salicylate anhydrous	diurex water pills|herbogesic|	DRUGBANK	DB01397	C14H10MgO6	small molecule	-	18917-89-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MQHWFIOJQSCFNM-UHFFFAOYSA-L
16435	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Schaefer MG (2003)	12901032	181297	1349	Salsalate	Sasapyrin|Disalicylsaeure|Sasapyrinum|2-Carboxyphenyl salicylate|Salsalato|salicylsalicylic acid|Salicyloxysalicylic acid|O-Salicylsalicylic acid|Salsalatum|O-Salicylcylsalicylsaeure|Disalicylic acid|Sasapyrine|Salicylic acid bimolecular ester|Disalcid|Salicyloylsalicylic acid	salsalate|disalcid tab 750mg|d	DRUGBANK	DB01399	C14H10O5	small molecule	N02BA06	552-94-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WVYADZUPLLSGPU-UHFFFAOYSA-N
16436	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Motsko SP (2006)	16808554	181296	1349	Salsalate	Sasapyrin|Disalicylsaeure|Sasapyrinum|2-Carboxyphenyl salicylate|Salsalato|salicylsalicylic acid|Salicyloxysalicylic acid|O-Salicylsalicylic acid|Salsalatum|O-Salicylcylsalicylsaeure|Disalicylic acid|Sasapyrine|Salicylic acid bimolecular ester|Disalcid|Salicyloylsalicylic acid	salsalate|disalcid tab 750mg|d	DRUGBANK	DB01399	C14H10O5	small molecule	N02BA06	552-94-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WVYADZUPLLSGPU-UHFFFAOYSA-N
16437	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Stichtenoth DO (1998)	9711054	181295	1349	Salsalate	Sasapyrin|Disalicylsaeure|Sasapyrinum|2-Carboxyphenyl salicylate|Salsalato|salicylsalicylic acid|Salicyloxysalicylic acid|O-Salicylsalicylic acid|Salsalatum|O-Salicylcylsalicylsaeure|Disalicylic acid|Sasapyrine|Salicylic acid bimolecular ester|Disalcid|Salicyloylsalicylic acid	salsalate|disalcid tab 750mg|d	DRUGBANK	DB01399	C14H10O5	small molecule	N02BA06	552-94-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WVYADZUPLLSGPU-UHFFFAOYSA-N
16438	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Josephs MD (1999)	10452868	181294	1349	Salsalate	Sasapyrin|Disalicylsaeure|Sasapyrinum|2-Carboxyphenyl salicylate|Salsalato|salicylsalicylic acid|Salicyloxysalicylic acid|O-Salicylsalicylic acid|Salsalatum|O-Salicylcylsalicylsaeure|Disalicylic acid|Sasapyrine|Salicylic acid bimolecular ester|Disalcid|Salicyloylsalicylic acid	salsalate|disalcid tab 750mg|d	DRUGBANK	DB01399	C14H10O5	small molecule	N02BA06	552-94-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WVYADZUPLLSGPU-UHFFFAOYSA-N
16449	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Simon RA (2004)	14680616	181305	1351	Trisalicylate-choline	Tricosal	-	DRUGBANK	DB01401	C26H29MgNO10	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQCQGOZEWWPOKI-UHFFFAOYSA-K
16450	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Shen J (2006)	17181859	179252	1351	Trisalicylate-choline	Tricosal	-	DRUGBANK	DB01401	C26H29MgNO10	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQCQGOZEWWPOKI-UHFFFAOYSA-K
16451	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Nakano M (2007)	17258197	179253	1351	Trisalicylate-choline	Tricosal	-	DRUGBANK	DB01401	C26H29MgNO10	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQCQGOZEWWPOKI-UHFFFAOYSA-K
16452	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Wang HJ (2006)	17037745	179254	1351	Trisalicylate-choline	Tricosal	-	DRUGBANK	DB01401	C26H29MgNO10	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQCQGOZEWWPOKI-UHFFFAOYSA-K
16453	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Brzozowski T (2006)	17033106	179256	1351	Trisalicylate-choline	Tricosal	-	DRUGBANK	DB01401	C26H29MgNO10	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQCQGOZEWWPOKI-UHFFFAOYSA-K
16471	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Green B (2004)	15701205	181306	1352	Methotrimeprazine	(-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum	riva-meprazine 5mg tablets|riv	DRUGBANK	DB01403	C19H24N2OS	small molecule	N05AA02	60-99-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRQVVMDWGGWHTJ-CQSZACIVSA-N
16492	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Kim SJ (2007)	17436372	181309	1353	Ginseng	-	ginsana cap 100mg|siberian gin	DRUGBANK	DB01404	-	small molecule	-	50647-08-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16493	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Yim HW (2005)	15753395	181312	1353	Ginseng	-	ginsana cap 100mg|siberian gin	DRUGBANK	DB01404	-	small molecule	-	50647-08-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16494	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Seo JY (2005)	15778128	181313	1353	Ginseng	-	ginsana cap 100mg|siberian gin	DRUGBANK	DB01404	-	small molecule	-	50647-08-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16575	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Essayan DM (2001)	11692087	174342	1361	Theobromine	Theobromine|Theobromin|3,7-dihydro-3,7-Dimethyl-1H-purine-2,6-dione|3,7-Dimethylxanthine|3,7-Dimethylpurine-2,6-dione	-	DRUGBANK	DB01412	C7H8N4O2	small molecule	C03BD01|R03DA57|R03DA07	83-67-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YAPQBXQYLJRXSA-UHFFFAOYSA-N
16576	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Daly JW (2007)	17514358	174335	1361	Theobromine	Theobromine|Theobromin|3,7-dihydro-3,7-Dimethyl-1H-purine-2,6-dione|3,7-Dimethylxanthine|3,7-Dimethylpurine-2,6-dione	-	DRUGBANK	DB01412	C7H8N4O2	small molecule	C03BD01|R03DA57|R03DA07	83-67-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YAPQBXQYLJRXSA-UHFFFAOYSA-N
16577	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Fisone G (2004)	15095008	181372	1361	Theobromine	Theobromine|Theobromin|3,7-dihydro-3,7-Dimethyl-1H-purine-2,6-dione|3,7-Dimethylxanthine|3,7-Dimethylpurine-2,6-dione	-	DRUGBANK	DB01412	C7H8N4O2	small molecule	C03BD01|R03DA57|R03DA07	83-67-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YAPQBXQYLJRXSA-UHFFFAOYSA-N
16578	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Deree J (2008)	18568240	181373	1361	Theobromine	Theobromine|Theobromin|3,7-dihydro-3,7-Dimethyl-1H-purine-2,6-dione|3,7-Dimethylxanthine|3,7-Dimethylpurine-2,6-dione	-	DRUGBANK	DB01412	C7H8N4O2	small molecule	C03BD01|R03DA57|R03DA07	83-67-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YAPQBXQYLJRXSA-UHFFFAOYSA-N
16614	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Dhir A (2007)	17604186	178398	1367	Antrafenine	-	-	DRUGBANK	DB01419	C30H26F6N4O2	small molecule	-	55300-29-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NWGGKKGAFZIVBJ-UHFFFAOYSA-N
16615	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	White WB (2007)	17612049	178399	1367	Antrafenine	-	-	DRUGBANK	DB01419	C30H26F6N4O2	small molecule	-	55300-29-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NWGGKKGAFZIVBJ-UHFFFAOYSA-N
16616	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1367	Antrafenine	-	-	DRUGBANK	DB01419	C30H26F6N4O2	small molecule	-	55300-29-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NWGGKKGAFZIVBJ-UHFFFAOYSA-N
16617	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Hassan-Alin M (2007)	17532719	178402	1367	Antrafenine	-	-	DRUGBANK	DB01419	C30H26F6N4O2	small molecule	-	55300-29-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NWGGKKGAFZIVBJ-UHFFFAOYSA-N
16618	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Kumar P (2007)	17521299	178400	1367	Antrafenine	-	-	DRUGBANK	DB01419	C30H26F6N4O2	small molecule	-	55300-29-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NWGGKKGAFZIVBJ-UHFFFAOYSA-N
16619	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Albertini R (2007)	17607546	178401	1367	Antrafenine	-	-	DRUGBANK	DB01419	C30H26F6N4O2	small molecule	-	55300-29-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NWGGKKGAFZIVBJ-UHFFFAOYSA-N
16631	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Hoogendijk MG (2009)	20022821	181394	1374	Ajmaline	(5AR,6S,8S,10S,11S,11as,12ar,13R)-5-methyl-5a,6,8,9,10,11,11a,12-octahydro-5H-6,10:11,12a-dimethanoindolo[3,2-b]quinolizine-8,13-diol|Ajmalin|(+)-Ajmaline	-	DRUGBANK	DB01426	C20H26N2O2	small molecule	C01BA05	4360-12-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJDRUOGAGYHKKD-HEFSZTOGSA-N
16632	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Khodorov BI (1983)	6088360	181395	1374	Ajmaline	(5AR,6S,8S,10S,11S,11as,12ar,13R)-5-methyl-5a,6,8,9,10,11,11a,12-octahydro-5H-6,10:11,12a-dimethanoindolo[3,2-b]quinolizine-8,13-diol|Ajmalin|(+)-Ajmaline	-	DRUGBANK	DB01426	C20H26N2O2	small molecule	C01BA05	4360-12-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJDRUOGAGYHKKD-HEFSZTOGSA-N
16633	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Barajas-Martinez HM (2008)	18599870	181392	1374	Ajmaline	(5AR,6S,8S,10S,11S,11as,12ar,13R)-5-methyl-5a,6,8,9,10,11,11a,12-octahydro-5H-6,10:11,12a-dimethanoindolo[3,2-b]quinolizine-8,13-diol|Ajmalin|(+)-Ajmaline	-	DRUGBANK	DB01426	C20H26N2O2	small molecule	C01BA05	4360-12-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJDRUOGAGYHKKD-HEFSZTOGSA-N
16634	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Hermida JS (2010)	21126620	181393	1374	Ajmaline	(5AR,6S,8S,10S,11S,11as,12ar,13R)-5-methyl-5a,6,8,9,10,11,11a,12-octahydro-5H-6,10:11,12a-dimethanoindolo[3,2-b]quinolizine-8,13-diol|Ajmalin|(+)-Ajmaline	-	DRUGBANK	DB01426	C20H26N2O2	small molecule	C01BA05	4360-12-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJDRUOGAGYHKKD-HEFSZTOGSA-N
16635	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Leoni AL (2010)	20174578	181390	1374	Ajmaline	(5AR,6S,8S,10S,11S,11as,12ar,13R)-5-methyl-5a,6,8,9,10,11,11a,12-octahydro-5H-6,10:11,12a-dimethanoindolo[3,2-b]quinolizine-8,13-diol|Ajmalin|(+)-Ajmaline	-	DRUGBANK	DB01426	C20H26N2O2	small molecule	C01BA05	4360-12-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJDRUOGAGYHKKD-HEFSZTOGSA-N
16636	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Hoogendijk MG (2011)	20870038	181391	1374	Ajmaline	(5AR,6S,8S,10S,11S,11as,12ar,13R)-5-methyl-5a,6,8,9,10,11,11a,12-octahydro-5H-6,10:11,12a-dimethanoindolo[3,2-b]quinolizine-8,13-diol|Ajmalin|(+)-Ajmaline	-	DRUGBANK	DB01426	C20H26N2O2	small molecule	C01BA05	4360-12-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJDRUOGAGYHKKD-HEFSZTOGSA-N
16637	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	1375	Amrinone	Inamrinone|Amrinonum|Amcoral|Amrinona	inocor  liq 5mg/ml	DRUGBANK	DB01427	C10H9N3O	small molecule	C01CE01	60719-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RNLQIBCLLYYYFJ-UHFFFAOYSA-N
16638	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	1375	Amrinone	Inamrinone|Amrinonum|Amcoral|Amrinona	inocor  liq 5mg/ml	DRUGBANK	DB01427	C10H9N3O	small molecule	C01CE01	60719-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RNLQIBCLLYYYFJ-UHFFFAOYSA-N
16649	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Sato R (1991)	1660104	181404	1377	Aprindine	Aprindine|Compound 99170|Aprindina|Aprindinum	-	DRUGBANK	DB01429	C22H30N2	small molecule	C01BB04	37640-71-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NZLBHDRPUJLHCE-UHFFFAOYSA-N
16650	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Kamiya K (1991)	1653644	181405	1377	Aprindine	Aprindine|Compound 99170|Aprindina|Aprindinum	-	DRUGBANK	DB01429	C22H30N2	small molecule	C01BB04	37640-71-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NZLBHDRPUJLHCE-UHFFFAOYSA-N
16673	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Brune K (2001)	11695253	181415	1383	Antipyrine	1,2-Dihydro-1,5-dimethyl-2-phenyl-3H-pyrazol-3-one|Phenazone|Fenazon|2,3-Dimethyl-1-phenyl-5-pyrazolone|Fenazona|Antipyrine|Analgesine|Phenazon	auralgan eardrops|antipyrine a	DRUGBANK	DB01435	C11H12N2O	small molecule	S02DA03|N02BB51|N02BB71|N02BB01	60-80-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VEQOALNAAJBPNY-UHFFFAOYSA-N
16702	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Sulzer D (2005)	15955613	174152	1390	MMDA	3-Methoxy-4,5-methylenedioxyphenylisopropylamine|5-Methoxy-3,4-methylenedioxyamphetamine|3-Methoxy-alpha-methyl-4,5-methylenedioxyphenethylamine|Amphetamine, 3,4-methylenedioxy-5-methoxy|(+-)-mmda|3-METHOXY-METHYLENEDIOXYAMPHETAMINE	-	DRUGBANK	DB01442	C11H15NO3	small molecule	-	13674-05-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQYUWUKDEVZFDB-UHFFFAOYSA-N
16766	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Green AL (1980)	6103055	181444	1418	4-Methoxyamphetamine	Paramethoxyamphetamine|(2RS)-1-(4-methoxyphenyl)propan-2-amine|P-methoxyamfetamine|P-methoxyamphetamine|4-methoxyamfetamine|Formoterol fumarate related compound G|D,L-p-methoxyamphetamine	-	DRUGBANK	DB01472	C10H15NO	small molecule	-	64-13-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NEGYEDYHPHMHGK-UHFFFAOYSA-N
16767	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Ask AL (1983)	6646243	181443	1418	4-Methoxyamphetamine	Paramethoxyamphetamine|(2RS)-1-(4-methoxyphenyl)propan-2-amine|P-methoxyamfetamine|P-methoxyamphetamine|4-methoxyamfetamine|Formoterol fumarate related compound G|D,L-p-methoxyamphetamine	-	DRUGBANK	DB01472	C10H15NO	small molecule	-	64-13-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NEGYEDYHPHMHGK-UHFFFAOYSA-N
16811	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	unknown	target	Su TP (2009)	19278957	181451	1434	Dimethyltryptamine	-	-	DRUGBANK	DB01488	C12H16N2	small molecule	-	61-50-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DMULVCHRPCFFGV-UHFFFAOYSA-N
17052	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Ulus IH (2000)	10799660	174228	1517	Methamphetamine	d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine	desoxyn|methamphetamine hydroc	DRUGBANK	DB01577	C10H15N	small molecule	N06BA03	537-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MYWUZJCMWCOHBA-VIFPVBQESA-N
17053	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Sulzer D (2005)	15955613	174152	1517	Methamphetamine	d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine	desoxyn|methamphetamine hydroc	DRUGBANK	DB01577	C10H15N	small molecule	N06BA03	537-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MYWUZJCMWCOHBA-VIFPVBQESA-N
17311	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Brandt KD (1990)	2277128	181583	1538	Tiaprofenic acid	Tiaprofensaeure|Tiaprofensure|Acide tiaprofenique|5-Benzoyl-alpha-methyl-2-thiopheneacetic acid|5-Benzoyl-alpha-methylthiophene-2-acetic acid|2-(5-Benzyl-2-thienyl)propionsaeure|alpha-Methyl-5-benzoyl-2-thienylacetic acid|Acido tiaprofenico|Acidum tiaprofenicum|2-(5-Benzoyl-thiophen-2-yl)-propionic acid	surgam|tiaprofenic-200 - tab|a	DRUGBANK	DB01600	C14H12O3S	small molecule	M01AE11	33005-95-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUHPRPJDBZHYCJ-UHFFFAOYSA-N
17312	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	1538	Tiaprofenic acid	Tiaprofensaeure|Tiaprofensure|Acide tiaprofenique|5-Benzoyl-alpha-methyl-2-thiopheneacetic acid|5-Benzoyl-alpha-methylthiophene-2-acetic acid|2-(5-Benzyl-2-thienyl)propionsaeure|alpha-Methyl-5-benzoyl-2-thienylacetic acid|Acido tiaprofenico|Acidum tiaprofenicum|2-(5-Benzoyl-thiophen-2-yl)-propionic acid	surgam|tiaprofenic-200 - tab|a	DRUGBANK	DB01600	C14H12O3S	small molecule	M01AE11	33005-95-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUHPRPJDBZHYCJ-UHFFFAOYSA-N
17313	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1538	Tiaprofenic acid	Tiaprofensaeure|Tiaprofensure|Acide tiaprofenique|5-Benzoyl-alpha-methyl-2-thiopheneacetic acid|5-Benzoyl-alpha-methylthiophene-2-acetic acid|2-(5-Benzyl-2-thienyl)propionsaeure|alpha-Methyl-5-benzoyl-2-thienylacetic acid|Acido tiaprofenico|Acidum tiaprofenicum|2-(5-Benzoyl-thiophen-2-yl)-propionic acid	surgam|tiaprofenic-200 - tab|a	DRUGBANK	DB01600	C14H12O3S	small molecule	M01AE11	33005-95-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUHPRPJDBZHYCJ-UHFFFAOYSA-N
17314	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	1538	Tiaprofenic acid	Tiaprofensaeure|Tiaprofensure|Acide tiaprofenique|5-Benzoyl-alpha-methyl-2-thiopheneacetic acid|5-Benzoyl-alpha-methylthiophene-2-acetic acid|2-(5-Benzyl-2-thienyl)propionsaeure|alpha-Methyl-5-benzoyl-2-thienylacetic acid|Acido tiaprofenico|Acidum tiaprofenicum|2-(5-Benzoyl-thiophen-2-yl)-propionic acid	surgam|tiaprofenic-200 - tab|a	DRUGBANK	DB01600	C14H12O3S	small molecule	M01AE11	33005-95-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUHPRPJDBZHYCJ-UHFFFAOYSA-N
17320	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Kanba S (1994)	7918347	176330	1546	Propericiazine	10-(3-(4-Hydroxypiperidino)propyl)phenothiazine-2-carbonitrile|Cyano-3 ((hydroxy-4 piperidyl-1)-3 propyl)-10 phenothiazine|Periciazinum|Piperocyanomazine|Pericyazine|2-Cyano-10-(3-(4-hydroxypiperidino)propyl)phenothiazine|Propericiazine|Periciazine|2-Cyano-10-(3-(4-hydroxy-1-piperidyl)propyl)phenothiazine|Periciazina	neuleptil 5mg capsules|neulept	DRUGBANK	DB01608	C21H23N3OS	small molecule	N05AC01	2622-26-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUALIOATIOESLM-UHFFFAOYSA-N
17346	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Kanba S (1994)	7918347	176330	1552	Acepromazine	Acetylpromazine|1-[10-(3-DIMETHYLAMINO-propyl)-10H-phenothiazin-2-yl]-ethanone|10-(3-dimethylaminopropyl)phenothiazin-3-yl methyl ketone|Acetazine|Acetopromazine|10-(3-dimethylaminopropyl)phenothiazine-3-ethylone	-	DRUGBANK	DB01614	C19H22N2OS	small molecule	N05AA04	61-00-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOSIYYJFMPDDSA-UHFFFAOYSA-N
17386	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Kanba S (1994)	7918347	176330	1558	Pipotiazine	Pipotiazina|Piportil|Pipothiazine|Pipotiazinum	piportil l4	DRUGBANK	DB01621	C24H33N3O3S2	small molecule	N05AC04	39860-99-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOMHSQGEWSNUKU-UHFFFAOYSA-N
17397	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Kanba S (1994)	7918347	176330	1559	Thioproperazine	Tioproferazina|(Thioproperazine)-2-dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|2-Dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]phenothiazine-2-sulfonamide|Thioproperazin|Thioperazine|Thioproperazinum|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]-10H-phenothiazine-2-sulfonamide|Tioproperazina	majeptil tab 10mg	DRUGBANK	DB01622	C22H30N4O2S2	small molecule	N05AB08	316-81-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VZYCZNZBPPHOFY-UHFFFAOYSA-N
17409	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Kanba S (1994)	7918347	176330	1560	Thiothixene	Tiotixene|(e)-thiothixene|Tiotixeno|Thiothixine|cis-thiothixene|Tiotixenum	navane capsules 10mg|thiothixe	DRUGBANK	DB01623	C23H29N3O2S2	small molecule	N05AF04	3313-26-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFBKORZTTCHDGY-UWVJOHFNSA-N
17410	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Shultz PJ (1987)	3039860	181603	1560	Thiothixene	Tiotixene|(e)-thiothixene|Tiotixeno|Thiothixine|cis-thiothixene|Tiotixenum	navane capsules 10mg|thiothixe	DRUGBANK	DB01623	C23H29N3O2S2	small molecule	N05AF04	3313-26-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFBKORZTTCHDGY-UWVJOHFNSA-N
17413	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Manzaneque JM (1999)	10222441	181604	1561	Zuclopenthixol	Zuclopentixol|Zuclopenthixolum|cis-Clopenthixol	clopixol tablets 25mg|clopixol	DRUGBANK	DB01624	C22H25ClN2OS	small molecule	N05AF05	53772-83-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WFPIAZLQTJBIFN-DVZOWYKESA-N
17414	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Lublin H (1991)	1822319	181605	1561	Zuclopenthixol	Zuclopentixol|Zuclopenthixolum|cis-Clopenthixol	clopixol tablets 25mg|clopixol	DRUGBANK	DB01624	C22H25ClN2OS	small molecule	N05AF05	53772-83-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WFPIAZLQTJBIFN-DVZOWYKESA-N
17443	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Patkar AA (2006)	16641841	179836	1563	Pargyline	Eutonyl|Pargyline|Eutron	-	DRUGBANK	DB01626	C11H13N	small molecule	C02KC01|C02LL01	555-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPWPWRLQFGFJFI-UHFFFAOYSA-N
17444	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Baker GB (2007)	17823646	179831	1563	Pargyline	Eutonyl|Pargyline|Eutron	-	DRUGBANK	DB01626	C11H13N	small molecule	C02KC01|C02LL01	555-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPWPWRLQFGFJFI-UHFFFAOYSA-N
17445	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Lee KC (2007)	19300583	179829	1563	Pargyline	Eutonyl|Pargyline|Eutron	-	DRUGBANK	DB01626	C11H13N	small molecule	C02KC01|C02LL01	555-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPWPWRLQFGFJFI-UHFFFAOYSA-N
17446	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Azzaro AJ (2007)	17715422	179828	1563	Pargyline	Eutonyl|Pargyline|Eutron	-	DRUGBANK	DB01626	C11H13N	small molecule	C02KC01|C02LL01	555-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPWPWRLQFGFJFI-UHFFFAOYSA-N
17447	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Murphy DL (1998)	9564606	181613	1563	Pargyline	Eutonyl|Pargyline|Eutron	-	DRUGBANK	DB01626	C11H13N	small molecule	C02KC01|C02LL01	555-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPWPWRLQFGFJFI-UHFFFAOYSA-N
17448	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Fuentes JA (1979)	477738	181612	1563	Pargyline	Eutonyl|Pargyline|Eutron	-	DRUGBANK	DB01626	C11H13N	small molecule	C02KC01|C02LL01	555-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPWPWRLQFGFJFI-UHFFFAOYSA-N
17449	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	1565	Etoricoxib	5-chloro-6'-Methyl-3-(P-(methylsulfonyl)phenyl)-2,3'-bipyridine|5-chloro-2-(6-Methylpyridin-3-yl)-3-(4-(methylsulfonyl)phenyl)pyridine|Etoricoxibum|5-Chloro-3-(4-methanesulfonyl-phenyl)-6'-methyl-[2,3']bipyridinyl|L791456|ETORICOXIB	-	DRUGBANK	DB01628	C18H15ClN2O2S	small molecule	M01AH05	202409-33-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNJVRJDLRVPLFE-UHFFFAOYSA-N
17450	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1565	Etoricoxib	5-chloro-6'-Methyl-3-(P-(methylsulfonyl)phenyl)-2,3'-bipyridine|5-chloro-2-(6-Methylpyridin-3-yl)-3-(4-(methylsulfonyl)phenyl)pyridine|Etoricoxibum|5-Chloro-3-(4-methanesulfonyl-phenyl)-6'-methyl-[2,3']bipyridinyl|L791456|ETORICOXIB	-	DRUGBANK	DB01628	C18H15ClN2O2S	small molecule	M01AH05	202409-33-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNJVRJDLRVPLFE-UHFFFAOYSA-N
17451	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	1565	Etoricoxib	5-chloro-6'-Methyl-3-(P-(methylsulfonyl)phenyl)-2,3'-bipyridine|5-chloro-2-(6-Methylpyridin-3-yl)-3-(4-(methylsulfonyl)phenyl)pyridine|Etoricoxibum|5-Chloro-3-(4-methanesulfonyl-phenyl)-6'-methyl-[2,3']bipyridinyl|L791456|ETORICOXIB	-	DRUGBANK	DB01628	C18H15ClN2O2S	small molecule	M01AH05	202409-33-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNJVRJDLRVPLFE-UHFFFAOYSA-N
17452	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Yuan Y (2007)	17691997	181616	1565	Etoricoxib	5-chloro-6'-Methyl-3-(P-(methylsulfonyl)phenyl)-2,3'-bipyridine|5-chloro-2-(6-Methylpyridin-3-yl)-3-(4-(methylsulfonyl)phenyl)pyridine|Etoricoxibum|5-Chloro-3-(4-methanesulfonyl-phenyl)-6'-methyl-[2,3']bipyridinyl|L791456|ETORICOXIB	-	DRUGBANK	DB01628	C18H15ClN2O2S	small molecule	M01AH05	202409-33-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNJVRJDLRVPLFE-UHFFFAOYSA-N
17453	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Capone ML (2007)	17164136	181615	1565	Etoricoxib	5-chloro-6'-Methyl-3-(P-(methylsulfonyl)phenyl)-2,3'-bipyridine|5-chloro-2-(6-Methylpyridin-3-yl)-3-(4-(methylsulfonyl)phenyl)pyridine|Etoricoxibum|5-Chloro-3-(4-methanesulfonyl-phenyl)-6'-methyl-[2,3']bipyridinyl|L791456|ETORICOXIB	-	DRUGBANK	DB01628	C18H15ClN2O2S	small molecule	M01AH05	202409-33-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNJVRJDLRVPLFE-UHFFFAOYSA-N
17454	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	FitzGerald GA (2007)	17573128	181614	1565	Etoricoxib	5-chloro-6'-Methyl-3-(P-(methylsulfonyl)phenyl)-2,3'-bipyridine|5-chloro-2-(6-Methylpyridin-3-yl)-3-(4-(methylsulfonyl)phenyl)pyridine|Etoricoxibum|5-Chloro-3-(4-methanesulfonyl-phenyl)-6'-methyl-[2,3']bipyridinyl|L791456|ETORICOXIB	-	DRUGBANK	DB01628	C18H15ClN2O2S	small molecule	M01AH05	202409-33-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNJVRJDLRVPLFE-UHFFFAOYSA-N
17499	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1584	(R)-Mesopram	-	-	DRUGBANK	DB01647	C14H19NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PCCPERGCFKIYIS-AWEZNQCLSA-N
17500	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1584	(R)-Mesopram	-	-	DRUGBANK	DB01647	C14H19NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PCCPERGCFKIYIS-AWEZNQCLSA-N
17501	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1584	(R)-Mesopram	-	-	DRUGBANK	DB01647	C14H19NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PCCPERGCFKIYIS-AWEZNQCLSA-N
17513	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Barone FC (2007)	17726343	181617	1592	Roflumilast	ROF|Daliresp|Roflumilastum	daxas|daliresp	DRUGBANK	DB01656	C17H14Cl2F2N2O3	small molecule	R03DX07	162401-32-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNDBXUUTURYVHR-UHFFFAOYSA-N
17630	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	agonist	target	Waterhouse RN (2007)	17447254	181623	1643	Prasterone	Dehydroandrosterone|3-hydroxyandrost-5-en-17-one|Dehydroepiandrosterone|Dehydroisoandrosterone|5-dehydroepiandrosterone|3beta-hydroxyandrost-5-en-17-one|3-beta-Hydroxy-5-androsten-17-one|5-DHEA|DHEA	prastera	DRUGBANK	DB01708	C19H28O2	small molecule	A14AA07|G03EA03	53-43-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FMGSKLZLMKYGDP-USOAJAOKSA-N
17706	109512	3276	-	PRMT1	ANM1|HCP1|HRMT1L2|IR1B4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1686	S-Adenosyl-L-Homocysteine	-	-	DRUGBANK	DB01752	C14H20N6O5S	small molecule	-	979-92-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZJUKTBDSGOFHSH-SRMDEQNCSA-N
17731	134206	392399	-	LCN9	9230102I19Rik|HEL129	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1693	2-Methoxy-3-Isopropylpyrazine	-	-	DRUGBANK	DB01760	C8H12N2O	small molecule	-	25773-40-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NTOPKICPEQUPPH-UHFFFAOYSA-N
17732	134206	392399	-	LCN9	9230102I19Rik|HEL129	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1693	2-Methoxy-3-Isopropylpyrazine	-	-	DRUGBANK	DB01760	C8H12N2O	small molecule	-	25773-40-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NTOPKICPEQUPPH-UHFFFAOYSA-N
17733	134206	392399	-	LCN9	9230102I19Rik|HEL129	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1693	2-Methoxy-3-Isopropylpyrazine	-	-	DRUGBANK	DB01760	C8H12N2O	small molecule	-	25773-40-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NTOPKICPEQUPPH-UHFFFAOYSA-N
17796	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	unknown	target	Beeh KM (2005)	15765929	181625	1722	Piclamilast	RP 73-401	-	DRUGBANK	DB01791	C18H18Cl2N2O3	small molecule	-	144035-83-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RRRUXBQSQLKHEL-UHFFFAOYSA-N
17797	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1722	Piclamilast	RP 73-401	-	DRUGBANK	DB01791	C18H18Cl2N2O3	small molecule	-	144035-83-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RRRUXBQSQLKHEL-UHFFFAOYSA-N
17885	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1760	{4-[2-Acetylamino-2-(3-Carbamoyl-2-Cyclohexylmethoxy-6,7,8,9-Tetrahydro-5h-Benzocyclohepten-5ylcarbamoyl)-Ethyl]-2-Phosphono-Phenyl}-Phosphonic Acid	-	-	DRUGBANK	DB01830	C30H41N3O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SPSGYTWOIGAABK-RPBOFIJWSA-N
17886	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1760	{4-[2-Acetylamino-2-(3-Carbamoyl-2-Cyclohexylmethoxy-6,7,8,9-Tetrahydro-5h-Benzocyclohepten-5ylcarbamoyl)-Ethyl]-2-Phosphono-Phenyl}-Phosphonic Acid	-	-	DRUGBANK	DB01830	C30H41N3O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SPSGYTWOIGAABK-RPBOFIJWSA-N
17990	115651	10376	-	TUBA1B	K-ALPHA-1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1801	Epothilone D	Desoxyepothilone B|12,13-desoxyepothilone B|(-)-desoxyepothilone B	-	DRUGBANK	DB01873	C27H41NO5S	small molecule	-	189453-10-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XOZIUKBZLSUILX-GIQCAXHBSA-N
17991	115651	10376	-	TUBA1B	K-ALPHA-1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1801	Epothilone D	Desoxyepothilone B|12,13-desoxyepothilone B|(-)-desoxyepothilone B	-	DRUGBANK	DB01873	C27H41NO5S	small molecule	-	189453-10-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XOZIUKBZLSUILX-GIQCAXHBSA-N
17998	115656	10383	RP13-122B23.2	TUBB4B	Beta2|TUBB2|TUBB2C	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1801	Epothilone D	Desoxyepothilone B|12,13-desoxyepothilone B|(-)-desoxyepothilone B	-	DRUGBANK	DB01873	C27H41NO5S	small molecule	-	189453-10-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XOZIUKBZLSUILX-GIQCAXHBSA-N
17999	115656	10383	RP13-122B23.2	TUBB4B	Beta2|TUBB2|TUBB2C	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1801	Epothilone D	Desoxyepothilone B|12,13-desoxyepothilone B|(-)-desoxyepothilone B	-	DRUGBANK	DB01873	C27H41NO5S	small molecule	-	189453-10-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XOZIUKBZLSUILX-GIQCAXHBSA-N
18153	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1878	Rolipram	4-[3-(cyclopentyloxy)-4-methoxyphenyl]-2-pyrrolidinone|(R,S)-rolipram|(+/-)-rolipram	-	DRUGBANK	DB01954	C16H21NO3	small molecule	-	61413-54-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HJORMJIFDVBMOB-UHFFFAOYSA-N
18154	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1878	Rolipram	4-[3-(cyclopentyloxy)-4-methoxyphenyl]-2-pyrrolidinone|(R,S)-rolipram|(+/-)-rolipram	-	DRUGBANK	DB01954	C16H21NO3	small molecule	-	61413-54-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HJORMJIFDVBMOB-UHFFFAOYSA-N
18155	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1878	Rolipram	4-[3-(cyclopentyloxy)-4-methoxyphenyl]-2-pyrrolidinone|(R,S)-rolipram|(+/-)-rolipram	-	DRUGBANK	DB01954	C16H21NO3	small molecule	-	61413-54-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HJORMJIFDVBMOB-UHFFFAOYSA-N
18170	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1883	3,5-Dimethyl-1-(3-Nitrophenyl)-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester	-	-	DRUGBANK	DB01959	C14H15N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSYGAHOHLUJIKV-UHFFFAOYSA-N
18171	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1883	3,5-Dimethyl-1-(3-Nitrophenyl)-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester	-	-	DRUGBANK	DB01959	C14H15N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSYGAHOHLUJIKV-UHFFFAOYSA-N
18172	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1883	3,5-Dimethyl-1-(3-Nitrophenyl)-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester	-	-	DRUGBANK	DB01959	C14H15N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSYGAHOHLUJIKV-UHFFFAOYSA-N
18342	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
18343	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
18411	107420	983	-	CDK1	CDC2|CDC28A|P34CDC2	9606	Homo sapiens	binder	target	Chen X (2002)	11752352	171740	1973	Indirubin-3'-Monoxime	-	-	DRUGBANK	DB02052	C16H11N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBDSHCUSXQATPO-BGBJRWHRSA-N
18422	108554	2263	-	FGFR2	BBDS|BEK|BFR-1|CD332|CEK3|CFD1|ECT1|JWS|K-SAM|KGFR|TK14|TK25	9606	Homo sapiens	unknown	target	Chen X (2002)	11752352	171740	1979	SU4984	-	-	DRUGBANK	DB02058	C20H21N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AZGZGRJOCKSSHA-GOSISDBHSA-N
18430	116982	23410	-	SIRT3	SIR2L3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1980	Adenosine-5-Diphosphoribose	ADPR	-	DRUGBANK	DB02059	C15H23N5O14P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SRNWOUGRCWSEMX-ZQSHOCFMSA-N
18513	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2011	4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine	-	-	DRUGBANK	DB02091	C9H10N4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CTFDMGIBHFQWKB-UHFFFAOYSA-N
18544	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2028	2-Aminoethanimidic Acid	-	-	DRUGBANK	DB02108	C2H6N2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AXQVKDQRBAXYBP-UHFFFAOYSA-N
18545	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2028	2-Aminoethanimidic Acid	-	-	DRUGBANK	DB02108	C2H6N2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AXQVKDQRBAXYBP-UHFFFAOYSA-N
18573	107420	983	-	CDK1	CDC2|CDC28A|P34CDC2	9606	Homo sapiens	binder	target	Chen X (2002)	11752352	171740	2036	Olomoucine	-	-	DRUGBANK	DB02116	C15H18N6O	small molecule	-	101622-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GTVPOLSIJWJJNY-UHFFFAOYSA-N
18614	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2067	3-Amino-4-Oxybenzyl-2-Butanone	-	-	DRUGBANK	DB02148	C11H15NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ISLRAQPEXPIKDJ-NSHDSACASA-N
18615	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2067	3-Amino-4-Oxybenzyl-2-Butanone	-	-	DRUGBANK	DB02148	C11H15NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ISLRAQPEXPIKDJ-NSHDSACASA-N
18616	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2067	3-Amino-4-Oxybenzyl-2-Butanone	-	-	DRUGBANK	DB02148	C11H15NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ISLRAQPEXPIKDJ-NSHDSACASA-N
18842	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	unknown	target	Ouellet M (1995)	7864817	181626	2175	Flufenamic Acid	-	-	DRUGBANK	DB02266	C14H10F3NO2	small molecule	M01AG03	530-78-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LPEPZBJOKDYZAD-UHFFFAOYSA-N
19157	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2310	6-O-Cyclohexylmethyl Guanine	-	-	DRUGBANK	DB02407	C12H17N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWGXGTJJAOZBNW-UHFFFAOYSA-N
19298	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2380	Phosphonothreonine	-	-	DRUGBANK	DB02482	C4H10NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	USRGIUJOYOXOQJ-STHAYSLISA-N
19299	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2380	Phosphonothreonine	-	-	DRUGBANK	DB02482	C4H10NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	USRGIUJOYOXOQJ-STHAYSLISA-N
19315	108554	2263	-	FGFR2	BBDS|BEK|BFR-1|CD332|CEK3|CFD1|ECT1|JWS|K-SAM|KGFR|TK14|TK25	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2388	4-[4-(1-Amino-1-Methylethyl)Phenyl]-5-Chloro-N-[4-(2-Morpholin-4-Ylethyl)Phenyl]Pyrimidin-2-Amine	-	-	DRUGBANK	DB02491	C25H30ClN5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJSSYVIHFXDFFC-UHFFFAOYSA-N
19316	108554	2263	-	FGFR2	BBDS|BEK|BFR-1|CD332|CEK3|CFD1|ECT1|JWS|K-SAM|KGFR|TK14|TK25	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2388	4-[4-(1-Amino-1-Methylethyl)Phenyl]-5-Chloro-N-[4-(2-Morpholin-4-Ylethyl)Phenyl]Pyrimidin-2-Amine	-	-	DRUGBANK	DB02491	C25H30ClN5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJSSYVIHFXDFFC-UHFFFAOYSA-N
19335	110874	4809	CTA-216E10.8	NHP2L1	15.5K|FA-1|FA1|NHPX|OTK27|SNRNP15-5|SNU13|SPAG12|SSFA1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2391	Alpha-Hydroxy-Beta-Phenyl-Propionic Acid	-	-	DRUGBANK	DB02494	C9H10O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOXXWSYKYCBWHO-QMMMGPOBSA-N
19358	111510	5518	-	PPP2R1A	PP2A-Aalpha|PP2AAALPHA|PR65A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2403	2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid	-	-	DRUGBANK	DB02506	C20H33NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SWTFXINHZPXNOX-DZBHQSCQSA-N
19593	107035	554	-	AVPR2	ADHR|DI1|DIR|DIR3|NDI|V2R	9606	Homo sapiens	agonist	target	Yi X (2007)	17287200	71892	2529	Terlipressin	Terlipressine|Terlipressina|Terlipressinum|Terlipressin	-	DRUGBANK	DB02638	C52H74N16O15S2	small molecule	H01BA04	14636-12-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BENFXAYNYRLAIU-QSVFAHTRSA-N
19594	107035	554	-	AVPR2	ADHR|DI1|DIR|DIR3|NDI|V2R	9606	Homo sapiens	agonist	target	Boson WL (2006)	17020465	172148	2529	Terlipressin	Terlipressine|Terlipressina|Terlipressinum|Terlipressin	-	DRUGBANK	DB02638	C52H74N16O15S2	small molecule	H01BA04	14636-12-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BENFXAYNYRLAIU-QSVFAHTRSA-N
19595	107035	554	-	AVPR2	ADHR|DI1|DIR|DIR3|NDI|V2R	9606	Homo sapiens	agonist	target	Slusarz MJ (2006)	16333859	171922	2529	Terlipressin	Terlipressine|Terlipressina|Terlipressinum|Terlipressin	-	DRUGBANK	DB02638	C52H74N16O15S2	small molecule	H01BA04	14636-12-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BENFXAYNYRLAIU-QSVFAHTRSA-N
19596	107035	554	-	AVPR2	ADHR|DI1|DIR|DIR3|NDI|V2R	9606	Homo sapiens	agonist	target	Bouley R (2006)	16563128	172149	2529	Terlipressin	Terlipressine|Terlipressina|Terlipressinum|Terlipressin	-	DRUGBANK	DB02638	C52H74N16O15S2	small molecule	H01BA04	14636-12-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BENFXAYNYRLAIU-QSVFAHTRSA-N
19661	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2551	Filaminast	-	-	DRUGBANK	DB02660	C15H20N2O4	small molecule	-	141184-34-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STTRYQAGHGJXJJ-LICLKQGHSA-N
19662	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2551	Filaminast	-	-	DRUGBANK	DB02660	C15H20N2O4	small molecule	-	141184-34-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STTRYQAGHGJXJJ-LICLKQGHSA-N
19663	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2551	Filaminast	-	-	DRUGBANK	DB02660	C15H20N2O4	small molecule	-	141184-34-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STTRYQAGHGJXJJ-LICLKQGHSA-N
19701	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2575	3-Methylphenylalanine	-	-	DRUGBANK	DB02685	C10H13NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZRBSTONIYRNRI-VIFPVBQESA-N
19702	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2575	3-Methylphenylalanine	-	-	DRUGBANK	DB02685	C10H13NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZRBSTONIYRNRI-VIFPVBQESA-N
19745	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	2597	Resveratrol	(E)-5-[2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol|trans-3,4',5-trihydroxystilbene|(E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzendiol|3,4',5-Stilbenetriol|3,4',5-Trihydroxystilbene|(E)-5-(p-Hydroxystyryl)resorcinol|3,4',5-trihydroxy-stilbene|(E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol|(E)-resveratrol	co-veratrol	DRUGBANK	DB02709	C14H12O3	small molecule	-	501-36-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUKBXSAWLPMMSZ-OWOJBTEDSA-N
19855	110251	4074	-	M6PR	CD-MPR|MPR 46|MPR-46|MPR46|SMPR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2640	1-3 Sugar Ring of Pentamannosyl 6-Phosphate	-	-	DRUGBANK	DB02755	C18H33O19P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HDQMHAJOIVYOIP-QPBMUXFQSA-N
19856	110251	4074	-	M6PR	CD-MPR|MPR 46|MPR-46|MPR46|SMPR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2640	1-3 Sugar Ring of Pentamannosyl 6-Phosphate	-	-	DRUGBANK	DB02755	C18H33O19P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HDQMHAJOIVYOIP-QPBMUXFQSA-N
19857	110251	4074	-	M6PR	CD-MPR|MPR 46|MPR-46|MPR46|SMPR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2640	1-3 Sugar Ring of Pentamannosyl 6-Phosphate	-	-	DRUGBANK	DB02755	C18H33O19P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HDQMHAJOIVYOIP-QPBMUXFQSA-N
19989	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2715	[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine	-	-	DRUGBANK	DB02833	C14H12N6O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYTKVFHLKPDNRW-UHFFFAOYSA-N
20032	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2737	N-(3-Propylcarbamoyloxirane-2-Carbonyl)-Isoleucyl-Proline	N-(3-Propylcarbamoyloxirane-2-carbonyl)-isoleucyl-proline	-	DRUGBANK	DB02855	C18H31N3O6	small molecule	-	134448-10-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UDNIFTKCMDIXFC-ABHRYQDASA-N
20103	110251	4074	-	M6PR	CD-MPR|MPR 46|MPR-46|MPR46|SMPR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2780	alpha-D-mannose 6-phosphate	Man6P|6-H2PO3Man|(6P)Man|(6P)Mana|6-O-phosphono--D-mannopyranose	-	DRUGBANK	DB02900	C6H13O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBSCHQHZLSJFNQ-PQMKYFCFSA-N
20104	110251	4074	-	M6PR	CD-MPR|MPR 46|MPR-46|MPR46|SMPR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2780	alpha-D-mannose 6-phosphate	Man6P|6-H2PO3Man|(6P)Man|(6P)Mana|6-O-phosphono--D-mannopyranose	-	DRUGBANK	DB02900	C6H13O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBSCHQHZLSJFNQ-PQMKYFCFSA-N
20105	110251	4074	-	M6PR	CD-MPR|MPR 46|MPR-46|MPR46|SMPR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2780	alpha-D-mannose 6-phosphate	Man6P|6-H2PO3Man|(6P)Man|(6P)Mana|6-O-phosphono--D-mannopyranose	-	DRUGBANK	DB02900	C6H13O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBSCHQHZLSJFNQ-PQMKYFCFSA-N
20130	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2794	4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(4-Trifluoromethyl-Phenyl)-Amine	-	-	DRUGBANK	DB02915	C16H13F3N4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEZFDQUDLQCVNX-UHFFFAOYSA-N
20138	134206	392399	-	LCN9	9230102I19Rik|HEL129	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2803	D-Limonene 1,2-Epoxide	-	-	DRUGBANK	DB02924	C10H16O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CCEFMUBVSUDRLG-KXUCPTDWSA-N
20139	134206	392399	-	LCN9	9230102I19Rik|HEL129	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2803	D-Limonene 1,2-Epoxide	-	-	DRUGBANK	DB02924	C10H16O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CCEFMUBVSUDRLG-KXUCPTDWSA-N
20140	134206	392399	-	LCN9	9230102I19Rik|HEL129	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2803	D-Limonene 1,2-Epoxide	-	-	DRUGBANK	DB02924	C10H16O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CCEFMUBVSUDRLG-KXUCPTDWSA-N
20189	107420	983	-	CDK1	CDC2|CDC28A|P34CDC2	9606	Homo sapiens	unknown	target	Chen X (2002)	11752352	171740	2827	Hymenialdisine	-	-	DRUGBANK	DB02950	C11H10BrN5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QPCBNXNDVYOBIP-WHFBIAKZSA-N
20294	115651	10376	-	TUBA1B	K-ALPHA-1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2886	Epothilone B	Patupilone|()-epothilone B|Epo B	-	DRUGBANK	DB03010	C27H41NO6S	small molecule	-	152044-54-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXRSDHAAWVKZLJ-PVYNADRNSA-N
20295	115651	10376	-	TUBA1B	K-ALPHA-1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2886	Epothilone B	Patupilone|()-epothilone B|Epo B	-	DRUGBANK	DB03010	C27H41NO6S	small molecule	-	152044-54-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXRSDHAAWVKZLJ-PVYNADRNSA-N
20302	115656	10383	RP13-122B23.2	TUBB4B	Beta2|TUBB2|TUBB2C	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2886	Epothilone B	Patupilone|()-epothilone B|Epo B	-	DRUGBANK	DB03010	C27H41NO6S	small molecule	-	152044-54-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXRSDHAAWVKZLJ-PVYNADRNSA-N
20303	115656	10383	RP13-122B23.2	TUBB4B	Beta2|TUBB2|TUBB2C	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2886	Epothilone B	Patupilone|()-epothilone B|Epo B	-	DRUGBANK	DB03010	C27H41NO6S	small molecule	-	152044-54-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXRSDHAAWVKZLJ-PVYNADRNSA-N
20333	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2897	1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine	-	-	DRUGBANK	DB03023	C15H17ClN5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PBBRWFOVCUAONR-UHFFFAOYSA-O
20334	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2897	1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine	-	-	DRUGBANK	DB03023	C15H17ClN5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PBBRWFOVCUAONR-UHFFFAOYSA-O
20335	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2897	1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine	-	-	DRUGBANK	DB03023	C15H17ClN5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PBBRWFOVCUAONR-UHFFFAOYSA-O
20448	134206	392399	-	LCN9	9230102I19Rik|HEL129	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2958	2-(Sec-Butyl)Thiazole	-	-	DRUGBANK	DB03087	C7H11NS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MHJSWOZJMPIGJQ-ZCFIWIBFSA-N
20449	134206	392399	-	LCN9	9230102I19Rik|HEL129	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2958	2-(Sec-Butyl)Thiazole	-	-	DRUGBANK	DB03087	C7H11NS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MHJSWOZJMPIGJQ-ZCFIWIBFSA-N
20450	134206	392399	-	LCN9	9230102I19Rik|HEL129	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2958	2-(Sec-Butyl)Thiazole	-	-	DRUGBANK	DB03087	C7H11NS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MHJSWOZJMPIGJQ-ZCFIWIBFSA-N
20532	112645	6768	-	ST14	ARCI11|HAI|MT-SP1|MTSP1|PRSS14|SNC19|TADG15|TMPRSS14	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2996	Benzamidine	-	-	DRUGBANK	DB03127	C7H9N2	small molecule	-	618-39-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PXXJHWLDUBFPOL-UHFFFAOYSA-O
20533	112645	6768	-	ST14	ARCI11|HAI|MT-SP1|MTSP1|PRSS14|SNC19|TADG15|TMPRSS14	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2996	Benzamidine	-	-	DRUGBANK	DB03127	C7H9N2	small molecule	-	618-39-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PXXJHWLDUBFPOL-UHFFFAOYSA-O
20601	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20602	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20603	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20609	108082	1738	tcag7.39	DLD	DLDD|DLDH|E3|GCSL|LAD|PHE3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20796	122308	64802	RP11-807G9.1	NMNAT1	LCA9|NMNAT|PNAT1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3095	Nicotinamide Mononucleotide	-	-	DRUGBANK	DB03227	C11H16N2O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DAYLJWODMCOQEW-WYOJIJJFSA-O
20797	122308	64802	RP11-807G9.1	NMNAT1	LCA9|NMNAT|PNAT1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3095	Nicotinamide Mononucleotide	-	-	DRUGBANK	DB03227	C11H16N2O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DAYLJWODMCOQEW-WYOJIJJFSA-O
20983	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3193	2-Pyridinethiol	-	-	DRUGBANK	DB03329	C5H5NS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHMDPDGBKYUEMW-UHFFFAOYSA-N
20984	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3193	2-Pyridinethiol	-	-	DRUGBANK	DB03329	C5H5NS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHMDPDGBKYUEMW-UHFFFAOYSA-N
20985	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3193	2-Pyridinethiol	-	-	DRUGBANK	DB03329	C5H5NS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHMDPDGBKYUEMW-UHFFFAOYSA-N
21027	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3212	8-Bromo-Adenosine-5'-Monophosphate	-	-	DRUGBANK	DB03349	C10H13BrN5O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNPIJKNXFSPNNY-BZKDHIKHSA-N
21028	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3212	8-Bromo-Adenosine-5'-Monophosphate	-	-	DRUGBANK	DB03349	C10H13BrN5O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNPIJKNXFSPNNY-BZKDHIKHSA-N
21190	107420	983	-	CDK1	CDC2|CDC28A|P34CDC2	9606	Homo sapiens	binder	target	Chen X (2002)	11752352	171740	3285	SU9516	-	-	DRUGBANK	DB03428	C13H11N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNUKRWAIZMBVCU-WCIBSUBMSA-N
21248	111967	6038	-	RNASE4	RAB1|RNS4	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3304	2'-Deoxyuridine 3'-Monophosphate	-	-	DRUGBANK	DB03448	C9H13N2O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXKGKXYIAAKOCT-SHYZEUOFSA-N
21249	111967	6038	-	RNASE4	RAB1|RNS4	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3304	2'-Deoxyuridine 3'-Monophosphate	-	-	DRUGBANK	DB03448	C9H13N2O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXKGKXYIAAKOCT-SHYZEUOFSA-N
21356	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3332	1-Phenylsulfonamide-3-Trifluoromethyl-5-Parabromophenylpyrazole	-	-	DRUGBANK	DB03477	C16H11BrF3N3O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OYZKFVIVPRQRQQ-UHFFFAOYSA-N
21391	107420	983	-	CDK1	CDC2|CDC28A|P34CDC2	9606	Homo sapiens	unknown	target	Chen X (2002)	11752352	171740	3351	Flavopiridol	Alvocidib freebase|Alvocidib	-	DRUGBANK	DB03496	C21H20ClNO5	small molecule	-	146426-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BIIVYFLTOXDAOV-YVEFUNNKSA-N
21521	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3424	Phencyclidine	1-(1-Phenylcyclohexyl)piperidine|PCP	-	DRUGBANK	DB03575	C17H25N	small molecule	-	77-10-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JTJMJGYZQZDUJJ-UHFFFAOYSA-N
21522	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3424	Phencyclidine	1-(1-Phenylcyclohexyl)piperidine|PCP	-	DRUGBANK	DB03575	C17H25N	small molecule	-	77-10-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JTJMJGYZQZDUJJ-UHFFFAOYSA-N
21546	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3436	Diphenylacetic Acid	-	-	DRUGBANK	DB03588	C14H12O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PYHXGXCGESYPCW-UHFFFAOYSA-N
21547	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3436	Diphenylacetic Acid	-	-	DRUGBANK	DB03588	C14H12O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PYHXGXCGESYPCW-UHFFFAOYSA-N
21548	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3436	Diphenylacetic Acid	-	-	DRUGBANK	DB03588	C14H12O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PYHXGXCGESYPCW-UHFFFAOYSA-N
21583	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	3454	(S)-Rolipram	(S)-(+)-rolipram|S-rolipram|(+)-rolipram	-	DRUGBANK	DB03606	C16H21NO3	small molecule	-	85416-73-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HJORMJIFDVBMOB-GFCCVEGCSA-N
21584	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	3454	(S)-Rolipram	(S)-(+)-rolipram|S-rolipram|(+)-rolipram	-	DRUGBANK	DB03606	C16H21NO3	small molecule	-	85416-73-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HJORMJIFDVBMOB-GFCCVEGCSA-N
21585	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	3454	(S)-Rolipram	(S)-(+)-rolipram|S-rolipram|(+)-rolipram	-	DRUGBANK	DB03606	C16H21NO3	small molecule	-	85416-73-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HJORMJIFDVBMOB-GFCCVEGCSA-N
21586	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	3454	(S)-Rolipram	(S)-(+)-rolipram|S-rolipram|(+)-rolipram	-	DRUGBANK	DB03606	C16H21NO3	small molecule	-	85416-73-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HJORMJIFDVBMOB-GFCCVEGCSA-N
21639	108070	1725	-	DHPS	DHS|DS|MIG13	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	3486	1-Guanidinium-7-Aminoheptane	-	-	DRUGBANK	DB03639	C8H22N4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SKGAVCHIFDRDTK-UHFFFAOYSA-N
21640	108070	1725	-	DHPS	DHS|DS|MIG13	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	3486	1-Guanidinium-7-Aminoheptane	-	-	DRUGBANK	DB03639	C8H22N4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SKGAVCHIFDRDTK-UHFFFAOYSA-N
21641	108070	1725	-	DHPS	DHS|DS|MIG13	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	3486	1-Guanidinium-7-Aminoheptane	-	-	DRUGBANK	DB03639	C8H22N4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SKGAVCHIFDRDTK-UHFFFAOYSA-N
21642	108070	1725	-	DHPS	DHS|DS|MIG13	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	3486	1-Guanidinium-7-Aminoheptane	-	-	DRUGBANK	DB03639	C8H22N4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SKGAVCHIFDRDTK-UHFFFAOYSA-N
21778	134206	392399	-	LCN9	9230102I19Rik|HEL129	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3555	6-Hydroxy-6-Methyl-Heptan-3-One	-	-	DRUGBANK	DB03711	C8H16O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FGPMBONEKHYAHO-UHFFFAOYSA-N
21779	134206	392399	-	LCN9	9230102I19Rik|HEL129	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3555	6-Hydroxy-6-Methyl-Heptan-3-One	-	-	DRUGBANK	DB03711	C8H16O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FGPMBONEKHYAHO-UHFFFAOYSA-N
21780	134206	392399	-	LCN9	9230102I19Rik|HEL129	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3555	6-Hydroxy-6-Methyl-Heptan-3-One	-	-	DRUGBANK	DB03711	C8H16O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FGPMBONEKHYAHO-UHFFFAOYSA-N
21990	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3645	1-(2-Chlorophenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester	-	-	DRUGBANK	DB03807	C14H15ClN2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XQCKNCFQOJFQFK-UHFFFAOYSA-N
21991	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3645	1-(2-Chlorophenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester	-	-	DRUGBANK	DB03807	C14H15ClN2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XQCKNCFQOJFQFK-UHFFFAOYSA-N
21992	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3645	1-(2-Chlorophenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester	-	-	DRUGBANK	DB03807	C14H15ClN2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XQCKNCFQOJFQFK-UHFFFAOYSA-N
22090	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3703	Prostaglandin G2	-	-	DRUGBANK	DB03866	C20H32O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGUKUZOVHSFKPH-YNNPMVKQSA-N
22288	112952	7097	-	TLR2	CD282|TIL4	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3798	S-(Dimethylarsenic)Cysteine	-	-	DRUGBANK	DB03963	C5H12AsNO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UKLXSOVDMSQHMM-SCSAIBSYSA-N
22289	112952	7097	-	TLR2	CD282|TIL4	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3798	S-(Dimethylarsenic)Cysteine	-	-	DRUGBANK	DB03963	C5H12AsNO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UKLXSOVDMSQHMM-SCSAIBSYSA-N
22355	110030	3832	-	KIF11	EG5|HKSP|KNSL1|MCLMR|TRIP5	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3830	3-[(5s)-1-Acetyl-3-(2-Chlorophenyl)-4,5-Dihydro-1h-Pyrazol-5-Yl]Phenol	-	-	DRUGBANK	DB03996	C17H15ClN2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QBZAPFWYAPXRGQ-KRWDZBQOSA-N
22356	110030	3832	-	KIF11	EG5|HKSP|KNSL1|MCLMR|TRIP5	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3830	3-[(5s)-1-Acetyl-3-(2-Chlorophenyl)-4,5-Dihydro-1h-Pyrazol-5-Yl]Phenol	-	-	DRUGBANK	DB03996	C17H15ClN2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QBZAPFWYAPXRGQ-KRWDZBQOSA-N
22357	110030	3832	-	KIF11	EG5|HKSP|KNSL1|MCLMR|TRIP5	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3830	3-[(5s)-1-Acetyl-3-(2-Chlorophenyl)-4,5-Dihydro-1h-Pyrazol-5-Yl]Phenol	-	-	DRUGBANK	DB03996	C17H15ClN2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QBZAPFWYAPXRGQ-KRWDZBQOSA-N
22369	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3837	(4-{2-Acetylamino-2-[1-(3-Carbamoyl-4-Cyclohexylmethoxy-Phenyl)-Ethylcarbamoyl}-Ethyl}-2-Phosphono-Phenoxy)-Acetic Acid	-	-	DRUGBANK	DB04003	C29H38N3O10P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FXUGQWABROMTDA-GAJHUEQPSA-N
22370	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3837	(4-{2-Acetylamino-2-[1-(3-Carbamoyl-4-Cyclohexylmethoxy-Phenyl)-Ethylcarbamoyl}-Ethyl}-2-Phosphono-Phenoxy)-Acetic Acid	-	-	DRUGBANK	DB04003	C29H38N3O10P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FXUGQWABROMTDA-GAJHUEQPSA-N
22390	107420	983	-	CDK1	CDC2|CDC28A|P34CDC2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	3848	Alsterpaullone	-	-	DRUGBANK	DB04014	C16H11N3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OLUKILHGKRVDCT-UHFFFAOYSA-N
22400	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3851	N-Methyl-N-Propargyl-3-(2,4-Dichlorophenoxy)Propylamine	-	-	DRUGBANK	DB04017	C13H15Cl2NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BTFHLQRNAMSNLC-UHFFFAOYSA-N
22568	122308	64802	RP11-807G9.1	NMNAT1	LCA9|NMNAT|PNAT1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3931	Deamido-Nad+	-	-	DRUGBANK	DB04099	C21H27N6O15P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SENPVEZBRZQVST-AAIUHBJKSA-O
22569	122308	64802	RP11-807G9.1	NMNAT1	LCA9|NMNAT|PNAT1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3931	Deamido-Nad+	-	-	DRUGBANK	DB04099	C21H27N6O15P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SENPVEZBRZQVST-AAIUHBJKSA-O
22609	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3958	N-[1-Hydroxycarboxyethyl-Carbonyl]Leucylamino-2-Methyl-Butane	-	-	DRUGBANK	DB04126	C15H28N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBIWEWPGBHKYML-RYUDHWBXSA-N
22677	107917	1537	-	CYC1	MC3DN6|UQCR4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3972	2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol	-	-	DRUGBANK	DB04141	C12H24O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JVAZJLFFSJARQM-YBXAARCKSA-N
22716	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	3979	(R)-Rolipram	R-rolipram|(-)-rolipram|(R)-(-)-rolipram	-	DRUGBANK	DB04149	C16H21NO3	small molecule	-	85416-75-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HJORMJIFDVBMOB-LBPRGKRZSA-N
22717	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	3979	(R)-Rolipram	R-rolipram|(-)-rolipram|(R)-(-)-rolipram	-	DRUGBANK	DB04149	C16H21NO3	small molecule	-	85416-75-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HJORMJIFDVBMOB-LBPRGKRZSA-N
22718	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	3979	(R)-Rolipram	R-rolipram|(-)-rolipram|(R)-(-)-rolipram	-	DRUGBANK	DB04149	C16H21NO3	small molecule	-	85416-75-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HJORMJIFDVBMOB-LBPRGKRZSA-N
23146	110030	3832	-	KIF11	EG5|HKSP|KNSL1|MCLMR|TRIP5	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4156	Monastrol	-	-	DRUGBANK	DB04331	C14H16N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LOBCDGHHHHGHFA-LBPRGKRZSA-N
23147	110030	3832	-	KIF11	EG5|HKSP|KNSL1|MCLMR|TRIP5	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4156	Monastrol	-	-	DRUGBANK	DB04331	C14H16N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LOBCDGHHHHGHFA-LBPRGKRZSA-N
23148	110030	3832	-	KIF11	EG5|HKSP|KNSL1|MCLMR|TRIP5	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4156	Monastrol	-	-	DRUGBANK	DB04331	C14H16N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LOBCDGHHHHGHFA-LBPRGKRZSA-N
23291	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23292	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23295	116195	11004	RP11-269F19.1	KIF2C	CT139|KNSL6|MCAK	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23296	116195	11004	RP11-269F19.1	KIF2C	CT139|KNSL6|MCAK	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23297	116195	11004	RP11-269F19.1	KIF2C	CT139|KNSL6|MCAK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23478	111814	5876	RP4-682C21.3	RABGGTB	GGTB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4278	N-Formylmethionine	-	-	DRUGBANK	DB04464	C6H11NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PYUSHNKNPOHWEZ-YFKPBYRVSA-N
23580	134206	392399	-	LCN9	9230102I19Rik|HEL129	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4324	2-Isobutyl-3-Methoxypyrazine	-	-	DRUGBANK	DB04512	C9H14N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UXFSPRAGHGMRSQ-UHFFFAOYSA-N
23632	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4342	S,S-(2-Hydroxyethyl)Thiocysteine	-	-	DRUGBANK	DB04530	C5H11NO3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPUBRSXDQSFQBA-BYPYZUCNSA-N
23633	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4342	S,S-(2-Hydroxyethyl)Thiocysteine	-	-	DRUGBANK	DB04530	C5H11NO3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPUBRSXDQSFQBA-BYPYZUCNSA-N
23687	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Alpert E (2007)	17098211	138173	4362	Niflumic Acid	Acidum niflumicum|Acide niflumique|Niflugel|NFA|Acido niflumico	-	DRUGBANK	DB04552	C13H9F3N2O2	small molecule	M02AA17|M01AX02	4394-00-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZFPYUNJRRFVQU-UHFFFAOYSA-N
23688	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Jabeen T (2005)	16301791	181921	4362	Niflumic Acid	Acidum niflumicum|Acide niflumique|Niflugel|NFA|Acido niflumico	-	DRUGBANK	DB04552	C13H9F3N2O2	small molecule	M02AA17|M01AX02	4394-00-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZFPYUNJRRFVQU-UHFFFAOYSA-N
23689	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Diao HL (2007)	17485303	182008	4362	Niflumic Acid	Acidum niflumicum|Acide niflumique|Niflugel|NFA|Acido niflumico	-	DRUGBANK	DB04552	C13H9F3N2O2	small molecule	M02AA17|M01AX02	4394-00-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZFPYUNJRRFVQU-UHFFFAOYSA-N
23752	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4389	N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-	-	-	DRUGBANK	DB04579	C16H28N2O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TUAMLRIDHTYTCM-WKLONVCASA-N
23768	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4417	9-HYDROXY-4-PHENYL-6H-PYRROLO[3,4-C]CARBAZOLE-1,3-DIONE	-	-	DRUGBANK	DB04608	C20H12N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IAUZTOZLTFSMIE-UHFFFAOYSA-N
23800	109418	3176	-	HNMT	HMT|HNMT-S1|HNMT-S2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4460	METOPRINE, METHODICHLOROPHEN	-	-	DRUGBANK	DB04655	C11H10Cl2N4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VQJHOPSWBGJHQS-UHFFFAOYSA-N
23814	108792	2516	RP11-101K10.1	NR5A1	AD4BP|ELP|FTZ1|FTZF1|POF7|SF-1|SF1|SPGF8|SRXY3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4487	(2R)-3-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-2-[(9E)-HEXADEC-9-ENOYLOXY]PROPYL (9E)-OCTADEC-9-ENOATE	-	-	DRUGBANK	DB04683	C40H75O10P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGIXWNRQEFVVRM-CTDKCSBDSA-N
23825	114646	9212	-	AURKB	AIK2|AIM-1|AIM1|ARK2|AurB|IPL1|PPP1R48|STK12|STK5|aurkb-sv1|aurkb-sv2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4507	HESPERIDIN	-	-	DRUGBANK	DB04703	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
23849	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	unknown	target	Vidal C (2007)	17015640	181969	4529	Licofelone	LCF|ML3000	-	DRUGBANK	DB04725	C23H22ClNO2	small molecule	-	156897-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UAWXGRJVZSAUSZ-UHFFFAOYSA-N
23862	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Rainsford KD (2006)	16846549	181954	4546	Nimesulide	-	-	DRUGBANK	DB04743	C13H12N2O5S	small molecule	M01AX17|M02AA26	51803-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYWYRSMBCFDLJT-UHFFFAOYSA-N
23863	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	4546	Nimesulide	-	-	DRUGBANK	DB04743	C13H12N2O5S	small molecule	M01AX17|M02AA26	51803-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYWYRSMBCFDLJT-UHFFFAOYSA-N
23919	107917	1537	-	CYC1	MC3DN6|UQCR4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4601	5-n-undecyl-6-hydroxy-4,7-dioxobenzothiazole	UHDBT|6-Hydroxy-5-undecyl-4,7-benzothiazoledione|6-hydroxy-5-undecyl-1,3-benzothiazole-4,7-dione|3-undecyl-2-hydroxydioxobenzothiazol	-	DRUGBANK	DB04799	C18H25NO3S	small molecule	-	43152-58-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QCWGBMWYLYKEIU-UHFFFAOYSA-N
23926	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	unknown	target	Hovevey-Sion D (1989)	2506486	181654	4622	Nialamide	2-(2-(Benzylcarbamyl)ethyl)hydrazide isonicotinic acid|Isonicitinic acid 2-[(2-benzylcarbamoyl)ethyl]hydrazide|2-(2-(Benzylcarbamoyl)ethyl)hydrazide isonicotinic acid|N-Benzyl-3-(2-isonicotinoylhydrazino)propanamide|2-(2-(Benzylcarbamoyl)ethyl)hydrazide, isonicotinic acid|Isonicotinic acid, 2-[2-(benzylcarbamoylethyl]hydrazide|Pyridine-4-carboxylic 2-[2-(benzylcarbamoyl)ethyl]hydrazide|1-(2-(Benzylcarbamoyl)ethyl)-2-isonicotinoylhydrazine|N-benzyl-beta-(isonicotinoylhydrazine)propionamide|N-benzyl-beta-(isonicotinylhydrazino)propionamide|Isonicotinic acid, 2-[2-(benzylcarbamoyl)ethyl]hydrazide|Isonicotinic acid, 2-[2- (benzylcarbamoyl)ethyl]hydrazide|BEIH|Isonicotinic acid 2-((2-benzylcarbamoyl)ethyl)hydrazide|N-isonicotinyl hydrazide|N-isonicotinoyl-n'(beta-n-benzylcarboxamidoethyl)hydrazine|Isonicotinic acid, {2-[2-(benzylcarbamoyl)ethyl]hydrazide}|Isonicotinic acid, 2-(2-(benzylcarbamoyl)ethyl)hydrazide|2-[2-(Benzylcarbamoyl)ethyl]hydrazide isonicotinic acid|N-(2-(Benzylcarbamyl)ethylamino)isonicotinamide|Isonicotinic acid, {2-[2-(benzylcarbamoylethyl]hydrazide}|1-[2-(Benzylcarbamoyl)ethyl]-2-isonicotinoylhydrazine|Nialamida|Nialamidum	-	DRUGBANK	DB04820	C16H18N4O2	small molecule	N06AF02	51-12-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOIIUHRQUVNIDD-UHFFFAOYSA-N
23929	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	unknown	target	Egashira T (1999)	10580379	181743	4623	Nomifensine	(+-)-nomifensin|Nomifensin|2-Methyl-4-phenyl-1,2,3,4-tetrahydro-8-isoquinolinamine|(+)-nomiphensine|8-Amino-2-methyl-4-phenyl-1,2,3,4-tetrahydroisoquinoline|Nomifensina|Nomifensinum|8-Amino-1,2,3,4-tetrahydro-2-methyl-4-phenylisochinolin|8-Amino-1,2,3,4-tetrahydro-2-methyl-4-phenylisoquinoline|(+-)-nomifensine|(+)-nomifensine|(R)-1,2,3,4-Tetrahydro-2-methyl-4-phenyl-8-isoquinolinamine	-	DRUGBANK	DB04821	C16H18N2	small molecule	N06AX04	24526-64-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XXPANQJNYNUNES-UHFFFAOYSA-N
23940	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Egashira T (1996)	8842678	181710	4634	Zimelidine	(z)-zimelidine|Zimeldine|(Z)-3-(4'-Bromophenyl)-3-(3''-pyridyl)dimethylallylamine|Cis-zimelidine|(Z)-3-[1-(p-Bromophenyl)-3-(dimethylamino)propenyl]pyridine	-	DRUGBANK	DB04832	C16H17BrN2	small molecule	N06AB02	56775-88-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OYPPVKRFBIWMSX-SXGWCWSVSA-N
24142	115656	10383	RP13-122B23.2	TUBB4B	Beta2|TUBB2|TUBB2C	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4710	Oxibendazole	methyl 5-[n-propoxy]benzimidazole-2-carbamate|Methyl 5-propoxy-2-benzimidazolecarbamate|(5-Propoxy-1H-benzimidazol-2-yl)carbamic acid methyl ester|Oxibendazolum|5-Propoxy-2-benzimidazolecarbamic acid methyl ester|Oxybendazole|Oxibendazolo|OBZ|Methyl (5-propoxy-1H-benzimidazol-2-yl)carbamate|Methyl 5-n-propoxy-2-benzimidazole carbamate	-	DRUGBANK	DB04910	C12H15N3O3	small molecule	-	20559-55-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAOCRURYZCVHMG-UHFFFAOYSA-N
24208	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Bobo WV (2013)	23272794	182224	4740	Iloperidone	HP 873|Zomaril|Fanapt|Fanapta|Iloperidonum|1-[4-[3-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1- piperidinyl]propoxy]-3-methoxyphenyl]ethanone|Iloperidona|4'-(3-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino)propoxy)-3'-methoxyacetophenone	fanapt	DRUGBANK	DB04946	C24H27FN2O4	small molecule	N05AX14	133454-47-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XMXHEBAFVSFQEX-UHFFFAOYSA-N
24286	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	unknown	target	Almansa C (2004)	15481993	181866	4878	Cimicoxib	-	-	DRUGBANK	DB05095	C16H13ClFN3O3S	small molecule	-	265114-23-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KYXDNECMRLFQMZ-UHFFFAOYSA-N
24317	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Huang Z (2006)	16313925	179103	5043	Ibudilast	Ke tas|3-isobutyryl-2-isopropylpyrazolo(1,5-a)pyridine|Ibudilast|Pyrazolo(1,5-a)pyridine, 3-isobutyryl-2-isopropyl-|2-Isopropyl-3-isobutyrylpyrazolo(1,5-a)pyridine|Ketas|Ibudilastum|AV-411|Tocris-1694|Ketas (TN)|3-Isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine|MN-166|Eyevinal	-	DRUGBANK	DB05266	C14H18N2O	small molecule	R03DC04	50847-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZJVFLBOZORBYFE-UHFFFAOYSA-N
24327	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	5046	Rotigotine	(6S)-6-(propyl(2-(2-thienyl)ethyl)amino)-5,6,7,8-tetrahydro-1-naphthalenol	neupro	DRUGBANK	DB05271	C19H25NOS	small molecule	N04BC09	99755-59-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KFQYTPMOWPVWEJ-INIZCTEOSA-N
24347	107438	1003	-	CDH5	7B4|CD144	9606	Homo sapiens	unknown	target	Atar D (2006)	17019083	181970	5289	FX06	-	-	DRUGBANK	DB05685	-	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24425	107035	554	-	AVPR2	ADHR|DI1|DIR|DIR3|NDI|V2R	9606	Homo sapiens	antagonist	target	Aperis G (2011)	20868352	182167	5531	Tolvaptan	Samsca	samsca|jinarc	DRUGBANK	DB06212	C26H25ClN2O3	small molecule	C03XA01	150683-30-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GYHCTFXIZSNGJT-XMMPIXPASA-N
24426	107035	554	-	AVPR2	ADHR|DI1|DIR|DIR3|NDI|V2R	9606	Homo sapiens	antagonist	target	Dixon MB (2008)	19337422	182101	5531	Tolvaptan	Samsca	samsca|jinarc	DRUGBANK	DB06212	C26H25ClN2O3	small molecule	C03XA01	150683-30-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GYHCTFXIZSNGJT-XMMPIXPASA-N
24439	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	antagonist	target	Shahid M (2009)	18308814	175311	5533	Asenapine	Saphris	saphris	DRUGBANK	DB06216	C21H20ClNO5	small molecule	N05AH05	65576-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMDCDXMAFMEDAG-BTJKTKAUSA-N
24440	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	antagonist	target	Citrome L (2011)	21655346	182190	5533	Asenapine	Saphris	saphris	DRUGBANK	DB06216	C21H20ClNO5	small molecule	N05AH05	65576-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMDCDXMAFMEDAG-BTJKTKAUSA-N
24456	109593	3361	-	HTR5A	5-HT5A	9606	Homo sapiens	antagonist	target	Shahid M (2009)	18308814	175311	5533	Asenapine	Saphris	saphris	DRUGBANK	DB06216	C21H20ClNO5	small molecule	N05AH05	65576-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMDCDXMAFMEDAG-BTJKTKAUSA-N
24457	109593	3361	-	HTR5A	5-HT5A	9606	Homo sapiens	antagonist	target	Citrome L (2011)	21655346	182190	5533	Asenapine	Saphris	saphris	DRUGBANK	DB06216	C21H20ClNO5	small molecule	N05AH05	65576-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMDCDXMAFMEDAG-BTJKTKAUSA-N
24466	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Shahid M (2009)	18308814	175311	5533	Asenapine	Saphris	saphris	DRUGBANK	DB06216	C21H20ClNO5	small molecule	N05AH05	65576-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMDCDXMAFMEDAG-BTJKTKAUSA-N
24467	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Citrome L (2011)	21655346	182190	5533	Asenapine	Saphris	saphris	DRUGBANK	DB06216	C21H20ClNO5	small molecule	N05AH05	65576-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMDCDXMAFMEDAG-BTJKTKAUSA-N
24559	112415	6524	-	SLC5A2	SGLT2	9606	Homo sapiens	antagonist	target	Obermeier M (2010)	19996149	182139	5548	Dapagliflozin	(2S,3R,4R,5S,6R)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-6- (hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol	qtern|xigduo xr|farxiga|xigduo	DRUGBANK	DB06292	C21H25ClO6	small molecule	A10BD21|A10BD15|A10BX09	461432-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JVHXJTBJCFBINQ-ADAARDCZSA-N
24560	112415	6524	-	SLC5A2	SGLT2	9606	Homo sapiens	inhibitor, competitive	target	Obermeier M (2010)	19996149	182139	5548	Dapagliflozin	(2S,3R,4R,5S,6R)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-6- (hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol	qtern|xigduo xr|farxiga|xigduo	DRUGBANK	DB06292	C21H25ClO6	small molecule	A10BD21|A10BD15|A10BX09	461432-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JVHXJTBJCFBINQ-ADAARDCZSA-N
24785	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Renner RM (2010)	20399943	182151	5605	Lornoxicam	Chlortenoxicam|Lornoxicamum	-	DRUGBANK	DB06725	C13H10ClN3O4S2	small molecule	M01AC05	70374-39-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WLHQHAUOOXYABV-UHFFFAOYSA-N
24786	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Rose P (2007)	17516707	182014	5605	Lornoxicam	Chlortenoxicam|Lornoxicamum	-	DRUGBANK	DB06725	C13H10ClN3O4S2	small molecule	M01AC05	70374-39-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WLHQHAUOOXYABV-UHFFFAOYSA-N
24787	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Berg J (1999)	10450786	181738	5605	Lornoxicam	Chlortenoxicam|Lornoxicamum	-	DRUGBANK	DB06725	C13H10ClN3O4S2	small molecule	M01AC05	70374-39-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WLHQHAUOOXYABV-UHFFFAOYSA-N
24788	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Bianchi M (2002)	11846620	181788	5605	Lornoxicam	Chlortenoxicam|Lornoxicamum	-	DRUGBANK	DB06725	C13H10ClN3O4S2	small molecule	M01AC05	70374-39-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WLHQHAUOOXYABV-UHFFFAOYSA-N
24839	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Gamache DA (2000)	10850857	181753	5639	Nepafenac	AHR 9434|Amfenac amide|AL-6515|Nepafenaco|2-amino-3-Benzoylbenzeneacetamide|AL 6515|Nepafenacum|AHR-9434|Nevanac	ilevro|nevanac	DRUGBANK	DB06802	C15H14N2O2	small molecule	S01BC10	78281-72-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QEFAQIPZVLVERP-UHFFFAOYSA-N
24871	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5665	4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE	-	-	DRUGBANK	DB06844	C21H15N5O3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBXKBJLIESPLIK-UHFFFAOYSA-N
24922	111362	5347	-	PLK1	PLK|STPK13	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5716	3-[3-chloro-5-(5-{[(1S)-1-phenylethyl]amino}isoxazolo[5,4-c]pyridin-3-yl)phenyl]propan-1-ol	-	-	DRUGBANK	DB06897	C23H22ClN3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MMGKIHLBFPJYJL-HNNXBMFYSA-N
24932	111510	5518	-	PPP2R1A	PP2A-Aalpha|PP2AAALPHA|PR65A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5724	(2S,3S,4E,6E,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid	-	-	DRUGBANK	DB06905	C20H29NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HJVCHYDYCYBBQX-HLTLHRPFSA-N
24935	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5728	1-ethyl-N-(phenylmethyl)-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridine-5-carboxamide	-	-	DRUGBANK	DB06909	C21H25N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZGJNFBMYYEFGM-UHFFFAOYSA-N
24948	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5744	3-(2-AMINOQUINAZOLIN-6-YL)-4-METHYL-N-[3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE	-	-	DRUGBANK	DB06925	C23H17F3N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEIASMOUYNOXGA-UHFFFAOYSA-N
24968	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5763	N-(3-cyclopropyl-1H-pyrazol-5-yl)-2-(2-naphthyl)acetamide	-	-	DRUGBANK	DB06944	C18H17N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RIGZCVNCFXYBEG-UHFFFAOYSA-N
24972	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5767	2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE	-	-	DRUGBANK	DB06948	C18H21N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XWWRLKIBRPJQJX-UHFFFAOYSA-N
24984	111362	5347	-	PLK1	PLK|STPK13	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5782	3-[3-(3-methyl-6-{[(1S)-1-phenylethyl]amino}-1H-pyrazolo[4,3-c]pyridin-1-yl)phenyl]propanamide	-	-	DRUGBANK	DB06963	C24H25N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZFGCLYUGFRNYFE-INIZCTEOSA-N
25019	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5824	9-HYDROXY-6-(3-HYDROXYPROPYL)-4-(2-METHOXYPHENYL)PYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE	-	-	DRUGBANK	DB07006	C24H20N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AOGOZJCRIFBTTN-UHFFFAOYSA-N
25068	110030	3832	-	KIF11	EG5|HKSP|KNSL1|MCLMR|TRIP5	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5882	(4R)-4-(3-HYDROXYPHENYL)-N,N,7,8-TETRAMETHYL-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE	-	-	DRUGBANK	DB07064	C20H24N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HPVCRUIDFODATB-LJQANCHMSA-N
25115	109418	3176	-	HNMT	HMT|HNMT-S1|HNMT-S2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5924	4-(DIMETHYLAMINO)BUTYL IMIDOTHIOCARBAMATE	-	-	DRUGBANK	DB07106	C7H17N3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UFYJLJINUGVUHO-UHFFFAOYSA-N
25135	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5944	O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE	-	-	DRUGBANK	DB07126	C18H22N6O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OWXORKPNCHJYOF-UHFFFAOYSA-N
25148	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5955	(2S)-N-[(3Z)-5-CYCLOPROPYL-3H-PYRAZOL-3-YLIDENE]-2-[4-(2-OXOIMIDAZOLIDIN-1-YL)PHENYL]PROPANAMIDE	-	-	DRUGBANK	DB07137	C18H19N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPAWNIKVRIVDBT-PORMKJMCSA-N
25157	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5964	2,3-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-B]PYRIDIN-4-AMINE	-	-	DRUGBANK	DB07146	C25H26N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QUIQCYFSBGOBKE-UHFFFAOYSA-N
25170	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5978	N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCINE	-	-	DRUGBANK	DB07160	C12H19NO6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MZJYLQZZISBOTF-JBDRJPRFSA-N
25175	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5982	N-cyclopropyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine	-	-	DRUGBANK	DB07164	C13H12N6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CAGHIASAHLPQMS-UHFFFAOYSA-N
25191	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6003	4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE	-	-	DRUGBANK	DB07186	C23H24N6O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TYYNSDQVFIOSFH-UHFFFAOYSA-N
25192	111362	5347	-	PLK1	PLK|STPK13	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6003	4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE	-	-	DRUGBANK	DB07186	C23H24N6O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TYYNSDQVFIOSFH-UHFFFAOYSA-N
25206	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6020	6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE	-	-	DRUGBANK	DB07203	C18H20ClN5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OUEGMEMDEAOAEG-UHFFFAOYSA-N
25227	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6035	BENZYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE	-	-	DRUGBANK	DB07219	C25H35N3O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OMQNYWZURFTFHE-MQBSTWLZSA-N
25230	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6039	METHYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE	-	-	DRUGBANK	DB07223	C19H31N3O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XGWSRLSPWIEMLQ-YTFOTSKYSA-N
25231	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6040	N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCYL-L-ALANINE	-	-	DRUGBANK	DB07224	C15H24N2O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FCCIQOJEDMDETP-QHZLYTNSSA-N
25232	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6041	N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCYL-L-ISOLEUCINE	-	-	DRUGBANK	DB07225	C18H30N2O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CFABOFMUPCWOPC-LHEWDLALSA-N
25233	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6042	N-[4-(2-CHLOROPHENYL)-1,3-DIOXO-1,2,3,6-TETRAHYDROPYRROLO[3,4-C]CARBAZOL-9-YL]FORMAMIDE	-	-	DRUGBANK	DB07226	C21H12ClN3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWZVNUNTFNELHL-UHFFFAOYSA-N
25241	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6047	N-({(2S,3S)-3-[(BENZYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINE	-	-	DRUGBANK	DB07231	C22H29N3O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MERYMLLGRCNRKE-HILJTLORSA-N
25269	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6073	4-(2-chlorophenyl)-8-(2-hydroxyethyl)-6-methylpyrrolo[3,4-e]indole-1,3(2H,6H)-dione	-	-	DRUGBANK	DB07257	C19H15ClN2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHMQZCPGFZBLBG-UHFFFAOYSA-N
25277	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6081	3-(9-HYDROXY-1,3-DIOXO-4-PHENYL-2,3-DIHYDROPYRROLO[3,4-C]CARBAZOL-6(1H)-YL)PROPANOIC ACID	-	-	DRUGBANK	DB07265	C23H16N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JDARUOOLJCFUOY-UHFFFAOYSA-N
25278	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6082	8-ethyl-3,10,10-trimethyl-4,5,6,8,10,12-hexahydropyrazolo[4',3':6,7]cyclohepta[1,2-b]pyrrolo[2,3-f]indol-9(1H)-one	-	-	DRUGBANK	DB07266	C21H24N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AOMMPEGZDRAGRC-UHFFFAOYSA-N
25305	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6113	5,6-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE	-	-	DRUGBANK	DB07297	C24H25N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PTILEOLOGGMFCS-UHFFFAOYSA-N
25344	109831	3619	-	INCENP	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6156	N~6~-cyclohexyl-N~2~-(4-morpholin-4-ylphenyl)-9H-purine-2,6-diamine	-	-	DRUGBANK	DB07340	C21H27N7O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZFLJHSQHILSNCM-UHFFFAOYSA-N
25345	114646	9212	-	AURKB	AIK2|AIM-1|AIM1|ARK2|AurB|IPL1|PPP1R48|STK12|STK5|aurkb-sv1|aurkb-sv2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6156	N~6~-cyclohexyl-N~2~-(4-morpholin-4-ylphenyl)-9H-purine-2,6-diamine	-	-	DRUGBANK	DB07340	C21H27N7O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZFLJHSQHILSNCM-UHFFFAOYSA-N
25367	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6176	1-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}-3-[3-(trifluoromethyl)phenyl]urea	-	-	DRUGBANK	DB07360	C19H15F3N6OS2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JJHXPDTVQKWKHA-UHFFFAOYSA-N
25368	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6177	1-(3-chlorophenyl)-3-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}urea	-	-	DRUGBANK	DB07361	C18H15ClN6OS2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAYAUAZLLLJJGH-UHFFFAOYSA-N
25369	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6178	1-(5-{2-[(1-methyl-1H-pyrazolo[4,3-d]pyrimidin-7-yl)amino]ethyl}-1,3-thiazol-2-yl)-3-[3-(trifluoromethyl)phenyl]urea	-	-	DRUGBANK	DB07362	C19H17F3N8OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UOLCZAFAGDOUFX-UHFFFAOYSA-N
25389	110874	4809	CTA-216E10.8	NHP2L1	15.5K|FA-1|FA1|NHPX|OTK27|SNRNP15-5|SNU13|SPAG12|SSFA1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6190	Anisomycin	-	-	DRUGBANK	DB07374	C14H19NO4	small molecule	-	22862-76-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YKJYKKNCCRKFSL-RDBSUJKOSA-N
25425	107917	1537	-	CYC1	MC3DN6|UQCR4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6215	METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE	-	-	DRUGBANK	DB07401	C22H17N3O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WFDXOXNFNRHQEC-GHRIWEEISA-N
25428	111189	5163	-	PDK1	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6217	4-[(3-CHLORO-4-{[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]AMINO}PHENYL)SULFONYL]-N,N-DIMETHYLBENZAMIDE	-	-	DRUGBANK	DB07403	C19H18ClF3N2O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTDZLJHKVNTQGZ-GOSISDBHSA-N
25485	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6282	5-[5,6-BIS(METHYLOXY)-1H-BENZIMIDAZOL-1-YL]-3-{[1-(2-CHLOROPHENYL)ETHYL]OXY}-2-THIOPHENECARBOXAMIDE	-	-	DRUGBANK	DB07471	C22H20ClN3O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UHCHLTQBLNUYRT-GFCCVEGCSA-N
25548	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6343	4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]-2-FURYL}-N-METHYLBENZENESULFONAMIDE	-	-	DRUGBANK	DB07533	C15H13N3O4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FJJJERLTHDXEPT-JYRVWZFOSA-N
25550	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6344	4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE	-	-	DRUGBANK	DB07534	C14H11N3O4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BKUMVXIXUVYKDQ-GHXNOFRVSA-N
25554	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6348	4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}-2-(TRIFLUOROMETHYL)BENZENESULFONAMIDE	-	-	DRUGBANK	DB07538	C15H10F3N3O4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGVVHQNJKUNSFQ-WDZFZDKYSA-N
25556	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6349	4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZOIC ACID	-	-	DRUGBANK	DB07539	C15H10N2O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JLRKRQCTYQGDKJ-GHXNOFRVSA-N
25562	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6355	N-{3-[(4-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-2-YL)AMINO]PHENYL}CYCLOPROPANECARBOXAMIDE	-	-	DRUGBANK	DB07545	C21H18F3N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RDTDWGQDFJPTPD-UHFFFAOYSA-N
25578	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6371	N-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'-DIMETHYL-BENZENE-1,4-DIAMINE	-	-	DRUGBANK	DB07562	C17H19N5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FGGSNQOBRJVAKL-UHFFFAOYSA-N
25586	115651	10376	-	TUBA1B	K-ALPHA-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6382	2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE	-	-	DRUGBANK	DB07574	C22H25NO6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TYDIWMTWTXFWSY-HNNXBMFYSA-N
25638	107917	1537	-	CYC1	MC3DN6|UQCR4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6442	5-HEPTYL-6-HYDROXY-1,3-BENZOTHIAZOLE-4,7-DIONE	-	-	DRUGBANK	DB07636	C14H17NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CAPIRLKYURUNFL-UHFFFAOYSA-N
25646	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6447	DECYL(DIMETHYL)PHOSPHINE OXIDE	-	-	DRUGBANK	DB07641	C12H27OP	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GSVLCKASFMVUSW-UHFFFAOYSA-N
25696	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6493	4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE	-	-	DRUGBANK	DB07688	C17H20N6O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPJIMTALCNCQLV-UHFFFAOYSA-N
25777	107917	1537	-	CYC1	MC3DN6|UQCR4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6564	(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE	-	-	DRUGBANK	DB07763	C16H12F2N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZZFJGCAYWBVBI-INIZCTEOSA-N
25798	107917	1537	-	CYC1	MC3DN6|UQCR4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6577	FAMOXADONE	-	-	DRUGBANK	DB07778	C22H18N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PCCSBWNGDMYFCW-QFIPXVFZSA-N
25803	111814	5876	RP4-682C21.3	RABGGTB	GGTB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6579	FARNESYL DIPHOSPHATE	-	-	DRUGBANK	DB07780	C15H28O7P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWFJDQUYCIWHTN-YFVJMOTDSA-N
25817	111362	5347	-	PLK1	PLK|STPK13	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6588	1-[5-methyl-2-(trifluoromethyl)furan-3-yl]-3-[(2Z)-5-(2-{[6-(1H-1,2,4-triazol-3-ylamino)pyrimidin-4-yl]amino}ethyl)-1,3-thiazol-2(3H)-ylidene]urea	-	-	DRUGBANK	DB07789	C18H17F3N10O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KNTGXMNWVXZIMW-UHFFFAOYSA-N
25827	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6599	N-butyl-3-{[6-(9H-purin-6-ylamino)hexanoyl]amino}benzamide	-	-	DRUGBANK	DB07801	C22H29N7O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WOYITRCGMUXUDE-UHFFFAOYSA-N
25859	111814	5876	RP4-682C21.3	RABGGTB	GGTB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6638	GERANYLGERANYL DIPHOSPHATE	-	-	DRUGBANK	DB07841	C20H36O7P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OINNEUNVOZHBOX-KGODAQDXSA-N
25877	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6649	1-(3,5-DICHLOROPHENYL)-5-METHYL-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID	-	-	DRUGBANK	DB07852	C10H7Cl2N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CZTNDZALWLHXBA-UHFFFAOYSA-N
25879	119722	51765	RP6-213H19.1	STK26	MASK|MST4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6650	[4-({4-[(5-CYCLOPROPYL-1H-PYRAZOL-3-YL)AMINO]QUINAZOLIN-2-YL}IMINO)CYCLOHEXA-2,5-DIEN-1-YL]ACETONITRILE	-	-	DRUGBANK	DB07853	C22H19N7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AWMNWCNUTIFHRJ-JLPGSUDCSA-N
25946	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6715	7-METHOXY-1-METHYL-9H-BETA-CARBOLINE	-	-	DRUGBANK	DB07919	C13H12N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BXNJHAXVSOCGBA-UHFFFAOYSA-N
26054	110030	3832	-	KIF11	EG5|HKSP|KNSL1|MCLMR|TRIP5	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6825	N,N-DIETHYL-2-[(2-THIENYLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE	-	-	DRUGBANK	DB08032	C18H22N2O2S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NZTHBWHANVWSRX-UHFFFAOYSA-N
26055	110030	3832	-	KIF11	EG5|HKSP|KNSL1|MCLMR|TRIP5	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6826	(5R)-N,N-DIETHYL-5-METHYL-2-[(THIOPHEN-2-YLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE	-	-	DRUGBANK	DB08033	C19H24N2O2S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UQKSYQYWUHUIEH-GFCCVEGCSA-N
26057	110030	3832	-	KIF11	EG5|HKSP|KNSL1|MCLMR|TRIP5	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6830	(2S)-4-(2,5-difluorophenyl)-N-[(3R,4S)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide	-	-	DRUGBANK	DB08037	C25H28F3N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MYBGWENAVMIGMM-GIFXNVAJSA-N
26076	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6848	N-(2-chlorophenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine	-	-	DRUGBANK	DB08055	C18H13ClN4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNBICZMPIJMWGC-UHFFFAOYSA-N
26077	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6849	N-(2,6-dimethylphenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine	-	-	DRUGBANK	DB08056	C20H18N4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KKYYLKPGILUPOA-UHFFFAOYSA-N
26078	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6850	N-(2-chloro-6-methylphenyl)-8-[(3S)-3-methylpiperazin-1-yl]imidazo[1,5-a]quinoxalin-4-amine	-	-	DRUGBANK	DB08057	C22H23ClN6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWJPPYCULHDHBB-HNNXBMFYSA-N
26083	111362	5347	-	PLK1	PLK|STPK13	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6852	(1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-[(METHYLOXY)METHYL]-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO[4,3,2-DE]INDENO[4,5-H][2]BENZOPYRAN-11-YL ACETATE	-	-	DRUGBANK	DB08059	C23H24O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QDLHCMPXEPAAMD-QAIWCSMKSA-N
26090	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6858	2-(1H-pyrazol-3-yl)-1H-benzimidazole	-	-	DRUGBANK	DB08065	C10H8N4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IYTGPPNUOLLGBE-UHFFFAOYSA-N
26091	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6859	N-[3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRAZOL-4-YL]BENZAMIDE	-	-	DRUGBANK	DB08066	C17H13N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPKSFXFWECAIBR-UHFFFAOYSA-N
26204	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6970	4-(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine	-	-	DRUGBANK	DB08178	C12H11N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GGEWEQJWGGJUHO-UHFFFAOYSA-N
26209	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6974	4-(4-propoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine	-	-	DRUGBANK	DB08182	C14H15N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZHMRPXZRUZLCNL-UHFFFAOYSA-N
26223	110030	3832	-	KIF11	EG5|HKSP|KNSL1|MCLMR|TRIP5	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6989	[(4R)-4-(3-HYDROXYPHENYL)-1,6-DIMETHYL-2-THIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-5-YL](PHENYL)METHANONE	-	-	DRUGBANK	DB08198	C19H18N2O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JGBBILLMZPWNFU-QGZVFWFLSA-N
26235	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7009	HYDROXY(OXO)(3-{[(2Z)-4-[3-(1H-1,2,4-TRIAZOL-1-YLMETHYL)PHENYL]PYRIMIDIN-2(5H)-YLIDENE]AMINO}PHENYL)AMMONIUM	-	-	DRUGBANK	DB08218	C19H15N7O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PLQVWKCQWFFUFJ-FCDQGJHFSA-N
26237	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7010	4-METHYL-5-{(2E)-2-[(4-MORPHOLIN-4-YLPHENYL)IMINO]-2,5-DIHYDROPYRIMIDIN-4-YL}-1,3-THIAZOL-2-AMINE	-	-	DRUGBANK	DB08219	C18H20N6OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPSZSAKYXPWBRR-RELWKKBWSA-N
26274	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7023	6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE	-	-	DRUGBANK	DB08233	C18H21N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RFSDQDHHBKYQOD-UHFFFAOYSA-N
26280	115415	10109	PRO2446	ARPC2	ARC34|PNAS-139|p34-Arc	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7025	N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide	-	-	DRUGBANK	DB08235	C16H16N2OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACAKNPKRLPMONU-UHFFFAOYSA-N
26287	115415	10109	PRO2446	ARPC2	ARC34|PNAS-139|p34-Arc	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7026	(2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one	-	-	DRUGBANK	DB08236	C15H11BrClNO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KEGQNJITMFBVAC-HNNXBMFYSA-N
26292	110030	3832	-	KIF11	EG5|HKSP|KNSL1|MCLMR|TRIP5	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7029	(2S)-4-(2,5-DIFLUOROPHENYL)-N-METHYL-2-PHENYL-N-PIPERIDIN-4-YL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE	-	-	DRUGBANK	DB08239	C23H25F2N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKLVBHMAIMEVEH-QFIPXVFZSA-N
26295	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7031	4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE	-	-	DRUGBANK	DB08241	C19H22N6O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUUOIINPNMNPIU-UHFFFAOYSA-N
26297	110030	3832	-	KIF11	EG5|HKSP|KNSL1|MCLMR|TRIP5	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7033	(1S)-1-CYCLOPROPYL-2-[(2S)-4-(2,5-DIFLUOROPHENYL)-2-PHENYL-2,5-DIHYDRO-1H-PYRROL-1-YL]-2-OXOETHANAMINE	-	-	DRUGBANK	DB08244	C21H20F2N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VCOUEHUEFUDZIS-PMACEKPBSA-N
26298	110030	3832	-	KIF11	EG5|HKSP|KNSL1|MCLMR|TRIP5	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7035	(2S)-4-(2,5-DIFLUOROPHENYL)-N,N-DIMETHYL-2-PHENYL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE	-	-	DRUGBANK	DB08246	C19H18F2N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WFFMEXQHWXEKBV-SFHVURJKSA-N
26301	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7037	3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE	-	-	DRUGBANK	DB08248	C18H22N6O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BKDUVKJYBJDZQW-UHFFFAOYSA-N
26303	110030	3832	-	KIF11	EG5|HKSP|KNSL1|MCLMR|TRIP5	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7039	(5S)-5-(3-AMINOPROPYL)-3-(2,5-DIFLUOROPHENYL)-N-ETHYL-5-PHENYL-4,5-DIHYDRO-1H-PYRAZOLE-1-CARBOXAMIDE	-	-	DRUGBANK	DB08250	C21H24F2N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OQMVLDZJPRSNOG-NRFANRHFSA-N
26326	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7073	(2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol	-	-	DRUGBANK	DB08285	C19H26N6O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SQUNOCMDMIQIQK-OAHLLOKOSA-N
26338	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7086	4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid	-	-	DRUGBANK	DB08299	C21H13N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QTNUWEKKZHSUQO-UHFFFAOYSA-N
26347	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7096	3-({2-[(4-{[6-(CYCLOHEXYLMETHOXY)-9H-PURIN-2-YL]AMINO}PHENYL)SULFONYL]ETHYL}AMINO)PROPAN-1-OL	-	-	DRUGBANK	DB08309	C23H32N6O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AMFGILNPFBVREA-UHFFFAOYSA-N
26371	107917	1537	-	CYC1	MC3DN6|UQCR4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7116	METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE	-	-	DRUGBANK	DB08330	C19H18O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VEJCBCPEURAYAS-MEAXDALNSA-N
26403	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7140	1-methyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxylic acid	-	-	DRUGBANK	DB08355	C17H15N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZOBRPBVIEUWYJR-UHFFFAOYSA-N
26414	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7150	8-bromo-4-(2-chlorophenyl)-N-(2-hydroxyethyl)-6-methyl-1,3-dioxo-1,2,3,6-tetrahydropyrrolo[3,4-e]indole-7-carboxamide	-	-	DRUGBANK	DB08365	C20H15BrClN3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUAHLMVOYLUYSB-UHFFFAOYSA-N
26427	126617	140465	-	MYL6B	MLC1SA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7163	4-[4-(2,5-DIOXO-PYRROLIDIN-1-YL)-PHENYLAMINO]-4-HYDROXY-BUTYRIC ACID	-	-	DRUGBANK	DB08378	C14H16N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SUETUOGYOWOLNJ-NSHDSACASA-N
26508	107917	1537	-	CYC1	MC3DN6|UQCR4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7234	2-NONYL-4-HYDROXYQUINOLINE N-OXIDE	-	-	DRUGBANK	DB08453	C18H25NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LMBFBUICIQJLPK-UHFFFAOYSA-N
26515	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7244	(2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol	-	-	DRUGBANK	DB08463	C24H29N7O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HOCBJBNQIQQQGT-LJQANCHMSA-N
26576	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7305	1-[4-(AMINOSULFONYL)PHENYL]-1,6-DIHYDROPYRAZOLO[3,4-E]INDAZOLE-3-CARBOXAMIDE	-	-	DRUGBANK	DB08527	C15H12N6O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HGAKLLFPOGATII-UHFFFAOYSA-N
26614	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7349	4-{[4-AMINO-6-(CYCLOHEXYLMETHOXY)-5-NITROSOPYRIMIDIN-2-YL]AMINO}BENZAMIDE	-	-	DRUGBANK	DB08572	C18H22N6O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YBKLJTXDSBEVRV-UHFFFAOYSA-N
26715	107917	1537	-	CYC1	MC3DN6|UQCR4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7464	UBIQUINONE-2	-	-	DRUGBANK	DB08690	C19H26O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SQQWBSBBCSFQGC-JLHYYAGUSA-N
26722	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7468	9-amino-5-(2-aminopyrimidin-4-yl)pyrido[3',2':4,5]pyrrolo[1,2-c]pyrimidin-4-ol	-	-	DRUGBANK	DB08694	C14H11N7O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RTHKPHCVZVYDFN-UHFFFAOYSA-N
26820	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	unknown	target	Dawson LA (2000)	10727715	179355	7578	Bopindolol	Sandonorm	-	DRUGBANK	DB08807	C23H28N2O3	small molecule	C07AA17|C07CA17	62658-63-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UUOJIACWOAYWEZ-UHFFFAOYSA-N
26821	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	unknown	target	Herrick-Davis K (1988)	3141589	179357	7578	Bopindolol	Sandonorm	-	DRUGBANK	DB08807	C23H28N2O3	small molecule	C07AA17|C07CA17	62658-63-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UUOJIACWOAYWEZ-UHFFFAOYSA-N
26822	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	unknown	target	Leonhardt S (1989)	2664084	179356	7578	Bopindolol	Sandonorm	-	DRUGBANK	DB08807	C23H28N2O3	small molecule	C07AA17|C07CA17	62658-63-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UUOJIACWOAYWEZ-UHFFFAOYSA-N
26823	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	unknown	target	Ariani K (1989)	2512511	179359	7578	Bopindolol	Sandonorm	-	DRUGBANK	DB08807	C23H28N2O3	small molecule	C07AA17|C07CA17	62658-63-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UUOJIACWOAYWEZ-UHFFFAOYSA-N
26824	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	unknown	target	Terron JA (1994)	7944828	179358	7578	Bopindolol	Sandonorm	-	DRUGBANK	DB08807	C23H28N2O3	small molecule	C07AA17|C07CA17	62658-63-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UUOJIACWOAYWEZ-UHFFFAOYSA-N
26829	111189	5163	-	PDK1	-	9606	Homo sapiens	inhibitor	target	Stacpoole PW (1989)	2554095	181656	7580	Dichloroacetic Acid	dichloracetic acid|dichloroacetate|DCA	bichloracetic acid 100%	DRUGBANK	DB08809	C2H2Cl2O2	small molecule	-	79-43-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JXTHNDFMNIQAHM-UHFFFAOYSA-N
26868	109404	3161	-	HMMR	CD168|IHABP|RHAMM	9606	Homo sapiens	unknown	target	Turley EA (1982)	6185115	181674	7587	Hyaluronic acid	Hyaluronan|Hyaluronate	wellage family mask small|deep	DRUGBANK	DB08818	C28H44N2O23	small molecule	S01KA01|M09AX01|S01KA51|D03AX05|R01AX09	9004-61-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KIUKXJAPPMFGSW-MNSSHETKSA-N
26907	107225	771	-	CA12	CAXII|HsT18816	9606	Homo sapiens	inhibitor	target	Innocenti A (2010)	20185318	182147	7605	Ellagic Acid	2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione|Benzoaric acid|Elagostasine|Lagistase|476-66-4|Alizarine Yellow	-	DRUGBANK	DB08846	C14H6O8	small molecule	-	476-66-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFSDNFLWKVMVRB-UHFFFAOYSA-N
26971	108554	2263	-	FGFR2	BBDS|BEK|BFR-1|CD332|CEK3|CFD1|ECT1|JWS|K-SAM|KGFR|TK14|TK25	9606	Homo sapiens	inhibitor	target	Gozgit JM (2013)	23468082	182234	7645	Ponatinib	AP24534|AP 24534|Ponatinibum	iclusig	DRUGBANK	DB08901	C29H27F3N6O	small molecule	L01XE24	943319-70-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHXJVRSECIGDHY-UHFFFAOYSA-N
26978	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	inhibitor	target	Gushwa NN (2012)	23190395	182219	7645	Ponatinib	AP24534|AP 24534|Ponatinibum	iclusig	DRUGBANK	DB08901	C29H27F3N6O	small molecule	L01XE24	943319-70-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHXJVRSECIGDHY-UHFFFAOYSA-N
26981	112415	6524	-	SLC5A2	SGLT2	9606	Homo sapiens	inhibitor	target	Lamos EM (2013)	23590413	182247	7651	Canagliflozin	Canagliflozin anhydrous	invokana|invokamet xr|invokame	DRUGBANK	DB08907	C24H25FO5S	small molecule	A10BX11|A10BD16	842133-18-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XTNGUQKDFGDXSJ-ZXGKGEBGSA-N
26983	115156	9817	-	KEAP1	INrf2|KLHL19	9606	Homo sapiens	binder	target	Oh CJ (2012)	23056222	182212	7652	Dimethyl fumarate	trans-1,2-Ethylenedicarboxylic acid dimethyl ester|trans-Butenedioic acid dimethyl ester|Tecfidera|(e)-But-2-enedioic acid dimethyl ester|BG-12|1,2-Bis(methoxycarbonyl)-trans-ethylene|Fumaric acid, dimethyl ester|dimethyl (E) butenedioate|Dimethyl trans-ethylenedicarboxylate	tecfidera	DRUGBANK	DB08908	-	small molecule	N07XX09	624-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
26988	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Ferguson GD (2007)	17308870	159982	7654	Pomalidomide	-	pomalyst	DRUGBANK	DB08910	C13H11N3O4	small molecule	L04AX06	19171-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVSMNLNDYGZFPF-UHFFFAOYNA-N
27014	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	agonist	target	Ring RM (2013)	23863923	182253	7747	Captodiame	Captodiame|2-[(4-butylsulfanylphenyl)-phenyl-methyl]sulfanyl-N,N-dimethylethanamine	-	DRUGBANK	DB09014	C21H29NS2	small molecule	N05BB02	486-17-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IZLPZXSZLLELBJ-UHFFFAOYNA-N
27150	109965	3763	-	KCNJ6	BIR1|GIRK-2|GIRK2|KATP-2|KATP2|KCNJ7|KIR3.2|hiGIRK2	9606	Homo sapiens	unknown	target	Spanagel R (2009)	19342616	188489	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27152	107560	1138	-	CHRNA5	LNCR2	9606	Homo sapiens	unknown	target	Hendrickson LM (2013)	23641218	188488	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27191	107935	1557	RP11-400G3.4	CYP2C19	CPCJ|CYP2C|CYPIIC17|CYPIIC19|P450C2C|P450IIC19	9606	Homo sapiens	unknown	target	Fontana E (2005)	16248836	188492	941	Isoniazid	Pyridine-4-carboxylic acid hydrazide|Isonicotinsaeurehydrazid|Isoniazid|Isonicotinohydrazide|Isonicotinic acid hydrazide|Isonicotinoylhydrazide|INH|Isonicotinylhydrazine|4-pyridinecarbohydrazide|Isonicotinic hydrazide	isotamine syr pediatric 50mg/5	DRUGBANK	DB00951	C6H7N3O	small molecule	J04AC01|J04AM03|J04AM02|J04AM01|J04AC51|J04AM06|J04AM05|J04AM04	54-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QRXWMOHMRWLFEY-UHFFFAOYSA-N
27422	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Talley JJ (2000)	10794682	188524	7221	Parecoxib	-	-	DRUGBANK	DB08439	C19H18N2O4S	small molecule	M01AH04	198470-84-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TZRHLKRLEZJVIJ-UHFFFAOYSA-N
27461	112415	6524	-	SLC5A2	SGLT2	9606	Homo sapiens	inhibitor	target	Vivian EM (2015)	25598831	188536	7801	Empagliflozin	(1S)-1,5-anhydro-1-(4-chloro-3-{4-[(3S)-tetrahydrofuran-3-yloxy]benzyl}phenyl)-D-glucitol|1-chloro-4-(glucopyranos-1-yl)-2-(4-(tetrahydrofuran-3-yloxy)benzyl)benzene	jardiance|glyxambi|synjardy|sy	DRUGBANK	DB09038	C23H27ClO7	small molecule	A10BD19|A10BD20|A10BX12	864070-44-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OBWASQILIWPZMG-QZMOQZSNSA-N
27462	112415	6524	-	SLC5A2	SGLT2	9606	Homo sapiens	antagonist	target	Vivian EM (2015)	25598831	188536	7801	Empagliflozin	(1S)-1,5-anhydro-1-(4-chloro-3-{4-[(3S)-tetrahydrofuran-3-yloxy]benzyl}phenyl)-D-glucitol|1-chloro-4-(glucopyranos-1-yl)-2-(4-(tetrahydrofuran-3-yloxy)benzyl)benzene	jardiance|glyxambi|synjardy|sy	DRUGBANK	DB09038	C23H27ClO7	small molecule	A10BD19|A10BD20|A10BX12	864070-44-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OBWASQILIWPZMG-QZMOQZSNSA-N
27489	108554	2263	-	FGFR2	BBDS|BEK|BFR-1|CD332|CEK3|CFD1|ECT1|JWS|K-SAM|KGFR|TK14|TK25	9606	Homo sapiens	inhibitor	target	Matsui J (2008)	17943726	188553	7825	Lenvatinib	4-{3-chloro-4-[(cyclopropylcarbamoyl)amino]phenoxy}-7-methoxyquinoline-6-carboxamide|Lenvatinib Mesylate	lenvima	DRUGBANK	DB09078	C21H19ClN4O4	small molecule	L01XE29	417716-92-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WOSKHXYHFSIKNG-UHFFFAOYSA-N
27497	108554	2263	-	FGFR2	BBDS|BEK|BFR-1|CD332|CEK3|CFD1|ECT1|JWS|K-SAM|KGFR|TK14|TK25	9606	Homo sapiens	inhibitor	target	Hilberg F (2008)	18559524	188554	7826	Nintedanib	methyl (3Z)-3-[(4-{methyl[(4-methylpiperazin-1-yl)acetyl]amino}anilino)(phenyl)methylidene]-2-oxo-2,3-dihydro-1H-indole-6-carboxylate	ofev	DRUGBANK	DB09079	C31H33N5O4	small molecule	L01XE31	656247-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XZXHXSATPCNXJR-ZIADKAODSA-N
27504	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	inhibitor	target	Hilberg F (2008)	18559524	188554	7826	Nintedanib	methyl (3Z)-3-[(4-{methyl[(4-methylpiperazin-1-yl)acetyl]amino}anilino)(phenyl)methylidene]-2-oxo-2,3-dihydro-1H-indole-6-carboxylate	ofev	DRUGBANK	DB09079	C31H33N5O4	small molecule	L01XE31	656247-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XZXHXSATPCNXJR-ZIADKAODSA-N
27521	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	unknown	target	McCann ME (2004)	15077695	188559	7961	Firocoxib	-	-	DRUGBANK	DB09217	C17H20O5S	small molecule	-	189954-96-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FULAPETWGIGNMT-UHFFFAOYSA-N
27578	107560	1138	-	CHRNA5	LNCR2	9606	Homo sapiens	unknown	target	Dopico AM (2009)	19270242	188491	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27585	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Zheng L (2007)	17259377	181291	926	Salicylic acid	2-Carboxyphenol|2-Hydroxybenzoic acid|O-hydroxybenzoic acid|O-carboxyphenol	md cell scalp|neutrogena oil f	DRUGBANK	DB00936	C7H6O3	small molecule	N02BA04|D01AE12|S01BC08	69-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YGSDEFSMJLZEOE-UHFFFAOYSA-N
27767	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Heal DJ (2013)	23539642	196018	175	Amphetamine	beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine	pms-amphetamines xr|act amphet	DRUGBANK	DB00182	C9H13N	small molecule	N06BA01	300-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-UHFFFAOYSA-N
27779	109965	3763	-	KCNJ6	BIR1|GIRK-2|GIRK2|KATP-2|KATP2|KCNJ7|KIR3.2|hiGIRK2	9606	Homo sapiens	unknown	target	Bodhinathan K (2013)	24145411	196019	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27804	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Kroegel C (2007)	17155857	195974	3686	Cilomilast	Ariflo|cis-4-cyano-4-(3-(cyclopentyloxy)-4-methoxyphenyl)cyclohexanecarboxylic acid	-	DRUGBANK	DB03849	C20H25NO4	small molecule	-	153259-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CFBUZOUXXHZCFB-OYOVHJISSA-N
27813	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	antagonist	target	Baeumer W (2007)	17352685	195977	8064	Apremilast	Aprmilast|Apremilastum|N-{2-[(1S)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl}acetamide|Apremilast	otezla	DRUGBANK	DB05676	C22H24N2O7S	small molecule	L04AA32	608141-41-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IMOZEMNVLZVGJZ-QGZVFWFLSA-N
27814	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	antagonist	target	Abdulrahim H (2015)	25864487	196025	8064	Apremilast	Aprmilast|Apremilastum|N-{2-[(1S)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl}acetamide|Apremilast	otezla	DRUGBANK	DB05676	C22H24N2O7S	small molecule	L04AA32	608141-41-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IMOZEMNVLZVGJZ-QGZVFWFLSA-N
27883	113281	7442	-	TRPV1	VR1	9606	Homo sapiens	agonist	target	Anand P (2011)	21852280	196010	8093	Capsaicin	-	coralite medicated heat|capzas	DRUGBANK	DB06774	C18H27NO3	small molecule	M02AB01|N01BX04	404-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YKPUWZUDDOIDPM-SOFGYWHQSA-N
27884	113281	7442	-	TRPV1	VR1	9606	Homo sapiens	agonist	target	Wallace M (2011)	21158551	196000	8093	Capsaicin	-	coralite medicated heat|capzas	DRUGBANK	DB06774	C18H27NO3	small molecule	M02AB01|N01BX04	404-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YKPUWZUDDOIDPM-SOFGYWHQSA-N
27899	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	partial agonist	target	Bang-Andersen B (2011)	21486038	196006	8112	Vortioxetine	4-{2-[(2,4-dimethylphenyl)sulfanyl]phenyl}piperazin-1-ium|vortioxetine cation	brintellix|trintellix	DRUGBANK	DB09068	C18H23N2S	small molecule	N06AX26	508233-74-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQNWZWMKLDQSAC-UHFFFAOYSA-O
27980	113281	7442	-	TRPV1	VR1	9606	Homo sapiens	unknown	target	Hoegestaett ED (2005)	15987694	198170	309	Acetaminophen	actaminophne|p-hydroxyacetanilide|p-acetamidophenol|p-hydroxy-acetanilid|p-acetaminophenol|Acenol|N-acetyl-p-aminophenol|4-(Acetylamino)phenol|Paracetamolum|4'-hydroxyacetanilide|Paractamol|p-Acetylaminophenol|Acetaminophen|p-hydroxyphenolacetamide|Paracetamol|4-acetamidophenol|APAP|acetaminofn	tylenol cold and flu nighttime	DRUGBANK	DB00316	C8H9NO2	small molecule	N02BE71|N02BE01|N02BE51	103-90-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZVAJINKPMORJF-UHFFFAOYSA-N
27981	113281	7442	-	TRPV1	VR1	9606	Homo sapiens	unknown	target	Mallet C (2010)	20862299	198171	309	Acetaminophen	actaminophne|p-hydroxyacetanilide|p-acetamidophenol|p-hydroxy-acetanilid|p-acetaminophenol|Acenol|N-acetyl-p-aminophenol|4-(Acetylamino)phenol|Paracetamolum|4'-hydroxyacetanilide|Paractamol|p-Acetylaminophenol|Acetaminophen|p-hydroxyphenolacetamide|Paracetamol|4-acetamidophenol|APAP|acetaminofn	tylenol cold and flu nighttime	DRUGBANK	DB00316	C8H9NO2	small molecule	N02BE71|N02BE01|N02BE51	103-90-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZVAJINKPMORJF-UHFFFAOYSA-N
27982	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Kraft SL (2014)	24038727	198172	1156	Procarbazine	Procarbazinum|p-(2-Methylhydrazinomethyl)-N-isopropylbenzamide|N-isopropyl-4-[(2-methylhydrazino)methyl]benzamide|N-4-Isopropylcarbamoylbenzyl-N'-methylhydrazine|1-Methyl-2-(p-(isopropylcarbamoyl)benzyl)hydrazine|Procarbazin|Procarbazina|N-Isopropyl--(2-methylhydrazino)-p-toluamide|2-(p-Isopropylcarbamoylbenzyl)-1-methylhydrazine|N-(1-Methylethyl)-4-((2-methylhydrazino)methyl)benzamide|4-((2-Methylhydrazino)methyl)-N-isopropylbenzamide|N-Isopropyl-p-(2-methylhydrazinomethyl)-benzamide	matulane	DRUGBANK	DB01168	C12H19N3O	small molecule	L01XB01	671-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CPTBDICYNRMXFX-UHFFFAOYSA-N
27983	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Holt A (1992)	1359073	198173	1156	Procarbazine	Procarbazinum|p-(2-Methylhydrazinomethyl)-N-isopropylbenzamide|N-isopropyl-4-[(2-methylhydrazino)methyl]benzamide|N-4-Isopropylcarbamoylbenzyl-N'-methylhydrazine|1-Methyl-2-(p-(isopropylcarbamoyl)benzyl)hydrazine|Procarbazin|Procarbazina|N-Isopropyl--(2-methylhydrazino)-p-toluamide|2-(p-Isopropylcarbamoylbenzyl)-1-methylhydrazine|N-(1-Methylethyl)-4-((2-methylhydrazino)methyl)benzamide|4-((2-Methylhydrazino)methyl)-N-isopropylbenzamide|N-Isopropyl-p-(2-methylhydrazinomethyl)-benzamide	matulane	DRUGBANK	DB01168	C12H19N3O	small molecule	L01XB01	671-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CPTBDICYNRMXFX-UHFFFAOYSA-N
28015	107772	1381	-	CRABP1	CRABP|CRABP-I|CRABPI|RBP5	9606	Homo sapiens	degradation	target	Itoh Y (2010)	20369832	125335	8428	Bivalent ligand 2	Bivalent_ligand_2|Compound 4b	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	SNIPER	Specific and Non-genetic Inhibitor-of-apoptosis proteins (IAPs)-dependent Protein Eraser; structured as IAP ligand--linker--target binding moiety; target degraded via UPS	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	recruited E3 ligase	Standardized BVL Name: Compound 4b(cIAP1:methyl bestatin --- CRABPI/II:ATRA)	-
28023	115723	10460	-	TACC3	ERIC-1|ERIC1	9606	Homo sapiens	degradation	target	Ohoka N (2014)	25375378	206180	8422	Bivalent ligand 5	Bivalent_ligand_5|SNIPER(TACC3)-1/SNIPER(TACC3)-2|SNIPER(TACC3)-1|SNIPER(TACC3)-2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	SNIPER	Specific and Non-genetic Inhibitor-of-apoptosis proteins (IAPs)-dependent Protein Eraser; structured as IAP ligand--linker--target binding moiety; target degraded via UPS	119489	51343	-	FZR1	CDC20C|CDH1|FZR|FZR2|HCDH|HCDH1	9606	Homo sapiens	recruited E3 ligase	Standardized BVL Name: SNIPER(TACC3)-1(cIAP1:bestatin --- TACC3:KHS108)	-
28107	107772	1381	-	CRABP1	CRABP|CRABP-I|CRABPI|RBP5	9606	Homo sapiens	degradation	target	Itoh Y (2011)	21515062	211395	8404	Bivalent ligand 38	Bivalent_ligand_38|SNIPER 6	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	recruited E3 ligase	Standardized BVL Name: SNIPER 6(cIAP-I:BE04- --- CRABP-I:ATRA)	-
28150	115156	9817	-	KEAP1	INrf2|KLHL19	9606	Homo sapiens	degradation	recruited E3 ligase	Lu M (2018)	29407955	211357	8435	Bivalent ligand 58	Bivalent_ligand_58|Peptide 1	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110308	4137	-	MAPT	DDPAC|FTDP-17|MAPTL|MSTD|MTBT1|MTBT2|PPND|PPP1R103|TAU	9606	Homo sapiens	target	Standardized BVL Name: Peptide 1(Keap1:peptide Ac-LDPETGEYL-OH --- Tau:b-tubulin derived peptide)	-
28157	116593	22933	-	SIRT2	SIR2|SIR2L|SIR2L2	9606	Homo sapiens	degradation	target	Schiedel M (2018)	28379698	211385	8406	Bivalent ligand 61	Bivalent_ligand_61|SirReal-based PROTAC (12)	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited E3 ligase	Standardized BVL Name: SirReal-based PROTAC (12)(CRBN:thalidomide --- SIRT2:SirReal3b)	-
28207	127816	162417	-	NAGS	AGAS|ARGA	9606	Homo sapiens	degradation	target	Bondeson DP (2018)	29129718	208144	8433	Bivalent ligand 63	Bivalent_ligand_63|PROTAC 1	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited E3 ligase	Standardized BVL Name: PROTAC1(VHL:VHL ligand --- NAGS:foretinib)	-
28339	127816	162417	-	NAGS	AGAS|ARGA	9606	Homo sapiens	degradation	target	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited E3 ligase	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- NAGS:foretinib)	-
28358	113241	7398	-	USP1	UBP	9606	Homo sapiens	inhibitor	target	Chen J (2011)	22118673	211359	8330	GW7647	GW7647|Propanoic acid, 2-[[4-[2-[[(cyclohexylamino)carbonyl](4-cyclohexylbutyl)amino]ethyl]phenyl]thio]-2-methyl-|2-[(4-{2-[(4-Cyclohexylbutyl)(cyclohexylcarbamoyl)amino]ethyl}phenyl)sulfanyl]-2-methylpropanoic acid	-	CHEMSPIDER	2637470	C29H46N2O3S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	PKNYXWMTHFMHKD-UHFFFAOYSA-N
28360	113241	7398	-	USP1	UBP	9606	Homo sapiens	inhibitor	target	Chen J (2011)	22118673	211359	1088	Pimozide	Orap|Halomonth|Pimozida|Pimozide|Opiran|Pimozidum|Neoperidole	orap|pms-pimozide|orap tab 10m	DRUGBANK	DB01100	C28H29F2N3O	small molecule	N05AG02	2062-78-4	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	YVUQSNJEYSNKRX-UHFFFAOYSA-N
28362	113241	7398	-	USP1	UBP	9606	Homo sapiens	inhibitor	target	Dexheimer TS (2014)	25229643	211355	8331	ML323	ML323|N-(4-(1H-1,2,3-triazol-1-yl)benzyl)-2-(2-isopropylphenyl)-5-methylpyrimidin-4-amine|4-Pyrimidinamine, 5-methyl-2-[2-(1-methylethyl)phenyl]-N-[[4-(1H-1,2,3-triazol-1-yl)phenyl]methyl]-|2-(2-Isopropylphenyl)-5-methyl-N-[4-(1H-1,2,3-triazol-1-yl)benzyl]-4-pyrimidinamine	-	CHEMSPIDER	30646677	C23H24N6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	VUIRVWPJNKZOSS-UHFFFAOYSA-N
28391	115156	9817	-	KEAP1	INrf2|KLHL19	9606	Homo sapiens	inhibitor	target	Yoshizaki Y (2017)	28638054	207216	8351	chlorophyllin sodium copper salt	Cuprate(3-), [18-carboxy-20-(carboxymethyl)-8-ethenyl-13-ethyl-3,7,12,17-tetramethyl-21H,23H-porphine-2-propanoato(5-)-kappaN~21~,kappaN~23~]-, sodium (1:3)|Trisodium [18-(2-carboxyethyl)-20-(carboxymethyl)-7-ethyl-3,8,13,17-tetramethyl-12-vinyl-2-porphyrincarboxylato(5-)-kappa~2~N,N']cuprate(3-)	-	CHEMSPIDER	32035047	C34H29CuN4Na3O6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	QDAAKTODRKELHM-PJABRTMHSA-I
28392	115156	9817	-	KEAP1	INrf2|KLHL19	9606	Homo sapiens	inhibitor	target	Yoshizaki Y (2017)	28638054	207216	8352	bonaphton	1,2-Naphthalenedione, 6-bromo-|6-Bromo-1,2-naphthalenedione	-	CHEMSPIDER	21868	C10H5BrO2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	MXWZRRPNVLCHMY-UHFFFAOYSA-N
28402	115156	9817	-	KEAP1	INrf2|KLHL19	9606	Homo sapiens	modulator	target	Ramkumar KM (2013)	23826874	211390	8358	Pterostilbene	4-[(E)-2-(3,5-Dimethoxyphenyl)vinyl]phenol|Phenol, 4-[(E)-2-(3,5-dimethoxyphenyl)ethenyl]-|26R60S6A5I|3,5-dimethoxy-4'-hydroxystilbene|Phenol, 4-(2-(3,5-dimethoxyphenyl)ethenyl)-, (E)-|4-(2-(3,5-Dimethoxyphenyl)ethenyl)phenol|4-Stilbenol, 3',5'-dimethoxy-, (E)-|3,5-Dimethoxy-4'-hydroxy-trans-stilbene|3',5'-Dimethoxy-4-stilbenol|Pterostilbene|4-[(E)-2-(3,5-dimethoxyphenyl)ethenyl]phenol|(E)-pterostilbene	-	CHEMSPIDER	4445042	C16H16O3	small molecule	-	537-42-8	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	VLEUZFDZJKSGMX-ONEGZZNKSA-N
28418	107427	991	-	CDC20	CDC20A|bA276H19.3|p55CDC	9606	Homo sapiens	inhibitor	target	Sackton KL (2014)	25156254	168402	8368	apcin	Carbamic acid, N-[2,2,2-trichloro-1-(2-pyrimidinylamino)ethyl]-, 2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl ester|2-(2-Methyl-5-nitro-1H-imidazol-1-yl)ethyl [2,2,2-trichloro-1-(2-pyrimidinylamino)ethyl]carbamate	-	CHEMSPIDER	2108234	C13H14Cl3N7O4	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	ZEXHXVOGJFGTRX-UHFFFAOYSA-N
28494	107427	991	-	CDC20	CDC20A|bA276H19.3|p55CDC	9606	Homo sapiens	inhibitor	target	Zeng X (2010)	20951947	139860	8463	TAMe	TAME|tosyl-arginine methyl ester|tosyl-L-arginine methyl ester|Ts-Arg-OMe|p-toluensulfonyl-L-arginine methyl ester|Nalpha-p-tosyl-L-arginine methyl ester|methyl N2-(p-tosyl)-L-argininate|methyl N2-(p-toluenenesulfonyl)-L-argininate|methyl N2-[(p-tolyl)sulphonyl]-L-argininate|N2-(p-tolylsulfonyl)-L-arginine methyl ester|methyl N2-[(4-methylphenyl)sulfonyl]-L-argininate	-	CHEBI	62167	C14H22N4O4S	small molecule	-	1784-03-08	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	FKMJXALNHKIDOD-LBPRGKRZSA-N
28502	115156	9817	-	KEAP1	INrf2|KLHL19	9606	Homo sapiens	inhibitor	target	Zhou B (2018)	30473361	212965	6528	TBHQ	2-tert-butylbenzene-1,4-diol|tert-butylhydroquinone|MTBHQ|MX4375000|1-t-Butyl-1,4-dihydroxybenzene|1948-33-0|Hydroquinone, tert-butyl-|1,4-Benzenediol, 2-(1,1-dimethylethyl)-|2-(2-Methyl-2-propanyl)-1,4-benzenediol	-	DRUGBANK	DB07726	C10H14O2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	tBHQ is shown to disrupt the interaction between KEAP1 and NFE2L2 preventing ubiquitination by KEAP1	BGNXCDMCOKJUMV-UHFFFAOYSA-N
28503	115156	9817	-	KEAP1	INrf2|KLHL19	9606	Homo sapiens	inhibitor	target	Zhou B (2018)	30473361	212965	315	Floxuridine	beta-5-Fluoro-2'-deoxyuridine|Floxuridin|1-beta-D-2'-Deoxyribofuranosyl-5-flurouracil|Floxuridinum|5-Fluorouracil deoxyriboside|5-Fluorodeoxyuridine|Deoxyfluorouridine|5-Fluoro-2-desoxyuridine|Floxiridina|Fluoruridine Deoxyribose|2'-Deoxy-5-fluorouridine|FdU|Floxuridine|Fluorodeoxyuridine|5-Fluorouracil 2'-deoxyriboside|5FDU|1beta-D-2'-Deoxyribofuranosyl-5-flurouracil|1-(2-Deoxy-beta-D-ribofuranosyl)-5-fluorouracil|FUDR	floxuridine	DRUGBANK	DB00322	C9H11FN2O5	small molecule	-	50-91-9	BIOGRID	-	-	-	-	-	-	-	-	-	-	F-dUrd is shown to disrupt the interaction between KEAP1 and NFE2L2 preventing ubiquitination by KEAP1	ODKNJVUHOIMIIZ-RRKCRQDMSA-N
28504	115156	9817	-	KEAP1	INrf2|KLHL19	9606	Homo sapiens	inhibitor	target	Mills EL (2018)	29590092	212817	8585	4-octyl Itaconate	Butanedioic acid, 2-methylene-, 4-octyl ester|2-Methylene-4-(octyloxy)-4-oxobutanoic acid	-	CHEMSPIDER	68003917	C13H22O4	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	KBASUIDPDITQHT-UHFFFAOYSA-N
28510	115156	9817	-	KEAP1	INrf2|KLHL19	9606	Homo sapiens	inhibitor	target	Wong DPW (2018)	30273379	213993	8600	andrographolide	[1R-[1a[E(S*)],4ab,5a,6a,8aa]]-3-[2-[Decahydro-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylene-1-naphthalenyl]ethylidene]dihydro-4-hydroxy-2(3H)-furanone|3a,14,15,18-Tetrahydroxy-5b,9bH,10a-labda-8(20),12-dien-16-oic Acid g-Lactone|Chuanxinlian|Kalmegh|(3E)-4-Hydroxy-3-{2-[(1R,4aS,6R,8aS)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylenedecahydro-1-naphthalenyl]ethylidene}dihydro-2(3H)-furanone|2(3H)-Furanone, 3-[2-[(1R,4aS,6R,8aS)-decahydro-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylene-1-naphthalenyl]ethylidene]dihydro-4-hydroxy-, (3E)-|(3E)-4-Hydroxy-3-{2-[(1R,4aS,6R,8aS)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylendecahydro-1-naphthalenyl]ethyliden}dihydro-2(3H)-furanon|(3E)-4-hydroxy-3-{2-[(1R,4aS,6R,8aS)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidenedecahydronaphthalen-1-yl]ethylidene}dihydrofuran-2(3H)-one|(3E)-4-Hydroxy-3-{2-[(1R,4aS,6R,8aS)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylenedecahydronaphthalen-1-yl]ethylidene}dihydrofuran-2(3H)-one	-	CHEMSPIDER	16735664	C20H30O5	small molecule	-	5508-58-7	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	BOJKULTULYSRAS-FNTFRYDESA-N
28524	124238	84749	-	USP30	-	9606	Homo sapiens	inhibitor	target	Kluge AF (2018)	29935771	216210	8598	Na-(Cyclohexylcarbonyl)-N-{5-[(2-methyl-2-propanyl)sulfamoyl]-1-naphthyl}-L-phenylalaninamide	Benzenepropanamide, alpha-[(cyclohexylcarbonyl)amino]-N-[5-[[(1,1-dimethylethyl)amino]sulfonyl]-1-naphthalenyl]-, (alphaS)-|Nalpha-(Cyclohexylcarbonyl)-N-{5-[(2-methyl-2-propanyl)sulfamoyl]-1-naphthyl}-L-phenylalaninamide	-	CHEMSPIDER	72380119	C30H37N3O4S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	DQXORJHBZHLLTE-SANMLTNESA-N
28691	107427	991	-	CDC20	CDC20A|bA276H19.3|p55CDC	9606	Homo sapiens	degradation	target	Chi JJ (2019)	31669221	222989	8469	Bivalent ligand 111	CP5V|Bivalent_ligand_111	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: CP5V (VHL:VHL1 --- CDC20:apcin-A)	-
28713	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	degradation	target	Huang HT (2018)	29129717	211728	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- AURKA:TL13-87)	-
28725	116520	22848	RP11-427H3.3	AAK1	-	9606	Homo sapiens	degradation	target	Huang HT (2018)	29129717	211728	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- AAK1:TL13-87)	-
28733	114646	9212	-	AURKB	AIK2|AIM-1|AIM1|ARK2|AurB|IPL1|PPP1R48|STK12|STK5|aurkb-sv1|aurkb-sv2	9606	Homo sapiens	degradation	target	Huang HT (2018)	29129717	211728	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- AURKB:TL13-87)	-
28735	114176	8621	-	CDK13	CDC2L|CDC2L5|CHED|hCDK13	9606	Homo sapiens	degradation	target	Huang HT (2018)	29129717	211728	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- CDK13:TL13-87)	-
28739	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	degradation	target	Huang HT (2018)	29129717	211728	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- WEE1:TL13-87)	-
28745	108853	2580	-	GAK	DNAJ26|DNAJC26	9606	Homo sapiens	degradation	target	Huang HT (2018)	29129717	211728	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- GAK:TL13-87)	-
28765	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	degradation	target	Huang HT (2018)	29129717	211728	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- LCK:TL13-87)	-
28849	111362	5347	-	PLK1	PLK|STPK13	9606	Homo sapiens	degradation	target	Mu X (2020)	31708096	223603	8559	Bivalent ligand 141	HBL-4|Bivalent_ligand_141	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: HBL-4  (CRBN:thalidomide --- PLK1:BI2536)	-
28889	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	degradation	target	Li Z (2020)	31735695	223644	8489	Bivalent ligand 81	Bivalent_ligand_81	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: (CRBN:pomalidomide ---Wee1:ZNL-02-096)	-
28897	116593	22933	-	SIRT2	SIR2|SIR2L|SIR2L2	9606	Homo sapiens	degradation	target	Schiedel M (2020)	32672888	223648	8566	Bivalent ligand 148	chloroalkylated SirReal 11|Bivalent_ligand_148	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	HaloPROTAC	PROTAC variant that induces degradation of HaloTag fusion proteins; structured as E3 binding moiety--linker--HaloTag binding moiety; target degraded via UPS	111105	5071	KB-152G3.1	PARK2	AR-JP|LPRS2|PDJ|PRKN	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: chloroalkylated SirReal 11 (HaloTag-PRKN--- SIRT2:SirReal3)	-
29416	115156	9817	-	KEAP1	INrf2|KLHL19	9606	Homo sapiens	unknown	target	Jain AD (2015)	26363505	224831	9407	(4S)-5-[[(2S)-1-[[(2S)-1-Amino-4-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-4-[[2-[[(2S,3R)-2-[[(2S)-4-carboxy-2-[[(2S)-4-carboxy-2-[[(2S)-3-carboxy-2-[[(2S)-2-[[2-(3-hydroxy-6-oxoxanthen-9-yl)-5-isothiocyanatobenzoyl]amino]-4-methylpentanoyl]amino]propanoyl]amino]butanoyl]amino]butanoyl]amino]-3-hydroxybutanoyl]amino]acetyl]amino]-5-oxopentanoic acid	BDBM50130558	-	PUBCHEM	122194818	C67H79N11O22S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	OQIWZBQSWOIZFA-IEZRXWCASA-N
29417	115156	9817	-	KEAP1	INrf2|KLHL19	9606	Homo sapiens	unknown	target	Jain AD (2015)	26363505	224831	9408	2,2'-(Naphthalene-1,4-Diylbis(((4-Methoxyphenyl)sulfonyl)azanediyl))diacetamide	2,2'-(NAPHTHALENE-1,4-DIYLBIS{[(4-METHOXYPHENYL)SULFONYL]IMINO})DIACETAMIDE (NON-PREFERRED NAME)|41P|2,2'-(NAPHTHALENE-1,4-DIYLBIS(((4-METHOXYPHENYL)SULFONYL)AZANEDIYL))DIACETAMIDE|Q27454330|BDBM50130549	-	PUBCHEM	91885637	C28H28N4O8S2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ZUIXHSIMKQZYPV-UHFFFAOYSA-N
29418	115156	9817	-	KEAP1	INrf2|KLHL19	9606	Homo sapiens	unknown	target	Jain AD (2015)	26363505	224831	9409	2,2'-(Naphthalene-1,4-diylbis(((4-methoxyphenyl)sulfonyl)azanediyl))diacetic acid	COMPOUND 2 [PMID: 24512214]|CPUY192018|2,2'-(NAPHTHALENE-1,4-DIYLBIS(((4-METHOXYPHENYL)SULFONYL)AZANEDIYL))DIACETIC ACID|2,2'-[1,4-NAPHTHALENEDIYLBIS[(4-METHOXYPHENYLSULFONYL)IMINO]]BISACETIC ACID|BRD-K55096910-001-01-4|COMPOUND 18E [PMID: 26258437]|GTPL9710|1567836-15-0|2-[[4-[CARBOXYMETHYL-(4-METHOXYPHENYL)SULFONYLAMINO]NAPHTHALEN-1-YL]-(4-METHOXYPHENYL)SULFONYLAMINO]ACETIC ACID|BDBM50006932	-	PUBCHEM	73330369	C28H26N2O10S2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	KWSIQJUNYMMCTB-UHFFFAOYSA-N
29610	115156	9817	-	KEAP1	INrf2|KLHL19	9606	Homo sapiens	unknown	target	Jiang ZY (2014)	24512214	163212	9409	2,2'-(Naphthalene-1,4-diylbis(((4-methoxyphenyl)sulfonyl)azanediyl))diacetic acid	COMPOUND 2 [PMID: 24512214]|CPUY192018|2,2'-(NAPHTHALENE-1,4-DIYLBIS(((4-METHOXYPHENYL)SULFONYL)AZANEDIYL))DIACETIC ACID|2,2'-[1,4-NAPHTHALENEDIYLBIS[(4-METHOXYPHENYLSULFONYL)IMINO]]BISACETIC ACID|BRD-K55096910-001-01-4|COMPOUND 18E [PMID: 26258437]|GTPL9710|1567836-15-0|2-[[4-[CARBOXYMETHYL-(4-METHOXYPHENYL)SULFONYLAMINO]NAPHTHALEN-1-YL]-(4-METHOXYPHENYL)SULFONYLAMINO]ACETIC ACID|BDBM50006932	-	PUBCHEM	73330369	C28H26N2O10S2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	KWSIQJUNYMMCTB-UHFFFAOYSA-N
29611	115156	9817	-	KEAP1	INrf2|KLHL19	9606	Homo sapiens	unknown	target	Jiang ZY (2014)	24512214	163212	9566	(4S)-5-[[(2S)-1-[[(2S)-1-Amino-4-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-4-[[2-[[(2S,3R)-2-[[(2S)-4-carboxy-2-[[(2S)-4-carboxy-2-[[(2S)-3-carboxy-2-[[(2S)-2-[(3',6'-dihydroxy-3-oxospiro[2-benzofuran-1,9'-xanthene]-5-yl)carbamothioylamino]-4-methylpentanoyl]amino]propanoyl]amino]butanoyl]amino]butanoyl]amino]-3-hydroxybutanoyl]amino]acetyl]amino]-5-oxopentanoic acid	BDBM50006930	-	PUBCHEM	90655040	C67H81N11O23S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WHORBCNXCLZUFL-HDFZMCSMSA-N
29931	113241	7398	-	USP1	UBP	9606	Homo sapiens	inhibitor	target	Ndubaku C (2015)	25364867	228674	9922	2-phenylbenzo[f][1,3]benzoxazole-4,9-dione	-	-	CHEMSPIDER	444479	C17H9NO3	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	CMYQQADDUUDCCA-UHFFFAOYSA-N
29975	124238	84749	-	USP30	-	9606	Homo sapiens	inhibitor	target	Yue W (2014)	24513856	228695	9846	15-Oxospiramilactone	8a,11-Ethano-6,12b-propano-9H-naphth[1,2-d]oxocin-1,9(2H)-dione, decahydro-8-hydroxy-6-methyl-10-methylene-, (6S,6aR,8R,8aR,11S,12aS,12bS)-|15-oxospiramilactone|(1S,2S,4S,7R,8R,10R,11S)-8-Hydroxy-11-methyl-5-methylene-14-oxapentacyclo[9.5.3.2~4,7~.0~1,10~.0~2,7~]henicosane-6,16-dione	-	CHEMSPIDER	65321854	C22H30O4	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	RCPPZYXWUAJXMA-KGYWYPJXSA-N
29976	113241	7398	-	USP1	UBP	9606	Homo sapiens	inhibitor	target	Chen J (2011)	22118673	211359	821	Trifluoperazine	10-[3-(4-Methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-10H-phenothiazine|10-[3-(4-METHYL-piperazin-1-yl)-propyl]-2-trifluoromethyl-10H-phenothiazine|Trifluoroperazine|Trifluoperazinum|Trifluoperazina|Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine|Trifluperazine|Trifluoperazine	pms trifluoperazine hcl syrup 	DRUGBANK	DB00831	C21H24F3N3S	small molecule	N05AB06	117-89-5	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	ZEWQUBUPAILYHI-UHFFFAOYSA-N
29978	113241	7398	-	USP1	UBP	9606	Homo sapiens	inhibitor	target	Mistry H (2013)	24130053	161617	9850	C527	c527|2-(4-Fluorophenyl)naphtho[2,3-d][1,3]oxazole-4,9-dione|Naphth[2,3-d]oxazole-4,9-dione, 2-(4-fluorophenyl)-	-	CHEMSPIDER	1725101	C17H8FNO3	small molecule	-	192718-06-2	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	ULJDFEYQOPCCPM-UHFFFAOYSA-N
29983	113241	7398	-	USP1	UBP	9606	Homo sapiens	inhibitor	target	Mistry H (2013)	24130053	161617	9916	SJB3-019A	Naphth[2,3-d]oxazole-4,9-dione, 2-(3-pyridinyl)-|2-(3-Pyridinyl)naphtho[2,3-d][1,3]oxazole-4,9-dione	-	CHEMSPIDER	44208868	C16H8N2O3	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	DOYPPVCQHGJUBC-UHFFFAOYSA-N
30067	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	degradation	target	Powell CE (2018)	29660984	228711	9756	Bivalent ligand 192	compound 9|Bivalent_ligand_192	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: compound 9 (CRBN:pomalidomide --- AURKA:TAE684)	-
30077	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	degradation	target	Powell CE (2018)	29660984	228711	9755	Bivalent ligand 193	compound 11|Bivalent_ligand_193	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: compound 11 (CRBN:pomalidomide --- AURKA:ceritinib)	-
30103	110971	4916	-	NTRK3	TRKC|gp145(trkC)	9606	Homo sapiens	degradation	target	Chen L (2020)	33058680	228712	9752	Bivalent ligand 196	CG416|Bivalent_ligand_196	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: CG416 (CRBN:pomalidomide --- NTRK3:GNF-8625)	-
30109	110971	4916	-	NTRK3	TRKC|gp145(trkC)	9606	Homo sapiens	degradation	target	Chen L (2020)	33058680	228712	9751	Bivalent ligand 197	CG428|Bivalent_ligand_197	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: CG428 (CRBN:pomalidomide --- NTRK3:GNF-8625)	-
30167	110971	4916	-	NTRK3	TRKC|gp145(trkC)	9606	Homo sapiens	degradation	target	Zhao B (2019)	31512882	228715	9820	Bivalent ligand 214	IYx96IY-pom (4)|Bivalent_ligand_214	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: IYIY-pom (4) (CRBN:pomalidomide --- NTRK3: IY-IY-TEG)	-
30183	111362	5347	-	PLK1	PLK|STPK13	9606	Homo sapiens	degradation	target	Nabet B (2018)	29581585	228717	9822	Bivalent ligand 216	dTAG-7|Bivalent_ligand_216	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: dTAG-7 (CRBN:phthalimide --- PLK1-FKBP12F36V:AP1867)	-
30185	111362	5347	-	PLK1	PLK|STPK13	9606	Homo sapiens	degradation	target	Nabet B (2018)	29581585	228717	9823	Bivalent ligand 217	dTAG-13|Bivalent_ligand_217	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: dTAG-13 (CRBN:phthalimide --- PLK1-FKBP12F36V:AP1867)	-
30398	124189	84669	-	USP32	NY-REN-60|USP10	9606	Homo sapiens	inhibitor	target	Yamanaka S (2020)	31898971	227000	9873	Subquinocin	L-Methionine, N-[[[1,2-dihydro-2-(2-methylpropyl)-1-oxo-4-isoquinolinyl]amino]carbonyl]-, methyl ester|Methyl N-[(2-isobutyl-1-oxo-1,2-dihydro-4-isoquinolinyl)carbamoyl]-L-methioninate	-	CHEMSPIDER	88297784	C20H27N3O4S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Inhibition (%) 45	MZBFFXLYQTWKNV-INIZCTEOSA-N
30532	116520	22848	RP11-427H3.3	AAK1	-	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide---AAK1:TAE684)	-
30542	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- AURKA:TAE684)	-
30544	114646	9212	-	AURKB	AIK2|AIM-1|AIM1|ARK2|AurB|IPL1|PPP1R48|STK12|STK5|aurkb-sv1|aurkb-sv2	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- AURKB:TAE684)	-
30552	107125	657	-	BMPR1A	10q23del|ACVRLK3|ALK3|CD292|SKR5	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- BMPR1A:TAE684)	-
30554	107164	699	-	BUB1	BUB1A|BUB1L|hBUB1	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- BUB1:TAE684)	-
30556	107166	701	-	BUB1B	BUB1beta|BUBR1|Bub1A|MAD3L|MVA1|SSK1|hBUBR1	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- BUB1B:TAE684)	-
30564	114176	8621	-	CDK13	CDC2L|CDC2L5|CHED|hCDK13	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- CDK13:TAE684)	-
30598	108853	2580	-	GAK	DNAJ26|DNAJC26	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- GAK:TAE684)	-
30606	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- LCK:TAE684)	-
30642	111362	5347	-	PLK1	PLK|STPK13	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- PLK1:TAE684)	-
30644	115956	10733	-	PLK4	SAK|STK18	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- PLK4:TAE684)	-
30704	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- WEE1:TAE684)	-
30708	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10009	Bivalent Ligand 265	dAURK-4|Bivalent_Ligand_265	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: dAURK-4 (CRBN:thalidomide---AURKA:Alisertib)	-
30710	114646	9212	-	AURKB	AIK2|AIM-1|AIM1|ARK2|AurB|IPL1|PPP1R48|STK12|STK5|aurkb-sv1|aurkb-sv2	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10009	Bivalent Ligand 265	dAURK-4|Bivalent_Ligand_265	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: dAURK-4 (CRBN:thalidomide--- AURKB:Alisertib)	-
30716	116520	22848	RP11-427H3.3	AAK1	-	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL12-186 (CRBN:pomalidomide---AAK1:TAE684)	-
30720	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- AURKA:TAE684)	-
30722	114646	9212	-	AURKB	AIK2|AIM-1|AIM1|ARK2|AurB|IPL1|PPP1R48|STK12|STK5|aurkb-sv1|aurkb-sv2	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- AURKB:TAE684)	-
30726	107125	657	-	BMPR1A	10q23del|ACVRLK3|ALK3|CD292|SKR5	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- BMPR1A:TAE684)	-
30728	107164	699	-	BUB1	BUB1A|BUB1L|hBUB1	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- BUB1:TAE684)	-
30730	107166	701	-	BUB1B	BUB1beta|BUBR1|Bub1A|MAD3L|MVA1|SSK1|hBUBR1	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- BUB1B:TAE684)	-
30736	114176	8621	-	CDK13	CDC2L|CDC2L5|CHED|hCDK13	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- CDK13:TAE684)	-
30766	108853	2580	-	GAK	DNAJ26|DNAJC26	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- GAK:TAE684)	-
30774	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- LCK:TAE684)	-
30802	115956	10733	-	PLK4	SAK|STK18	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- PLK4:TAE684)	-
30832	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- WEE1:TAE684)	-
30838	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- AURKA:GNF-7)	-
30842	107164	699	-	BUB1	BUB1A|BUB1L|hBUB1	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- BUB1:GNF-7)	-
30846	107421	984	-	CDK11B	CDC2L1|CDK11|CDK11-p110|CDK11-p46|CDK11-p58|CLK-1|PITSLREA|PK58|p58|p58CDC2L1|p58CLK-1	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- CDK11B:GNF-7)	-
30864	108853	2580	-	GAK	DNAJ26|DNAJC26	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- GAK:GNF-7)	-
30868	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- LCK:GNF-7)	-
30906	111362	5347	-	PLK1	PLK|STPK13	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- PLK1:GNF-7)	-
30934	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- WEE1:GNF-7)	-
30938	116520	22848	RP11-427H3.3	AAK1	-	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10006	Bivalent Ligand 268	FMF-06-098-1|Bivalent_Ligand_268	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: FMF-06-098-1 (VHL:VHL-1---AAK1:TAE)	-
30942	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10006	Bivalent Ligand 268	FMF-06-098-1|Bivalent_Ligand_268	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: FMF-06-098-1 (VHL:VHL-1--- AURKA:TAE)	-
30944	114646	9212	-	AURKB	AIK2|AIM-1|AIM1|ARK2|AurB|IPL1|PPP1R48|STK12|STK5|aurkb-sv1|aurkb-sv2	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10006	Bivalent Ligand 268	FMF-06-098-1|Bivalent_Ligand_268	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: FMF-06-098-1 (VHL:VHL-1--- AURKB:TAE)	-
30946	107166	701	-	BUB1B	BUB1beta|BUBR1|Bub1A|MAD3L|MVA1|SSK1|hBUBR1	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10006	Bivalent Ligand 268	FMF-06-098-1|Bivalent_Ligand_268	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: FMF-06-098-1 (VHL:VHL-1--- BUB1B:TAE)	-
30950	107420	983	-	CDK1	CDC2|CDC28A|P34CDC2	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10006	Bivalent Ligand 268	FMF-06-098-1|Bivalent_Ligand_268	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: FMF-06-098-1 (VHL:VHL-1--- CDK1:TAE)	-
30954	114176	8621	-	CDK13	CDC2L|CDC2L5|CHED|hCDK13	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10006	Bivalent Ligand 268	FMF-06-098-1|Bivalent_Ligand_268	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: FMF-06-098-1 (VHL:VHL-1--- CDK13:TAE)	-
30976	108853	2580	-	GAK	DNAJ26|DNAJC26	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10006	Bivalent Ligand 268	FMF-06-098-1|Bivalent_Ligand_268	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: FMF-06-098-1 (VHL:VHL-1--- GAK:TAE)	-
30998	115956	10733	-	PLK4	SAK|STK18	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10006	Bivalent Ligand 268	FMF-06-098-1|Bivalent_Ligand_268	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: FMF-06-098-1 (VHL:VHL-1--- PLK4:TAE)	-
31018	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10006	Bivalent Ligand 268	FMF-06-098-1|Bivalent_Ligand_268	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: FMF-06-098-1 (VHL:VHL-1--- WEE1:TAE)	-
31020	116520	22848	RP11-427H3.3	AAK1	-	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10005	Bivalent Ligand 269	TMX-02-174|Bivalent_Ligand_269	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TMX-02-174 (CRBN:pomalidomide---AAK1:Ceritinib)	-
31022	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10005	Bivalent Ligand 269	TMX-02-174|Bivalent_Ligand_269	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TMX-02-174 (CRBN:pomalidomide--- AURKA:Ceritinib)	-
31024	114646	9212	-	AURKB	AIK2|AIM-1|AIM1|ARK2|AurB|IPL1|PPP1R48|STK12|STK5|aurkb-sv1|aurkb-sv2	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10005	Bivalent Ligand 269	TMX-02-174|Bivalent_Ligand_269	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TMX-02-174 (CRBN:pomalidomide--- AURKB:Ceritinib)	-
31026	107420	983	-	CDK1	CDC2|CDC28A|P34CDC2	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10005	Bivalent Ligand 269	TMX-02-174|Bivalent_Ligand_269	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TMX-02-174 (CRBN:pomalidomide--- CDK1:Ceritinib)	-
31094	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10005	Bivalent Ligand 269	TMX-02-174|Bivalent_Ligand_269	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TMX-02-174 (CRBN:pomalidomide--- WEE1:Ceritinib)	-
31102	107164	699	-	BUB1	BUB1A|BUB1L|hBUB1	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10035	Bivalent Ligand 270	DB0662|Bivalent_Ligand_270	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0662 (CRBN:thalidomide--- BUB1:GNF-7)	-
31104	107421	984	-	CDK11B	CDC2L1|CDK11|CDK11-p110|CDK11-p46|CDK11-p58|CLK-1|PITSLREA|PK58|p58|p58CDC2L1|p58CLK-1	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10035	Bivalent Ligand 270	DB0662|Bivalent_Ligand_270	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0662 (CRBN:thalidomide--- CDK11B:GNF-7)	-
31116	108853	2580	-	GAK	DNAJ26|DNAJC26	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10035	Bivalent Ligand 270	DB0662|Bivalent_Ligand_270	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0662 (CRBN:thalidomide--- GAK:GNF-7)	-
31118	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10035	Bivalent Ligand 270	DB0662|Bivalent_Ligand_270	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0662 (CRBN:thalidomide--- LCK:GNF-7)	-
31162	116520	22848	RP11-427H3.3	AAK1	-	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10036	Bivalent Ligand 271	TL13-97|Bivalent_Ligand_271	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL13-97 (CRBN:pomalidomide---AAK1:Rebastinib)	-
31166	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10036	Bivalent Ligand 271	TL13-97|Bivalent_Ligand_271	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL13-97 (CRBN:pomalidomide--- AURKA:Rebastinib)	-
31168	114646	9212	-	AURKB	AIK2|AIM-1|AIM1|ARK2|AurB|IPL1|PPP1R48|STK12|STK5|aurkb-sv1|aurkb-sv2	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10036	Bivalent Ligand 271	TL13-97|Bivalent_Ligand_271	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL13-97 (CRBN:pomalidomide--- AURKB:Rebastinib)	-
31172	107166	701	-	BUB1B	BUB1beta|BUBR1|Bub1A|MAD3L|MVA1|SSK1|hBUBR1	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10036	Bivalent Ligand 271	TL13-97|Bivalent_Ligand_271	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL13-97 (CRBN:pomalidomide--- BUB1B:Rebastinib)	-
31174	114176	8621	-	CDK13	CDC2L|CDC2L5|CHED|hCDK13	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10036	Bivalent Ligand 271	TL13-97|Bivalent_Ligand_271	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL13-97 (CRBN:pomalidomide--- CDK13:Rebastinib)	-
31194	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10036	Bivalent Ligand 271	TL13-97|Bivalent_Ligand_271	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL13-97 (CRBN:pomalidomide--- LCK:Rebastinib)	-
31204	115956	10733	-	PLK4	SAK|STK18	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10036	Bivalent Ligand 271	TL13-97|Bivalent_Ligand_271	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL13-97 (CRBN:pomalidomide--- PLK4:Rebastinib)	-
31224	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10036	Bivalent Ligand 271	TL13-97|Bivalent_Ligand_271	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL13-97 (CRBN:pomalidomide--- WEE1:Rebastinib)	-
31250	108853	2580	-	GAK	DNAJ26|DNAJC26	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10033	Bivalent Ligand 272	SB1-G-187|Bivalent_Ligand_272	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SB1-G-187 (CRBN:Thalidomide--- GAK:Ponatinib)	-
31254	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10033	Bivalent Ligand 272	SB1-G-187|Bivalent_Ligand_272	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SB1-G-187 (CRBN:Thalidomide--- LCK:Ponatinib)	-
31270	111189	5163	-	PDK1	-	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10033	Bivalent Ligand 272	SB1-G-187|Bivalent_Ligand_272	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SB1-G-187 (CRBN:Thalidomide--- PDK1:Ponatinib)	-
31294	107421	984	-	CDK11B	CDC2L1|CDK11|CDK11-p110|CDK11-p46|CDK11-p58|CLK-1|PITSLREA|PK58|p58|p58CDC2L1|p58CLK-1	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10034	Bivalent Ligand 273	DB1114|Bivalent_Ligand_273	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB1114 (VHL:VHL-1--- CDK11B:GNF-7)	-
31298	116290	11113	-	CIT	CRIK|STK21	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10034	Bivalent Ligand 273	DB1114|Bivalent_Ligand_273	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB1114 (VHL:VHL-1--- CIT:GNF-7)	-
31306	108853	2580	-	GAK	DNAJ26|DNAJC26	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10034	Bivalent Ligand 273	DB1114|Bivalent_Ligand_273	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB1114 (VHL:VHL-1--- GAK:GNF-7)	-
31308	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10034	Bivalent Ligand 273	DB1114|Bivalent_Ligand_273	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB1114 (VHL:VHL-1---a LCK:GNF-7)	-
31356	107421	984	-	CDK11B	CDC2L1|CDK11|CDK11-p110|CDK11-p46|CDK11-p58|CLK-1|PITSLREA|PK58|p58|p58CDC2L1|p58CLK-1	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10039	Bivalent Ligand 274	DB1113|Bivalent_Ligand_274	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB1113 (VHL:VHL-1--- CDK11B:GNF-7)	-
31366	108853	2580	-	GAK	DNAJ26|DNAJC26	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10039	Bivalent Ligand 274	DB1113|Bivalent_Ligand_274	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB1113 (VHL:VHL-1--- GAK:GNF-7)	-
31414	116520	22848	RP11-427H3.3	AAK1	-	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10040	Bivalent Ligand 275	TMX-02-138|Bivalent_Ligand_275	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TMX-02-138 (CRBN:pomalidomide---AAK1:Ceritinib)	-
31416	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10040	Bivalent Ligand 275	TMX-02-138|Bivalent_Ligand_275	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TMX-02-138 (CRBN:pomalidomide--- AURKA:Ceritinib)	-
31418	114646	9212	-	AURKB	AIK2|AIM-1|AIM1|ARK2|AurB|IPL1|PPP1R48|STK12|STK5|aurkb-sv1|aurkb-sv2	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10040	Bivalent Ligand 275	TMX-02-138|Bivalent_Ligand_275	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TMX-02-138 (CRBN:pomalidomide--- AURKB:Ceritinib)	-
31420	107420	983	-	CDK1	CDC2|CDC28A|P34CDC2	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10040	Bivalent Ligand 275	TMX-02-138|Bivalent_Ligand_275	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TMX-02-138 (CRBN:pomalidomide--- CDK1:Ceritinib)	-
31470	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10037	Bivalent Ligand 276	MFH-5-126-1|Bivalent_Ligand_276	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: MFH-5-126-1 (CRBN:pomalidomide---AURKA:AT7519)	-
31472	107164	699	-	BUB1	BUB1A|BUB1L|hBUB1	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10037	Bivalent Ligand 276	MFH-5-126-1|Bivalent_Ligand_276	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: MFH-5-126-1 (CRBN:pomalidomide--- BUB1:AT7519)	-
31474	107166	701	-	BUB1B	BUB1beta|BUBR1|Bub1A|MAD3L|MVA1|SSK1|hBUBR1	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10037	Bivalent Ligand 276	MFH-5-126-1|Bivalent_Ligand_276	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: MFH-5-126-1 (CRBN:pomalidomide--- BUB1B:AT7519)	-
31476	114176	8621	-	CDK13	CDC2L|CDC2L5|CHED|hCDK13	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10037	Bivalent Ligand 276	MFH-5-126-1|Bivalent_Ligand_276	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: MFH-5-126-1 (CRBN:pomalidomide--- CDK13:AT7519)	-
31510	111362	5347	-	PLK1	PLK|STPK13	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10037	Bivalent Ligand 276	MFH-5-126-1|Bivalent_Ligand_276	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: MFH-5-126-1 (CRBN:pomalidomide--- PLK1:AT7519)	-
31522	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10037	Bivalent Ligand 276	MFH-5-126-1|Bivalent_Ligand_276	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: MFH-5-126-1 (CRBN:pomalidomide--- WEE1:AT7519)	-
31524	116520	22848	RP11-427H3.3	AAK1	-	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10038	Bivalent Ligand 277	RSS0680|Bivalent_Ligand_277	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: RSS0680 (VHL:VHL-1---AAK1:Thienopyrimidines)	-
31526	107420	983	-	CDK1	CDC2|CDC28A|P34CDC2	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10038	Bivalent Ligand 277	RSS0680|Bivalent_Ligand_277	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: RSS0680 (VHL:VHL-1--- CDK1:Thienopyrimidines)	-
31538	108853	2580	-	GAK	DNAJ26|DNAJC26	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10038	Bivalent Ligand 277	RSS0680|Bivalent_Ligand_277	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: RSS0680 (VHL:VHL-1--- GAK:Thienopyrimidines)	-
31568	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10038	Bivalent Ligand 277	RSS0680|Bivalent_Ligand_277	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: RSS0680 (VHL:VHL-1--- WEE1:Thienopyrimidines)	-
31570	116520	22848	RP11-427H3.3	AAK1	-	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10041	Bivalent Ligand 278	SK-3-93|Bivalent_Ligand_278	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-93 (CRBN:Thalidomide---AAK1:TAE684)	-
31574	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10041	Bivalent Ligand 278	SK-3-93|Bivalent_Ligand_278	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-93 (CRBN:Thalidomide--- AURKA:TAE684)	-
31582	114176	8621	-	CDK13	CDC2L|CDC2L5|CHED|hCDK13	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10041	Bivalent Ligand 278	SK-3-93|Bivalent_Ligand_278	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-93 (CRBN:Thalidomide--- CDK13:TAE684)	-
31600	108853	2580	-	GAK	DNAJ26|DNAJC26	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10041	Bivalent Ligand 278	SK-3-93|Bivalent_Ligand_278	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-93 (CRBN:Thalidomide--- GAK:TAE684)	-
31604	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10041	Bivalent Ligand 278	SK-3-93|Bivalent_Ligand_278	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-93 (CRBN:Thalidomide--- LCK:TAE684)	-
31616	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10041	Bivalent Ligand 278	SK-3-93|Bivalent_Ligand_278	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-93 (CRBN:Thalidomide--- WEE1:TAE684)	-
31618	116520	22848	RP11-427H3.3	AAK1	-	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10042	Bivalent Ligand 279	DB0614|Bivalent_Ligand_279	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0614 (CRBN:Thalidomide---AAK1:Thienopyrimidines)	-
31620	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10042	Bivalent Ligand 279	DB0614|Bivalent_Ligand_279	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0614 (CRBN:Thalidomide--- AURKA:Thienopyrimidines)	-
31636	108853	2580	-	GAK	DNAJ26|DNAJC26	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10042	Bivalent Ligand 279	DB0614|Bivalent_Ligand_279	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0614 (CRBN:Thalidomide--- GAK:Thienopyrimidines)	-
31638	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10042	Bivalent Ligand 279	DB0614|Bivalent_Ligand_279	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0614 (CRBN:Thalidomide--- LCK:Thienopyrimidines)	-
31650	115956	10733	-	PLK4	SAK|STK18	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10042	Bivalent Ligand 279	DB0614|Bivalent_Ligand_279	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0614 (CRBN:Thalidomide--- PLK4:Thienopyrimidines)	-
31664	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10042	Bivalent Ligand 279	DB0614|Bivalent_Ligand_279	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0614 (CRBN:Thalidomide--- WEE1:Thienopyrimidines)	-
31674	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10067	Bivalent Ligand 283	LT2-49|Bivalent_Ligand_283	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: LT2-49 (CRBN:Thalidomide--- AURKA:TAE684)	-
31676	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10067	Bivalent Ligand 283	LT2-49|Bivalent_Ligand_283	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: LT2-49 (CRBN:Thalidomide--- WEE1:TAE684)	-
31686	116520	22848	RP11-427H3.3	AAK1	-	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10067	Bivalent Ligand 283	LT2-49|Bivalent_Ligand_283	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: LT2-49 (CRBN:Thalidomide--- AAK1:TAE684)	-
31696	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10067	Bivalent Ligand 283	LT2-49|Bivalent_Ligand_283	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: LT2-49 (CRBN:Thalidomide--- LCK:TAE684)	-
31704	114176	8621	-	CDK13	CDC2L|CDC2L5|CHED|hCDK13	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10067	Bivalent Ligand 283	LT2-49|Bivalent_Ligand_283	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: LT2-49 (CRBN:Thalidomide--- CDK13:TAE684)	-
31714	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10066	Bivalent Ligand 284	DD-03-106|Bivalent_Ligand_284	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DD-03-106 (CRBN:pomalidomide---AURKA:Dabrafenib)	-
31718	107420	983	-	CDK1	CDC2|CDC28A|P34CDC2	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10066	Bivalent Ligand 284	DD-03-106|Bivalent_Ligand_284	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DD-03-106 (CRBN:pomalidomide--- CDK1:Dabrafenib)	-
31748	111362	5347	-	PLK1	PLK|STPK13	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10066	Bivalent Ligand 284	DD-03-106|Bivalent_Ligand_284	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DD-03-106 (CRBN:pomalidomide--- PLK1:Dabrafenib)	-
31750	111189	5163	-	PDK1	-	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10066	Bivalent Ligand 284	DD-03-106|Bivalent_Ligand_284	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DD-03-106 (CRBN:pomalidomide--- PDK1:Dabrafenib)	-
31760	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10065	Bivalent Ligand 285	SB1-G-192-1|Bivalent_Ligand_285	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SB1-G-192-1 (CRBN:Thalidomide--- AURKA:PP58 (kinobeads) 212391-57-6)	-
31772	108853	2580	-	GAK	DNAJ26|DNAJC26	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10065	Bivalent Ligand 285	SB1-G-192-1|Bivalent_Ligand_285	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SB1-G-192-1 (CRBN:Thalidomide--- GAK:PP58 (kinobeads) 212391-57-6)	-
31774	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10065	Bivalent Ligand 285	SB1-G-192-1|Bivalent_Ligand_285	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SB1-G-192-1 (CRBN:Thalidomide--- LCK:PP58 (kinobeads) 212391-57-6)	-
31782	111189	5163	-	PDK1	-	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10065	Bivalent Ligand 285	SB1-G-192-1|Bivalent_Ligand_285	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SB1-G-192-1 (CRBN:Thalidomide--- PDK1:PP58 (kinobeads) 212391-57-6)	-
31792	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10065	Bivalent Ligand 285	SB1-G-192-1|Bivalent_Ligand_285	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SB1-G-192-1 (CRBN:Thalidomide--- WEE1:PP58 (kinobeads) 212391-57-6)	-
31796	116520	22848	RP11-427H3.3	AAK1	-	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10064	Bivalent Ligand 286	SK-3-89|Bivalent_Ligand_286	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-89 (CRBN:Thalidomide---AAK1:TAE684)	-
31798	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10064	Bivalent Ligand 286	SK-3-89|Bivalent_Ligand_286	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-89 (CRBN:Thalidomide--- AURKA:TAE684)	-
31822	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10064	Bivalent Ligand 286	SK-3-89|Bivalent_Ligand_286	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-89 (CRBN:Thalidomide--- LCK:TAE684)	-
31830	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10064	Bivalent Ligand 286	SK-3-89|Bivalent_Ligand_286	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-89 (CRBN:Thalidomide--- WEE1:TAE684)	-
31840	108853	2580	-	GAK	DNAJ26|DNAJC26	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10063	Bivalent Ligand 287	DB0663|Bivalent_Ligand_287	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0663 (CRBN:Thalidomide--- GAK:GNF-7)	-
31846	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10063	Bivalent Ligand 287	DB0663|Bivalent_Ligand_287	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0663 (CRBN:Thalidomide--- LCK:GNF-7)	-
31876	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10062	Bivalent Ligand 288	DB0661|Bivalent_Ligand_288	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0661 (CRBN:Thalidomide--- LCK:GNF-7)	-
31886	111362	5347	-	PLK1	PLK|STPK13	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10062	Bivalent Ligand 288	DB0661|Bivalent_Ligand_288	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0661 (CRBN:Thalidomide--- PLK1:GNF-7)	-
31900	116520	22848	RP11-427H3.3	AAK1	-	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10061	Bivalent Ligand 289	BSJ-04-178|Bivalent_Ligand_289	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: BSJ-04-178 (CRBN:Thalidomide---AAK1:MRT68921)	-
31902	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10061	Bivalent Ligand 289	BSJ-04-178|Bivalent_Ligand_289	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: BSJ-04-178 (CRBN:Thalidomide--- AURKA:MRT68921)	-
31904	114646	9212	-	AURKB	AIK2|AIM-1|AIM1|ARK2|AurB|IPL1|PPP1R48|STK12|STK5|aurkb-sv1|aurkb-sv2	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10061	Bivalent Ligand 289	BSJ-04-178|Bivalent_Ligand_289	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: BSJ-04-178 (CRBN:Thalidomide--- AURKB:MRT68921)	-
31912	108853	2580	-	GAK	DNAJ26|DNAJC26	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10061	Bivalent Ligand 289	BSJ-04-178|Bivalent_Ligand_289	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: BSJ-04-178 (CRBN:Thalidomide--- GAK:MRT68921)	-
31930	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10061	Bivalent Ligand 289	BSJ-04-178|Bivalent_Ligand_289	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: BSJ-04-178 (CRBN:Thalidomide--- WEE1:MRT68921)	-
31932	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10089	Bivalent Ligand 290	TMX-01-160-1|Bivalent_Ligand_290	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TMX-01-160-1 (CRBN:Thalidomide---AURKA:Ceritinib)	-
31934	107420	983	-	CDK1	CDC2|CDC28A|P34CDC2	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10089	Bivalent Ligand 290	TMX-01-160-1|Bivalent_Ligand_290	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TMX-01-160-1 (CRBN:Thalidomide--- CDK1:Ceritinib)	-
31962	116520	22848	RP11-427H3.3	AAK1	-	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10090	Bivalent Ligand 291	SK-3-87|Bivalent_Ligand_291	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-87 (CRBN:pomalidomide---AAK1:TAE684)	-
31964	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10090	Bivalent Ligand 291	SK-3-87|Bivalent_Ligand_291	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-87 (CRBN:pomalidomide--- AURKA:TAE684)	-
31984	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10090	Bivalent Ligand 291	SK-3-87|Bivalent_Ligand_291	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-87 (CRBN:pomalidomide--- LCK:TAE684)	-
31990	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10090	Bivalent Ligand 291	SK-3-87|Bivalent_Ligand_291	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-87 (CRBN:pomalidomide--- WEE1:TAE684)	-
31994	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10091	Bivalent Ligand 292	MFH-5-115-2|Bivalent_Ligand_292	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: MFH-5-115-2 (CRBN:pomalidomide--- WEE1:Dinaciclib)	-
31998	111362	5347	-	PLK1	PLK|STPK13	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10091	Bivalent Ligand 292	MFH-5-115-2|Bivalent_Ligand_292	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: MFH-5-115-2 (CRBN:pomalidomide--- PLK1:Dinaciclib)	-
32000	107164	699	-	BUB1	BUB1A|BUB1L|hBUB1	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10091	Bivalent Ligand 292	MFH-5-115-2|Bivalent_Ligand_292	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: MFH-5-115-2 (CRBN:pomalidomide--- BUB1:Dinaciclib)	-
32008	107166	701	-	BUB1B	BUB1beta|BUBR1|Bub1A|MAD3L|MVA1|SSK1|hBUBR1	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10091	Bivalent Ligand 292	MFH-5-115-2|Bivalent_Ligand_292	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: MFH-5-115-2 (CRBN:pomalidomide--- BUB1B:Dinaciclib)	-
32018	116520	22848	RP11-427H3.3	AAK1	-	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10092	Bivalent Ligand 293	BJG-04-203|Bivalent_Ligand_293	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: BJG-04-203 (VHL:pomalidomide---AAK1:APY-24)	-
32020	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10092	Bivalent Ligand 293	BJG-04-203|Bivalent_Ligand_293	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: BJG-04-203 (VHL:pomalidomide--- AURKA:APY-24)	-
32022	114646	9212	-	AURKB	AIK2|AIM-1|AIM1|ARK2|AurB|IPL1|PPP1R48|STK12|STK5|aurkb-sv1|aurkb-sv2	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10092	Bivalent Ligand 293	BJG-04-203|Bivalent_Ligand_293	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: BJG-04-203 (VHL:pomalidomide--- AURKB:APY-24)	-
32042	115956	10733	-	PLK4	SAK|STK18	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10092	Bivalent Ligand 293	BJG-04-203|Bivalent_Ligand_293	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: BJG-04-203 (VHL:pomalidomide--- PLK4:APY-24)	-
32078	116520	22848	RP11-427H3.3	AAK1	-	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10086	Bivalent Ligand 295	RSS0628|Bivalent_Ligand_295	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: RSS0628 (CRBN:Thalidomide---AAK1:Thienopyrimidines)	-
32080	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10086	Bivalent Ligand 295	RSS0628|Bivalent_Ligand_295	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: RSS0628 (CRBN:Thalidomide--- AURKA:Thienopyrimidines)	-
32102	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10086	Bivalent Ligand 295	RSS0628|Bivalent_Ligand_295	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: RSS0628 (CRBN:Thalidomide--- WEE1:Thienopyrimidines)	-
32104	116520	22848	RP11-427H3.3	AAK1	-	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10087	Bivalent Ligand 296	BSJ-05-026|Bivalent_Ligand_296	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: BSJ-05-026 (VHL:VHL-1---AAK1:MRT68921)	-
32106	108853	2580	-	GAK	DNAJ26|DNAJC26	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10087	Bivalent Ligand 296	BSJ-05-026|Bivalent_Ligand_296	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: BSJ-05-026 (VHL:VHL-1--- GAK:MRT68921)	-
32128	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10087	Bivalent Ligand 296	BSJ-05-026|Bivalent_Ligand_296	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: BSJ-05-026 (VHL:VHL-1--- WEE1:MRT68921)	-
32130	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10088	Bivalent Ligand 297	TMX-02-172|Bivalent_Ligand_297	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TMX-02-172 (CRBN:pomalidomide---AURKA:Ceritinib)	-
32132	114646	9212	-	AURKB	AIK2|AIM-1|AIM1|ARK2|AurB|IPL1|PPP1R48|STK12|STK5|aurkb-sv1|aurkb-sv2	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10088	Bivalent Ligand 297	TMX-02-172|Bivalent_Ligand_297	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TMX-02-172 (CRBN:pomalidomide--- AURKB:Ceritinib)	-
32134	107420	983	-	CDK1	CDC2|CDC28A|P34CDC2	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10088	Bivalent Ligand 297	TMX-02-172|Bivalent_Ligand_297	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TMX-02-172 (CRBN:pomalidomide--- CDK1:Ceritinib)	-
32158	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10083	Bivalent Ligand 298	SB1-G-181|Bivalent_Ligand_298	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SB1-G-181 (CRBN:pomalidomide--- AURKA:TX1-85-1)	-
32170	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10083	Bivalent Ligand 298	SB1-G-181|Bivalent_Ligand_298	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SB1-G-181 (CRBN:pomalidomide--- LCK:TX1-85-1)	-
32178	116520	22848	RP11-427H3.3	AAK1	-	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10084	Bivalent Ligand 299	JWG-123|Bivalent_Ligand_299	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: JWG-123 (VHL:VHL-1---AAK1:TG101209)	-
32182	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10084	Bivalent Ligand 299	JWG-123|Bivalent_Ligand_299	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: JWG-123 (VHL:VHL-1--- WEE1:TG101209)	-
32184	108853	2580	-	GAK	DNAJ26|DNAJC26	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10084	Bivalent Ligand 299	JWG-123|Bivalent_Ligand_299	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: JWG-123 (VHL:VHL-1--- GAK:TG101209)	-
32216	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10021	Bivalent Ligand 300	SB1-G-200|Bivalent_Ligand_300	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SB1-G-200 (CRBN:Thalidomide--- LCK:TX1-85-1)	-
32230	108853	2580	-	GAK	DNAJ26|DNAJC26	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10022	Bivalent Ligand 301	TL13-150|Bivalent_Ligand_301	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL13-150 (CRBN:pomalidomide--- GAK:Quizartinib)	-
32234	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10022	Bivalent Ligand 301	TL13-150|Bivalent_Ligand_301	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL13-150 (CRBN:pomalidomide--- LCK:Quizartinib)	-
32268	111189	5163	-	PDK1	-	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10020	Bivalent Ligand 303	ZNL-02-096|Bivalent_Ligand_303	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: ZNL-02-096 (CRBN:pomalidomide--- PDK1:Adavosertib)	-
32278	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10020	Bivalent Ligand 303	ZNL-02-096|Bivalent_Ligand_303	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: ZNL-02-096 (CRBN:pomalidomide--- WEE1:Adavosertib)	-
32282	107164	699	-	BUB1	BUB1A|BUB1L|hBUB1	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10017	Bivalent Ligand 304	DB118430|Bivalent_Ligand_304	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB118430 (IAP:LCL161 derivative--- BUB1:GNF-7)	-
32298	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10018	Bivalent Ligand 305	MFH-5-103-1|Bivalent_Ligand_305	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: MFH-5-103-1 (CRBN:pomalidomide---AURKA:PND-1186)	-
32314	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10018	Bivalent Ligand 305	MFH-5-103-1|Bivalent_Ligand_305	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: MFH-5-103-1 (CRBN:pomalidomide--- WEE1:PND-1186)	-
32324	111189	5163	-	PDK1	-	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	8516	Bivalent ligand 76	protac 6|BSJ-03-123|Bivalent_ligand_76	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: BSJ-03-123 (CRBN:pomalidomide--- PDK1:Palbociclib)	-
32330	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	8516	Bivalent ligand 76	protac 6|BSJ-03-123|Bivalent_ligand_76	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: BSJ-03-123 (CRBN:pomalidomide--- WEE1:Palbociclib)	-
32332	116520	22848	RP11-427H3.3	AAK1	-	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10015	Bivalent Ligand 306	SB1-G-194|Bivalent_Ligand_306	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SB1-G-194 (CRBN:Thalidomide---AAK1:kinobeads)	-
32334	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10015	Bivalent Ligand 306	SB1-G-194|Bivalent_Ligand_306	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SB1-G-194 (CRBN:Thalidomide--- AURKA:kinobeads)	-
32336	114646	9212	-	AURKB	AIK2|AIM-1|AIM1|ARK2|AurB|IPL1|PPP1R48|STK12|STK5|aurkb-sv1|aurkb-sv2	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10015	Bivalent Ligand 306	SB1-G-194|Bivalent_Ligand_306	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SB1-G-194 (CRBN:Thalidomide--- AURKB:kinobeads)	-
32342	108554	2263	-	FGFR2	BBDS|BEK|BFR-1|CD332|CEK3|CFD1|ECT1|JWS|K-SAM|KGFR|TK14|TK25	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10015	Bivalent Ligand 306	SB1-G-194|Bivalent_Ligand_306	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SB1-G-194 (CRBN:Thalidomide--- FGR2:kinobeads)	-
32362	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10013	Bivalent Ligand 308	MFH-5-116-1|Bivalent_Ligand_308	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: MFH-5-116-1 (CRBN:pomalidomide---AURKA:PND-1186)	-
32374	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10013	Bivalent Ligand 308	MFH-5-116-1|Bivalent_Ligand_308	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: MFH-5-116-1 (CRBN:pomalidomide--- WEE1:PND-1186)	-
32384	111189	5163	-	PDK1	-	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10014	Bivalent Ligand 309	BSJ-04-132|Bivalent_Ligand_309	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: BSJ-04-132 (CRBN:Thalidomide--- PDK1:Ribociclib)	-
32398	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	9990	Bivalent Ligand 310	DD-03-119|Bivalent_Ligand_310	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DD-03-119 (CRBN:pomalidomide--- LCK:Ibrutinib)	-
32408	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	9989	Bivalent Ligand 311	dRAF-3|Bivalent_Ligand_311	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: dRAF-3 (CRBN:Thalidomide--- LCK:Vemurafenib)	-
32450	111189	5163	-	PDK1	-	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	9993	Bivalent Ligand 315	DD-03-107|Bivalent_Ligand_315	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DD-03-107 (CRBN:lenalidomide--- PDK1:Dabrafenib)	-
32464	116520	22848	RP11-427H3.3	AAK1	-	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	9995	Bivalent Ligand 317	JWG-118|Bivalent_Ligand_317	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: JWG-118 (CRBN:Thalidomide---AAK1:TG101209)	-
32466	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	9995	Bivalent Ligand 317	JWG-118|Bivalent_Ligand_317	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: JWG-118 (CRBN:Thalidomide--- AURKA:TG101209)	-
32470	108853	2580	-	GAK	DNAJ26|DNAJC26	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	9995	Bivalent Ligand 317	JWG-118|Bivalent_Ligand_317	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: JWG-118 (CRBN:Thalidomide--- GAK:TG101209)	-
32472	116520	22848	RP11-427H3.3	AAK1	-	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	9987	Bivalent Ligand 318	SB1-G-190|Bivalent_Ligand_318	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SB1-G-190 (CRBN:Thalidomide---AAK1:APY-24)	-
32474	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	9987	Bivalent Ligand 318	SB1-G-190|Bivalent_Ligand_318	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SB1-G-190 (CRBN:Thalidomide--- AURKA:APY-24)	-
32484	111189	5163	-	PDK1	-	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	9986	Bivalent Ligand 319	BSJ-03-204|Bivalent_Ligand_319	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: BSJ-03-204 (CRBN:Thalidomide--- PDK1:Palbociclib)	-
32486	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	9986	Bivalent Ligand 319	BSJ-03-204|Bivalent_Ligand_319	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: BSJ-03-204 (CRBN:Thalidomide--- WEE1:Palbociclib)	-
32494	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10138	Bivalent Ligand 320	DB-3-291|Bivalent_Ligand_320	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB-3-291 (CRBN:thalidomide--- WEE1:dasatinib)	-
32514	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10141	Bivalent Ligand 323	BSJ-01-147|Bivalent_Ligand_323	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: BSJ-01-147 (CRBN:pomalidomide--- WEE1:Palbociclib)	-
32516	111189	5163	-	PDK1	-	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10134	Bivalent Ligand 324	INY-01-140-1|Bivalent_Ligand_324	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: INY-01-140-1 (CRBN:Thalidomide---PDK1:MK-2206)	-
32522	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10135	Bivalent Ligand 325	TL13-12|Bivalent_Ligand_325	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL13-12 (CRBN:pomalidomide---AURKA:TAE684)	-
32528	116520	22848	RP11-427H3.3	AAK1	-	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10136	Bivalent Ligand 326	JWG-120|Bivalent_Ligand_326	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: JWG-120 (CRBN:Thalidomide---AAK1:not specified)	-
32530	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10136	Bivalent Ligand 326	JWG-120|Bivalent_Ligand_326	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: JWG-120 (CRBN:Thalidomide--- AURKA:not specified)	-
32536	116520	22848	RP11-427H3.3	AAK1	-	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10142	Bivalent Ligand 328	JWG-122|Bivalent_Ligand_328	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: JWG-122 (VHL:VHL-1---AAK1:TG101209)	-
32538	108853	2580	-	GAK	DNAJ26|DNAJC26	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10142	Bivalent Ligand 328	JWG-122|Bivalent_Ligand_328	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: JWG-122 (VHL:VHL-1--- GAK:TG101209)	-
32554	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10116	Bivalent Ligand 331	YKL-06-102|Bivalent_Ligand_331	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: YKL-06-102 (CRBN:pomalidomide---WEE1:Palbociclib)	-
32558	117017	23451	-	SF3B1	Hsh155|MDS|PRP10|PRPF10|SAP155|SF3b155	9606	Homo sapiens	degradation	target	Gama-Brambila RA (2021)	34048672	232264	10114	Bivalent Ligand 333	Bivalent_Ligand_333	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: PROTAC-O4I2 (CRBN:Thalidomide---SF3B1:O4I2)	-
32582	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	degradation	target	Zhang C (2021)	34927316	232727	10096	Bivalent Ligand 342	SPNCOX|Bivalent_Ligand_342	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	nano-PROTAC	A nano-particle containing a Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety, which is activatable in the presence of a specific stimulus; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SPNCOX (VHL:GSGSALAPYIP---PTGS2:indomethacin)	-
32710	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	degradation	target	Adhikari B (2020)	32989298	235317	10007	Bivalent Ligand 380	compound 8|Bivalent_Ligand_380	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: JB158 (CRBN:thalidomide---AURKA:alisertib)	-
32712	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	degradation	target	Adhikari B (2020)	32989298	235317	10008	Bivalent Ligand 381	JB170|Bivalent_Ligand_381	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: JB170 (CRBN:thalidomide---AURKA:alisertib)	-
32718	107420	983	-	CDK1	CDC2|CDC28A|P34CDC2	9606	Homo sapiens	degradation	target	Riching KM (2021)	33190579	235709	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- CDK1:TL13-87)	-
32740	114176	8621	-	CDK13	CDC2L|CDC2L5|CHED|hCDK13	9606	Homo sapiens	degradation	target	Riching KM (2021)	33190579	235709	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- CDK13:TL13-87)	-
32771	115156	9817	-	KEAP1	INrf2|KLHL19	9606	Homo sapiens	degradation	recruited e3 ligase	Wei J (2021)	34520194	236464	10082	Bivalent ligand 389	MS83|Bivalent_ligand_389	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: MS83 (KEAP1:KEAP1-L --- BRD4:unspecified)	-
32773	115156	9817	-	KEAP1	INrf2|KLHL19	9606	Homo sapiens	degradation	recruited e3 ligase	Wei J (2021)	34520194	236464	10082	Bivalent ligand 389	MS83|Bivalent_ligand_389	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113715	8019	RP11-374P20.3	BRD3	ORFX|RING3L	9606	Homo sapiens	target	Standardized BVL Name: MS83 (KEAP1:KEAP1-L --- BRD3:unspecified)	-
33015	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	deubiquitination	target	Henning NJ (2022)	35210618	236326	10358	Bivalent ligand 470	LEB-03-144|Bivalent_ligand_470	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	DUBTAC	Deubiquitinase-targeting chimera; structured as DUB binding moiety--linker--target binding moiety; target deubiquitinated via recruited deubiquitinase (DUB)	120751	55611	HSPC263	OTUB1	OTB1|OTU1	9606	Homo sapiens	recruited deubiquitinase	Standardized BVL Name: LEB-03-144 (OTUB1:EN523 --- WEE1:AZD1775)	-
33017	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	deubiquitination	target	Henning NJ (2022)	35210618	236326	10375	Bivalent ligand 471	LEB-03-146|Bivalent_ligand_471	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	DUBTAC	Deubiquitinase-targeting chimera; structured as DUB binding moiety--linker--target binding moiety; target deubiquitinated via recruited deubiquitinase (DUB)	120751	55611	HSPC263	OTUB1	OTB1|OTU1	9606	Homo sapiens	recruited deubiquitinase	Standardized BVL Name: LEB-03-146 (OTUB1:EN523 --- WEE1:AZD1775)	-
33045	108202	1870	-	E2F2	E2F-2	9606	Homo sapiens	degradation	target	Liu TT (2022)	36375317	244515	10412	Bivalent ligand 482	bufalin|Bivalent_ligand_482	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	123322	80829	FKSG11	ZFP91	DMS-8|DSM-8|PZF|ZFP-91|ZNF757	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: bufalin (ZFP91:bufalin---E2F2:bufalin)	-
33062	112615	6737	-	TRIM21	RNF81|RO52|Ro/SSA|SSA|SSA1	9606	Homo sapiens	antiviral	recruited e3 ligase	Chatterjee P (2020)	33230174	239810	10425	Bivalent ligand 491	23-mer|Bivalent_ligand_491	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	bioPROTAC	Engineered intracellular proteins consisting of a target-binding domain directly fused to an E3 ubiquitin ligase; NOTE: the format for this BVL name is (E3:GFP binding scaffold fusion --- Target:GFP fusion)	4383848	43740568	GU280_gp02	S	spike|SARS-CoV2 S|SARS-CoV2 spike|S protein|surface|SARS-CoV-2 spike|SARS-CoV-2 S|SPIKE_SARS2|PRO_0000449646	2697049	Severe acute respiratory syndrome coronavirus 2	target	The authors fused the RBD-binding proteins to the CHIPTPR modified E3 ubiquitin ligase domain to prevent circumvent the need to express Trim21 in trans|Standardized BVL Name: 23-mer (A2N)-CHIPTPR (TRIM21:NA --- S RBD domain: sACE2 derived 23-mer (A2N) peptide; Coronavirus Project; Target UniProt ID PRO_0000449646 (S))	-
33066	112615	6737	-	TRIM21	RNF81|RO52|Ro/SSA|SSA|SSA1	9606	Homo sapiens	degradation 	recruited e3 ligase	Fletcher A (2023)	37925433	246254	10427	Bivalent ligand 493	T21RBCC-VHHHuR|Bivalent_ligand_493	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	bioPROTAC	Engineered intracellular proteins consisting of a target-binding domain directly fused to an E3 ubiquitin ligase; NOTE: the format for this BVL name is (E3:GFP binding scaffold fusion --- Target:GFP fusion)	108309	1994	-	ELAVL1	ELAV1|HUR|Hua|MelG	9606	Homo sapiens	target	Standardized BVL Name: T21RBCC-VHHHuR (TRIM21:NA--- ELAVL1:VHH ab)	-
33174	116520	22848	RP11-427H3.3	AAK1	-	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Cantini F (2020)	32333918	239617	9958	Baricitinib	3-Azetidineacetonitrile, 1-(ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-|Baricitinib|INCB028050|LY3009104|{1-(ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]azetidin-3-yl}ethanenitrile|{1-(Ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-3-azetidinyl}acetonitrile|Olumiant	-	CHEMSPIDER	26373084	C16H17N7O2S	small molecule	-	1187594-09-7	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: AP2 Associated kinase inhibitor	XUZMWHLSFXCVMG-UHFFFAOYSA-N
33614	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	degradation	target	Aublette MC (2022)	35231578	254243	10776	Bivalent ligand 547	MA055|bivalent_ligand_547	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: MA055 (VHL:VH032 --- Wee1:AZD1775)	-
33616	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	degradation	target	Aublette MC (2022)	35231578	254243	10777	Bivalent ligand 548	MA071|bivalent_ligand_548	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: MA071 (CRBN:pomalidomide --- Wee1:AZD1775)	-
33640	115723	10460	-	TACC3	ERIC-1|ERIC1	9606	Homo sapiens	degradation	target	Shibata N (2022)	35085722	254450	10788	Bivalent ligand 559	Compound 5a/SNIPER(TACC3)-11|bivalent_ligand_559	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	SNIPER	Specific and Non-genetic Inhibitor-of-apoptosis proteins (IAPs)-dependent Protein Eraser; structured as IAP ligand--linker--target binding moiety; target degraded via UPS	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: Compound 5a/SNIPER(TACC3)-11 (cIAP1:LCL161 derivative Compound 11 --- FGFR3-TACC3:KHS108)	-
33862	115156	9817	-	KEAP1	INrf2|KLHL19	9606	Homo sapiens	degradation	target	Park SY (2023)	37348157	254854	10879	Bivalent ligand 658	SD2267|bivalent_ligand_658	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SD2267 (CRBN:pomalidomide --- KEAP1:Compound 8)	-
33920	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	degradation	target	Liu F (2022)	35652200	256647	10906	Bivalent ligand 685	dAurA383|bivalent_ligand_685	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: dAurA383 (CRBN:thalidomide --- AURKA:MLN8237)	-
33922	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	degradation	target	Liu F (2022)	35652200	256647	10907	Bivalent ligand 686	dAurA425|bivalent_ligand_686	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: dAurA425 (VHL:VH032 --- AURKA:MLN8237)	-
33924	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	degradation	target	Liu F (2022)	35652200	256647	10908	Bivalent ligand 687	dAurA450|bivalent_ligand_687	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: dAurA450 (cIAP1:cIAP1 ligand --- AURKA:MLN8237)	-
33936	115156	9817	-	KEAP1	INrf2|KLHL19	9606	Homo sapiens	degradation	target	Chen H (2023)	36473314	256651	10914	Bivalent ligand 693	PROTAC 14|bivalent_ligand_693	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: PROTAC 14 (CRBN:thalidomide --- KEAP1:inhibitor 2)	-
33946	108554	2263	-	FGFR2	BBDS|BEK|BFR-1|CD332|CEK3|CFD1|ECT1|JWS|K-SAM|KGFR|TK14|TK25	9606	Homo sapiens	degradation	target	Du G (2021)	33915015	255461	10918	Bivalent ligand 697	DGY-09-192|bivalent_ligand_697	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DGY-09-192 (VHL:VHL ligand --- FGFR2:BGJ398)	-
34082	116593	22933	-	SIRT2	SIR2|SIR2L|SIR2L2	9606	Homo sapiens	degradation	target	Hong JY (2020)	33214845	256667	10969	Bivalent ligand 748	TM-P2-Thal|bivalent_ligand_748	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TM-P2-Thal (CRBN:thalidomide --- SIRT2: TM)	-
34084	116593	22933	-	SIRT2	SIR2|SIR2L|SIR2L2	9606	Homo sapiens	degradation	target	Hong JY (2020)	33214845	256667	10970	Bivalent ligand 749	TM-P4-Thal|bivalent_ligand_749	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TM-P4-Thal (CRBN:thalidomide --- SIRT2: TM)	-
34124	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	degradation	target	Kim Y (2023)	37567174	256416	10978	Bivalent ligand 757	KYH1872/Compound 26|bivalent_ligand_757	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117123	23588	-	KLHDC2	HCLP-1|HCLP1|LCP	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: KYH1872 (KLHDC2:SelK peptide --- WEE1:YHJ1039)	-
34130	115956	10733	-	PLK4	SAK|STK18	9606	Homo sapiens	degradation	target	Sun Y (2023)	37279162	256430	10981	Bivalent ligand 760	SP27|bivalent_ligand_760	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SP27 (CRBN:thalidomide --- PLK4:CZS-035)	-
34146	108554	2263	-	FGFR2	BBDS|BEK|BFR-1|CD332|CEK3|CFD1|ECT1|JWS|K-SAM|KGFR|TK14|TK25	9606	Homo sapiens	degradation	target	Ma L (2023)	37220310	256439	10987	Bivalent ligand 766	LC-MB12|bivalent_ligand_766	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: LC-MB12 (CRBN:thalidomide --- FGFR2 :infigratinib)	-
34150	116520	22848	RP11-427H3.3	AAK1	-	9606	Homo sapiens	degradation	target	Zhang Y (2023)	37196766	256442	10989	Bivalent ligand 768	SIAIS352008|bivalent_ligand_768	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SIAIS352008 (CRBN:lenalidomide --- AAK1:brigatinib)	-
34152	108853	2580	-	GAK	DNAJ26|DNAJC26	9606	Homo sapiens	degradation	target	Zhang Y (2023)	37196766	256442	10989	Bivalent ligand 768	SIAIS352008|bivalent_ligand_768	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SIAIS352008 (CRBN:lenalidomide --- GAK:brigatinib)	-
34156	116520	22848	RP11-427H3.3	AAK1	-	9606	Homo sapiens	degradation	target	Zhang Y (2023)	37196766	256442	10990	Bivalent ligand 769	SIAIS262039|bivalent_ligand_769	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SIAIS262039 (CRBN:lenalidomide --- AAK1:brigatinib)	-
34158	108853	2580	-	GAK	DNAJ26|DNAJC26	9606	Homo sapiens	degradation	target	Zhang Y (2023)	37196766	256442	10990	Bivalent ligand 769	SIAIS262039|bivalent_ligand_769	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SIAIS262039 (CRBN:lenalidomide --- GAK:brigatinib)	-
34204	116593	22933	-	SIRT2	SIR2|SIR2L|SIR2L2	9606	Homo sapiens	degradation	target	Sharma C (2023)	37063743	256456	11010	Bivalent ligand 789	PRO-SIRT2|bivalent_ligand_789	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: PRO-SIRT2 (CRBN:thalidomide --- SIRT2:Probe 3A)	-
34248	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	degradation	target	Jarusiewicz JA (2023)	36793425	256510	11027	Bivalent ligand 805	SJ34739/PD-PROTAC 2|bivalent_ligand_805	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SJ34739/PD-PROTAC 2 (CRBN:phenyl dihydrouracil (PD) --- LCK:dasatinib)	-
34250	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	degradation	target	Jarusiewicz JA (2023)	36793425	256510	11028	Bivalent ligand 806	SJ42176/thal-PROTAC 3|bivalent_ligand_806	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SJ42176/thal-PROTAC 3 (CRBN:thalidamide) --- LCK:dasatinib)	-
34252	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	degradation	target	Jarusiewicz JA (2023)	36793425	256510	11029	Bivalent ligand 807	SJ34769/PG-PROTAC 4|bivalent_ligand_807	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SJ34769/PG-PROTAC 4 (CRBN:phenyl glutarimide (PG) --- LCK:dasatinib)	-
34254	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	degradation	target	Jarusiewicz JA (2023)	36793425	256510	11030	Bivalent ligand 808	SJ43489/PD-PROTAC 5|bivalent_ligand_808	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SJ43489/PD-PROTAC 5 (CRBN:phenyl dihydrouracil (PD) --- LCK:dasatinib)	-
34256	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	degradation	target	Hu J (2022)	36001679	256518	11031	Bivalent ligand 809	SJ11646|bivalent_ligand_809	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SJ11646 (CRBN:phenyl glutarimide (PG) --- LCK:dasatinib)	-
34263	115156	9817	-	KEAP1	INrf2|KLHL19	9606	Homo sapiens	degradation	recruited e3 ligase	Pei J (2023)	36750097	256521	11033	Bivalent ligand 811	Conjugate 955|bivalent_ligand_811	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107459	1025	RP11-228B15.5	CDK9	C-2k|CDC2L4|CTK1|PITALRE|TAK	9606	Homo sapiens	target	Standardized BVL Name: Conjugate 955 (KEAP1:piperlongumine (PL) --- CDK9:SNS-032)	-
34265	115156	9817	-	KEAP1	INrf2|KLHL19	9606	Homo sapiens	degradation	recruited e3 ligase	Pei J (2023)	36750097	256521	11033	Bivalent ligand 811	Conjugate 955|bivalent_ligand_811	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114128	8558	-	CDK10	PISSLRE	9606	Homo sapiens	target	Standardized BVL Name: Conjugate 955 (KEAP1:piperlongumine (PL) --- CDK10:SNS-032)	-
34267	115156	9817	-	KEAP1	INrf2|KLHL19	9606	Homo sapiens	degradation	recruited e3 ligase	Pei J (2023)	36750097	256521	11034	Bivalent ligand 812	Conjugate 819|bivalent_ligand_812	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106739	238	-	ALK	CD246|NBLST3	9606	Homo sapiens	target	Standardized BVL Name: Conjugate 819 (KEAP1:piperlongumine (PL) --- EML4-ALK:ceritinib)	-
